assays_ss_cll_tp,assays_ss_tst_tp,assays_vrnt_d,assays_cll_d,assays_crtd_b,assays_b_frmt,assays_ss_d,assays_cnfdnc_scr,assays_ss_tx_d,assays_rltnshp_tp,assays_ss_ctgr,assays_src_ss_d,assays_dc_d,assays_chmbl_d,assays_ss_strn,assays_dscrptn,assays_ss_tss,assays_ss_tp,assays_td,assays_src_d,assays_ss_sbclllr_frctn,assays_tss_d,assays_ss_rgnsm
,In vivo,,,Intermediate,BAO_0000218,7524,1,10116.0,N,,,9866,CHEMBL618647,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7525,1,10116.0,N,,,9866,CHEMBL618648,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7526,1,10116.0,N,,,9866,CHEMBL618649,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7527,1,10116.0,N,,,9866,CHEMBL618650,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7528,1,10116.0,N,,,9866,CHEMBL618651,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7529,1,10116.0,N,,,9866,CHEMBL876497,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7530,1,10116.0,N,,,9866,CHEMBL618652,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7531,1,10116.0,N,,,9866,CHEMBL618653,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7532,1,10116.0,N,,,9866,CHEMBL618654,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7533,1,10116.0,N,,,6351,CHEMBL618655,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7534,1,10116.0,N,,,1465,CHEMBL618656,,Compound was tested for solubility in water,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000100,7535,0,,U,,,5182,CHEMBL618657,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,P,22229,1,,,
,,,,Intermediate,BAO_0000218,7536,1,10116.0,N,,,17847,CHEMBL618658,,Solubility was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7537,1,10116.0,N,,,15339,CHEMBL618659,,solubility in water (ug/mL) at 37 degree C.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7538,1,10116.0,N,,,5202,CHEMBL618660,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7539,1,10116.0,N,,,1088,CHEMBL618661,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7540,1,10116.0,N,,,3169,CHEMBL873807,,Half life in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7541,1,10116.0,N,,,5353,CHEMBL618662,,Half life in Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7542,1,10116.0,N,,,2864,CHEMBL618663,,Half life period after 3 mg/kg iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7543,1,10116.0,N,,,2864,CHEMBL618664,,Half life period after 3 mg/kg iv administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7544,1,10116.0,N,,,2864,CHEMBL618665,,Half life period after 3 mg/kg iv administration in the rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7545,1,10116.0,N,,,6362,CHEMBL876498,,Half life period in female Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7546,1,10116.0,N,,,6249,CHEMBL618666,,Half life period in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7547,1,10116.0,N,,,3169,CHEMBL620440,,Half-life in rats was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7548,1,10116.0,N,,,3169,CHEMBL620441,,Half-life in rats with metabolic oxidation,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7549,1,10116.0,N,,,3169,CHEMBL620442,,Half-life in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7550,1,10116.0,N,,,17260,CHEMBL620443,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7551,1,10116.0,N,,,17260,CHEMBL620444,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7552,1,10116.0,N,,,17260,CHEMBL620445,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7553,1,10116.0,N,,,17260,CHEMBL620446,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7554,1,10116.0,N,,,2879,CHEMBL620447,,Biological half-life measured in plasma of rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7555,1,10116.0,N,,,2879,CHEMBL621129,,Biological half-life measured in plasma of rat; 22-25,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7556,1,10116.0,N,,,2879,CHEMBL621130,,Biological half-life measured in plasma of rat; 9-16,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7557,1,10116.0,N,,,3184,CHEMBL873808,,Compound was evaluated for its half life when administered intravenously in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7558,1,10116.0,N,,,4891,CHEMBL876598,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7559,1,10116.0,N,,,429,CHEMBL621131,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7560,1,10116.0,N,,,5656,CHEMBL621132,,Half life (T1/2) after oral administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7561,1,10116.0,N,,,4413,CHEMBL621133,,Half life of compound after iv administration of 20 mg/kg dose in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Expert,BAO_0000218,7562,1,10116.0,N,,,3598,CHEMBL621312,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7563,1,10116.0,N,,,17267,CHEMBL621313,,Half life of compound was determined in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7564,1,10116.0,N,,,4727,CHEMBL621314,,Half life of compound was determined in rat blood,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7565,1,10116.0,N,,,17651,CHEMBL621315,,Half life at 1 mg/kg was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7566,1,10116.0,N,,,17651,CHEMBL621316,,Half life at 10 mg/kg was determined in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7567,1,10116.0,N,,,401,CHEMBL621317,,Half life in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7568,1,10116.0,N,,,4942,CHEMBL621318,,Half life in rats in hours,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7569,1,10116.0,N,,,17735,CHEMBL621319,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7570,1,10116.0,N,,,6056,CHEMBL621377,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7571,1,10116.0,N,,,5213,CHEMBL621378,,Half life was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7572,1,10116.0,N,,,6616,CHEMBL876599,,Half life after i.v. administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7573,1,10116.0,N,,,5937,CHEMBL621379,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7574,1,10116.0,N,,,5819,CHEMBL621380,,Half life in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7575,1,10116.0,N,,,5819,CHEMBL621381,,Half life in rat plasma; Not detected,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7576,1,10116.0,N,,,6803,CHEMBL618515,,Half life in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7577,1,10116.0,N,,,17804,CHEMBL618516,,Half life period of compound was determined after peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7578,1,10116.0,N,,,17804,CHEMBL618517,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7579,1,10116.0,N,,,5948,CHEMBL618518,,Half life period in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7580,1,10116.0,N,,,1916,CHEMBL618519,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7581,1,10116.0,N,,,1916,CHEMBL618698,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7582,1,10116.0,N,,,1916,CHEMBL618862,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7583,1,10116.0,N,,,4890,CHEMBL618863,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7584,1,10116.0,N,,,17764,CHEMBL618864,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7585,1,10116.0,N,,,4727,CHEMBL618865,,Half life time in rat the dose of 2 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7586,1,10116.0,N,,,17509,CHEMBL618866,,Half-life 24 hr after 10 mg/kg iv administration in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7587,1,10116.0,N,,,17509,CHEMBL618867,,Half-life 24 hr after 2 mg/kg iv administration in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7588,1,10116.0,N,,,6597,CHEMBL875828,,Half-life consistent with the observed metabolic steady state in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7589,1,10116.0,N,,,17735,CHEMBL618868,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7590,1,10116.0,N,,,6597,CHEMBL618869,,Half-life for oxidative metabolic stability was determined using male human,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7591,1,10116.0,N,,,17670,CHEMBL618870,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7592,1,10116.0,N,,,1696,CHEMBL618871,,Half-life in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7593,1,10116.0,N,,,1742,CHEMBL618872,,Half-life in rat plasma was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7594,1,10116.0,N,,,17800,CHEMBL873816,,Half-life in rats was determined,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,7595,0,,U,,,12923,CHEMBL618873,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7596,0,,U,,,11954,CHEMBL621602,,Area under curve after oral dose of 0.1 mg//kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,7597,0,,U,,,11954,CHEMBL621603,,Area under curve after oral dose of 0.3 mg/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,7598,0,,U,,,11954,CHEMBL621604,,Area under curve after oral dose of 1 mg/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,7599,0,,U,,,11954,CHEMBL621605,,Area under curve after oral dose of 10 mg/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,7600,0,,U,,,11954,CHEMBL621606,,Area under curve after oral dose of 23.4 mg/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,7601,0,,U,,,11954,CHEMBL621607,,Area under curve after oral dose of 3 mg/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,7602,0,,U,,,11954,CHEMBL621608,,Area under curve after oral dose of 3.87 mg/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7603,0,,U,,,5237,CHEMBL621609,,Area under curve was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,7604,0,,U,,,4026,CHEMBL621610,,Area under curve at a dose of 10 mg/kg,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,7605,1,10116.0,N,,,5237,CHEMBL621611,,Area under curve was determined; ND=No data,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7606,1,10116.0,N,,,14793,CHEMBL621612,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7607,1,10116.0,N,,,14793,CHEMBL622308,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7608,1,10116.0,N,,,14793,CHEMBL622309,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7609,1,10116.0,N,,,14793,CHEMBL622310,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7610,1,10116.0,N,,,14793,CHEMBL622311,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7611,1,10116.0,N,,,14793,CHEMBL622312,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7612,1,10116.0,N,,,14793,CHEMBL622931,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7613,1,10116.0,N,,,14793,CHEMBL622932,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7614,1,10116.0,N,,,14793,CHEMBL622736,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7615,1,10116.0,N,,,14793,CHEMBL622737,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7616,1,10116.0,N,,,14793,CHEMBL622738,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7617,1,10116.0,N,,,14793,CHEMBL622739,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7618,1,10116.0,N,,,14793,CHEMBL622740,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7619,1,10116.0,N,,,14793,CHEMBL622741,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7620,1,10116.0,N,,,14793,CHEMBL622742,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7621,1,10116.0,N,,,14793,CHEMBL622743,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7622,1,10090.0,N,,,11637,CHEMBL622744,,AUC in mice,Plasma,A,50594,1,,1969.0,Mus musculus
,,,,Autocuration,BAO_0000019,7623,0,,U,,,11149,CHEMBL624134,,Area under curve was measured from the graph obtained from concentration Vs time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7624,0,,U,,,10016,CHEMBL624135,,Area under curve value of compound per hour after oral administration,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,7625,1,10116.0,N,,,17796,CHEMBL624136,,Area under curve was determined after oral administration in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7626,1,10116.0,N,,,17796,CHEMBL624137,,Area under curve was determined after oral administration in rats; No data,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7627,1,10116.0,N,,,17796,CHEMBL624320,,Area under curve was determined after oral administration in rats;No data,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7628,1,9615.0,N,,,12923,CHEMBL624321,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7629,1,10116.0,N,,,15372,CHEMBL624322,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7630,1,10116.0,N,,,15372,CHEMBL624323,,Area under curve was determined for the compound after iv dose of 5.06 in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7631,1,10116.0,N,,,15372,CHEMBL624324,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7632,1,10116.0,N,,,15372,CHEMBL624325,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7633,1,10116.0,N,,,15372,CHEMBL624326,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7634,1,10116.0,N,,,15372,CHEMBL624327,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7635,1,10116.0,N,,,15372,CHEMBL624328,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7636,1,9615.0,N,,,14169,CHEMBL627848,,Area under curve was determined in Dogs after peroral administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7637,1,10116.0,N,,,14169,CHEMBL627849,,Area under curve was determined in Rats after peroral administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7638,1,10116.0,N,,,14258,CHEMBL627850,,Area under curve was determined in carotid blood of rat when administered intradermally,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7639,1,10116.0,N,,,14258,CHEMBL627851,,Area under curve was determined in portal blood of rat when administered intradermally,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7640,1,10090.0,N,,,15011,CHEMBL627852,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,7641,1,10090.0,N,,,15011,CHEMBL627853,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,7642,1,10090.0,N,,,15011,CHEMBL627854,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,7643,1,10090.0,N,,,15011,CHEMBL627855,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,7644,1,10090.0,N,,,15011,CHEMBL627856,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,7645,1,10090.0,N,,,15011,CHEMBL875339,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,7646,1,10090.0,N,,,15011,CHEMBL627857,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,7647,1,10116.0,N,,,11195,CHEMBL627858,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7648,1,10116.0,N,,,10130,CHEMBL627859,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7649,1,10116.0,N,,,10130,CHEMBL627860,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7650,1,10116.0,N,,,10130,CHEMBL627019,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7651,1,10116.0,N,,,10130,CHEMBL627020,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7652,1,10116.0,N,,,10130,CHEMBL627021,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7653,1,10116.0,N,,,10130,CHEMBL627022,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7654,1,10116.0,N,,,10130,CHEMBL627023,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7655,1,10116.0,N,,,10130,CHEMBL627024,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7656,1,10116.0,N,,,10130,CHEMBL627025,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7657,1,10116.0,N,,,10130,CHEMBL627026,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7658,1,10116.0,N,,,10130,CHEMBL627027,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7659,1,10116.0,N,,,10130,CHEMBL627028,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7660,1,10116.0,N,,,10130,CHEMBL627029,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7661,1,10116.0,N,,,10130,CHEMBL627030,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7662,1,10116.0,N,,,10130,CHEMBL627031,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7663,1,10116.0,N,,,10130,CHEMBL627032,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7664,1,10116.0,N,,,10130,CHEMBL627033,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7665,1,10116.0,N,,,10130,CHEMBL627034,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7666,1,10116.0,N,,,10130,CHEMBL627035,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7667,1,10116.0,N,,,10130,CHEMBL627036,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7668,1,10116.0,N,,,10130,CHEMBL875340,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7669,1,10116.0,N,,,10130,CHEMBL627037,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7670,1,10116.0,N,,,10130,CHEMBL627038,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7671,1,10116.0,N,,,10130,CHEMBL627039,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7672,1,10116.0,N,,,10130,CHEMBL627040,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7673,1,10116.0,N,,,10130,CHEMBL624663,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7674,1,10116.0,N,,,10130,CHEMBL625963,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7675,1,10116.0,N,,,10130,CHEMBL876799,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7676,1,10116.0,N,,,10130,CHEMBL626133,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7677,1,10116.0,N,,,10130,CHEMBL626134,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7678,1,10116.0,N,,,6295,CHEMBL626135,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7679,1,10116.0,N,,,6296,CHEMBL626136,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7680,1,10116.0,N,,,6296,CHEMBL626137,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7681,1,10116.0,N,,,6295,CHEMBL626138,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7682,1,10116.0,N,,,6296,CHEMBL626139,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7683,1,10116.0,N,,,17260,CHEMBL626140,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7684,1,10116.0,N,,,17260,CHEMBL626141,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7685,1,10116.0,N,,,17686,CHEMBL626142,,C24h in rat p.o. at 20 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7686,1,10116.0,N,,,9866,CHEMBL627930,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7687,1,10116.0,N,,,9866,CHEMBL627931,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7688,1,10116.0,N,,,9866,CHEMBL627932,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7689,1,10116.0,N,,,9866,CHEMBL627933,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7690,1,10116.0,N,,,9866,CHEMBL627934,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7691,1,10116.0,N,,,9866,CHEMBL627935,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7692,1,10116.0,N,,,9866,CHEMBL627936,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7693,1,10116.0,N,,,9866,CHEMBL627937,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7694,1,10116.0,N,,,9866,CHEMBL627938,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7695,1,10116.0,N,,,9866,CHEMBL627939,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7696,1,10116.0,N,,,9866,CHEMBL627940,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7697,1,10116.0,N,,,9866,CHEMBL627941,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7698,1,10116.0,N,,,9866,CHEMBL876800,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7699,1,10116.0,N,,,9866,CHEMBL627942,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7700,1,10116.0,N,,,9866,CHEMBL627943,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7701,1,10116.0,N,,,9866,CHEMBL627944,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7702,1,10116.0,N,,,9866,CHEMBL627945,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7703,1,10116.0,N,,,9866,CHEMBL628584,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7704,1,10116.0,N,,,9866,CHEMBL628585,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7705,1,10116.0,N,,,9866,CHEMBL628586,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7706,1,10116.0,N,,,9866,CHEMBL628587,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7707,1,10116.0,N,,,9866,CHEMBL628588,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7708,1,10116.0,N,,,9866,CHEMBL628589,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7709,1,10116.0,N,,,9866,CHEMBL625304,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7710,1,10116.0,N,,,9866,CHEMBL625305,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7711,1,10116.0,N,,,9866,CHEMBL625306,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7712,1,10116.0,N,,,9866,CHEMBL625307,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7713,1,10116.0,N,,,9866,CHEMBL625308,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7714,1,10116.0,N,,,9866,CHEMBL627740,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7715,1,10116.0,N,,,9866,CHEMBL627741,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7716,1,10116.0,N,,,9866,CHEMBL627742,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7717,1,10116.0,N,,,9866,CHEMBL627743,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7718,1,10116.0,N,,,9866,CHEMBL627744,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7719,1,10116.0,N,,,9866,CHEMBL627745,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7720,1,10116.0,N,,,9866,CHEMBL627746,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7721,1,10116.0,N,,,9866,CHEMBL627747,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7722,1,10116.0,N,,,9866,CHEMBL876810,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7723,1,10116.0,N,,,9866,CHEMBL627748,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7724,1,10116.0,N,,,9866,CHEMBL627749,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7725,1,10116.0,N,,,9866,CHEMBL627750,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7726,1,10116.0,N,,,9866,CHEMBL618728,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7727,1,10116.0,N,,,9866,CHEMBL618729,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7728,1,10116.0,N,,,9866,CHEMBL618730,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7729,1,10116.0,N,,,9866,CHEMBL618731,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7730,1,10116.0,N,,,9866,CHEMBL618732,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7731,1,10116.0,N,,,9866,CHEMBL618733,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7732,1,10116.0,N,,,9866,CHEMBL618734,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7733,1,10116.0,N,,,9866,CHEMBL618735,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7734,1,10116.0,N,,,9866,CHEMBL876602,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7735,1,10116.0,N,,,9866,CHEMBL618736,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7736,1,10116.0,N,,,9866,CHEMBL618737,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7737,1,10116.0,N,,,9866,CHEMBL618738,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7738,1,10116.0,N,,,9866,CHEMBL618739,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7739,1,10116.0,N,,,9866,CHEMBL618740,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7740,1,10116.0,N,,,9866,CHEMBL618741,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7741,1,10116.0,N,,,9866,CHEMBL618742,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7742,1,10116.0,N,,,9866,CHEMBL618743,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7743,1,10116.0,N,,,17752,CHEMBL618744,,Half-life from rat plasma at a single oral dose of 25 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7744,1,10116.0,N,,,5610,CHEMBL618745,,Half-life in male rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7745,1,10116.0,N,,,5939,CHEMBL620479,,Half-life in rat after peroral administration at 10 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7746,1,10116.0,N,,,5939,CHEMBL620480,,Half-life in rat after peroral administration at 5 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7747,1,10116.0,N,,,17771,CHEMBL620481,,Half-life in rat at a dose of 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7748,1,10116.0,N,,,1974,CHEMBL620482,,Half-life was evaluated in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7749,1,10116.0,N,,,4239,CHEMBL876603,,Half-life was measured in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7750,1,10116.0,N,,,6681,CHEMBL620483,,Half-life period for the compound was determined in rats at 50 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7751,1,10116.0,N,,,17752,CHEMBL620484,,Half-life period in rats after intravenous administration at 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7752,1,10116.0,N,,,6046,CHEMBL620485,,Half-life period in rat at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7753,1,10116.0,N,,,6685,CHEMBL620486,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7754,1,10116.0,N,,,6685,CHEMBL620487,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7755,1,10116.0,N,,,6685,CHEMBL620488,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7756,1,10116.0,N,,,4727,CHEMBL620489,,Half-life time in rat the dose of 2 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7757,1,10116.0,N,,,1088,CHEMBL620490,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7758,1,10116.0,N,,,5610,CHEMBL620491,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7759,1,10116.0,N,,,3032,CHEMBL876604,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7760,1,10116.0,N,,,5199,CHEMBL620492,,Oral half life was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7761,1,10116.0,N,,,14941,CHEMBL620493,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7762,1,10116.0,N,,,4408,CHEMBL620494,,Pharmacokinetic property (t1/2) in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7763,1,10116.0,N,,,2552,CHEMBL620495,,Plasma elimination half-life was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7764,1,10116.0,N,,,5199,CHEMBL620496,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7765,1,10116.0,N,,,15662,CHEMBL620497,,Plasma half life was observed after intravenous administration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7766,1,10116.0,N,,,1465,CHEMBL620498,,Plasma half-life was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7767,1,10116.0,N,,,1446,CHEMBL620499,,Plasma half-life following oral administration in Fisher rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7768,1,10116.0,N,,,6824,CHEMBL620500,,Plasma half-life in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7769,1,10116.0,N,,,17533,CHEMBL873809,,Plasmatic Half-life after intravenous administration to rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7770,1,10116.0,N,,,5979,CHEMBL620501,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7771,1,10116.0,N,,,4689,CHEMBL620502,,Terminal half life after intravenous administration (1 mg/kg) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7772,1,10116.0,N,,,4689,CHEMBL620503,,Terminal half life in Rat at a oral dose of 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7773,1,10116.0,N,,,2463,CHEMBL620504,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7774,1,10116.0,N,,,4883,CHEMBL876605,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7775,1,10116.0,N,,,4883,CHEMBL620505,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7776,1,10116.0,N,,,15662,CHEMBL873811,,plasma half life was observed after intravenous administration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Expert,BAO_0000218,7777,1,10116.0,N,,,3598,CHEMBL624016,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7778,1,10116.0,N,,,4576,CHEMBL624017,,Half life of compound determined in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7779,1,10116.0,N,,,4576,CHEMBL624018,,Mean residence time determined in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7780,1,10116.0,N,,,4576,CHEMBL624019,,Plasma half life determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7781,1,10116.0,N,,,4910,CHEMBL624020,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7782,1,10116.0,N,,,4891,CHEMBL624201,,Compound was evaluated for pharmacokinetic parameter maximum time period,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7783,1,10116.0,N,,,429,CHEMBL872528,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7784,1,10116.0,N,,,5974,CHEMBL624202,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7785,1,10116.0,N,,,5974,CHEMBL624203,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7786,1,10116.0,N,,,5974,CHEMBL624350,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7787,1,10116.0,N,,,5974,CHEMBL621320,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7788,1,10116.0,N,,,17582,CHEMBL621321,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7789,1,10116.0,N,,,4026,CHEMBL621322,,Maximum time (Tmax) required to reach Cmax in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7790,1,10116.0,N,,,4890,CHEMBL621323,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7791,1,10116.0,N,,,6571,CHEMBL621324,,Maximum time of clearance of compound in rats after peroral administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7792,1,10116.0,N,,,4727,CHEMBL621325,,Maximum time at the dose of 2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7793,1,10116.0,N,,,17651,CHEMBL875837,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7794,1,10116.0,N,,,17651,CHEMBL621326,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7795,1,10116.0,N,,,14465,CHEMBL621327,,Tmax in Guinea pig (PO dose),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7796,1,10116.0,N,,,14941,CHEMBL621328,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7797,1,10116.0,N,,,5960,CHEMBL621329,,Pharmacokinetic parameter (Tmax) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7798,1,10116.0,N,,,5022,CHEMBL621330,,Pharmacokinetic parameter (Tmax) was estimated,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7799,1,10116.0,N,,,4408,CHEMBL621331,,Pharmacokinetic property (Tmax) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7800,1,10116.0,N,,,5983,CHEMBL621332,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7801,1,10116.0,N,,,4689,CHEMBL621333,,T max in Rat at a oral dose of 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7802,1,10116.0,N,,,2792,CHEMBL621334,,T max was determined at 10 mg/kg po dose in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7803,1,10090.0,N,,,15011,CHEMBL621335,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,7804,1,9615.0,N,,,14180,CHEMBL621336,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7805,1,10116.0,N,,,14180,CHEMBL621337,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7806,1,9615.0,N,,,14599,CHEMBL621338,,Area under curve was measured after i.v. administration into Beagle dog.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7807,1,9615.0,N,,,14599,CHEMBL875838,,Area under curve was measured after iv administration into Beagle dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7808,1,9615.0,N,,,14599,CHEMBL621339,,Area under curve was measured after po administration into Beagle dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7809,1,9615.0,N,,,14599,CHEMBL621340,,Area under curve was measured after po administration into Beagle dog.,,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,7810,0,,U,,,15675,CHEMBL621341,,Area under curve was measured at peroral dose of 3 mg/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7811,0,,U,,,12706,CHEMBL621342,,Area under curve was measured by using concentration Vs time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7812,0,,U,,,12706,CHEMBL621343,,Area under curve was measured by using concentration Vs time; not tested,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,7813,1,10090.0,N,,,9750,CHEMBL621344,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,7814,1,10090.0,N,,,9750,CHEMBL621345,,Area under curve(AUC) was measured in mice after oral administration.,,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000019,7815,0,,U,,,14691,CHEMBL621346,,Area under curve(AUC) value of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,7816,0,,U,,,14691,CHEMBL621347,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,7817,1,9615.0,N,,,14691,CHEMBL621348,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000019,7818,0,,U,,,2939,CHEMBL621349,,Area under curve(carotid artery) was determined by the availability in blood,Blood,A,22224,1,,178.0,
,,,,Autocuration,BAO_0000019,7819,0,,U,,,2939,CHEMBL621350,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,Blood,A,22224,1,,178.0,
,,,,Autocuration,BAO_0000019,7820,0,,U,,,2939,CHEMBL875839,,Area under curve(carotid artery) was determined by the availability in blood; No data,Blood,A,22224,1,,178.0,
,,,,Autocuration,BAO_0000019,7821,0,,U,,,2939,CHEMBL620211,,Area under curve(portal vein) was determined by the availability in blood,Blood,A,22224,1,,178.0,
,,,,Autocuration,BAO_0000019,7822,0,,U,,,2939,CHEMBL620212,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,Blood,A,22224,1,,178.0,
,,,,Autocuration,BAO_0000019,7823,0,,U,,,2939,CHEMBL620213,,Area under curve(portal vein) was determined by the availability in blood; No data,Blood,A,22224,1,,178.0,
,,,,Intermediate,BAO_0000218,7824,1,9544.0,N,,,9552,CHEMBL620214,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Plasma,A,50797,1,,1969.0,Macaca mulatta
,,,,Intermediate,BAO_0000218,7825,1,9544.0,N,,,9552,CHEMBL620215,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Plasma,A,50797,1,,1969.0,Macaca mulatta
,,,,Intermediate,BAO_0000218,7826,1,9544.0,N,,,9552,CHEMBL620216,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Plasma,A,50797,1,,1969.0,Macaca mulatta
,,,,Intermediate,BAO_0000218,7827,1,9615.0,N,,,9552,CHEMBL620888,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7828,1,9615.0,N,,,9552,CHEMBL620889,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Autocuration,BAO_0000019,7829,0,,U,,,9552,CHEMBL620890,,Area under plasma concentration vs time curve observed in rats for 0-3 h,Plasma,A,22224,1,,1969.0,
,,,,Intermediate,BAO_0000218,7830,1,10116.0,N,,,11911,CHEMBL620891,,Area under plasma time curve determined in male rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,7831,0,,U,,,16618,CHEMBL620892,,Area under the MAP curve measured over 5 min.,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,7832,1,10090.0,N,,,14387,CHEMBL621079,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,7833,1,10090.0,N,,,14387,CHEMBL621080,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,7834,1,9615.0,N,,,12836,CHEMBL621081,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7835,1,10026.0,N,,,12836,CHEMBL621082,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,A,100712,1,,,Cricetinae
,,,,Intermediate,BAO_0000218,7836,1,10116.0,N,,,12836,CHEMBL621083,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7837,1,9615.0,N,,,14339,CHEMBL621084,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7838,1,9615.0,N,,,14339,CHEMBL621085,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7839,1,9615.0,N,,,14339,CHEMBL621086,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7840,1,9615.0,N,,,10524,CHEMBL621087,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7841,1,9615.0,N,,,9994,CHEMBL622607,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7842,1,9615.0,N,,,11325,CHEMBL622608,,Serum AUC in marmosets (IV dose),,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000019,7843,0,,U,,,12536,CHEMBL624481,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7844,0,,U,,,12536,CHEMBL624482,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7845,0,,U,,,12536,CHEMBL624483,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7846,0,,U,,,12536,CHEMBL624484,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7847,0,,U,,,12536,CHEMBL624485,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,7848,1,10116.0,N,,,15556,CHEMBL624486,,Area under the curve for fumarate salt was evaluated in F344 Rats.,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,7849,0,,U,,,2809,CHEMBL624487,,Area under the curve for the compound was calculated.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7850,0,,U,,,9511,CHEMBL624488,,Area under the curve in concentration/ time,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,7851,1,10116.0,N,,,12818,CHEMBL624489,,Area under the curve administered intraintestinal in rats.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7852,1,10116.0,N,,,12818,CHEMBL625184,,Area under the curve administered intravenously in rats.,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,7853,0,,U,,,15118,CHEMBL625185,,Area under the curve during intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7854,0,,U,,,15118,CHEMBL875954,,Area under the curve during intravenous administration; Not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7855,0,,U,,,15118,CHEMBL625186,,Area under the curve during systemic administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7856,0,,U,,,15118,CHEMBL625187,,Area under the curve during systemic administration; Not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,7857,0,,U,,,2632,CHEMBL625188,,Area under the curve was calculated for the compound.,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,7858,1,9615.0,N,,,14346,CHEMBL625189,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7859,1,9615.0,N,,,14346,CHEMBL625190,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,7860,1,10116.0,N,,,14346,CHEMBL621733,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7861,1,10116.0,N,,,14346,CHEMBL621734,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7862,1,10116.0,N,,,11149,CHEMBL621735,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7863,1,10116.0,N,,,17796,CHEMBL621736,,Clearance of the drug was measured in the plasma of rat; No data,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7864,1,10116.0,N,,,5247,CHEMBL621737,,The pharmacokinetic parameter plasma clearance in vivo in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7865,1,10116.0,N,,,4727,CHEMBL621738,,Plasma clearance at the dose of 2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7866,1,10116.0,N,,,5654,CHEMBL622806,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7867,1,10116.0,N,,,5654,CHEMBL623519,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7868,1,10116.0,N,,,17260,CHEMBL623520,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7869,1,10116.0,N,,,17065,CHEMBL623521,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7870,1,10116.0,N,,,17671,CHEMBL623522,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7871,1,10116.0,N,,,6672,CHEMBL623523,,Clearance rate in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7872,1,10116.0,N,,,6673,CHEMBL623690,,Clearance rate in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7873,1,10116.0,N,,,5978,CHEMBL623691,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7874,1,10116.0,N,,,5978,CHEMBL623692,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7875,1,10116.0,N,,,5978,CHEMBL623693,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7876,1,10116.0,N,,,5978,CHEMBL623694,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7877,1,10116.0,N,,,4413,CHEMBL623695,,Clearance of compound after iv administration of 20 mg/kg dose in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7878,1,10116.0,N,,,2661,CHEMBL623696,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7879,1,10116.0,N,,,2661,CHEMBL623697,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7880,0,9544.0,U,,,5005,CHEMBL623698,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Plasma,A,22224,1,,1969.0,Macaca mulatta
,In vivo,,,Intermediate,BAO_0000218,7881,0,10116.0,U,,,5005,CHEMBL623699,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Plasma,A,22224,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7882,1,10116.0,N,,,15765,CHEMBL623700,,Mean (%CV) PK parameters for CL(mL/min/kg).,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7883,1,10116.0,N,,,3747,CHEMBL623701,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7884,1,10116.0,N,,,16366,CHEMBL623702,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7885,1,10116.0,N,,,4199,CHEMBL623703,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7886,1,10116.0,N,,,17267,CHEMBL623704,,Plasma clearance in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7887,1,10116.0,N,,,6535,CHEMBL623705,,Plasma clearance in rat after administration of 2 mg/kg iv,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7888,1,10116.0,N,,,6535,CHEMBL623706,,Plasma clearance in rat after administration of 2 mg/kg iv,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7889,1,10116.0,N,,,5041,CHEMBL623707,,Plasma clearance was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7890,1,10116.0,N,,,5960,CHEMBL623708,,Plasma clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7891,1,10116.0,N,,,5937,CHEMBL623709,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7892,1,10116.0,N,,,5871,CHEMBL623710,,Plasma clearance in rat by iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7893,1,10116.0,N,,,5874,CHEMBL623711,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7894,1,10116.0,N,,,6504,CHEMBL623712,,Plasma clearance in rat p.o.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7895,1,10116.0,N,,,6803,CHEMBL623713,,Plasma clearance in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7896,1,10116.0,N,,,5041,CHEMBL623714,,Plasma clearance was determined; ND denotes no data,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7897,1,10116.0,N,,,5041,CHEMBL623715,,Plasma clearance was determined; ND denotes not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7898,1,10116.0,N,,,1916,CHEMBL623716,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7899,1,10116.0,N,,,5199,CHEMBL622980,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7900,1,10116.0,N,,,16367,CHEMBL622981,,Plasma administration to rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7901,1,10116.0,N,,,6362,CHEMBL622982,,Plasma clearance of the compound in female Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7902,1,10116.0,N,,,15662,CHEMBL622983,,Plasma clearance was observed after intravenous administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7903,1,10116.0,N,,,6215,CHEMBL622984,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7904,1,10116.0,N,,,1466,CHEMBL622985,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7905,1,10116.0,N,,,15662,CHEMBL623631,,plasma clearance was observed after intravenous administration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7906,1,10116.0,N,,,4723,CHEMBL623632,,In vivo CL/F determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7907,1,10116.0,N,,,2792,CHEMBL623633,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7908,1,10116.0,N,,,2792,CHEMBL623634,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7909,1,10116.0,N,,,5213,CHEMBL623635,,Compound was tested for the lower blood clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7910,1,10116.0,N,,,4687,CHEMBL621195,,Evaluated for the low clearance in rat (in vivo),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7911,1,10116.0,N,,,3371,CHEMBL621196,,Pharmacokinetic property (CLb)of the compound was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7912,1,10116.0,N,,,4690,CHEMBL875287,,Rapid clearance after intravenous administration in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7913,1,10116.0,N,,,5702,CHEMBL621197,,Clearance measured in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7914,1,10116.0,N,,,740,CHEMBL621198,,Compound was evaluated for plasma clearance in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7915,1,10116.0,N,,,4853,CHEMBL621199,,Low plasma clearance was calculated in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7916,1,10116.0,N,,,5789,CHEMBL621200,,Pharmacokinetic property (Clp) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7917,1,10116.0,N,,,4527,CHEMBL621201,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7918,1,10116.0,N,,,4527,CHEMBL621202,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7919,1,10116.0,N,,,6518,CHEMBL621203,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7920,1,10116.0,N,,,6518,CHEMBL621204,,Plasma clearance after IV dosing at 1 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7921,1,10116.0,N,,,9866,CHEMBL621205,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7922,1,10116.0,N,,,9866,CHEMBL621206,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7923,1,10116.0,N,,,9866,CHEMBL621207,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7924,1,10116.0,N,,,9866,CHEMBL621208,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7925,1,10116.0,N,,,9866,CHEMBL621209,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7926,1,10116.0,N,,,9866,CHEMBL876484,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7927,1,10116.0,N,,,9866,CHEMBL621210,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7928,1,10116.0,N,,,9866,CHEMBL621211,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7929,1,10116.0,N,,,9866,CHEMBL621212,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7930,1,10116.0,N,,,9866,CHEMBL621213,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7931,1,10116.0,N,,,9866,CHEMBL621214,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7932,1,10116.0,N,,,9866,CHEMBL621215,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7933,1,10116.0,N,,,9866,CHEMBL621216,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7934,1,10116.0,N,,,9866,CHEMBL621217,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7935,1,10116.0,N,,,9866,CHEMBL621218,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7936,1,10116.0,N,,,9866,CHEMBL621219,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7937,1,10116.0,N,,,9866,CHEMBL621220,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7938,1,10116.0,N,,,9866,CHEMBL621221,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7939,1,10116.0,N,,,9866,CHEMBL621222,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7940,1,10116.0,N,,,9866,CHEMBL621223,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7941,1,10116.0,N,,,9866,CHEMBL876485,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7942,1,10116.0,N,,,9866,CHEMBL621224,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7943,1,10116.0,N,,,9866,CHEMBL621225,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7944,1,10116.0,N,,,9866,CHEMBL621226,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7945,1,10116.0,N,,,9866,CHEMBL621227,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7946,1,10116.0,N,,,9866,CHEMBL621228,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7947,1,10116.0,N,,,9866,CHEMBL621229,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7948,1,10116.0,N,,,9866,CHEMBL621230,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7949,1,10116.0,N,,,9866,CHEMBL621231,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7950,1,10116.0,N,,,9866,CHEMBL621232,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7951,1,10116.0,N,,,9866,CHEMBL621233,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7952,1,10116.0,N,,,9866,CHEMBL621234,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7953,1,10116.0,N,,,9866,CHEMBL621235,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7954,1,10116.0,N,,,9866,CHEMBL621236,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7955,1,10116.0,N,,,9866,CHEMBL621237,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7956,1,10116.0,N,,,9866,CHEMBL876486,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7957,1,10116.0,N,,,9866,CHEMBL622436,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7958,1,10116.0,N,,,9866,CHEMBL622437,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7959,1,10116.0,N,,,9866,CHEMBL622438,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7960,1,10116.0,N,,,9866,CHEMBL622439,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7961,1,10116.0,N,,,9866,CHEMBL622440,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7962,1,10116.0,N,,,9866,CHEMBL622441,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7963,1,10116.0,N,,,9866,CHEMBL622442,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7964,1,10116.0,N,,,9866,CHEMBL622443,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7965,1,10116.0,N,,,9866,CHEMBL622444,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7966,1,10116.0,N,,,9866,CHEMBL622445,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7967,1,10116.0,N,,,9866,CHEMBL622446,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7968,1,10116.0,N,,,9866,CHEMBL622447,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7969,1,10116.0,N,,,9866,CHEMBL622448,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7970,1,10116.0,N,,,9866,CHEMBL622449,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7971,1,10116.0,N,,,9866,CHEMBL622450,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7972,1,10116.0,N,,,9866,CHEMBL622451,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7973,1,10116.0,N,,,9866,CHEMBL622452,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7974,1,10116.0,N,,,9866,CHEMBL622453,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7975,1,10116.0,N,,,9866,CHEMBL622454,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7976,1,10116.0,N,,,9866,CHEMBL622455,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7977,1,10116.0,N,,,9866,CHEMBL876024,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7978,1,10116.0,N,,,2792,CHEMBL622456,,T max was determined at 3 mg/kg po dose in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7979,1,10116.0,N,,,15078,CHEMBL622457,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7980,1,10116.0,N,,,15078,CHEMBL622458,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7981,1,10116.0,N,,,15022,CHEMBL622459,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7982,1,10116.0,N,,,15022,CHEMBL873343,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7983,1,10116.0,N,,,15022,CHEMBL622460,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7984,1,10116.0,N,,,4576,CHEMBL622461,,Time for maximum plasma concentration determined in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7985,1,10116.0,N,,,6681,CHEMBL622462,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7986,1,10116.0,N,,,16365,CHEMBL622463,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7987,1,10116.0,N,,,16365,CHEMBL622464,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7988,1,10116.0,N,,,16365,CHEMBL622465,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7989,1,10116.0,N,,,16365,CHEMBL622466,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7990,1,10116.0,N,,,16365,CHEMBL622467,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7991,1,10116.0,N,,,6824,CHEMBL622468,,Time of maximum plasma concentration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7992,1,10116.0,N,,,6685,CHEMBL876025,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7993,1,10116.0,N,,,6685,CHEMBL622469,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7994,1,10116.0,N,,,6685,CHEMBL622470,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7995,1,10116.0,N,,,15662,CHEMBL622471,,Time required to reach maximum concentration (Cmax) after oral administration in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,7996,1,10116.0,N,,,1742,CHEMBL622472,,Time required to reach maximum concentration in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7997,1,10116.0,N,,,2774,CHEMBL622473,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7998,1,10116.0,N,,,5199,CHEMBL624282,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,7999,1,10116.0,N,,,12873,CHEMBL624283,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8000,1,10116.0,N,,,12873,CHEMBL624284,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8001,1,10116.0,N,,,1916,CHEMBL624285,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8002,1,10116.0,N,,,16367,CHEMBL624286,,Time to reach Cmax after oral administration to rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8003,1,10116.0,N,,,16366,CHEMBL624287,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8004,1,10116.0,N,,,216,CHEMBL624288,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8005,1,10116.0,N,,,6410,CHEMBL624289,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8006,1,10116.0,N,,,6410,CHEMBL873344,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8007,1,10116.0,N,,,6215,CHEMBL619623,,Tmax after peroral administration (10 mg/kg) was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Expert,BAO_0000218,8008,1,10116.0,N,,,3598,CHEMBL621399,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8009,1,10116.0,N,,,4527,CHEMBL621400,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8010,1,10116.0,N,,,17670,CHEMBL621401,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8011,1,10116.0,N,,,1465,CHEMBL621402,,Tmax was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8012,1,10116.0,N,,,2552,CHEMBL621403,,Tmax was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8013,1,10116.0,N,,,5656,CHEMBL621121,,Tmax after oral administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8014,1,10116.0,N,,,17764,CHEMBL872525,,Tmax after peroral administration in rats at 2.4 uM/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8015,1,10116.0,N,,,5610,CHEMBL621122,,Tmax in male rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8016,1,10116.0,N,,,6046,CHEMBL621123,,Tmax in rat at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8017,1,10116.0,N,,,5874,CHEMBL621124,,Tmax in rat by po administration at a dose of 40 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8018,1,10116.0,N,,,17596,CHEMBL621125,,Tmax in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8019,1,10116.0,N,,,17804,CHEMBL621126,,Tmax was measured in rats after peroral administration at 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8020,1,10116.0,N,,,1908,CHEMBL621127,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8021,1,10116.0,N,,,2959,CHEMBL621128,,Tmax value after administration of 20 mg/Kg oral dose in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8022,1,10116.0,N,,,6757,CHEMBL618263,,Tmax value at a dose of 10 mg/kg in male SD rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8023,1,10116.0,N,,,6757,CHEMBL618264,,Tmax value at a dose of 100 mg/kg in male SD rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8024,1,10116.0,N,,,6757,CHEMBL618265,,Tmax value at a dose of 50 mg/kg in male SD rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8025,1,10116.0,N,,,4186,CHEMBL618266,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8026,1,10116.0,N,,,15662,CHEMBL618267,,time required to reach maximum concentration (Cmax) after oral administration in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8027,1,10116.0,N,,,429,CHEMBL618450,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8028,1,10116.0,N,,,429,CHEMBL618451,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8029,1,10116.0,N,,,5546,CHEMBL618452,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8030,1,10116.0,N,,,3173,CHEMBL618453,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8031,1,10116.0,N,,,3173,CHEMBL618454,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8032,1,10116.0,N,,,3173,CHEMBL618455,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Urine,A,50597,1,,1088.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8033,1,10116.0,N,,,4257,CHEMBL618456,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8034,1,10116.0,N,,,6011,CHEMBL618457,,Compound distribution in rat tissues was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8035,1,10116.0,N,,,5472,CHEMBL618458,,Volume of distribution was evaluated in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8036,1,10116.0,N,,,14346,CHEMBL618459,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8037,1,10116.0,N,,,14346,CHEMBL876733,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8038,1,9615.0,N,,,14346,CHEMBL618460,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,8039,1,10116.0,N,,,14346,CHEMBL618461,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,8040,0,,U,,,15469,CHEMBL618462,,Area under the curve was determined after oral administration (300 uM/Kg),,A,22224,1,,,
,,,,Intermediate,BAO_0000218,8041,1,10116.0,N,,,14346,CHEMBL618463,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8042,1,10116.0,N,,,14346,CHEMBL618464,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8043,1,10116.0,N,,,14346,CHEMBL618465,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8044,1,10116.0,N,,,14346,CHEMBL618466,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8045,1,10116.0,N,,,14346,CHEMBL618467,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8046,1,10116.0,N,,,15372,CHEMBL618468,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8047,1,9615.0,N,,,12935,CHEMBL618469,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,8048,1,9615.0,N,,,12935,CHEMBL618470,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,8049,0,,U,,,14813,CHEMBL618471,,Plasma drug AUC in rat (PO dose),,A,22224,1,,,
,,,,Intermediate,BAO_0000218,8050,1,10090.0,N,,,15792,CHEMBL618472,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000218,8051,0,,U,,,3579,CHEMBL618473,,Area under was determined at a dose of 30 mg/kg,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,8052,1,9669.0,N,,,12487,CHEMBL621699,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,A,50506,1,,,Mustela putorius furo
,,,,Intermediate,BAO_0000218,8053,1,10116.0,N,,,12487,CHEMBL621700,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8054,1,10116.0,N,,,12487,CHEMBL621701,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8055,1,9669.0,N,,,12487,CHEMBL621702,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,A,50506,1,,,Mustela putorius furo
,,,,Intermediate,BAO_0000218,8056,1,9615.0,N,,,12487,CHEMBL621703,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,8057,1,9615.0,N,,,12487,CHEMBL621704,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,8058,1,10116.0,N,,,12902,CHEMBL624259,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8059,1,10116.0,N,,,12902,CHEMBL624260,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8060,1,10116.0,N,,,12902,CHEMBL624430,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8061,1,10116.0,N,,,12902,CHEMBL624431,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8062,1,10116.0,N,,,12902,CHEMBL624432,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8063,1,10116.0,N,,,12902,CHEMBL624433,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8064,1,10116.0,N,,,12902,CHEMBL624434,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8065,1,10116.0,N,,,12902,CHEMBL624435,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8066,1,10090.0,N,,,12745,CHEMBL618570,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8067,1,10090.0,N,,,12745,CHEMBL618571,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8068,1,10090.0,N,,,12745,CHEMBL618572,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8069,1,10090.0,N,,,12745,CHEMBL618573,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8070,1,10090.0,N,,,12745,CHEMBL619267,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8071,1,10090.0,N,,,12745,CHEMBL619431,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8072,1,10090.0,N,,,12745,CHEMBL619432,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8073,1,10090.0,N,,,12745,CHEMBL619433,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000218,8074,0,,U,,,13298,CHEMBL619434,,AUC in mice after oral dose (50 mg/kg),Plasma,A,22224,1,,1969.0,
,,,,Intermediate,BAO_0000218,8075,1,10090.0,N,,,12226,CHEMBL619435,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Serum,A,50594,1,,1977.0,Mus musculus
,,,,Autocuration,BAO_0000019,8076,0,,U,,,12634,CHEMBL619436,,AUC (0-4 hr) ug/ml/h,Plasma,A,22224,1,,1969.0,
,,,,Intermediate,BAO_0000218,8077,1,10116.0,N,,,14810,CHEMBL619437,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,8078,0,,U,,,13889,CHEMBL619438,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,8079,1,10090.0,N,,,10018,CHEMBL619439,,Compound was evaluated for Area under curve in mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8080,1,10116.0,N,,,8758,CHEMBL619440,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,8081,0,,U,,,8758,CHEMBL619441,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,F,22224,1,,,
,,,,Intermediate,BAO_0000218,8082,1,10116.0,N,,,8758,CHEMBL619442,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,8083,0,,U,,,2249,CHEMBL875156,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,8084,0,,U,,,2249,CHEMBL619443,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,8085,0,,U,,,2249,CHEMBL619444,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,8086,0,,U,,,2249,CHEMBL623464,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,8087,1,10090.0,N,,,15115,CHEMBL623465,,Compound was evaluated for area under curve when administered through oral route in mouse,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8088,1,10116.0,N,,,6518,CHEMBL623466,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8089,1,10116.0,N,,,6518,CHEMBL623467,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8090,1,10116.0,N,,,6249,CHEMBL623468,,Plasma clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8091,1,10116.0,N,,,2463,CHEMBL622660,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8092,1,10116.0,N,,,4969,CHEMBL622661,,Plasma clearance rate in Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8093,1,10116.0,N,,,17720,CHEMBL622662,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,F,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8094,1,10116.0,N,,,3457,CHEMBL622663,,Pharmacokinetic property (total body clearance) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8095,1,10116.0,N,,,5983,CHEMBL622664,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8096,1,10116.0,N,,,6295,CHEMBL622665,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8097,1,10116.0,N,,,6296,CHEMBL622666,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8098,1,10116.0,N,,,17686,CHEMBL621615,,Cl in rat i.v. at 2 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8099,1,10116.0,N,,,17764,CHEMBL621616,,Clearance of compound after intravenous administration in rats at 24 uM/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8100,1,10116.0,N,,,5503,CHEMBL621617,,Clearance was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8101,1,10116.0,N,,,4368,CHEMBL621618,,Clearance by intravenous administration of 3.4 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8102,1,10116.0,N,,,6005,CHEMBL621619,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8103,1,10116.0,N,,,5031,CHEMBL621620,,Clearance rate after i.v. administration in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8104,1,10116.0,N,,,4890,CHEMBL621786,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8105,1,10116.0,N,,,5182,CHEMBL621787,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8106,1,10116.0,N,,,5979,CHEMBL621788,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8107,1,10116.0,N,,,5656,CHEMBL621789,,Clearance (Cl) after oral administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8108,1,10116.0,N,,,17804,CHEMBL621790,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8109,1,10116.0,N,,,4839,CHEMBL621791,,Compound was tested for plasma clearance in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,8110,1,10116.0,N,,,5041,CHEMBL621792,,In vitro microsome metabolism clearance in rat was determined,,A,50597,1,Microsomes,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,8111,1,10116.0,N,,,5041,CHEMBL621793,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,A,50597,1,Microsomes,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8112,1,10116.0,N,,,5974,CHEMBL621794,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8113,1,10116.0,N,,,5496,CHEMBL621795,,In vivo plasma clearance was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8114,1,10116.0,N,,,5739,CHEMBL621796,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,A,50597,1,,,Rattus norvegicus
Hepatocyte,In vivo,,401.0,Intermediate,BAO_0000218,8115,1,10116.0,N,,,5676,CHEMBL621797,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8116,1,10116.0,N,,,4239,CHEMBL621798,,Pharmacokinetic property (Plasma clearance) was measured in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8117,1,10116.0,N,,,5676,CHEMBL621799,,Pharmacokinetic property (clearance) in rat i.v.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8118,1,10116.0,N,,,1918,CHEMBL621800,,"Plasma Clearance was evaluated in rats, iv",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8119,1,10116.0,N,,,17800,CHEMBL621801,,Plasma clearance (in vivo) in rats was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8120,1,10116.0,N,,,6056,CHEMBL621802,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8121,1,10116.0,N,,,5496,CHEMBL618596,,Plasma clearance was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8122,1,10116.0,N,,,5939,CHEMBL618597,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8123,1,10116.0,N,,,5939,CHEMBL618598,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8124,1,10116.0,N,,,17752,CHEMBL618599,,Plasma clearance in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8125,1,10116.0,N,,,4576,CHEMBL618600,,Plasma clearance rate determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8126,1,10116.0,N,,,6011,CHEMBL618601,,Plasma clearance was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8127,1,10116.0,N,,,5510,CHEMBL618602,,Plasma clearance was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8128,1,10116.0,N,,,5948,CHEMBL618603,,Plasma clearance value in rat,,A,50597,1,,,Rattus norvegicus
,Ex vivo,,,Intermediate,BAO_0000218,8129,1,10116.0,N,,,6125,CHEMBL618604,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8130,1,10116.0,N,,,4839,CHEMBL618605,,Clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8131,1,10116.0,N,,,17686,CHEMBL618606,,Total body clearance in rat i.v. at 2 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8132,1,10116.0,N,,,6571,CHEMBL618607,,Clearance of compound in rats after intravenous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8133,1,10116.0,N,,,3364,CHEMBL618608,,Clearance after iv administration to rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8134,1,10116.0,N,,,13569,CHEMBL618609,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8135,1,10116.0,N,,,13569,CHEMBL618610,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8136,1,10116.0,N,,,13569,CHEMBL618611,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8137,1,10116.0,N,,,13569,CHEMBL618612,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8138,1,10116.0,N,,,13569,CHEMBL618613,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8139,1,10116.0,N,,,13569,CHEMBL621076,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8140,1,10116.0,N,,,13569,CHEMBL621077,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8141,1,10116.0,N,,,17670,CHEMBL621078,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8142,1,10116.0,N,,,5970,CHEMBL621251,,Clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8143,1,10116.0,N,,,6495,CHEMBL621252,,Clearance in rat after oral administration at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8144,1,10116.0,N,,,4590,CHEMBL621253,,Clearance in rat.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8145,1,10116.0,N,,,6193,CHEMBL621254,,Clearance rate following an oral dose of 20 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8146,1,10116.0,N,,,2832,CHEMBL621255,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8147,1,10116.0,N,,,1052,CHEMBL621256,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8148,1,10116.0,N,,,9866,CHEMBL621257,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8149,1,10116.0,N,,,9866,CHEMBL621258,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8150,1,10116.0,N,,,9866,CHEMBL621259,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8151,1,10116.0,N,,,9866,CHEMBL621260,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8152,1,10116.0,N,,,9866,CHEMBL876494,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8153,1,10116.0,N,,,9866,CHEMBL621261,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8154,1,10116.0,N,,,9866,CHEMBL621262,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8155,1,10116.0,N,,,9866,CHEMBL621263,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8156,1,10116.0,N,,,9866,CHEMBL621264,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8157,1,10116.0,N,,,9866,CHEMBL621265,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8158,1,10116.0,N,,,9866,CHEMBL621266,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8159,1,10116.0,N,,,9866,CHEMBL621267,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8160,1,10116.0,N,,,9866,CHEMBL621268,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8161,1,10116.0,N,,,9866,CHEMBL621269,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8162,1,10116.0,N,,,9866,CHEMBL621270,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8163,1,10116.0,N,,,9866,CHEMBL621271,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8164,1,10116.0,N,,,9866,CHEMBL621272,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8165,1,10116.0,N,,,9866,CHEMBL621273,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8166,1,10116.0,N,,,9866,CHEMBL621274,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8167,1,10116.0,N,,,9866,CHEMBL876495,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8168,1,10116.0,N,,,9866,CHEMBL621275,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8169,1,10116.0,N,,,9866,CHEMBL621276,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8170,1,10116.0,N,,,9866,CHEMBL621277,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8171,1,10116.0,N,,,9866,CHEMBL621278,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8172,1,10116.0,N,,,9866,CHEMBL621279,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8173,1,10116.0,N,,,9866,CHEMBL621280,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8174,1,10116.0,N,,,9866,CHEMBL621281,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8175,1,10116.0,N,,,9866,CHEMBL621282,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8176,1,10116.0,N,,,9866,CHEMBL621283,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8177,1,10116.0,N,,,9866,CHEMBL621284,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8178,1,10116.0,N,,,9866,CHEMBL621285,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8179,1,10116.0,N,,,9866,CHEMBL621286,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8180,1,10116.0,N,,,9866,CHEMBL623220,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8181,1,10116.0,N,,,9866,CHEMBL623221,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8182,1,10116.0,N,,,9866,CHEMBL876029,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8183,1,10116.0,N,,,9866,CHEMBL623222,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8184,1,10116.0,N,,,9866,CHEMBL623223,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8185,1,10116.0,N,,,9866,CHEMBL621445,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8186,1,10116.0,N,,,13950,CHEMBL621446,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8187,1,10116.0,N,,,13950,CHEMBL621447,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8188,1,10116.0,N,,,13950,CHEMBL619681,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8189,1,10116.0,N,,,13950,CHEMBL619682,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8190,1,10116.0,N,,,13950,CHEMBL619683,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8191,1,10116.0,N,,,13950,CHEMBL619684,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8192,1,10116.0,N,,,13950,CHEMBL619685,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8193,1,10116.0,N,,,13950,CHEMBL619686,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8194,1,10116.0,N,,,13950,CHEMBL619687,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8195,1,10116.0,N,,,13950,CHEMBL619688,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8196,1,10116.0,N,,,13950,CHEMBL619689,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8197,1,10116.0,N,,,13950,CHEMBL619690,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8198,1,10116.0,N,,,13950,CHEMBL619691,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8199,1,10116.0,N,,,6062,CHEMBL619692,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Expert,BAO_0000218,8200,1,10116.0,N,,,3598,CHEMBL619693,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8201,1,10116.0,N,,,1908,CHEMBL619694,,Vc value after IV dose at a dose of 5 mg/kg in rats.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8202,1,10116.0,N,,,17596,CHEMBL619695,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8203,1,10116.0,N,,,4891,CHEMBL619696,,Compound was evaluated for pharmacokinetic parameter volume of distribution,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8204,1,10116.0,N,,,740,CHEMBL619697,,Compound was evaluated for volume of distribution in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8205,1,10116.0,N,,,16366,CHEMBL619698,,Steady state volume distribution was determined; steady state(ss),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8206,1,10116.0,N,,,3364,CHEMBL619699,,Steady state volume of distribution after iv administration to rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8207,1,10116.0,N,,,2552,CHEMBL619700,,Steady state volume of distribution dosing at 3 mg/kg iv,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8208,1,10116.0,N,,,406,CHEMBL619701,,The compound was evaluated for volume of distribution in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8209,1,10116.0,N,,,12500,CHEMBL619702,,The compound was tested for volume of distribution in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8210,1,10116.0,N,,,12500,CHEMBL620335,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8211,1,10116.0,N,,,5656,CHEMBL620336,,Volume distribution (VD) after oral administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8212,1,10116.0,N,,,17671,CHEMBL620337,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8213,1,10116.0,N,,,1094,CHEMBL620520,,Volume distribution in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8214,1,10116.0,N,,,5833,CHEMBL620521,,Volume distribution in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8215,1,10116.0,N,,,5939,CHEMBL875825,,Volume distribution in rat after peroral administration at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8216,1,10116.0,N,,,5939,CHEMBL620522,,Volume distribution in rat after peroral administration at 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8217,1,10116.0,N,,,6005,CHEMBL620523,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8218,1,10116.0,N,,,1696,CHEMBL620524,,Volume of distribution in rat.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8219,1,10116.0,N,,,6672,CHEMBL620525,,Volume of distribution in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8220,1,10116.0,N,,,6673,CHEMBL620526,,Volume of distribution in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8221,1,10116.0,N,,,5871,CHEMBL620527,,Volume of distribution in rat by iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8222,1,10116.0,N,,,6803,CHEMBL620528,,Volume of distribution in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8223,1,10116.0,N,,,5199,CHEMBL620529,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8224,1,10116.0,N,,,4727,CHEMBL620530,,Volume distribution at the dose of 2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8225,1,10116.0,N,,,16367,CHEMBL620531,,Steady state volume of distribution was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8226,0,9544.0,U,,,5005,CHEMBL620532,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,A,22224,1,,,Macaca mulatta
,In vivo,,,Intermediate,BAO_0000218,8227,0,10116.0,U,,,5005,CHEMBL620533,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8228,0,10116.0,U,,,5005,CHEMBL620534,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8229,1,10116.0,N,,,15765,CHEMBL620535,,Mean (%CV) PK parameters for Vdss(mL/kg).,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8230,1,10116.0,N,,,2792,CHEMBL875826,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8231,1,10116.0,N,,,2792,CHEMBL620536,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8232,1,10116.0,N,,,5334,CHEMBL620537,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8233,1,10116.0,N,,,5334,CHEMBL618526,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8234,1,10116.0,N,,,5739,CHEMBL618527,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8235,1,10116.0,N,,,5789,CHEMBL618528,,Pharmacokinetic property (Vdss) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8236,1,10116.0,N,,,4239,CHEMBL618529,,Pharmacokinetic property (vdss) was measured in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8237,1,10116.0,N,,,4709,CHEMBL618530,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8238,1,10116.0,N,,,6642,CHEMBL618531,,Volume of distribution in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8239,1,10116.0,N,,,5247,CHEMBL618532,,The pharmacokinetic parameter volume of distribution in vivo in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8240,1,10116.0,N,,,17720,CHEMBL618533,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,F,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8241,1,10116.0,N,,,17686,CHEMBL618534,,Vdss in rat i.v. at 2 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8242,1,10116.0,N,,,4689,CHEMBL618535,,Volume distribution after intravenous administration (1 mg/kg) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8243,1,10116.0,N,,,5654,CHEMBL618536,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8244,1,10116.0,N,,,5654,CHEMBL618537,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8245,1,10116.0,N,,,4527,CHEMBL618538,,Volume distribution at a dose of 10 uM/kg in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8246,1,10116.0,N,,,4521,CHEMBL618539,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8247,1,10116.0,N,,,6057,CHEMBL618540,,Volume distribution was calculated in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8248,1,10116.0,N,,,5510,CHEMBL618541,,Volume distribution was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8249,1,10116.0,N,,,2938,CHEMBL618542,,Volume of distribution after intravenous administration was evaluated in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8250,1,10116.0,N,,,6679,CHEMBL622544,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8251,1,10116.0,N,,,6685,CHEMBL622545,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8252,1,10116.0,N,,,6685,CHEMBL622546,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8253,1,10116.0,N,,,6685,CHEMBL622547,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8254,1,10116.0,N,,,5145,CHEMBL622548,,Volume of distribution in steady state was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8255,1,10116.0,N,,,6467,CHEMBL622549,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8256,1,10116.0,N,,,6467,CHEMBL622550,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8257,1,10090.0,N,,,15115,CHEMBL622551,,Compound was evaluated for area under curve when administered through oral route to mouse,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8258,1,10116.0,N,,,8758,CHEMBL622552,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8259,1,10116.0,N,,,8758,CHEMBL622553,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,8260,0,,U,,,8267,CHEMBL622554,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,F,22224,1,,,
,,,,Intermediate,BAO_0000218,8261,1,9615.0,N,,,8267,CHEMBL622555,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,8262,1,10090.0,N,,,14239,CHEMBL622556,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8263,1,10090.0,N,,,14239,CHEMBL622557,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8264,1,10090.0,N,,,10754,CHEMBL622558,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Blood,A,50594,1,,178.0,Mus musculus
,,,,Intermediate,BAO_0000218,8265,1,10090.0,N,,,10754,CHEMBL622559,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Blood,A,50594,1,,178.0,Mus musculus
,,,,Intermediate,BAO_0000218,8266,1,9615.0,N,,,10754,CHEMBL622560,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,8267,1,10116.0,N,,,14681,CHEMBL622561,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8268,1,10116.0,N,,,14681,CHEMBL622562,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8269,1,10116.0,N,,,14681,CHEMBL622563,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,8270,0,,U,,,13118,CHEMBL622564,,Concentration of compound in Central nervous system,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,8271,0,,U,,,13118,CHEMBL622565,,Concentration of compound in Central nervous system; Not detectable,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,8272,1,10090.0,N,,,13318,CHEMBL622566,,"Concentration of diester in the blood, following oral administration in mice",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8273,1,10090.0,N,,,13318,CHEMBL624515,,"Concentration of monoester in the blood, following oral administration in mice",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8274,1,10090.0,N,,,13318,CHEMBL624516,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000019,8275,0,,U,,,15692,CHEMBL624517,,Evaluated for Pharmacokinetic property: Area under the curve,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,8276,1,10090.0,N,,,14839,CHEMBL624518,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8277,1,9541.0,N,,,14839,CHEMBL624519,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8278,1,9541.0,N,,,14839,CHEMBL624520,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8279,1,9541.0,N,,,14839,CHEMBL624521,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8280,1,9541.0,N,,,14839,CHEMBL624522,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8281,1,9541.0,N,,,14839,CHEMBL624523,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8282,1,9541.0,N,,,14839,CHEMBL624409,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8283,1,9541.0,N,,,14839,CHEMBL624410,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8284,1,9541.0,N,,,14839,CHEMBL624411,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8285,1,9541.0,N,,,14839,CHEMBL623531,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8286,1,9541.0,N,,,14839,CHEMBL623532,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8287,1,9541.0,N,,,14839,CHEMBL623533,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8288,1,9541.0,N,,,14839,CHEMBL623534,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,8289,1,10090.0,N,,,14839,CHEMBL623535,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8290,1,10090.0,N,,,14839,CHEMBL623536,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8291,1,10090.0,N,,,14839,CHEMBL623537,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8292,1,10090.0,N,,,14839,CHEMBL623538,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8293,1,10090.0,N,,,14839,CHEMBL623539,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8294,1,10090.0,N,,,14839,CHEMBL623540,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8295,1,10090.0,N,,,14839,CHEMBL623541,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8296,1,10090.0,N,,,14839,CHEMBL623542,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8297,1,10090.0,N,,,14839,CHEMBL623543,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8298,1,10090.0,N,,,14839,CHEMBL623544,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8299,1,10090.0,N,,,14839,CHEMBL623545,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8300,1,10090.0,N,,,14839,CHEMBL623546,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8301,1,10116.0,N,,,5408,CHEMBL623547,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8302,1,10116.0,N,,,6827,CHEMBL623548,,High i.v. clearance in Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,8303,1,10116.0,N,,,17538,CHEMBL623549,,In vitro clearance in rat liver microsomes,Liver,A,50597,1,Microsomes,2107.0,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,8304,1,10116.0,N,,,6331,CHEMBL623550,,Intrinsic clearance in rat liver microsomes was determined,Liver,A,50597,1,Microsomes,2107.0,Rattus norvegicus
Hepatocyte,In vitro,,401.0,Intermediate,BAO_0000218,8305,1,10116.0,N,,,5948,CHEMBL875276,,Intrinsic clearance in rat hepatocytes was determined,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8306,1,10116.0,N,,,4026,CHEMBL621872,,Plasma Clearance was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8307,1,10116.0,N,,,6647,CHEMBL621873,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8308,1,10116.0,N,,,1696,CHEMBL621874,,Plasma clearance in rat.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8309,1,10116.0,N,,,6597,CHEMBL621875,,Plasma clearance in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8310,1,10116.0,N,,,347,CHEMBL621876,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8311,1,10116.0,N,,,16423,CHEMBL621877,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8312,1,10116.0,N,,,2879,CHEMBL621878,,Plasma clearance was measured in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8313,1,10116.0,N,,,4883,CHEMBL621879,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8314,1,10116.0,N,,,5328,CHEMBL621880,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8315,1,10116.0,N,,,5160,CHEMBL621881,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8316,1,10116.0,N,,,17582,CHEMBL621882,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8317,1,10116.0,N,,,17651,CHEMBL875283,,Total clearance at 1 mg/kg was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8318,1,10116.0,N,,,17651,CHEMBL621883,,Total clearance at 10 mg/kg was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8319,1,10116.0,N,,,6596,CHEMBL621884,,Clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8320,1,10116.0,N,,,4796,CHEMBL621885,,Plasma clearance rate determined in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8321,1,10116.0,N,,,6850,CHEMBL621886,,Clearance of compound in rat was evaluated,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8322,1,10116.0,N,,,5932,CHEMBL621887,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8323,1,10116.0,N,,,3371,CHEMBL621888,,Pharmacokinetic property (blood clearance) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8324,1,10116.0,N,,,2083,CHEMBL621889,,Plasma clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8325,1,10116.0,N,,,4942,CHEMBL621890,,Plasma clearance in rats,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,8326,1,10116.0,N,,,6838,CHEMBL621891,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Liver,A,50597,1,Microsomes,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8327,1,10116.0,N,,,5353,CHEMBL621892,,Clearance in Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8328,1,10116.0,N,,,6641,CHEMBL621893,,Clearance rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8329,1,10116.0,N,,,6641,CHEMBL621894,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8330,1,10116.0,N,,,6641,CHEMBL621895,,Clearance rat; Not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8331,1,10116.0,N,,,6444,CHEMBL875284,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8332,1,10116.0,N,,,6444,CHEMBL618699,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8333,1,10116.0,N,,,6444,CHEMBL618700,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8334,1,10116.0,N,,,6211,CHEMBL618701,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8335,1,10116.0,N,,,12873,CHEMBL876600,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8336,1,10116.0,N,,,6570,CHEMBL618702,,Clearance of compound in rat after 1 mg/kg i.v. administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8337,1,10116.0,N,,,3341,CHEMBL618703,,Compound was evaluated for Hepatic clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8338,1,10116.0,N,,,4891,CHEMBL618704,,In vivo clearance after 5 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8339,1,10116.0,N,,,1094,CHEMBL618705,,Compound was tested for plasma clearance in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8340,1,10116.0,N,,,2938,CHEMBL618706,,Hepatic clearance after intravenous administration was evaluated in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8341,1,10116.0,N,,,17853,CHEMBL618707,,Lower clearance in rat (i.v.) at 0.5 mpk,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8342,1,10116.0,N,,,6049,CHEMBL618708,,Pharmacokinetic parameter expressed as plasma clearance in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8343,1,10116.0,N,,,5789,CHEMBL618709,,Pharmacokinetic property (Clp) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8344,1,10116.0,N,,,4514,CHEMBL618710,,Plasma clearance in Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8345,1,10116.0,N,,,6448,CHEMBL618711,,Plasma clearance (Clp) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8346,1,10116.0,N,,,6062,CHEMBL618712,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8347,1,10116.0,N,,,5710,CHEMBL618713,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8348,1,10116.0,N,,,4709,CHEMBL618714,,Plasma clearance after intravenous administration of 1 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8349,1,10116.0,N,,,4521,CHEMBL618715,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8350,1,10116.0,N,,,1742,CHEMBL618716,,Plasma clearance in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8351,1,10116.0,N,,,6057,CHEMBL876601,,Plasma clearance measured in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8352,1,10116.0,N,,,6057,CHEMBL618717,,Plasma clearance was calculated in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8353,1,10116.0,N,,,5145,CHEMBL618718,,Plasma clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8354,1,10116.0,N,,,5833,CHEMBL618719,,Plasma clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8355,1,10116.0,N,,,6453,CHEMBL618720,,Plasma clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8356,1,10116.0,N,,,6640,CHEMBL618721,,Plasma clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8357,1,10116.0,N,,,6305,CHEMBL621477,,Plasma clearance in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8358,1,10116.0,N,,,6642,CHEMBL621478,,Plasma clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8359,1,10116.0,N,,,5472,CHEMBL621479,,Plasma clearance was evaluated in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8360,1,10116.0,N,,,5472,CHEMBL621480,,Plasma clearance was evaluated in rat; Not tested,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8361,1,10116.0,N,,,5144,CHEMBL621481,,Plasma clearance rate was determined for the compound in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8362,1,10116.0,N,,,6685,CHEMBL621482,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8363,1,10116.0,N,,,6685,CHEMBL621483,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8364,1,10116.0,N,,,6685,CHEMBL621484,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8365,1,10116.0,N,,,13950,CHEMBL621485,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8366,1,10116.0,N,,,13950,CHEMBL621486,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8367,1,10116.0,N,,,13950,CHEMBL621487,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8368,1,10116.0,N,,,13950,CHEMBL621488,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8369,1,10116.0,N,,,13950,CHEMBL621489,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8370,1,10116.0,N,,,13950,CHEMBL621490,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8371,1,10116.0,N,,,13950,CHEMBL621491,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8372,1,10116.0,N,,,13950,CHEMBL621492,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8373,1,10116.0,N,,,13950,CHEMBL621493,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8374,1,10116.0,N,,,13950,CHEMBL621494,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8375,1,10116.0,N,,,13950,CHEMBL621495,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8376,1,10116.0,N,,,13950,CHEMBL621496,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8377,1,10116.0,N,,,13950,CHEMBL621497,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8378,1,10116.0,N,,,13950,CHEMBL621498,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8379,1,10116.0,N,,,13950,CHEMBL621499,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8380,1,10116.0,N,,,13950,CHEMBL618634,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8381,1,10116.0,N,,,13950,CHEMBL618635,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8382,1,10116.0,N,,,13950,CHEMBL618636,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8383,1,10116.0,N,,,13950,CHEMBL619737,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8384,1,10116.0,N,,,13950,CHEMBL619738,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8385,1,10116.0,N,,,13950,CHEMBL624329,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8386,1,10116.0,N,,,13950,CHEMBL624330,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8387,1,10116.0,N,,,13950,CHEMBL624331,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8388,1,10116.0,N,,,13950,CHEMBL624332,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8389,1,10116.0,N,,,13950,CHEMBL624333,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8390,1,10116.0,N,,,13950,CHEMBL624334,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8391,1,10116.0,N,,,13950,CHEMBL624335,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8392,1,10116.0,N,,,13950,CHEMBL620016,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8393,1,10116.0,N,,,13950,CHEMBL620169,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8394,1,10116.0,N,,,13950,CHEMBL620170,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8395,1,10116.0,N,,,13950,CHEMBL620171,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8396,1,10116.0,N,,,13950,CHEMBL620172,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8397,1,10116.0,N,,,13950,CHEMBL620173,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8398,1,10116.0,N,,,13950,CHEMBL620174,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8399,1,10116.0,N,,,13950,CHEMBL620175,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8400,1,10116.0,N,,,13950,CHEMBL620176,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8401,1,10116.0,N,,,13950,CHEMBL620177,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Stomach,A,50597,1,,945.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8402,1,10116.0,N,,,13950,CHEMBL620178,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8403,1,10116.0,N,,,13950,CHEMBL620179,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8404,1,10116.0,N,,,13950,CHEMBL620180,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8405,1,10116.0,N,,,6570,CHEMBL620181,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8406,1,10116.0,N,,,6571,CHEMBL620182,,Volume of distribution of compound in rats after intravenous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8407,1,10116.0,N,,,6453,CHEMBL620183,,Volume of distribution in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8408,1,10116.0,N,,,6444,CHEMBL620184,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8409,1,10116.0,N,,,6444,CHEMBL620185,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8410,1,10116.0,N,,,6444,CHEMBL620186,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8411,1,10116.0,N,,,5353,CHEMBL620187,,Volume of distribution was determined in Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8412,1,10116.0,N,,,5334,CHEMBL620188,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8413,1,10116.0,N,,,5334,CHEMBL620189,,Volume of distribution was reported in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8414,1,10116.0,N,,,6641,CHEMBL620190,,Volumes of distribution in rat after peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8415,1,10116.0,N,,,6641,CHEMBL620191,,Volumes of distribution in rat after po administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8416,1,10116.0,N,,,6641,CHEMBL620192,,Volumes of distribution in rat after po administration; Not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8417,1,10116.0,N,,,5676,CHEMBL620193,,Pharmacokinetic property (Volume) in rat i.v.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8418,1,10116.0,N,,,6410,CHEMBL620194,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8419,1,10116.0,N,,,17670,CHEMBL876730,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8420,1,10116.0,N,,,6495,CHEMBL620195,,Volume distribution in rat after oral administration at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8421,1,10116.0,N,,,5408,CHEMBL620196,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8422,1,10116.0,N,,,4883,CHEMBL620197,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8423,1,10116.0,N,,,6647,CHEMBL620198,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8424,1,10116.0,N,,,6495,CHEMBL620199,,Volume of distribution in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8425,1,10116.0,N,,,2661,CHEMBL620200,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8426,1,10116.0,N,,,2661,CHEMBL620201,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8427,1,10116.0,N,,,5974,CHEMBL620202,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8428,1,10116.0,N,,,5974,CHEMBL620203,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8429,1,10116.0,N,,,5974,CHEMBL620204,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8430,1,10116.0,N,,,5974,CHEMBL620205,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8431,1,10116.0,N,,,5960,CHEMBL624664,,Pharmacokinetic parameter (Vss) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8432,1,10116.0,N,,,5676,CHEMBL624665,,Pharmacokinetic property (Volume) in rat i.v.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8433,1,10116.0,N,,,5948,CHEMBL624666,,Pharmacokinetic property (Vss) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8434,1,10116.0,N,,,5979,CHEMBL624667,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8435,1,10116.0,N,,,5978,CHEMBL624668,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8436,1,10116.0,N,,,5978,CHEMBL624669,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8437,1,10116.0,N,,,5978,CHEMBL624670,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8438,1,10116.0,N,,,5978,CHEMBL624671,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8439,1,10116.0,N,,,6448,CHEMBL624672,,Steady state volume distribution in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8440,1,10116.0,N,,,12873,CHEMBL624673,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8441,1,10116.0,N,,,4576,CHEMBL624674,,Steady state volume of distribution determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8442,1,10116.0,N,,,17582,CHEMBL624675,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8443,1,10116.0,N,,,1466,CHEMBL621728,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8444,1,10116.0,N,,,5182,CHEMBL621729,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8445,1,10116.0,N,,,5182,CHEMBL621730,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8446,1,10116.0,N,,,6535,CHEMBL621731,,Volume distribution in rat after administration of 2 mg/kg iv,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8447,1,10116.0,N,,,6535,CHEMBL621732,,Volume distribution in rat after administration of 2 mg/kg iv,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8448,1,10116.0,N,,,5041,CHEMBL621908,,Volume in steady state distribution value was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8449,1,10116.0,N,,,5041,CHEMBL875347,,Volume in steady state distribution value was determined; ND denotes no data,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8450,1,10116.0,N,,,5041,CHEMBL621909,,Volume in steady state distribution value was determined; ND denotes not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8451,1,10116.0,N,,,17065,CHEMBL621910,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8452,1,10116.0,N,,,6597,CHEMBL621911,,Volume of distribution at steady state was evaluated in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8453,1,10116.0,N,,,15662,CHEMBL621912,,Volume of distribution at steady state was observed after intravenous administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8454,1,10116.0,N,,,6485,CHEMBL621913,,Volume of distribution in steady state was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8455,1,10116.0,N,,,17655,CHEMBL621914,,Volume of distribution in steady state was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8456,1,10116.0,N,,,6616,CHEMBL621915,,Volume of distribution after i.v. administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8457,1,10116.0,N,,,1916,CHEMBL621916,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8458,1,10090.0,N,,,16438,CHEMBL621917,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8459,1,10090.0,N,,,16438,CHEMBL621918,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8460,1,10090.0,N,,,16438,CHEMBL621919,,Biodistribution of compound (oxidized form) in spleen tissue,Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8461,1,10090.0,N,,,16438,CHEMBL621920,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8462,1,10090.0,N,,,16438,CHEMBL621921,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8463,1,10090.0,N,,,16438,CHEMBL622401,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8464,1,10090.0,N,,,16438,CHEMBL875348,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8465,1,10090.0,N,,,16438,CHEMBL622402,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8466,1,10090.0,N,,,16438,CHEMBL622403,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8467,1,10090.0,N,,,16438,CHEMBL622404,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8468,1,10090.0,N,,,16438,CHEMBL622405,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Brain,A,50594,1,,955.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8469,1,10090.0,N,,,16438,CHEMBL622406,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Brain,A,50594,1,,955.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8470,1,10090.0,N,,,16438,CHEMBL622407,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Brain,A,50594,1,,955.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8471,1,10090.0,N,,,16438,CHEMBL622408,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8472,1,10090.0,N,,,16438,CHEMBL622409,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8473,1,10090.0,N,,,16438,CHEMBL622410,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8474,1,10090.0,N,,,16438,CHEMBL622411,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8475,1,10090.0,N,,,16438,CHEMBL627864,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8476,1,10090.0,N,,,16438,CHEMBL627865,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8477,1,10090.0,N,,,16438,CHEMBL627866,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8478,1,10090.0,N,,,16438,CHEMBL627751,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8479,1,10090.0,N,,,16438,CHEMBL627752,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8480,1,10090.0,N,,,16438,CHEMBL627753,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8481,1,10090.0,N,,,16438,CHEMBL627754,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Spleen,A,50594,1,,2106.0,Mus musculus
,,,,Intermediate,BAO_0000218,8482,1,10090.0,N,,,12467,CHEMBL627755,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8483,1,10090.0,N,,,17208,CHEMBL627756,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Brain,A,50594,1,,955.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8484,1,10090.0,N,,,17208,CHEMBL627757,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Brain,A,50594,1,,955.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8485,1,10090.0,N,,,17208,CHEMBL627758,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Brain,A,50594,1,,955.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8486,1,10090.0,N,,,17208,CHEMBL627759,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Brain,A,50594,1,,955.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8487,1,10090.0,N,,,17208,CHEMBL627760,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Brain,A,50594,1,,955.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8488,1,10090.0,N,,,17208,CHEMBL627761,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Brain,A,50594,1,,955.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8489,1,10090.0,N,,,17208,CHEMBL876811,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8490,1,10090.0,N,,,17208,CHEMBL627762,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8491,1,10090.0,N,,,17208,CHEMBL627763,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8492,1,10090.0,N,,,17208,CHEMBL627764,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8493,1,10090.0,N,,,17208,CHEMBL627765,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8494,1,10090.0,N,,,17208,CHEMBL627766,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8495,1,10090.0,N,,,17208,CHEMBL627767,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8496,1,10090.0,N,,,17208,CHEMBL627768,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8497,1,10090.0,N,,,17208,CHEMBL628422,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8498,1,10090.0,N,,,17208,CHEMBL628423,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8499,1,10116.0,N,,,5089,CHEMBL628424,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8500,1,10116.0,N,,,5089,CHEMBL628425,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8501,1,10116.0,N,,,4257,CHEMBL628426,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8502,1,10116.0,N,,,6679,CHEMBL628427,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8503,1,10116.0,N,,,5546,CHEMBL626938,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8504,1,10116.0,N,,,6141,CHEMBL626939,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8505,1,10116.0,N,,,5334,CHEMBL626940,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8506,1,10116.0,N,,,5334,CHEMBL626941,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8507,1,10116.0,N,,,5334,CHEMBL626942,,Plasma clearance was reported in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8508,1,10116.0,N,,,4689,CHEMBL876812,,Plasma clearance after intravenous administration (1 mg/kg) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8509,1,10116.0,N,,,6848,CHEMBL626943,,Plasma clearance of compound in rats was evaluated,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8510,1,10116.0,N,,,6848,CHEMBL626944,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8511,1,10116.0,N,,,6467,CHEMBL626945,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8512,1,10116.0,N,,,6467,CHEMBL626946,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8513,1,10116.0,N,,,4956,CHEMBL626856,,Plasma clearance rate in Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8514,1,10116.0,N,,,5529,CHEMBL626857,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8515,1,10116.0,N,,,406,CHEMBL626858,,The compound was evaluated for plasma clearance in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8516,1,10116.0,N,,,17655,CHEMBL627018,,Total plasma clearance in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8517,1,10116.0,N,,,3293,CHEMBL625331,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8518,1,10116.0,N,,,4075,CHEMBL625332,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8519,1,10116.0,N,,,2792,CHEMBL877590,,C max was determined at 10 mg/kg po dose in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8520,1,10116.0,N,,,2792,CHEMBL625333,,C max was determined at 3 mg/kg po dose in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8521,1,10116.0,N,,,17594,CHEMBL625334,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8522,1,10116.0,N,,,17594,CHEMBL625335,,Cmax after single intravenous bolus of 1 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8523,1,10116.0,N,,,4762,CHEMBL625336,,Cmax of compound at 5 mg/kg after po administration was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8524,1,10116.0,N,,,17509,CHEMBL625337,,Cmax 24 hr after 10 mg/kg oral administration in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8525,1,10116.0,N,,,17509,CHEMBL625338,,Cmax 24 hr after 2 mg/kg oral administration in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8526,1,10116.0,N,,,1466,CHEMBL625339,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8527,1,10116.0,N,,,6535,CHEMBL625340,,Cmax in rat after administration of 2 mg/kg iv,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8528,1,10116.0,N,,,6535,CHEMBL625341,,Cmax in rat after administration of 2 mg/kg iv,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8529,1,10116.0,N,,,3169,CHEMBL622687,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8530,1,10116.0,N,,,6515,CHEMBL622688,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8531,1,10116.0,N,,,11149,CHEMBL622689,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8532,1,10116.0,N,,,11149,CHEMBL620295,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8533,1,10116.0,N,,,17858,CHEMBL620296,,Cmax after 10 mg/kg oral administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8534,1,10116.0,N,,,6518,CHEMBL620297,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8535,1,10116.0,N,,,6518,CHEMBL620298,,Cmax after IV dosing at 1 mg/kg in rat; no data,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8536,1,10116.0,N,,,4426,CHEMBL620299,,Cmax after oral administration at 20 mpk in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8537,1,10116.0,N,,,4426,CHEMBL620300,,Cmax after oral administration at 20 mpk in rats; Not performed.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8538,1,10116.0,N,,,4426,CHEMBL620301,,Cmax after oral administration at 20 mpk in rats d; Not performed.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8539,1,10116.0,N,,,5656,CHEMBL620302,,Cmax after oral administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8540,1,10116.0,N,,,6518,CHEMBL620303,,Cmax after oral administration at a dose of 2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8541,1,10116.0,N,,,6518,CHEMBL620304,,Cmax after oral administration at a dose of 4 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8542,1,10116.0,N,,,6113,CHEMBL620305,,Cmax in rats after 20 mg/kg oral dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8543,1,10116.0,N,,,17764,CHEMBL620306,,Cmax after peroral administration in rats at 2.4 uM/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8544,1,10116.0,N,,,4756,CHEMBL620307,,Cmax at the dose of 2 mg/Kg administered perorally in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8545,1,10116.0,N,,,4756,CHEMBL620308,,Cmax at the dose of 5 mg/Kg administered perorally in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8546,1,10116.0,N,,,6402,CHEMBL620309,,Cmax by administering at 20 mg/kg p.o. in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8547,1,10116.0,N,,,5610,CHEMBL620310,,Cmax in male rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8548,1,10116.0,N,,,5207,CHEMBL620311,,Cmax in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8549,1,10116.0,N,,,6011,CHEMBL620312,,Cmax in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8550,1,10116.0,N,,,6504,CHEMBL620313,,Cmax in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8551,1,10116.0,N,,,6046,CHEMBL620314,,Cmax in rat at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8552,1,10116.0,N,,,6504,CHEMBL620315,,Cmax in rat at the dose of 1 mg/kg i.v.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8553,1,10116.0,N,,,5874,CHEMBL620316,,Cmax in rat by po administration at a dose of 40 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8554,1,10116.0,N,,,17686,CHEMBL620317,,Cmax in rat p.o. at 20 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8555,1,10116.0,N,,,5836,CHEMBL620318,,Cmax in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8556,1,10116.0,N,,,17596,CHEMBL620319,,Cmax in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8557,1,10116.0,N,,,16423,CHEMBL620320,,Cmax was evaluated after 20 uM/kg of peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8558,1,10116.0,N,,,17804,CHEMBL620321,,Cmax was measured in rats after peroral administration at 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8559,1,10116.0,N,,,1908,CHEMBL620322,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8560,1,10116.0,N,,,13950,CHEMBL620323,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8561,1,10116.0,N,,,13950,CHEMBL620324,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Frontal cortex,A,50597,1,,1870.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8562,1,10116.0,N,,,13950,CHEMBL620325,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Frontal cortex,A,50597,1,,1870.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8563,1,10116.0,N,,,13950,CHEMBL620326,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8564,1,10116.0,N,,,13950,CHEMBL620327,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8565,1,10116.0,N,,,13950,CHEMBL620328,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8566,1,10116.0,N,,,13950,CHEMBL620329,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8567,1,10116.0,N,,,13950,CHEMBL620330,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Midbrain,A,50597,1,,1891.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8568,1,10116.0,N,,,13950,CHEMBL875286,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Midbrain,A,50597,1,,1891.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8569,1,10116.0,N,,,13950,CHEMBL620331,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8570,1,10116.0,N,,,13950,CHEMBL620332,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8571,1,10116.0,N,,,13950,CHEMBL620333,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8572,1,10116.0,N,,,13950,CHEMBL620334,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8573,1,10116.0,N,,,16434,CHEMBL621015,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8574,1,10116.0,N,,,16434,CHEMBL621016,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8575,1,10116.0,N,,,16434,CHEMBL621191,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8576,1,10116.0,N,,,16434,CHEMBL621192,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8577,1,10116.0,N,,,16434,CHEMBL621193,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8578,1,10116.0,N,,,16434,CHEMBL621194,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8579,1,10116.0,N,,,16434,CHEMBL624204,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8580,1,10116.0,N,,,16434,CHEMBL624205,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8581,1,10116.0,N,,,16435,CHEMBL624206,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8582,1,10116.0,N,,,16435,CHEMBL624207,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8583,1,10116.0,N,,,16435,CHEMBL624208,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8584,1,10116.0,N,,,16435,CHEMBL624209,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8585,1,10116.0,N,,,16435,CHEMBL624210,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8586,1,10116.0,N,,,16435,CHEMBL624211,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8587,1,10116.0,N,,,16435,CHEMBL624212,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8588,1,10116.0,N,,,16435,CHEMBL624213,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8589,1,10116.0,N,,,16434,CHEMBL876611,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8590,1,10116.0,N,,,16434,CHEMBL624214,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8591,1,10116.0,N,,,16434,CHEMBL624215,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8592,1,10116.0,N,,,16435,CHEMBL624216,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8593,1,10116.0,N,,,16435,CHEMBL624217,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8594,1,10116.0,N,,,16435,CHEMBL624218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8595,1,10116.0,N,,,16435,CHEMBL624219,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8596,1,10116.0,N,,,16435,CHEMBL624220,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8597,1,10116.0,N,,,16435,CHEMBL624221,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8598,1,10116.0,N,,,16434,CHEMBL624222,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8599,1,10116.0,N,,,16434,CHEMBL624223,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8600,1,10116.0,N,,,16434,CHEMBL624224,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8601,1,10116.0,N,,,16434,CHEMBL624225,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8602,1,10116.0,N,,,17764,CHEMBL622420,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8603,1,10116.0,N,,,5031,CHEMBL622421,,Volume of steady state distribution after i.v. administration in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8604,1,10116.0,N,,,6215,CHEMBL622422,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8605,1,10116.0,N,,,17671,CHEMBL622423,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8606,1,10116.0,N,,,17752,CHEMBL622424,,Vss was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8607,1,10116.0,N,,,6596,CHEMBL622425,,Vss in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8608,1,10116.0,N,,,16423,CHEMBL876612,,Vss was evaluated after 10 uM/kg of intra arterial administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8609,1,10116.0,N,,,15662,CHEMBL622426,,volume of distribution at steady state was observed after intravenous administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8610,1,10116.0,N,,,6062,CHEMBL622427,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8611,1,10116.0,N,,,5874,CHEMBL622428,,Pharmacokinetic (PK) parameter Vz in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8612,1,10116.0,N,,,4942,CHEMBL622429,,Volume distribution in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8613,1,10116.0,N,,,17796,CHEMBL622430,,Volume of distribution in rat; No data,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8614,1,10116.0,N,,,4890,CHEMBL622431,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8615,1,10116.0,N,,,15765,CHEMBL622432,,% absorption predicted from in vitro rat ileum transport studies,Ileum,A,50597,1,,2116.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8616,1,10116.0,N,,,13569,CHEMBL622433,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8617,1,10116.0,N,,,13569,CHEMBL622434,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8618,1,10116.0,N,,,13569,CHEMBL622435,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8619,1,10116.0,N,,,13569,CHEMBL618748,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8620,1,10116.0,N,,,13569,CHEMBL618749,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8621,1,10116.0,N,,,13569,CHEMBL618750,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8622,1,10116.0,N,,,13569,CHEMBL618751,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8623,1,10116.0,N,,,13569,CHEMBL618752,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8624,1,10116.0,N,,,4576,CHEMBL618753,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8625,1,10116.0,N,,,750,CHEMBL618754,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8626,1,10116.0,N,,,750,CHEMBL618755,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8627,1,10116.0,N,,,4590,CHEMBL618756,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8628,1,10116.0,N,,,1716,CHEMBL618757,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8629,1,10116.0,N,,,1974,CHEMBL618758,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8630,1,10116.0,N,,,4502,CHEMBL621088,,Oral bioavailability in rat (dose 30 mg/kg),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8631,1,10116.0,N,,,3371,CHEMBL621089,,Pharmacokinetic property (cLogP) in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8632,1,10116.0,N,,,9099,CHEMBL621090,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Blood,F,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8633,1,10116.0,N,,,9099,CHEMBL621091,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Blood,F,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8634,1,10116.0,N,,,4590,CHEMBL876731,,Clearance in rat.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8635,1,10116.0,N,,,3184,CHEMBL621092,,Compound was evaluated for its clearance when administered intravenously in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8636,1,10116.0,N,,,16456,CHEMBL621093,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8637,1,10116.0,N,,,4199,CHEMBL621094,,Blood: Brain distribution ratio is determined in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8638,1,10116.0,N,,,4199,CHEMBL621095,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8639,1,10116.0,N,,,4199,CHEMBL621096,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8640,1,10116.0,N,,,8677,CHEMBL621097,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8641,1,10116.0,N,,,7449,CHEMBL621098,,Percent dose excreted in 0-48 hours administered ip to male rat,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8642,1,10116.0,N,,,11977,CHEMBL621099,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8643,1,10116.0,N,,,11977,CHEMBL621100,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8644,1,10116.0,N,,,11977,CHEMBL621101,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8645,1,10116.0,N,,,11977,CHEMBL621102,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8646,1,10116.0,N,,,11977,CHEMBL876732,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8647,1,10116.0,N,,,11977,CHEMBL621103,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8648,1,10116.0,N,,,11977,CHEMBL621104,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8649,1,10116.0,N,,,11977,CHEMBL621105,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8650,1,10116.0,N,,,11977,CHEMBL621106,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8651,1,10116.0,N,,,11977,CHEMBL621107,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8652,1,10116.0,N,,,11977,CHEMBL621108,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8653,1,10116.0,N,,,11977,CHEMBL621109,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8654,1,10090.0,N,,,17208,CHEMBL621110,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8655,1,10090.0,N,,,17208,CHEMBL621111,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8656,1,10090.0,N,,,17208,CHEMBL622541,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8657,1,10090.0,N,,,17208,CHEMBL622542,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8658,1,10090.0,N,,,17208,CHEMBL622543,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8659,1,10090.0,N,,,17208,CHEMBL624412,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8660,1,10090.0,N,,,17208,CHEMBL624413,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8661,1,10090.0,N,,,17208,CHEMBL624414,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8662,1,10090.0,N,,,17208,CHEMBL624415,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Lung,A,50594,1,,2048.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8663,1,10090.0,N,,,17208,CHEMBL624416,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Lung,A,50594,1,,2048.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8664,1,10090.0,N,,,17208,CHEMBL624417,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Lung,A,50594,1,,2048.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8665,1,10090.0,N,,,17208,CHEMBL624418,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Lung,A,50594,1,,2048.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8666,1,10090.0,N,,,17208,CHEMBL624419,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Lung,A,50594,1,,2048.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8667,1,10090.0,N,,,17208,CHEMBL624420,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Lung,A,50594,1,,2048.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8668,1,10090.0,N,,,17208,CHEMBL624421,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Muscle tissue,A,50594,1,,2385.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8669,1,10090.0,N,,,17208,CHEMBL624422,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Muscle tissue,A,50594,1,,2385.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8670,1,10090.0,N,,,17208,CHEMBL624423,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Muscle tissue,A,50594,1,,2385.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8671,1,10090.0,N,,,17208,CHEMBL625123,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Muscle tissue,A,50594,1,,2385.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8672,1,10090.0,N,,,17208,CHEMBL625124,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Muscle tissue,A,50594,1,,2385.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8673,1,10090.0,N,,,17208,CHEMBL625125,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Muscle tissue,A,50594,1,,2385.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8674,1,10090.0,N,,,17208,CHEMBL625126,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Zone of skin,A,50594,1,,14.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8675,1,10090.0,N,,,17208,CHEMBL626947,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Zone of skin,A,50594,1,,14.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8676,1,10090.0,N,,,17208,CHEMBL626948,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Zone of skin,A,50594,1,,14.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8677,1,10090.0,N,,,17208,CHEMBL626949,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Zone of skin,A,50594,1,,14.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8678,1,10090.0,N,,,17208,CHEMBL626950,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Zone of skin,A,50594,1,,14.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8679,1,10090.0,N,,,17208,CHEMBL626951,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Zone of skin,A,50594,1,,14.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8680,1,10090.0,N,,,17208,CHEMBL626952,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8681,1,10090.0,N,,,17208,CHEMBL626953,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8682,1,10090.0,N,,,17208,CHEMBL626954,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8683,1,10090.0,N,,,17208,CHEMBL626955,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8684,1,10090.0,N,,,17208,CHEMBL626956,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8685,1,10090.0,N,,,17208,CHEMBL626957,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8686,1,10090.0,N,,,17208,CHEMBL626958,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8687,1,10090.0,N,,,17208,CHEMBL626959,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8688,1,10090.0,N,,,17208,CHEMBL626960,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8689,1,10090.0,N,,,17208,CHEMBL626961,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8690,1,10090.0,N,,,17208,CHEMBL627589,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8691,1,10090.0,N,,,17208,CHEMBL627590,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Blood,A,50594,1,,178.0,Mus musculus
,,,,Intermediate,BAO_0000218,8692,1,10090.0,N,,,3132,CHEMBL627591,,Time taken for EC90 was determined when tested in mouse,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8693,1,10090.0,N,,,3132,CHEMBL627592,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8694,1,10090.0,N,,,16597,CHEMBL627593,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8695,1,10090.0,N,,,5727,CHEMBL627594,,Half life in mice,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8696,1,10090.0,N,,,5302,CHEMBL876813,,Half life period in mouse after 10 mg/Kg dose,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8697,1,10090.0,N,,,5302,CHEMBL627595,,Half life period in mouse after 10 mg/kg dose,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8698,1,10090.0,N,,,6348,CHEMBL627596,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8699,1,10116.0,N,,,5964,CHEMBL627597,,Cmax value at 5 mg/kg po was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8700,1,10116.0,N,,,6078,CHEMBL627598,,Cmax value evaluated in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8701,1,10116.0,N,,,5206,CHEMBL627599,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8702,1,10116.0,N,,,2959,CHEMBL627600,,Cmax value after administration of 20 mg/Kg oral dose in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8703,1,10116.0,N,,,5964,CHEMBL627601,,Cmax value at 1 mg/kg po in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8704,1,10116.0,N,,,5964,CHEMBL627776,,Cmax value at 5 mg/kg po in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8705,1,10116.0,N,,,6757,CHEMBL627777,,Cmax value at a dose of 10 mg/kg in male SD rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8706,1,10116.0,N,,,6757,CHEMBL627778,,Cmax value at a dose of 100 mg/kg in male SD rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8707,1,10116.0,N,,,6757,CHEMBL627779,,Cmax value at a dose of 50 mg/kg in male SD rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8708,1,10116.0,N,,,17617,CHEMBL876814,,Cmax value in rats at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8709,1,10116.0,N,,,1445,CHEMBL627780,,Cmax value was evaluated in rats at a dose of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8710,1,10116.0,N,,,6082,CHEMBL627781,,Cmax value was determined after peroral administration of 20 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8711,1,10116.0,N,,,1446,CHEMBL627782,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8712,1,10116.0,N,,,5407,CHEMBL627783,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8713,1,10116.0,N,,,2690,CHEMBL627784,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8714,1,10116.0,N,,,2661,CHEMBL627785,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8715,1,10116.0,N,,,2661,CHEMBL627786,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8716,1,10116.0,N,,,4891,CHEMBL627787,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8717,1,10116.0,N,,,2807,CHEMBL627788,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8718,1,10116.0,N,,,2807,CHEMBL626579,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8719,1,10116.0,N,,,2807,CHEMBL626580,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8720,1,10116.0,N,,,3634,CHEMBL876815,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8721,1,10116.0,N,,,1881,CHEMBL626581,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8722,1,10116.0,N,,,1881,CHEMBL626582,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8723,1,10116.0,N,,,429,CHEMBL626583,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8724,1,10116.0,N,,,5974,CHEMBL626205,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8725,1,10116.0,N,,,5974,CHEMBL626206,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8726,1,10116.0,N,,,5974,CHEMBL626207,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8727,1,10116.0,N,,,5974,CHEMBL623882,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8728,1,10116.0,N,,,17582,CHEMBL623883,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8729,1,10116.0,N,,,17582,CHEMBL623884,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8730,1,10116.0,N,,,3032,CHEMBL623885,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8731,1,10116.0,N,,,6295,CHEMBL623886,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8732,1,10116.0,N,,,6619,CHEMBL623887,,Maximal concentration in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8733,1,10116.0,N,,,6616,CHEMBL623888,,Maximal concentration after i.v. administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8734,1,10116.0,N,,,3249,CHEMBL623889,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8735,1,10116.0,N,,,17791,CHEMBL623890,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8736,1,10116.0,N,,,17791,CHEMBL623891,,Cmax in rat plasma after oral dose (50 mg/Kg),Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8737,1,10116.0,N,,,1360,CHEMBL623892,,Maximal plasma concentration was determined.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8738,1,10116.0,N,,,2552,CHEMBL623893,,Maximal plasma drug concentration was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8739,1,10116.0,N,,,6571,CHEMBL877616,,Maximal concentration in rats after peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8740,1,10116.0,N,,,6570,CHEMBL623894,,Maximum concentration in rat after 2 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8741,1,10116.0,N,,,6567,CHEMBL623895,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8742,1,10116.0,N,,,3031,CHEMBL623896,,Maximum concentration of compound in rat was evaluated.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8743,1,10116.0,N,,,3436,CHEMBL623897,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8744,1,10116.0,N,,,3436,CHEMBL623898,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8745,1,10116.0,N,,,2083,CHEMBL623899,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8746,1,10116.0,N,,,3436,CHEMBL623900,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8747,1,10116.0,N,,,4527,CHEMBL623901,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8748,1,10116.0,N,,,1974,CHEMBL623902,,Maximum concentration was evaluated in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8749,1,10116.0,N,,,3307,CHEMBL623903,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Cerebrospinal fluid,A,50597,1,,1359.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8750,1,10116.0,N,,,3307,CHEMBL623904,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8751,1,10116.0,N,,,1916,CHEMBL877617,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8752,1,10116.0,N,,,1500,CHEMBL623905,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8753,1,10116.0,N,,,1500,CHEMBL623906,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8754,1,10116.0,N,,,4186,CHEMBL623907,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8755,1,10116.0,N,,,16434,CHEMBL623908,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8756,1,10116.0,N,,,16434,CHEMBL623909,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8757,1,10116.0,N,,,16434,CHEMBL623910,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8758,1,10116.0,N,,,16434,CHEMBL623911,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8759,1,10116.0,N,,,16435,CHEMBL623912,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8760,1,10116.0,N,,,16435,CHEMBL624616,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8761,1,10116.0,N,,,16435,CHEMBL624617,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8762,1,10116.0,N,,,16435,CHEMBL624618,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8763,1,10116.0,N,,,16435,CHEMBL624619,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8764,1,10116.0,N,,,16435,CHEMBL624794,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8765,1,10116.0,N,,,16435,CHEMBL624795,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8766,1,10116.0,N,,,16435,CHEMBL623921,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8767,1,10116.0,N,,,16434,CHEMBL623922,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8768,1,10116.0,N,,,16434,CHEMBL623923,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8769,1,10116.0,N,,,16434,CHEMBL623924,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8770,1,10116.0,N,,,16435,CHEMBL623925,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8771,1,10116.0,N,,,16435,CHEMBL623926,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8772,1,10116.0,N,,,16435,CHEMBL623927,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8773,1,10116.0,N,,,16435,CHEMBL623928,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8774,1,10116.0,N,,,16435,CHEMBL623929,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8775,1,10116.0,N,,,16435,CHEMBL623930,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8776,1,10116.0,N,,,16434,CHEMBL623931,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8777,1,10116.0,N,,,16434,CHEMBL622165,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8778,1,10116.0,N,,,16434,CHEMBL621249,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8779,1,10116.0,N,,,16434,CHEMBL621250,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8780,1,10116.0,N,,,16434,CHEMBL621448,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8781,1,10116.0,N,,,16434,CHEMBL621449,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8782,1,10116.0,N,,,16434,CHEMBL621450,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8783,1,10116.0,N,,,16434,CHEMBL621451,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8784,1,10116.0,N,,,16435,CHEMBL621452,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8785,1,10116.0,N,,,16435,CHEMBL621453,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8786,1,10116.0,N,,,16435,CHEMBL621454,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8787,1,10116.0,N,,,16435,CHEMBL621455,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8788,1,10116.0,N,,,16435,CHEMBL621456,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8789,1,10116.0,N,,,16435,CHEMBL625145,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8790,1,10116.0,N,,,16435,CHEMBL875847,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8791,1,10116.0,N,,,16435,CHEMBL625146,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8792,1,10116.0,N,,,16434,CHEMBL625147,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8793,1,10116.0,N,,,16434,CHEMBL625148,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8794,1,10116.0,N,,,16434,CHEMBL625149,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8795,1,10116.0,N,,,16435,CHEMBL625150,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8796,1,10116.0,N,,,16435,CHEMBL625151,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8797,1,10116.0,N,,,16435,CHEMBL625152,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8798,1,10116.0,N,,,16435,CHEMBL625153,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8799,1,10116.0,N,,,16435,CHEMBL625154,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8800,1,10116.0,N,,,16435,CHEMBL625155,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8801,1,10116.0,N,,,11977,CHEMBL625156,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8802,1,10116.0,N,,,11977,CHEMBL624354,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8803,1,10116.0,N,,,11977,CHEMBL624355,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8804,1,10116.0,N,,,11977,CHEMBL624356,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8805,1,10116.0,N,,,11977,CHEMBL624357,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8806,1,10116.0,N,,,11977,CHEMBL624358,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8807,1,10116.0,N,,,11977,CHEMBL624359,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Striatum,A,50597,1,,2435.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8808,1,10116.0,N,,,11977,CHEMBL624360,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Striatum,A,50597,1,,2435.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8809,1,10116.0,N,,,11977,CHEMBL624361,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Striatum,A,50597,1,,2435.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8810,1,10116.0,N,,,11977,CHEMBL624362,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Striatum,A,50597,1,,2435.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8811,1,10116.0,N,,,11977,CHEMBL624363,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8812,1,10116.0,N,,,11977,CHEMBL624364,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8813,1,10116.0,N,,,11977,CHEMBL624365,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8814,1,10116.0,N,,,11977,CHEMBL624366,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8815,1,10116.0,N,,,11977,CHEMBL624367,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8816,1,10116.0,N,,,11977,CHEMBL624368,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8817,1,10116.0,N,,,11977,CHEMBL624369,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8818,1,10116.0,N,,,11977,CHEMBL624370,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8819,1,10116.0,N,,,11977,CHEMBL625069,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8820,1,10116.0,N,,,11977,CHEMBL625070,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8821,1,10116.0,N,,,11977,CHEMBL626051,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8822,1,10116.0,N,,,11977,CHEMBL626052,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8823,1,10116.0,N,,,11977,CHEMBL626053,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8824,1,10116.0,N,,,11977,CHEMBL626054,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8825,1,10116.0,N,,,11977,CHEMBL626055,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8826,1,10116.0,N,,,11977,CHEMBL626056,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8827,1,10116.0,N,,,11977,CHEMBL626057,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8828,1,10116.0,N,,,11977,CHEMBL625193,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8829,1,10116.0,N,,,11977,CHEMBL625194,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8830,1,10116.0,N,,,11977,CHEMBL625195,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8831,1,10116.0,N,,,11977,CHEMBL625196,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8832,1,10116.0,N,,,11977,CHEMBL625197,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8833,1,10116.0,N,,,11977,CHEMBL625198,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8834,1,10116.0,N,,,11977,CHEMBL627929,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8835,1,10116.0,N,,,11977,CHEMBL627074,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8836,1,10116.0,N,,,11977,CHEMBL627075,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8837,1,10116.0,N,,,11977,CHEMBL627076,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8838,1,10116.0,N,,,11977,CHEMBL627077,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8839,1,10116.0,N,,,11977,CHEMBL627078,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8840,1,10116.0,N,,,11977,CHEMBL627079,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8841,1,10090.0,N,,,4573,CHEMBL873824,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8842,1,10090.0,N,,,3132,CHEMBL627080,,Half life in mouse plasma was determined at dose 25 mg/kg,Plasma,A,50594,1,,1969.0,Mus musculus
,,,,Intermediate,BAO_0000218,8843,1,10090.0,N,,,17718,CHEMBL627081,,Half life was determined,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8844,1,10090.0,N,,,17728,CHEMBL627082,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8845,1,10090.0,N,,,5961,CHEMBL627083,,Half-life in male mice after 1 mg/kg intravenous dose,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8847,1,10090.0,N,,,17731,CHEMBL627085,,Half life in mice plasma,Plasma,A,50594,1,,1969.0,Mus musculus
,,,,Intermediate,BAO_0000218,8848,1,10090.0,N,,,17592,CHEMBL627086,,Half life in mouse,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8849,1,10090.0,N,,,3132,CHEMBL627087,,Half life in mouse plasma at dose 25 mg/kg,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8850,1,10090.0,N,,,17729,CHEMBL627088,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8851,1,10090.0,N,,,17729,CHEMBL627089,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8852,1,10090.0,N,,,17729,CHEMBL627090,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8853,1,10090.0,N,,,3277,CHEMBL627091,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8854,1,10090.0,N,,,3760,CHEMBL627092,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8855,1,10090.0,N,,,3760,CHEMBL876785,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8856,1,10090.0,N,,,2862,CHEMBL627093,,Half-life by iv administration in mouse,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8857,1,10090.0,N,,,2862,CHEMBL627094,,Half-life by oral administration in mouse,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8858,1,10090.0,N,,,5980,CHEMBL627095,,Half-life in mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8859,1,10090.0,N,,,6159,CHEMBL627096,,Half-life using mouse brain homogenate,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,8860,1,10090.0,N,,,6254,CHEMBL627097,,Half-life was measured in mice,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8861,1,10090.0,N,,,6062,CHEMBL627098,,Half-life was measured in mouse after an iv dose of 1 mg/kg,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8862,1,10090.0,N,,,1574,CHEMBL627099,,Half-life period was determined in mouse blood,Blood,A,50594,1,,178.0,Mus musculus
,,,,Intermediate,BAO_0000218,8863,1,10090.0,N,,,56,CHEMBL627100,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,8864,1,10090.0,N,,,993,CHEMBL627101,,Plasma half life in mouse,Plasma,A,50594,1,,1969.0,Mus musculus
,,,,Intermediate,BAO_0000218,8865,1,10090.0,N,,,6652,CHEMBL627102,,Stability of the peptide in the presence of mouse serum,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8866,1,10090.0,N,,,17852,CHEMBL627103,,Terminal half life of compound was determined in mouse,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8867,1,10090.0,N,,,2675,CHEMBL627104,,Terminal half life was evaluated in mice after intravenous administration,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8868,1,10090.0,N,,,2675,CHEMBL627105,,Terminal half life was evaluated in mice after oral administration,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8869,1,10090.0,N,,,499,CHEMBL876786,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8870,1,10090.0,N,,,499,CHEMBL873825,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8871,1,10090.0,N,,,499,CHEMBL627106,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8872,1,10090.0,N,,,14239,CHEMBL626336,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8873,1,10090.0,N,,,5506,CHEMBL877462,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8874,1,10090.0,N,,,5506,CHEMBL626337,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,8875,1,10090.0,N,,,17734,CHEMBL626338,,Half life after intraperitoneal administration of 100 mg/kg in mice,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8876,1,10090.0,N,,,17728,CHEMBL626339,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8877,1,10090.0,N,,,17728,CHEMBL626340,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8878,1,10090.0,N,,,17728,CHEMBL625377,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8879,1,10090.0,N,,,17728,CHEMBL625378,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,8880,1,10090.0,N,,,17728,CHEMBL625379,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000251,8881,0,9823.0,U,,,14294,CHEMBL625380,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,A,22224,1,Microsomes,,Sus scrofa
,,,,Autocuration,BAO_0000251,8882,0,9823.0,U,,,14294,CHEMBL625381,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,A,22224,1,Microsomes,,Sus scrofa
,,,,Autocuration,BAO_0000019,8883,0,9823.0,U,,,6056,CHEMBL625382,,Stability to porcine renal DHP-I,,A,22224,1,,,Sus scrofa
,In vivo,,,Autocuration,BAO_0000218,8884,0,9823.0,U,,,1317,CHEMBL873828,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,A,22224,1,,,Sus scrofa
,In vivo,,,Autocuration,BAO_0000218,8885,0,9823.0,U,,,1317,CHEMBL625383,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,A,22224,1,,,Sus scrofa
,,,,Autocuration,BAO_0000019,8886,0,9823.0,U,,,5229,CHEMBL625384,,Half-life of the parent prodrug in porcine esterase solution,,A,22224,1,,,Sus scrofa
,,,,Autocuration,BAO_0000019,8887,0,9823.0,U,,,4231,CHEMBL625385,,"First order rate constant, k was determined in in pig liver Esterase",,A,22224,1,,,Sus scrofa
,,,,Autocuration,BAO_0000221,8888,0,9823.0,U,,,4231,CHEMBL625386,,Half life of the in pig liver Esterase,Liver,A,22224,1,,2107.0,Sus scrofa
,,,,Autocuration,BAO_0000221,8889,0,9823.0,U,,,5318,CHEMBL623571,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Liver,A,22224,1,,2107.0,Sus scrofa
,,,,Autocuration,BAO_0000221,8890,0,9823.0,U,,,5318,CHEMBL623572,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Liver,A,22224,1,,2107.0,Sus scrofa
,,,,Autocuration,BAO_0000221,8891,0,9823.0,U,,,5318,CHEMBL623573,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Liver,A,22224,1,,2107.0,Sus scrofa
,,,,Autocuration,BAO_0000221,8892,0,9823.0,U,,,3305,CHEMBL623574,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Liver,A,22224,1,,2107.0,Sus scrofa
,,,,Autocuration,BAO_0000221,8893,0,9823.0,U,,,3305,CHEMBL623575,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Liver,A,22224,1,,2107.0,Sus scrofa
,,,,Autocuration,BAO_0000221,8894,0,9823.0,U,,,2842,CHEMBL623749,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Liver,A,22224,1,,2107.0,Sus scrofa
,,,,Autocuration,BAO_0000221,8895,0,9823.0,U,,,2842,CHEMBL623750,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Liver,A,22224,1,,2107.0,Sus scrofa
,In vitro,,,Autocuration,BAO_0000221,8896,0,9823.0,U,,,889,CHEMBL623751,,Half-life in vitro in pig liver,Liver,A,22224,1,,2107.0,Sus scrofa
,,,,Autocuration,BAO_0000221,8897,0,9823.0,U,,,1904,CHEMBL623752,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Liver,A,22224,1,,2107.0,Sus scrofa
,In vivo,,,Intermediate,BAO_0000218,8898,1,10116.0,N,,,4186,CHEMBL623753,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8899,1,10116.0,N,,,2774,CHEMBL623754,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8900,1,10116.0,N,,,1742,CHEMBL623755,,Maximum concentration in rat plasma was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8901,1,10116.0,N,,,3169,CHEMBL623756,,Maximum concentration in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8902,1,10116.0,N,,,3169,CHEMBL623757,,Maximum concentration in rats at 1-2 hours,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8903,1,10116.0,N,,,2081,CHEMBL623758,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8904,1,10116.0,N,,,3307,CHEMBL623759,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8905,1,10116.0,N,,,4727,CHEMBL623760,,Maximum concentration at the dose of 2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8906,1,10116.0,N,,,6597,CHEMBL623761,,Maximum concentration was evaluated in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8907,1,10116.0,N,,,16365,CHEMBL623762,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8908,1,10116.0,N,,,16365,CHEMBL877594,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8909,1,10116.0,N,,,16365,CHEMBL623763,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8910,1,10116.0,N,,,16365,CHEMBL623764,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8911,1,10116.0,N,,,16365,CHEMBL623765,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8912,1,10116.0,N,,,2591,CHEMBL623766,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8913,1,10116.0,N,,,2591,CHEMBL623767,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8914,1,10116.0,N,,,2591,CHEMBL623768,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8915,1,10116.0,N,,,5978,CHEMBL623769,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8916,1,10116.0,N,,,5978,CHEMBL623770,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8917,1,10116.0,N,,,5978,CHEMBL623771,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8918,1,10116.0,N,,,5978,CHEMBL623772,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8919,1,10116.0,N,,,5978,CHEMBL623773,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8920,1,10116.0,N,,,5978,CHEMBL623774,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8921,1,10116.0,N,,,5978,CHEMBL623775,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8922,1,10116.0,N,,,14465,CHEMBL623776,,Cmax in rat (PO dose),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8923,1,10116.0,N,,,4723,CHEMBL622191,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8924,1,10116.0,N,,,4723,CHEMBL622192,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8925,1,10116.0,N,,,4576,CHEMBL622193,,Maximum plasma concentration determined in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8926,1,10116.0,N,,,12873,CHEMBL622194,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8927,1,10116.0,N,,,12873,CHEMBL622195,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8928,1,10116.0,N,,,6824,CHEMBL622196,,Maximum plasma concentration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8929,1,10116.0,N,,,17065,CHEMBL622197,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8930,1,10116.0,N,,,2932,CHEMBL622198,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8931,1,10116.0,N,,,2932,CHEMBL622199,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8932,1,10116.0,N,,,2879,CHEMBL622200,,Maximum plasma concentration of compound was measured in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8933,1,10116.0,N,,,2864,CHEMBL622201,,Maximum plasma concentration after 20 mg/kg oral administration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8934,1,10116.0,N,,,16367,CHEMBL623990,,Maximum plasma concentration after oral administration to rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8935,1,10116.0,N,,,17717,CHEMBL623991,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8936,1,10116.0,N,,,17717,CHEMBL623992,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8937,1,10116.0,N,,,17717,CHEMBL623993,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8938,1,10116.0,N,,,17717,CHEMBL623994,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8939,1,10116.0,N,,,17720,CHEMBL623995,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Plasma,F,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8940,1,10116.0,N,,,17720,CHEMBL623996,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Plasma,F,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8941,1,10116.0,N,,,17720,CHEMBL623997,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Plasma,F,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8942,1,10116.0,N,,,4516,CHEMBL623998,,Maximum plasma concentration dosed orally in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8943,1,10116.0,N,,,4516,CHEMBL623999,,Maximum plasma concentration dosed orally in rats after 6 hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8944,1,10116.0,N,,,4516,CHEMBL624000,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8945,1,10116.0,N,,,5199,CHEMBL624001,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8946,1,10116.0,N,,,17538,CHEMBL624002,,Maximum plasma concentration in rat after po administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8947,1,10116.0,N,,,6685,CHEMBL624003,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8948,1,10116.0,N,,,6685,CHEMBL624004,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8949,1,10116.0,N,,,16434,CHEMBL624005,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8950,1,10116.0,N,,,16434,CHEMBL624006,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8951,1,10116.0,N,,,16434,CHEMBL624007,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8952,1,10116.0,N,,,16434,CHEMBL624008,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8953,1,10116.0,N,,,16434,CHEMBL624009,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8954,1,10116.0,N,,,16434,CHEMBL874387,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8955,1,10116.0,N,,,16434,CHEMBL624010,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8956,1,10116.0,N,,,16434,CHEMBL624011,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8957,1,10116.0,N,,,16435,CHEMBL624012,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8958,1,10116.0,N,,,16435,CHEMBL624013,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8959,1,10116.0,N,,,16435,CHEMBL624736,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8960,1,10116.0,N,,,16435,CHEMBL624737,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8961,1,10116.0,N,,,16434,CHEMBL624738,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8962,1,10116.0,N,,,16434,CHEMBL624739,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8963,1,10116.0,N,,,16434,CHEMBL624740,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8964,1,10116.0,N,,,16435,CHEMBL624896,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8965,1,10116.0,N,,,16435,CHEMBL624897,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8966,1,10116.0,N,,,16435,CHEMBL624108,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8967,1,10116.0,N,,,16435,CHEMBL624109,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8968,1,10116.0,N,,,16435,CHEMBL624110,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8969,1,10116.0,N,,,16435,CHEMBL624111,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8970,1,10116.0,N,,,16435,CHEMBL624112,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8971,1,10116.0,N,,,16435,CHEMBL624113,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8972,1,10116.0,N,,,16435,CHEMBL619709,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8973,1,10116.0,N,,,16435,CHEMBL619710,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8974,1,10116.0,N,,,16434,CHEMBL619711,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8975,1,10116.0,N,,,16434,CHEMBL619712,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8976,1,10116.0,N,,,16434,CHEMBL619713,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8977,1,10116.0,N,,,16434,CHEMBL619714,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8978,1,10116.0,N,,,16434,CHEMBL619715,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8979,1,10116.0,N,,,16434,CHEMBL619716,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8980,1,10116.0,N,,,16434,CHEMBL619717,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8981,1,10116.0,N,,,16434,CHEMBL619718,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8982,1,10116.0,N,,,16435,CHEMBL619719,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8983,1,10116.0,N,,,16435,CHEMBL875329,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8984,1,10116.0,N,,,16435,CHEMBL619720,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8985,1,10116.0,N,,,16435,CHEMBL619721,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8986,1,10116.0,N,,,16435,CHEMBL619722,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8987,1,10116.0,N,,,16435,CHEMBL619723,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8988,1,10116.0,N,,,16435,CHEMBL619724,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8989,1,10116.0,N,,,16435,CHEMBL619725,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8990,1,10116.0,N,,,16434,CHEMBL619726,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8991,1,10116.0,N,,,16434,CHEMBL619727,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8992,1,10116.0,N,,,16434,CHEMBL619728,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,8993,1,10116.0,N,,,16435,CHEMBL619729,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8994,1,10116.0,N,,,11977,CHEMBL619730,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8995,1,10116.0,N,,,11977,CHEMBL619731,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8996,1,10116.0,N,,,11977,CHEMBL619732,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8997,1,10116.0,N,,,11977,CHEMBL619733,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8998,1,10116.0,N,,,11977,CHEMBL619734,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,8999,1,10116.0,N,,,11977,CHEMBL619735,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9000,1,10116.0,N,,,11977,CHEMBL875330,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9001,1,10116.0,N,,,11977,CHEMBL628465,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9002,1,10116.0,N,,,11977,CHEMBL628466,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9003,1,10116.0,N,,,11977,CHEMBL628467,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9004,1,10116.0,N,,,11977,CHEMBL628468,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9005,1,10116.0,N,,,11977,CHEMBL628469,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9006,1,10116.0,N,,,11977,CHEMBL628470,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9007,1,10116.0,N,,,11977,CHEMBL628471,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9008,1,10116.0,N,,,11977,CHEMBL628472,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9009,1,10116.0,N,,,11977,CHEMBL625191,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9010,1,10116.0,N,,,11977,CHEMBL625192,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9011,1,10116.0,N,,,11977,CHEMBL875337,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9012,1,10116.0,N,,,11977,CHEMBL626341,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9013,1,10116.0,N,,,11977,CHEMBL626342,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9014,1,10116.0,N,,,11977,CHEMBL621943,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9015,1,10116.0,N,,,3748,CHEMBL621944,,Half life in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9016,1,10116.0,N,,,15765,CHEMBL621945,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9017,1,10116.0,N,,,4871,CHEMBL621946,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9018,1,10116.0,N,,,4871,CHEMBL621947,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9019,1,10116.0,N,,,4872,CHEMBL621948,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9020,1,10116.0,N,,,4872,CHEMBL621949,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9021,1,10116.0,N,,,5413,CHEMBL621950,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9022,1,10116.0,N,,,5413,CHEMBL621951,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9023,1,10116.0,N,,,15272,CHEMBL621952,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9024,1,10116.0,N,,,4689,CHEMBL621953,,Stability (%) in rat liver microsomes,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9025,1,10116.0,N,,,6057,CHEMBL621954,,Area under curve was calculated after intravenous administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9026,1,10116.0,N,,,6057,CHEMBL621955,,Area under the curve was calculated after iv administration in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9027,1,10116.0,N,,,6057,CHEMBL621956,,Area under the curve was calculated in rat after peroral administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9028,1,10116.0,N,,,6211,CHEMBL621957,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9029,1,10116.0,N,,,5710,CHEMBL621958,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9030,1,10116.0,N,,,5710,CHEMBL621959,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9031,1,10116.0,N,,,17853,CHEMBL621960,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9032,1,10116.0,N,,,17853,CHEMBL621961,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9033,1,10116.0,N,,,15765,CHEMBL621962,,p value of the compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9034,1,10116.0,N,,,15765,CHEMBL876787,,p value of the compound,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9035,1,10116.0,N,,,15765,CHEMBL621963,,p value of the compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9036,1,10116.0,N,,,6175,CHEMBL622637,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,A,50597,1,,945.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9037,1,10116.0,N,,,6175,CHEMBL622638,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,A,50597,1,,945.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9038,1,10116.0,N,,,6175,CHEMBL626561,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,A,50597,1,,945.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,9039,0,9986.0,U,,,7991,CHEMBL626562,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,F,22224,1,,,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000218,9040,0,9986.0,U,,,429,CHEMBL626563,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,A,22224,1,,,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000218,9041,0,9986.0,U,,,429,CHEMBL626564,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9042,0,9986.0,U,,,6253,CHEMBL626565,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9043,0,9986.0,U,,,6253,CHEMBL626566,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9044,0,9986.0,U,,,3615,CHEMBL626567,,Clearance rate in rabbits,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9045,0,9986.0,U,,,4059,CHEMBL626568,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9046,0,9986.0,U,,,5124,CHEMBL626569,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9047,0,9986.0,U,,,5124,CHEMBL626570,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9048,0,9986.0,U,,,5124,CHEMBL626571,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9049,0,9986.0,U,,,429,CHEMBL626572,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9050,0,9986.0,U,,,4059,CHEMBL626573,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Plasma,A,22224,1,,1969.0,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000251,9051,0,9986.0,U,,,9659,CHEMBL626574,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Liver,A,22224,1,Microsomes,2107.0,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000251,9052,0,9986.0,U,,,9659,CHEMBL626575,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Liver,A,22224,1,Microsomes,2107.0,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000218,9053,0,9986.0,U,,,3639,CHEMBL626576,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,A,22224,1,,,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000218,9054,0,9986.0,U,,,3639,CHEMBL626577,,Dose at which bioavailability of perorally administered compound was tested in rabbit,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9055,0,9986.0,U,,,3639,CHEMBL626578,,The compound was tested for its bioavailability in rabbit (by oral dosage).,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9056,0,9986.0,U,,,5124,CHEMBL625263,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9057,0,9986.0,U,,,5124,CHEMBL625264,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9058,0,9986.0,U,,,5124,CHEMBL625265,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,A,22224,1,,,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000251,9059,0,9986.0,U,,,14294,CHEMBL625266,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,A,22224,1,Microsomes,,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000251,9060,0,9986.0,U,,,14294,CHEMBL876796,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,A,22224,1,Microsomes,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9061,0,9986.0,U,,,429,CHEMBL625267,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9062,0,9986.0,U,,,5124,CHEMBL625268,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Plasma,A,22224,1,,1969.0,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9063,0,9986.0,U,,,5124,CHEMBL625269,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Plasma,A,22224,1,,1969.0,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9064,0,9986.0,U,,,5124,CHEMBL624689,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Plasma,A,22224,1,,1969.0,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9065,0,9986.0,U,,,429,CHEMBL624690,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,A,22224,1,,,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000218,9066,0,9986.0,U,,,429,CHEMBL624691,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Urine,A,22224,1,,1088.0,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000218,9067,0,9986.0,U,,,429,CHEMBL624692,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Urine,A,22224,1,,1088.0,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9068,0,9986.0,U,,,4059,CHEMBL624693,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9069,0,9986.0,U,,,4137,CHEMBL624694,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,A,22224,1,,,Oryctolagus cuniculus
,In vitro,,,Autocuration,BAO_0000221,9070,0,9986.0,U,,,11672,CHEMBL877596,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,A,22224,1,,,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000019,9071,0,9986.0,U,,,12886,CHEMBL624695,,Time within which only 10% of the drug was degraded,,A,22224,1,,,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000221,9072,0,9986.0,U,,,3853,CHEMBL624696,,Half life period in rabbit liver homogenate,Liver,A,22224,1,,2107.0,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000019,9073,0,9986.0,U,,,3615,CHEMBL624697,,Half life value in rabbits,,A,22224,1,,,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9074,0,9986.0,U,,,6253,CHEMBL624698,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Blood,A,22224,1,,178.0,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9075,0,9986.0,U,,,6253,CHEMBL624699,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Blood,A,22224,1,,178.0,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,9076,0,9986.0,U,,,6077,CHEMBL624700,,Half-life period in rabbits following intravenous administration at 2 mg/kg,,A,22224,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,9077,1,10116.0,N,,,17617,CHEMBL622903,,AUC 0-8 hr value in rats at 10 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9078,1,10116.0,N,,,17594,CHEMBL622904,,AUC after administration at 2000 mg/kg/day in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9079,1,10116.0,N,,,6149,CHEMBL622905,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9080,1,10116.0,N,,,17260,CHEMBL622906,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9081,1,10116.0,N,,,17260,CHEMBL622907,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9082,1,10116.0,N,,,6644,CHEMBL622908,,AUC in rat after oral administration at 10.5 mg/kg dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9083,1,10116.0,N,,,6644,CHEMBL622909,,AUC in rat after oral administration at 11.2 mg/kg dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9084,1,10116.0,N,,,6644,CHEMBL622910,,AUC in rat after oral administration at 9.7 mg/kg dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9085,1,10116.0,N,,,6495,CHEMBL622911,,AUC in rat brain after oral administration at 10 mg/kg,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9086,1,10116.0,N,,,6504,CHEMBL622912,,AUC in rat p.o.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9087,1,10116.0,N,,,17686,CHEMBL622913,,AUC in rat p.o. at 20 mg/kg concentration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9088,1,10116.0,N,,,6495,CHEMBL622914,,AUC in rat plasma after oral administration at 10 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9089,1,10116.0,N,,,216,CHEMBL622915,,AUC in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9090,1,10116.0,N,,,1908,CHEMBL622916,,AUC value after IV dose at a dose of 5 mg/kg in rats.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9091,1,10116.0,N,,,1908,CHEMBL622917,,AUC value after oral dose at a dose of 10 mg/kg in rats.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9092,1,10116.0,N,,,6685,CHEMBL622918,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9093,1,10116.0,N,,,216,CHEMBL622919,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9094,1,10116.0,N,,,6049,CHEMBL622920,,Maximum plasma concentration was evaluated in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9095,1,10116.0,N,,,2463,CHEMBL622921,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9096,1,10116.0,N,,,6679,CHEMBL622922,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9097,1,10116.0,N,,,6681,CHEMBL622923,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9098,1,10116.0,N,,,4890,CHEMBL877604,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9099,1,10116.0,N,,,6410,CHEMBL622924,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9100,1,10116.0,N,,,6410,CHEMBL622925,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9101,1,10116.0,N,,,16366,CHEMBL622926,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9102,1,10116.0,N,,,6227,CHEMBL623625,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Expert,BAO_0000218,9103,1,10116.0,N,,,3598,CHEMBL623626,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9104,1,10116.0,N,,,1465,CHEMBL623627,,Maximum plasma drug concentration was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9105,1,10116.0,N,,,4368,CHEMBL623628,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9106,1,10116.0,N,,,15662,CHEMBL623629,,Mean peak plasma concentration was observed after intravenous administration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9107,1,10116.0,N,,,15662,CHEMBL623630,,Mean peak plasma concentration was observed after oral administration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9108,1,10116.0,N,,,5355,CHEMBL623804,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9109,1,10116.0,N,,,5355,CHEMBL623805,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9110,1,10116.0,N,,,1567,CHEMBL623806,,Peak oral plasma concentration was determined in rats by oral administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9111,1,10116.0,N,,,4026,CHEMBL623807,,Peak plasma concentration (Cmax) was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9112,1,10116.0,N,,,6193,CHEMBL623808,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9113,1,10116.0,N,,,4026,CHEMBL623809,,Peak plasma concentration (Cmax) in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9114,1,10116.0,N,,,6485,CHEMBL623810,,Peak plasma concentration at 1 mg/kg peroral administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9115,1,10116.0,N,,,17655,CHEMBL623811,,Peak plasma concentration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9116,1,10116.0,N,,,14941,CHEMBL623812,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9117,1,10116.0,N,,,5394,CHEMBL877605,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9118,1,10116.0,N,,,4408,CHEMBL623813,,Pharmacokinetic property (Cmax) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9119,1,10116.0,N,,,5983,CHEMBL623814,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9120,1,10116.0,N,,,4878,CHEMBL623815,,Cmax in rat after 3mg/kg oral dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9121,1,10116.0,N,,,5862,CHEMBL623816,Sprague-Dawley,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9122,1,10116.0,N,,,4517,CHEMBL623145,,Cmax in rats after 20 mg/kg oral dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9123,1,10116.0,N,,,5932,CHEMBL623146,,Cmax in rat plasma after 30mg/kg oral dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9124,1,10116.0,N,,,5436,CHEMBL623147,,Plasma concentration after oral administration of 100 mg/kg to rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9125,1,10116.0,N,,,4910,CHEMBL623042,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9126,1,10116.0,N,,,4950,CHEMBL623043,,Tested for the Cmax in rat at 10 mg/kg per orally,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9127,1,10116.0,N,,,15078,CHEMBL623044,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9128,1,10116.0,N,,,15078,CHEMBL623045,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9129,1,10116.0,N,,,3360,CHEMBL623046,,Bioavailability as oral Cmax in rats at 30 mins,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9130,1,10116.0,N,,,3360,CHEMBL623226,,Bioavailability as oral Cmax in rats at 6hr,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9131,1,10116.0,N,,,15022,CHEMBL623227,,The maximum concentration of compound was measured at the dose of 100 umol/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9132,1,10116.0,N,,,15022,CHEMBL623228,,The maximum concentration of compound was measured at the dose of 300 umol/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9133,1,10116.0,N,,,15022,CHEMBL623229,,The maximum concentration of compound was measured at the dose of 30 umol/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9134,1,10116.0,N,,,5160,CHEMBL623230,,The maximum plasma levels for the compounds were determined by LC-MS.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9135,1,10116.0,N,,,15662,CHEMBL623231,,mean peak plasma concentration was observed after intravenous administration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9136,1,10116.0,N,,,15662,CHEMBL623232,,mean peak plasma concentration was observed after oral administration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9137,1,10116.0,N,,,4709,CHEMBL623233,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9138,1,10116.0,N,,,3535,CHEMBL623234,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9139,1,10116.0,N,,,3535,CHEMBL623235,,Concentration in plasma (portal) following oral dose in rats at 1 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9140,1,10116.0,N,,,3535,CHEMBL623236,,Concentration in plasma (portal) following oral dose in rats at 2 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9141,1,10116.0,N,,,3535,CHEMBL623237,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9142,1,10116.0,N,,,3535,CHEMBL623238,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9143,1,10116.0,N,,,3535,CHEMBL623239,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9144,0,10116.0,U,,,5005,CHEMBL623240,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Plasma,A,22224,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9145,1,10116.0,N,,,6326,CHEMBL623241,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Hypothalamus,A,50597,1,,1898.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9146,1,10116.0,N,,,6326,CHEMBL623242,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Hypothalamus,A,50597,1,,1898.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9147,1,10116.0,N,,,6326,CHEMBL874394,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9148,1,10116.0,N,,,6326,CHEMBL623243,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9149,1,10116.0,N,,,17411,CHEMBL623244,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9150,1,10116.0,N,,,16435,CHEMBL623245,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9151,1,10116.0,N,,,16435,CHEMBL623246,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9152,1,10116.0,N,,,16435,CHEMBL623247,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9153,1,10116.0,N,,,16435,CHEMBL623248,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9154,1,10116.0,N,,,16435,CHEMBL623249,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9155,1,10116.0,N,,,16434,CHEMBL625072,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9156,1,10116.0,N,,,16434,CHEMBL625073,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9157,1,10116.0,N,,,16434,CHEMBL625074,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9158,1,10116.0,N,,,16434,CHEMBL625075,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9159,1,10116.0,N,,,16434,CHEMBL625076,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9160,1,10116.0,N,,,16434,CHEMBL625077,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9161,1,10116.0,N,,,16434,CHEMBL625078,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9162,1,10116.0,N,,,16434,CHEMBL874395,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9163,1,10116.0,N,,,16435,CHEMBL625079,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9164,1,10116.0,N,,,16435,CHEMBL625080,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9165,1,10116.0,N,,,16435,CHEMBL625081,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9166,1,10116.0,N,,,16435,CHEMBL625082,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9167,1,10116.0,N,,,16435,CHEMBL625083,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9168,1,10116.0,N,,,16435,CHEMBL625084,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9169,1,10116.0,N,,,16435,CHEMBL625085,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9170,1,10116.0,N,,,16435,CHEMBL625086,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9171,1,10116.0,N,,,16434,CHEMBL625087,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9172,1,10116.0,N,,,16434,CHEMBL625088,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9173,1,10116.0,N,,,16434,CHEMBL622205,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9174,1,10116.0,N,,,16435,CHEMBL622206,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9175,1,10116.0,N,,,16435,CHEMBL622207,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9176,1,10116.0,N,,,16435,CHEMBL622366,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9177,1,10116.0,N,,,16435,CHEMBL622367,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9178,1,10116.0,N,,,16435,CHEMBL875331,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9179,1,10116.0,N,,,16435,CHEMBL622368,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9180,1,10116.0,N,,,16434,CHEMBL622369,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9181,1,10116.0,N,,,16434,CHEMBL622370,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9182,1,10116.0,N,,,16434,CHEMBL622371,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9183,1,10116.0,N,,,16434,CHEMBL622372,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9184,1,10116.0,N,,,16434,CHEMBL622373,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9185,1,10116.0,N,,,16434,CHEMBL622374,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9186,1,10116.0,N,,,16434,CHEMBL622375,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9187,1,10116.0,N,,,16434,CHEMBL622376,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9188,1,10116.0,N,,,16435,CHEMBL622377,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9189,1,10116.0,N,,,16435,CHEMBL622378,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9190,1,10116.0,N,,,16435,CHEMBL622379,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9191,1,10116.0,N,,,16435,CHEMBL622380,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9192,1,10116.0,N,,,16435,CHEMBL622381,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9193,1,10116.0,N,,,16435,CHEMBL622382,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9194,1,10116.0,N,,,16434,CHEMBL622383,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9195,1,10116.0,N,,,6175,CHEMBL875332,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,A,50597,1,,945.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9196,1,10116.0,N,,,6175,CHEMBL622384,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,A,50597,1,,945.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9197,1,10116.0,N,,,6175,CHEMBL622385,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,A,50597,1,,945.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9198,1,10116.0,N,,,6175,CHEMBL622386,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,A,50597,1,,945.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9199,1,10116.0,N,,,10839,CHEMBL622387,,The compound was tested for the plasma binding in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9200,1,10116.0,N,,,16459,CHEMBL622388,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9201,1,10116.0,N,,,16459,CHEMBL622389,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9202,1,10116.0,N,,,16459,CHEMBL622390,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9203,1,10116.0,N,,,16459,CHEMBL622391,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9204,1,10116.0,N,,,16459,CHEMBL622392,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9205,1,10116.0,N,,,16459,CHEMBL622393,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9206,1,10116.0,N,,,3278,CHEMBL622394,,Plasma level at 2 hr after administration of the compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9207,1,10116.0,N,,,3278,CHEMBL622395,,plasma level at 2 hr after administration of the compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9208,1,10116.0,N,,,4684,CHEMBL622396,,Stability in rat serum measured as % recovery at 1 min,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9209,1,10116.0,N,,,4684,CHEMBL624894,,Stability in rat serum measured as % recovery at 10 min,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9210,1,10116.0,N,,,4684,CHEMBL624895,,Stability in rat serum measured as % recovery at 10 mins,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9211,1,10116.0,N,,,4684,CHEMBL624058,,Stability in rat serum measured as % recovery at 2 hr,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9212,1,10116.0,N,,,4684,CHEMBL624059,,Stability in rat serum measured as % recovery at 3 min,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9213,1,10116.0,N,,,4684,CHEMBL624060,,Stability in rat serum measured as % recovery at 3 mins,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9214,1,10116.0,N,,,4684,CHEMBL624061,,Stability in rat serum measured as % recovery at 5 min,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9215,1,10116.0,N,,,4684,CHEMBL624062,,Stability in rat serum measured as % recovery at 5 mins,Serum,A,50597,1,,1977.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9216,1,10116.0,N,,,16456,CHEMBL624063,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9217,1,10116.0,N,,,16456,CHEMBL624064,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9218,1,10116.0,N,,,723,CHEMBL624065,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9219,1,10116.0,N,,,723,CHEMBL624066,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9220,1,10116.0,N,,,5160,CHEMBL877490,,Half life tested in mature male rat at a dose of 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9221,1,10116.0,N,,,4709,CHEMBL874442,,Half life after intravenous administration of 1 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9222,1,10116.0,N,,,5633,CHEMBL626890,,Half life period after administration (30 mg/kg) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9223,1,10116.0,N,,,5302,CHEMBL626891,,Half life period in rat after 5 mg/Kg dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9224,1,10116.0,N,,,5302,CHEMBL626892,,Half life period in rat after 5 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9225,1,10116.0,N,,,17791,CHEMBL626893,,Half life period was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9226,1,10116.0,N,,,17791,CHEMBL626894,,Half life period was evaluated in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9227,1,10116.0,N,,,17791,CHEMBL626895,,Half life period was evaluated in rat; 0.5-1.0,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9228,1,10116.0,N,,,17791,CHEMBL626896,,Half life period was evaluated in rat; 5.9-7.5,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9229,1,10116.0,N,,,14512,CHEMBL626897,,Half-life in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9230,1,10116.0,N,,,6230,CHEMBL626898,,Half-life time in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9231,1,10116.0,N,,,3364,CHEMBL626899,,Terminal half-life after iv administration to rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9232,1,10116.0,N,,,6874,CHEMBL626900,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9233,1,10116.0,N,,,857,CHEMBL626901,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9234,1,10116.0,N,,,858,CHEMBL626902,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9235,1,10116.0,N,,,858,CHEMBL626903,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9236,1,10116.0,N,,,5355,CHEMBL874443,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9237,1,10116.0,N,,,5355,CHEMBL626904,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9238,1,10116.0,N,,,6305,CHEMBL626905,,Half life in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9239,1,10116.0,N,,,13501,CHEMBL873830,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9240,1,10116.0,N,,,17594,CHEMBL626906,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9241,1,10116.0,N,,,4186,CHEMBL631076,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9242,1,10116.0,N,,,2932,CHEMBL631077,,Biological half-life was measured in plasma of rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9243,1,10116.0,N,,,17065,CHEMBL631078,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9244,1,10116.0,N,,,15765,CHEMBL631079,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9245,1,10116.0,N,,,2713,CHEMBL631080,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9246,1,10116.0,N,,,2661,CHEMBL631081,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9247,1,10116.0,N,,,2661,CHEMBL631239,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9248,1,10116.0,N,,,740,CHEMBL631240,,Compound was evaluated for plasma half life in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9249,1,10116.0,N,,,6597,CHEMBL631241,,AUC value at a dose of 5 mg/kg (p.o.) in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9250,1,10116.0,N,,,2959,CHEMBL631242,,AUC value after administration of 20 mg/Kg oral dose in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9251,1,10116.0,N,,,17594,CHEMBL631243,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9252,1,10116.0,N,,,17596,CHEMBL874444,,AUC0-96 after administration at 50 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9253,1,10116.0,N,,,17594,CHEMBL631244,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9254,1,10116.0,N,,,3293,CHEMBL631245,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9255,1,10116.0,N,,,6757,CHEMBL627162,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9256,1,10116.0,N,,,6757,CHEMBL627163,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9257,1,10116.0,N,,,6757,CHEMBL627164,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9258,1,10116.0,N,,,5979,CHEMBL627165,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9259,1,10116.0,N,,,5979,CHEMBL627166,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9260,1,10116.0,N,,,5979,CHEMBL627167,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9261,1,10116.0,N,,,4026,CHEMBL627822,,Area under curve (AUC) at a dose of 30 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9262,1,10116.0,N,,,5355,CHEMBL627823,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9263,1,10116.0,N,,,5355,CHEMBL627824,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9264,1,10116.0,N,,,5355,CHEMBL627825,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9265,1,10116.0,N,,,5633,CHEMBL627826,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9266,1,10116.0,N,,,1716,CHEMBL627827,,Area under curve (Pharmacokinetic property) was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9267,1,10116.0,N,,,1716,CHEMBL627828,,Area under curve (Pharmacokinetic property) of the compound; Not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9268,1,10116.0,N,,,4689,CHEMBL627829,,Area under curve after intravenous administration (1 mg/kg) in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9269,1,10116.0,N,,,4527,CHEMBL627830,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9270,1,10116.0,N,,,4527,CHEMBL627831,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9271,1,10116.0,N,,,15662,CHEMBL627832,,Area under curve in male SD rats was observed after oral administration in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9272,1,10116.0,N,,,4413,CHEMBL627833,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,A,50597,1,,,Rattus norvegicus
,,,,Expert,BAO_0000218,9273,1,10116.0,N,,,3598,CHEMBL627834,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Expert,BAO_0000218,9274,1,10116.0,N,,,3598,CHEMBL628004,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9275,1,10116.0,N,,,5964,CHEMBL628005,,Area under curve at 5 mg/kg po was determined in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9276,1,10116.0,N,,,4689,CHEMBL628006,,Area under curve in Rat at a oral dose of 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9277,1,10116.0,N,,,4186,CHEMBL628007,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9278,1,10116.0,N,,,5510,CHEMBL625676,,Area under curve was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9279,1,10116.0,N,,,17858,CHEMBL631309,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9280,1,10116.0,N,,,17804,CHEMBL631310,,Area under curve after intravenous administration at 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9281,1,10116.0,N,,,6106,CHEMBL631311,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9282,1,10116.0,N,,,5964,CHEMBL631312,,Area under curve at 4 hr in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9283,1,10116.0,N,,,4026,CHEMBL631313,,Area under curve at a dose of 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9284,1,10116.0,N,,,4756,CHEMBL631314,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9285,1,10116.0,N,,,4756,CHEMBL631315,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9286,1,10116.0,N,,,5862,CHEMBL631316,,Area under curve for a 2-mpk po dose in SD rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9287,1,10116.0,N,,,5862,CHEMBL631317,,Area under curve in SD rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9288,1,10116.0,N,,,6644,CHEMBL874471,,Area under curve in rat after oral administration at 13 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9289,1,10116.0,N,,,5871,CHEMBL631318,,Area under curve in rat by po administration at 0-24 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9290,1,10116.0,N,,,5919,CHEMBL631319,,Area under curve in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9291,1,10116.0,N,,,5939,CHEMBL631320,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9292,1,10116.0,N,,,5939,CHEMBL631321,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9293,1,10116.0,N,,,10,CHEMBL631322,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9294,1,10116.0,N,,,11149,CHEMBL631323,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9295,1,10116.0,N,,,5302,CHEMBL631324,,Area under curve value in rat at a dose of 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9296,1,10116.0,N,,,17796,CHEMBL631325,,Area under curve was determined after oral administration in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9297,1,10116.0,N,,,4890,CHEMBL631326,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9298,1,10116.0,N,,,6011,CHEMBL631327,,Area under curve was determined after peroral administration in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9299,1,10116.0,N,,,5375,CHEMBL631328,,Area under curve was determined at a dose 30 mpk administered orally.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9300,1,10116.0,N,,,17764,CHEMBL631329,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9301,1,10116.0,N,,,4368,CHEMBL627217,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9302,1,10116.0,N,,,5610,CHEMBL626352,,Area under curve was determined in male rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9303,1,10116.0,N,,,5833,CHEMBL626353,,Area under curve was determined in rat after PO administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9304,1,10116.0,N,,,4257,CHEMBL626354,,Area under curve was determined in rat after a 3 mg/kg of oral dose,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9305,1,10116.0,N,,,5937,CHEMBL626355,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9306,1,10116.0,N,,,5932,CHEMBL626356,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9307,1,10116.0,N,,,5932,CHEMBL626357,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9308,1,10116.0,N,,,17411,CHEMBL626358,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9309,1,10116.0,N,,,17411,CHEMBL626359,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9310,1,10116.0,N,,,17771,CHEMBL626360,,Peak plasma concentration in rat at a dose of 3 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9311,1,10116.0,N,,,1628,CHEMBL626361,,Plasma concentration at 2 hr in rats was evaluated.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9312,1,10116.0,N,,,1628,CHEMBL626362,,Plasma concentration at 2 hr in rats was evaluated; Not available,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9313,1,10116.0,N,,,17411,CHEMBL626363,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9314,1,10116.0,N,,,4910,CHEMBL626970,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9315,1,10116.0,N,,,4910,CHEMBL626971,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9316,1,10116.0,N,,,4910,CHEMBL626972,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9317,1,10116.0,N,,,4910,CHEMBL626973,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9318,1,10116.0,N,,,4910,CHEMBL626974,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9319,1,10116.0,N,,,4910,CHEMBL874592,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9320,1,10116.0,N,,,5510,CHEMBL626975,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9321,1,10116.0,N,,,5510,CHEMBL626976,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9322,1,10116.0,N,,,5510,CHEMBL626977,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9323,1,10116.0,N,,,5510,CHEMBL626978,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9324,1,10116.0,N,,,16427,CHEMBL626979,,PK study was carried to determine the relative absorption ranking in rat.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9325,1,10116.0,N,,,4689,CHEMBL626980,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9326,1,10116.0,N,,,11450,CHEMBL626981,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9327,1,10116.0,N,,,11450,CHEMBL626982,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9328,1,10116.0,N,,,11450,CHEMBL626983,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9329,1,10116.0,N,,,11450,CHEMBL622522,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9330,1,10116.0,N,,,11450,CHEMBL622523,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9331,1,10116.0,N,,,11450,CHEMBL622524,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9332,1,10116.0,N,,,11450,CHEMBL622525,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9333,1,10116.0,N,,,11450,CHEMBL622526,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9334,1,10116.0,N,,,11450,CHEMBL619849,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9335,1,10116.0,N,,,11450,CHEMBL619850,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9336,1,10116.0,N,,,11450,CHEMBL623864,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9337,1,10116.0,N,,,11450,CHEMBL623865,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9338,1,10116.0,N,,,11450,CHEMBL623866,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9339,1,10116.0,N,,,11450,CHEMBL623867,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9340,1,10116.0,N,,,11450,CHEMBL877615,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9341,1,10116.0,N,,,11450,CHEMBL623868,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9342,1,10116.0,N,,,11450,CHEMBL623869,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9343,1,10116.0,N,,,11450,CHEMBL623870,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9344,1,10116.0,N,,,16434,CHEMBL623871,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9345,1,10116.0,N,,,16434,CHEMBL623872,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9346,1,10116.0,N,,,16435,CHEMBL622129,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9347,1,10116.0,N,,,16435,CHEMBL622130,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9348,1,10116.0,N,,,16435,CHEMBL622131,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9349,1,10116.0,N,,,16435,CHEMBL622132,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9350,1,10116.0,N,,,16435,CHEMBL622133,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9351,1,10116.0,N,,,16435,CHEMBL622134,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9352,1,10116.0,N,,,16435,CHEMBL622135,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9353,1,10116.0,N,,,16435,CHEMBL622136,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9354,1,10116.0,N,,,16434,CHEMBL622137,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9355,1,10116.0,N,,,16434,CHEMBL622138,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9356,1,10116.0,N,,,16434,CHEMBL623017,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9357,1,10116.0,N,,,16434,CHEMBL623018,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9358,1,10116.0,N,,,16434,CHEMBL623019,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9359,1,10116.0,N,,,16434,CHEMBL623020,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9360,1,10116.0,N,,,16434,CHEMBL623021,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9361,1,10116.0,N,,,16434,CHEMBL623022,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9362,1,10116.0,N,,,16435,CHEMBL623023,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9363,1,10116.0,N,,,16435,CHEMBL623024,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9364,1,10116.0,N,,,16435,CHEMBL623025,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9365,1,10116.0,N,,,16435,CHEMBL620545,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9366,1,10116.0,N,,,16435,CHEMBL620546,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9367,1,10116.0,N,,,16435,CHEMBL620547,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9368,1,10116.0,N,,,16435,CHEMBL620548,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9369,1,10116.0,N,,,16435,CHEMBL620549,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9370,1,10116.0,N,,,16434,CHEMBL620550,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9371,1,10116.0,N,,,16434,CHEMBL620551,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9372,1,10116.0,N,,,16434,CHEMBL620552,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9373,1,10116.0,N,,,16435,CHEMBL620553,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9374,1,10116.0,N,,,16435,CHEMBL620554,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9375,1,10116.0,N,,,16435,CHEMBL875845,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9376,1,10116.0,N,,,16435,CHEMBL620555,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9377,1,10116.0,N,,,16435,CHEMBL620556,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9378,1,10116.0,N,,,16435,CHEMBL620557,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9379,1,10116.0,N,,,16434,CHEMBL620558,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9380,1,10116.0,N,,,16434,CHEMBL620559,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9381,1,10116.0,N,,,16434,CHEMBL622939,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9382,1,10116.0,N,,,16434,CHEMBL622940,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9383,1,10116.0,N,,,16434,CHEMBL622941,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9384,1,10116.0,N,,,16434,CHEMBL622942,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9385,1,10116.0,N,,,16434,CHEMBL622943,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9386,1,10116.0,N,,,16434,CHEMBL622944,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9387,1,10116.0,N,,,16435,CHEMBL622945,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9388,1,10116.0,N,,,16435,CHEMBL622946,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9389,1,10116.0,N,,,3341,CHEMBL622947,,Compound was evaluated for terminal half life in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9390,1,10116.0,N,,,3634,CHEMBL622948,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9391,1,10116.0,N,,,3634,CHEMBL622949,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9392,1,10116.0,N,,,4839,CHEMBL622950,,Compound was tested for its half life in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9393,0,9544.0,U,,,5005,CHEMBL622951,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Plasma,A,22224,1,,1969.0,Macaca mulatta
,,,,Intermediate,BAO_0000366,9394,0,10116.0,U,,,5005,CHEMBL622952,,Compound was tested for its plasma half life in Sprague Dawley rats,Plasma,A,22224,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000366,9395,0,10116.0,U,,,5005,CHEMBL622953,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Plasma,A,22224,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9396,1,10116.0,N,,,1094,CHEMBL873818,,Compound was tested for plasma half-life period in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9397,1,10116.0,N,,,5031,CHEMBL622954,,Elimination half life after i.v. administration of compound in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9398,1,10116.0,N,,,6518,CHEMBL622955,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9399,1,10116.0,N,,,6518,CHEMBL875229,,Elimination half-life after IV dosing at 1 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9400,1,10116.0,N,,,6518,CHEMBL622956,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9401,1,10116.0,N,,,6518,CHEMBL622957,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9402,1,10116.0,N,,,5408,CHEMBL622958,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9403,1,10116.0,N,,,5408,CHEMBL622959,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9404,1,10116.0,N,,,5408,CHEMBL622960,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9405,1,10116.0,N,,,5408,CHEMBL622961,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9406,1,10116.0,N,,,4687,CHEMBL622962,,Evaluated for the half life in rat (in vivo),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9407,1,10116.0,N,,,6640,CHEMBL622963,,Hafl life in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9408,1,10116.0,N,,,6640,CHEMBL622964,,Hafl life rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9409,1,10116.0,N,,,6641,CHEMBL622965,,Hafl life rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9410,1,10116.0,N,,,6640,CHEMBL622966,,Hafl life rat; Not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9411,1,10116.0,N,,,6641,CHEMBL622967,,Hafl life rat; Not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9412,1,10116.0,N,,,17411,CHEMBL622968,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9413,1,10116.0,N,,,17411,CHEMBL622969,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9414,1,10116.0,N,,,17411,CHEMBL875327,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9415,1,10116.0,N,,,6570,CHEMBL628638,,Half life in rat after 1 mg/kg i.v. administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9416,1,10116.0,N,,,6570,CHEMBL628639,,Half life in rat after 2 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9417,1,10116.0,N,,,17411,CHEMBL625840,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9418,1,10116.0,N,,,4722,CHEMBL625841,,Half life of 10 mg/kg oral dose determined in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9419,1,10116.0,N,,,5978,CHEMBL625842,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9420,1,10116.0,N,,,5978,CHEMBL625843,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9421,1,10116.0,N,,,5978,CHEMBL625844,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9422,1,10116.0,N,,,5978,CHEMBL873822,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9423,1,10116.0,N,,,5978,CHEMBL625845,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9424,1,10116.0,N,,,5978,CHEMBL627059,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9425,1,10116.0,N,,,5978,CHEMBL627060,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9426,1,10116.0,N,,,5978,CHEMBL627061,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9427,1,10116.0,N,,,4762,CHEMBL627709,,Half life of compound at 5 mg/kg after po administration was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9428,1,10116.0,N,,,5327,CHEMBL627710,,Half life of compound determined after intravenous administration to rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9429,1,10116.0,N,,,4847,CHEMBL627711,,Half life of compound was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9430,1,10116.0,N,,,17720,CHEMBL627712,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9431,1,10116.0,N,,,4723,CHEMBL627713,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9432,1,10116.0,N,,,4723,CHEMBL627714,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9433,0,9541.0,U,,,4256,CHEMBL627889,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,A,22224,1,,,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,9434,0,10116.0,U,,,4256,CHEMBL627890,,Half life determined in rat by intravenous administration,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9435,1,10116.0,N,,,4722,CHEMBL627891,,Half life determined in rats after iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9436,1,10116.0,N,,,6535,CHEMBL627892,,Half life in rat plasma after administration of 2 mg/kg iv,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9437,1,10116.0,N,,,6535,CHEMBL627893,,Half life in rat plasma after administration of 2 mg/kg iv,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9438,1,10116.0,N,,,1435,CHEMBL627894,,Half life in rat plasma was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9439,1,10116.0,N,,,1435,CHEMBL627895,,Half life in rat plasma was determined; NA means not applicable,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9440,1,10116.0,N,,,5206,CHEMBL627896,,Half life in rat was tested,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9441,1,10116.0,N,,,6080,CHEMBL627897,,Half life measured in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9442,1,10116.0,N,,,4449,CHEMBL627898,,Half life recorded in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9443,1,10116.0,N,,,6057,CHEMBL627899,,Half life was calculated,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9444,1,10116.0,N,,,6057,CHEMBL873823,,Half life was calculated in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9445,1,10116.0,N,,,3747,CHEMBL627900,,Half life was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9446,1,10116.0,N,,,17858,CHEMBL627901,,Half life after 10 mg/kg oral administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9447,1,10116.0,N,,,16365,CHEMBL627902,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9448,1,10116.0,N,,,16365,CHEMBL627903,,Half life after administering orally a dose of 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9449,1,10116.0,N,,,5031,CHEMBL627904,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9450,1,10116.0,N,,,4722,CHEMBL627905,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9451,1,10116.0,N,,,6078,CHEMBL627906,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9452,1,10116.0,N,,,6078,CHEMBL627907,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9453,1,10116.0,N,,,6078,CHEMBL876783,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9454,1,10116.0,N,,,6078,CHEMBL627908,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9455,1,10116.0,N,,,17065,CHEMBL627909,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9456,1,10116.0,N,,,1353,CHEMBL627910,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9457,1,10116.0,N,,,1353,CHEMBL627911,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9458,1,10116.0,N,,,1353,CHEMBL627912,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9459,1,10116.0,N,,,1353,CHEMBL627913,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9460,1,10116.0,N,,,1353,CHEMBL627914,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9461,1,10116.0,N,,,16423,CHEMBL627915,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9462,1,10116.0,N,,,16423,CHEMBL627916,,Area under the curve was evaluated after 20 uM/kg of peroral administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9463,1,10116.0,N,,,6062,CHEMBL627917,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9464,1,10116.0,N,,,6056,CHEMBL627918,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9465,1,10116.0,N,,,5182,CHEMBL627919,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9466,1,10116.0,N,,,6410,CHEMBL627920,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9467,1,10116.0,N,,,6410,CHEMBL627921,,Area under the curve was evaluated at an oral dose of 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9468,1,10116.0,N,,,4723,CHEMBL627922,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9469,1,10116.0,N,,,4723,CHEMBL876784,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9470,1,10116.0,N,,,4723,CHEMBL627923,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9471,1,10116.0,N,,,4723,CHEMBL626208,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9472,1,10116.0,N,,,4723,CHEMBL626209,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9473,1,10116.0,N,,,4723,CHEMBL626210,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9474,1,10116.0,N,,,2463,CHEMBL627994,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9475,1,10116.0,N,,,4709,CHEMBL627995,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9476,1,10116.0,N,,,4075,CHEMBL627996,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9477,1,10116.0,N,,,5394,CHEMBL627997,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9478,1,10116.0,N,,,2661,CHEMBL627998,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9479,1,10116.0,N,,,2661,CHEMBL628640,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9480,1,10116.0,N,,,2661,CHEMBL628641,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9481,1,10116.0,N,,,2661,CHEMBL628642,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9482,1,10116.0,N,,,17791,CHEMBL628643,,Compound was evaluated for area under the curve expressed as (h*ug/ml),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9483,1,10116.0,N,,,2591,CHEMBL628644,,Compound was tested for area under curve in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9484,1,10116.0,N,,,6567,CHEMBL628645,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9485,1,10116.0,N,,,6211,CHEMBL628646,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9486,1,10116.0,N,,,5529,CHEMBL628647,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9487,1,10116.0,N,,,5408,CHEMBL628648,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9488,1,10116.0,N,,,5408,CHEMBL625358,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9489,1,10116.0,N,,,5408,CHEMBL625359,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9490,1,10116.0,N,,,5408,CHEMBL625360,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9491,1,10116.0,N,,,429,CHEMBL625361,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9492,1,10116.0,N,,,429,CHEMBL625362,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9493,1,10116.0,N,,,429,CHEMBL625363,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9494,1,10116.0,N,,,4796,CHEMBL625364,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9495,1,10116.0,N,,,5974,CHEMBL625365,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9496,1,10116.0,N,,,5974,CHEMBL625366,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9497,1,10116.0,N,,,5974,CHEMBL625367,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9498,1,10116.0,N,,,11450,CHEMBL625368,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9499,1,10116.0,N,,,11450,CHEMBL625369,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9500,1,10116.0,N,,,11450,CHEMBL625370,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9501,1,10116.0,N,,,11450,CHEMBL625371,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9502,1,10116.0,N,,,11450,CHEMBL625372,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9503,1,10116.0,N,,,11450,CHEMBL625373,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9504,1,10116.0,N,,,11450,CHEMBL625374,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9505,1,10116.0,N,,,11450,CHEMBL877593,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9506,1,10116.0,N,,,11450,CHEMBL625375,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9507,1,10116.0,N,,,11450,CHEMBL625376,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9508,1,10116.0,N,,,11450,CHEMBL621973,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9509,1,10116.0,N,,,11450,CHEMBL621974,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9510,1,10116.0,N,,,11450,CHEMBL621975,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9511,1,10116.0,N,,,11450,CHEMBL622166,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9512,1,10116.0,N,,,11450,CHEMBL622167,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9513,1,10116.0,N,,,11450,CHEMBL622168,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9514,1,10116.0,N,,,11450,CHEMBL622169,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9515,1,10116.0,N,,,11450,CHEMBL622170,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9516,1,10116.0,N,,,11450,CHEMBL622171,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9517,1,10116.0,N,,,11450,CHEMBL622172,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9518,1,10116.0,N,,,11450,CHEMBL622173,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9519,1,10116.0,N,,,11450,CHEMBL622174,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9520,1,10116.0,N,,,11450,CHEMBL622175,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9521,1,10116.0,N,,,11450,CHEMBL622176,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9522,1,10116.0,N,,,11450,CHEMBL622177,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9523,1,10116.0,N,,,11450,CHEMBL622178,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9524,1,10116.0,N,,,11450,CHEMBL622179,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9525,1,10116.0,N,,,11450,CHEMBL622180,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9526,1,10116.0,N,,,16435,CHEMBL622181,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9527,1,10116.0,N,,,16435,CHEMBL622182,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9528,1,10116.0,N,,,16435,CHEMBL622183,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9529,1,10116.0,N,,,16435,CHEMBL622184,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9530,1,10116.0,N,,,16435,CHEMBL622185,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9531,1,10116.0,N,,,16435,CHEMBL622186,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9532,1,10116.0,N,,,16434,CHEMBL622187,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9533,1,10116.0,N,,,16434,CHEMBL625002,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9534,1,10116.0,N,,,16434,CHEMBL622090,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9535,1,10116.0,N,,,16435,CHEMBL622091,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9536,1,10116.0,N,,,16435,CHEMBL622092,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9537,1,10116.0,N,,,16435,CHEMBL622093,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9538,1,10116.0,N,,,16435,CHEMBL622094,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9539,1,10116.0,N,,,16435,CHEMBL622095,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9540,1,10116.0,N,,,16435,CHEMBL622264,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9541,1,10116.0,N,,,16434,CHEMBL622265,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9542,1,10116.0,N,,,16434,CHEMBL622266,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9543,1,10116.0,N,,,16434,CHEMBL622267,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9544,1,10116.0,N,,,16434,CHEMBL622268,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9545,1,10116.0,N,,,16434,CHEMBL622269,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9546,1,10116.0,N,,,16434,CHEMBL625071,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9547,1,10116.0,N,,,16434,CHEMBL621621,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9548,1,10116.0,N,,,16434,CHEMBL621622,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9549,1,10116.0,N,,,16435,CHEMBL621623,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9550,1,10116.0,N,,,16435,CHEMBL621624,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9551,1,10116.0,N,,,16435,CHEMBL621625,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9552,1,10116.0,N,,,16435,CHEMBL621626,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9553,1,10116.0,N,,,16435,CHEMBL621627,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9554,1,10116.0,N,,,16435,CHEMBL621628,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9555,1,10116.0,N,,,16435,CHEMBL875328,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9556,1,10116.0,N,,,16435,CHEMBL621629,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9557,1,10116.0,N,,,16434,CHEMBL621630,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9558,1,10116.0,N,,,16434,CHEMBL621631,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9559,1,10116.0,N,,,16434,CHEMBL621632,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9560,1,10116.0,N,,,16435,CHEMBL621633,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9561,1,10116.0,N,,,16435,CHEMBL621634,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9562,1,10116.0,N,,,16435,CHEMBL621635,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9563,1,10116.0,N,,,16435,CHEMBL621636,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9564,1,10116.0,N,,,16435,CHEMBL621637,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9565,1,10116.0,N,,,16435,CHEMBL621638,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9566,1,10116.0,N,,,16434,CHEMBL618883,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9567,1,10116.0,N,,,16434,CHEMBL618884,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9568,1,10116.0,N,,,16434,CHEMBL628627,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9569,1,10116.0,N,,,16434,CHEMBL628628,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9570,1,10116.0,N,,,16434,CHEMBL628629,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9571,1,10116.0,N,,,16365,CHEMBL628630,,Half life after administering orally a dose of 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9572,1,10116.0,N,,,16365,CHEMBL628631,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9573,1,10116.0,N,,,16365,CHEMBL628632,,Half life after administering intravenously a dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9574,1,10116.0,N,,,526,CHEMBL628633,,Half life after oral dosing in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9575,1,10116.0,N,,,16365,CHEMBL628634,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9576,1,10116.0,N,,,4368,CHEMBL627789,,Half life by intravenous administration of 3.4 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9577,1,10116.0,N,,,3371,CHEMBL627790,,Half life in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9578,1,10116.0,N,,,6448,CHEMBL627791,,Half life in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9579,1,10116.0,N,,,6453,CHEMBL627792,,Half life in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9580,1,10116.0,N,,,4353,CHEMBL627793,,Half life in rat after intravenous administration of the compound,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9581,1,10116.0,N,,,4353,CHEMBL627794,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9582,1,10116.0,N,,,4353,CHEMBL627795,,Half life in rat after po administration of the compound,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9583,1,10116.0,N,,,4353,CHEMBL627796,,Half life in rat after po administration of the compound; ND means Not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9584,1,10116.0,N,,,4353,CHEMBL875335,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9585,1,10116.0,N,,,4353,CHEMBL627797,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9586,1,10116.0,N,,,5789,CHEMBL627798,,Half life in rat i.v.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9587,1,10116.0,N,,,17686,CHEMBL627799,,Half life in rat i.v. at 2 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9588,1,10116.0,N,,,6495,CHEMBL627800,,Half life in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9589,1,10116.0,N,,,484,CHEMBL627801,,Half life in rats after intravenous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9590,1,10116.0,N,,,6467,CHEMBL627802,,Half life in rats at the dose of 1.0 mpk by i.v. administration,,A,50597,1,,,Rattus norvegicus
,,,,Expert,BAO_0000218,9591,1,10116.0,N,,,6642,CHEMBL627803,,Half life in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9592,1,10116.0,N,,,16367,CHEMBL873820,,Half life was evaluated after intravenous administration to rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9593,1,10116.0,N,,,1369,CHEMBL627804,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9594,1,10116.0,N,,,5472,CHEMBL627805,,Half life was evaluated in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9595,1,10116.0,N,,,6049,CHEMBL627806,,Half life was evaluated in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9596,1,10116.0,N,,,5472,CHEMBL627107,,Half life was evaluated in rat; Not tested,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9597,1,10116.0,N,,,16366,CHEMBL627108,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9598,1,10116.0,N,,,11149,CHEMBL627109,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9599,1,10116.0,N,,,11149,CHEMBL627110,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9600,0,9443.0,U,,,2891,CHEMBL627111,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,A,22224,1,,,Primates
,In vivo,,,Intermediate,BAO_0000218,9601,0,9443.0,U,,,2891,CHEMBL627112,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,A,22224,1,,,Primates
,In vivo,,,Intermediate,BAO_0000218,9602,0,10116.0,U,,,2891,CHEMBL627113,,Half life was measured in rat at dose of 30 mg/kg by iv administration,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9603,0,10116.0,U,,,2891,CHEMBL627114,,Half life was measured in rat at dose of 30 mg/kg by po administration,,A,22224,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9604,1,10116.0,N,,,4026,CHEMBL627115,,Half life (t1/2) was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9605,1,10116.0,N,,,4527,CHEMBL627116,,Half life period at a dose of 10 uM/kg in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9606,1,10116.0,N,,,4527,CHEMBL627117,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9607,1,10116.0,N,,,5503,CHEMBL627118,,Half life period was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9608,1,10116.0,N,,,4426,CHEMBL627119,,Half life period after intravenous administration at 20 mpk in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9609,1,10116.0,N,,,4426,CHEMBL627120,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9610,1,10116.0,N,,,6109,CHEMBL626922,,Half life period after intravenous administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9611,1,10116.0,N,,,5654,CHEMBL626923,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9612,1,10116.0,N,,,5654,CHEMBL626924,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9613,1,10116.0,N,,,4755,CHEMBL626925,,Half life period in 80% rat plasma at 37 degree Centigrade,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9614,1,10116.0,N,,,5862,CHEMBL626926,,Half life period in SD rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9615,1,10116.0,N,,,1515,CHEMBL626927,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9616,1,10116.0,N,,,1515,CHEMBL626928,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9617,1,10116.0,N,,,1515,CHEMBL626929,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9618,1,10116.0,N,,,1515,CHEMBL626930,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9619,1,10116.0,N,,,5960,CHEMBL626931,,Half life period in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9620,1,10116.0,N,,,6103,CHEMBL626932,,Half life period in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9621,1,10116.0,N,,,6317,CHEMBL626933,,Half life period in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9622,1,10116.0,N,,,6644,CHEMBL873826,,Half life period in rat after oral administration at 10.5 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9623,1,10116.0,N,,,6644,CHEMBL626934,,Half life period in rat after oral administration at 11.2 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9624,1,10116.0,N,,,6644,CHEMBL626935,,Half life period in rat after oral administration at 13 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9625,1,10116.0,N,,,6644,CHEMBL626936,,Half life period in rat after oral administration at 9.7 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9626,1,10116.0,N,,,5974,CHEMBL626937,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9627,1,10116.0,N,,,6295,CHEMBL625906,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9628,1,10116.0,N,,,6296,CHEMBL625907,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9629,1,10116.0,N,,,16427,CHEMBL625908,,PK study was carried to determine AUC (area under curve) value in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9630,1,10116.0,N,,,16367,CHEMBL625909,,Pharmacokinetic parameter AUC after intravenous administration to rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9631,1,10116.0,N,,,16367,CHEMBL625910,,Pharmacokinetic parameter AUC after oral administration to rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9632,1,10116.0,N,,,16365,CHEMBL625911,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9633,1,10116.0,N,,,16365,CHEMBL625912,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9634,1,10116.0,N,,,16365,CHEMBL626538,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9635,1,10116.0,N,,,16365,CHEMBL876794,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9636,1,10116.0,N,,,16365,CHEMBL626539,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9637,1,10116.0,N,,,16365,CHEMBL626540,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9638,1,10116.0,N,,,5394,CHEMBL626541,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9639,1,10116.0,N,,,5394,CHEMBL626542,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9640,1,10116.0,N,,,2792,CHEMBL626543,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9641,1,10116.0,N,,,2792,CHEMBL626544,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9642,1,10116.0,N,,,2792,CHEMBL626545,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9643,1,10116.0,N,,,2792,CHEMBL626546,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9644,1,10116.0,N,,,5334,CHEMBL626547,,Pharmacokinetic parameter area under curve was reported,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9645,1,10116.0,N,,,4408,CHEMBL626548,,Pharmacokinetic property (AUC) in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9646,1,10116.0,N,,,5983,CHEMBL626549,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9647,1,10116.0,N,,,4397,CHEMBL626550,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9648,1,10116.0,N,,,4397,CHEMBL626551,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9649,1,10116.0,N,,,5491,CHEMBL623777,,Pharmacokinetic property was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9650,1,10116.0,N,,,5491,CHEMBL623778,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9651,1,10116.0,N,,,5491,CHEMBL623779,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9652,1,10116.0,N,,,4199,CHEMBL623780,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9653,1,10116.0,N,,,4199,CHEMBL622015,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9654,1,10116.0,N,,,4199,CHEMBL622016,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9655,1,10116.0,N,,,5173,CHEMBL622017,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9656,1,10116.0,N,,,5173,CHEMBL622018,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9657,1,10116.0,N,,,5173,CHEMBL622019,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9658,1,10116.0,N,,,5173,CHEMBL622020,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9659,1,10116.0,N,,,16366,CHEMBL622021,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9660,1,10116.0,N,,,16366,CHEMBL622022,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9661,1,10116.0,N,,,5327,CHEMBL622023,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9662,1,10116.0,N,,,6681,CHEMBL622024,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9663,1,10116.0,N,,,12873,CHEMBL622693,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9664,1,10116.0,N,,,12873,CHEMBL622694,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9665,1,10116.0,N,,,6685,CHEMBL622695,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9666,1,10116.0,N,,,6685,CHEMBL622696,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9667,1,10116.0,N,,,6685,CHEMBL622697,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9668,1,10116.0,N,,,6619,CHEMBL622874,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9669,1,10116.0,N,,,6619,CHEMBL622875,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9670,1,10116.0,N,,,10363,CHEMBL622876,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9671,1,10116.0,N,,,4796,CHEMBL622877,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9672,1,10116.0,N,,,4910,CHEMBL622878,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9673,1,10116.0,N,,,4910,CHEMBL622879,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9674,1,10116.0,N,,,4839,CHEMBL877602,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9675,1,10116.0,N,,,15078,CHEMBL622880,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9676,1,10116.0,N,,,15078,CHEMBL622881,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9677,1,10116.0,N,,,15078,CHEMBL622882,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9678,1,10116.0,N,,,15078,CHEMBL622883,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9679,1,10116.0,N,,,11450,CHEMBL622884,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9680,1,10116.0,N,,,11450,CHEMBL622885,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9681,1,10116.0,N,,,8151,CHEMBL622886,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9682,1,10116.0,N,,,8151,CHEMBL622887,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9683,1,10116.0,N,,,8151,CHEMBL622888,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Urine,A,50597,1,,1088.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9684,1,10116.0,N,,,8677,CHEMBL622889,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9685,1,10116.0,N,,,8677,CHEMBL622890,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9686,1,10116.0,N,,,8677,CHEMBL622891,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9687,1,10116.0,N,,,8677,CHEMBL877603,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9688,1,10116.0,N,,,8677,CHEMBL622892,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9689,1,10116.0,N,,,8677,CHEMBL622893,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9690,1,10116.0,N,,,8677,CHEMBL622894,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9691,1,10116.0,N,,,8677,CHEMBL622895,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9692,1,10116.0,N,,,8677,CHEMBL622896,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9693,1,10116.0,N,,,8677,CHEMBL622897,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9694,1,10116.0,N,,,8677,CHEMBL622898,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9695,1,10116.0,N,,,8677,CHEMBL622899,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9696,1,10116.0,N,,,8677,CHEMBL622900,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9697,1,10116.0,N,,,8677,CHEMBL624114,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9698,1,10116.0,N,,,8677,CHEMBL624115,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9699,1,10116.0,N,,,8677,CHEMBL624116,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9700,1,10116.0,N,,,8677,CHEMBL624117,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9701,1,10116.0,N,,,8677,CHEMBL624118,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9702,1,10116.0,N,,,8677,CHEMBL624119,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9703,1,10116.0,N,,,8677,CHEMBL624120,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9704,1,10116.0,N,,,8677,CHEMBL624121,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9705,1,10116.0,N,,,8677,CHEMBL624122,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9706,1,10116.0,N,,,8677,CHEMBL624123,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9707,1,10116.0,N,,,8677,CHEMBL624124,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9708,1,10116.0,N,,,8677,CHEMBL624125,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9709,1,10116.0,N,,,8677,CHEMBL624126,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9710,1,10116.0,N,,,8677,CHEMBL624127,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9711,1,10116.0,N,,,8677,CHEMBL624128,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9712,1,10116.0,N,,,8677,CHEMBL624129,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9713,1,10116.0,N,,,8677,CHEMBL624130,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9714,1,10116.0,N,,,8677,CHEMBL622340,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9715,1,10116.0,N,,,8677,CHEMBL622341,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9716,1,10116.0,N,,,8677,CHEMBL622342,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9717,1,10116.0,N,,,8677,CHEMBL622343,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9718,1,10116.0,N,,,8677,CHEMBL622344,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9719,1,10116.0,N,,,8677,CHEMBL622345,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9720,1,10116.0,N,,,8677,CHEMBL622346,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9721,1,10116.0,N,,,8677,CHEMBL622347,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9722,1,10116.0,N,,,8677,CHEMBL622348,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9723,1,10116.0,N,,,8677,CHEMBL622349,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9724,1,10116.0,N,,,16434,CHEMBL622350,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9725,1,10116.0,N,,,16434,CHEMBL622351,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9726,1,10116.0,N,,,16434,CHEMBL622352,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9727,1,10116.0,N,,,16435,CHEMBL622353,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9728,1,10116.0,N,,,16435,CHEMBL622354,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9729,1,10116.0,N,,,16435,CHEMBL622355,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9730,1,10116.0,N,,,16435,CHEMBL622356,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9731,1,10116.0,N,,,16435,CHEMBL622357,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9732,1,10116.0,N,,,16435,CHEMBL622358,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9733,1,10116.0,N,,,16435,CHEMBL622359,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9734,1,10116.0,N,,,16435,CHEMBL874393,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9735,1,10116.0,N,,,16434,CHEMBL622872,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9736,1,10116.0,N,,,16434,CHEMBL622873,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9737,1,10116.0,N,,,16434,CHEMBL623047,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9738,1,10116.0,N,,,16435,CHEMBL623048,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9739,1,10116.0,N,,,16435,CHEMBL623049,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9740,1,10116.0,N,,,16435,CHEMBL623050,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9741,1,10116.0,N,,,16435,CHEMBL623051,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9742,1,10116.0,N,,,16435,CHEMBL623052,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9743,1,10116.0,N,,,16435,CHEMBL626343,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9744,1,10116.0,N,,,16434,CHEMBL626344,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9745,1,10116.0,N,,,16434,CHEMBL626345,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9746,1,10116.0,N,,,16434,CHEMBL626346,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9747,1,10116.0,N,,,16434,CHEMBL626347,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9748,1,10116.0,N,,,16434,CHEMBL626348,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9749,1,10116.0,N,,,16434,CHEMBL626349,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9750,1,10116.0,N,,,16435,CHEMBL626350,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9751,1,10116.0,N,,,16435,CHEMBL626351,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9752,1,10116.0,N,,,16435,CHEMBL627650,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9753,1,10116.0,N,,,16435,CHEMBL627651,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9754,1,10116.0,N,,,16435,CHEMBL627652,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9755,1,10116.0,N,,,16435,CHEMBL627653,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9756,1,10116.0,N,,,13091,CHEMBL627654,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9757,1,10116.0,N,,,13091,CHEMBL627835,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9758,1,10116.0,N,,,13091,CHEMBL627836,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9759,1,10116.0,N,,,13091,CHEMBL627837,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9760,1,10116.0,N,,,13091,CHEMBL627838,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9761,1,10116.0,N,,,13091,CHEMBL875338,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9762,1,10116.0,N,,,13091,CHEMBL627839,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9763,1,10116.0,N,,,13091,CHEMBL627840,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9764,1,10116.0,N,,,13091,CHEMBL627841,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9765,1,10116.0,N,,,13091,CHEMBL627842,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9766,1,10116.0,N,,,13091,CHEMBL627843,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9767,1,10116.0,N,,,13091,CHEMBL627844,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9768,1,10116.0,N,,,13091,CHEMBL627845,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9769,1,10116.0,N,,,5874,CHEMBL627846,,Half life period in rat by iv administration at a dose of 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9770,1,10116.0,N,,,1515,CHEMBL627847,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9771,1,10116.0,N,,,1515,CHEMBL873821,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9772,1,10116.0,N,,,1515,CHEMBL626079,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9773,1,10116.0,N,,,1515,CHEMBL626080,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9774,1,10116.0,N,,,5491,CHEMBL626081,,Half life period was evaluated in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9775,1,10116.0,N,,,5491,CHEMBL875344,,Half life period was evaluated in rat plasma; Not tested,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9776,1,10116.0,N,,,1918,CHEMBL626082,,Half life period was evaluated in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9777,1,10116.0,N,,,1918,CHEMBL626250,,"Half life period was evaluated in rats, iv",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9778,1,10116.0,N,,,6113,CHEMBL626251,,Half life period after intravenous administration at 5 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9779,1,10116.0,N,,,5546,CHEMBL626252,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9780,1,10116.0,N,,,5553,CHEMBL626253,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9781,1,10116.0,N,,,4188,CHEMBL626254,,Half life stability of compound was evaluated in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9782,1,10116.0,N,,,6215,CHEMBL626255,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9783,1,10116.0,N,,,6141,CHEMBL626256,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9784,1,10116.0,N,,,5182,CHEMBL626257,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9785,1,10116.0,N,,,5182,CHEMBL626258,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9786,1,10116.0,N,,,5710,CHEMBL626259,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9787,1,10116.0,N,,,5789,CHEMBL626260,,Half in rat i.v.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9788,1,10116.0,N,,,6011,CHEMBL875345,,Half period in rat after intravenous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9789,1,10116.0,N,,,17594,CHEMBL626261,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,9790,1,10116.0,N,,,12357,CHEMBL626262,,Half-life measured in in vitro Cathepsin B assay in rat liver,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9791,1,10116.0,N,,,5210,CHEMBL626263,,Half-life of compound was determined in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9792,1,10116.0,N,,,17596,CHEMBL625270,,Half-life at 10 mg/kg in rat upon intravenous administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9793,1,10116.0,N,,,6672,CHEMBL625271,,Half-life determined in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9794,1,10116.0,N,,,6673,CHEMBL625272,,Half-life determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9795,1,10116.0,N,,,4910,CHEMBL625273,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9796,1,10116.0,N,,,3741,CHEMBL625274,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9797,1,10116.0,N,,,17671,CHEMBL625275,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9798,1,10116.0,N,,,4910,CHEMBL625276,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9799,1,10116.0,N,,,17537,CHEMBL625277,,Half-life in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9800,1,10116.0,N,,,4965,CHEMBL625278,,Half-life in rat plasma was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9801,1,10116.0,N,,,17537,CHEMBL625279,,Half-life in rat plasma; Not tested,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9802,1,10116.0,N,,,6124,CHEMBL625280,,Half-life in rat serum,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9803,1,10116.0,N,,,6124,CHEMBL876797,,Half-life in rat serum; na is not available,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9804,1,10116.0,N,,,6078,CHEMBL625281,,Half-life was calculated in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9805,1,10116.0,N,,,17668,CHEMBL873827,,Half-life was calculated in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9806,1,10116.0,N,,,3185,CHEMBL625282,,Half-life was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9807,1,10116.0,N,,,4883,CHEMBL625283,,Half-life was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9808,1,10116.0,N,,,2959,CHEMBL625284,,Half-life after administration of 20 mg/Kg oral dose in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9809,1,10116.0,N,,,4029,CHEMBL625285,,Half-life after administration of 3.2 mg/kg intravenously in male rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9810,1,10116.0,N,,,4029,CHEMBL625286,,Half-life after intravenous administration in female rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9811,1,10116.0,N,,,4029,CHEMBL625287,,Half-life after intravenous administration in male rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9812,1,10116.0,N,,,6180,CHEMBL625288,,Half-life after intravenous dose in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9813,1,10116.0,N,,,1557,CHEMBL625289,,Half-life in a rat liver homogenate preparation,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9814,1,10116.0,N,,,12500,CHEMBL625290,,Half-life in plasma of rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9815,1,10116.0,N,,,12500,CHEMBL876798,,Half-life in plasma of rat at dose of 3-10 mgkg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9816,1,10116.0,N,,,5064,CHEMBL625291,,Half-life in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9817,1,10116.0,N,,,5145,CHEMBL625292,,Half-life in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9818,1,10116.0,N,,,5147,CHEMBL625293,,Half-life in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9819,1,10116.0,N,,,5833,CHEMBL622832,,Half-life in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9820,1,10116.0,N,,,6596,CHEMBL622833,,Half-life in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9821,1,10116.0,N,,,17655,CHEMBL622834,,Half-life in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9822,1,10116.0,N,,,6495,CHEMBL622835,,Half-life in rat after oral administration at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9823,1,10116.0,N,,,17538,CHEMBL622836,,Half-life in rat after po administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9824,1,10116.0,N,,,17538,CHEMBL622837,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9825,1,10116.0,N,,,10,CHEMBL622838,,Half-life in rat at 3 mg/kg dose administered intravenously,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9826,1,10116.0,N,,,17669,CHEMBL622839,,Half-life in rat brain homogenate,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9827,1,10116.0,N,,,17065,CHEMBL622840,,Half-life in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9828,1,10116.0,N,,,4333,CHEMBL622841,,Half-life in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9829,1,10116.0,N,,,6827,CHEMBL622842,,Half-life in Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,9830,1,10116.0,N,,,889,CHEMBL622843,,Half-life in vitro in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,9831,1,10116.0,N,,,889,CHEMBL622844,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9832,1,10116.0,N,,,3747,CHEMBL622845,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9833,1,10116.0,N,,,15022,CHEMBL622846,,The area under the curve of compound was measured at the dose of 100 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9834,1,10116.0,N,,,15022,CHEMBL622847,,The area under the curve of compound was measured at the dose of 300 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9835,1,10116.0,N,,,15022,CHEMBL622848,,The area under the curve of compound was measured at the dose of 30 umol/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9836,1,10116.0,N,,,3360,CHEMBL622849,,Bioavailability as oral AUC in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9837,1,10116.0,N,,,5334,CHEMBL622850,,The plasma concentration versus time curve (AUC) was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9838,1,10116.0,N,,,17411,CHEMBL876807,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9839,1,10116.0,N,,,17411,CHEMBL622851,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9840,1,10116.0,N,,,17411,CHEMBL622852,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9841,1,10116.0,N,,,6570,CHEMBL622853,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9842,1,10116.0,N,,,6570,CHEMBL622854,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9843,1,10116.0,N,,,17411,CHEMBL622855,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9844,1,10116.0,N,,,14941,CHEMBL622856,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9845,1,10116.0,N,,,14941,CHEMBL622857,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9846,1,10116.0,N,,,17538,CHEMBL622858,,AUC in rat after po administration at a dose of 10 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9847,1,10116.0,N,,,17752,CHEMBL622859,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9848,1,10116.0,N,,,17509,CHEMBL622860,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9849,1,10116.0,N,,,17509,CHEMBL622861,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9850,1,10116.0,N,,,17509,CHEMBL622862,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9851,1,10116.0,N,,,17509,CHEMBL622863,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9852,1,10116.0,N,,,17509,CHEMBL623817,,Area under curve value 6 hr after po administration in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9853,1,10116.0,N,,,17717,CHEMBL623818,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9854,1,10116.0,N,,,17717,CHEMBL623819,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9855,1,10116.0,N,,,17717,CHEMBL623820,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9856,1,10116.0,N,,,17717,CHEMBL623821,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9857,1,10116.0,N,,,6642,CHEMBL623822,,AUC normalized for dose (AUCN) in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9858,1,10116.0,N,,,6640,CHEMBL623823,,Area under curve in rat after p.o. administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9859,1,10116.0,N,,,6641,CHEMBL623824,,Area under curve in rat after p.o. administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9860,1,10116.0,N,,,6641,CHEMBL623825,,Area under curve in rat after p.o. administration; Not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9861,1,10116.0,N,,,6641,CHEMBL622070,,Area under curve in rat after peroral administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9862,1,10116.0,N,,,3603,CHEMBL622071,,Area under curve (carotid artery) value of the compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9863,1,10116.0,N,,,3550,CHEMBL622072,,Bioavailability expressed as the area under curve of rat carotid artery,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9864,1,10116.0,N,,,15662,CHEMBL622073,,Area under curve in male SD rats was observed after intravenous administration in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9865,1,10116.0,N,,,17720,CHEMBL622074,,Area under curve of the compound was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9866,1,10116.0,N,,,5407,CHEMBL622075,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9867,1,10116.0,N,,,17752,CHEMBL622076,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9868,1,10116.0,N,,,17752,CHEMBL622077,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9869,1,10116.0,N,,,3603,CHEMBL622078,,Area under curve (portal vein) value of the compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9870,1,10116.0,N,,,3550,CHEMBL622079,,Bioavailability expressed as the area under curve of rat portal vein,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9871,1,10116.0,N,,,17655,CHEMBL622080,,Area Under plasma concentration time curve in rat upon peroral administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9872,1,10116.0,N,,,17582,CHEMBL877612,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9873,1,10116.0,N,,,17582,CHEMBL622081,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9874,1,10116.0,N,,,17791,CHEMBL622082,,Compound was evaluated for oral bioavailability in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9875,1,10116.0,N,,,17791,CHEMBL622083,,Compound was evaluated for oral bioavailability in rats after iv administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9876,1,10116.0,N,,,17791,CHEMBL622084,,Compound was evaluated for oral bioavailability in rats; 30-80,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9877,1,10116.0,N,,,17791,CHEMBL622085,,Compound was evaluated for oral bioavailability in rats; 50-60,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9878,1,10116.0,N,,,17791,CHEMBL622086,,Compound was evaluated for oral bioavailability in rats; no data,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9879,1,10116.0,N,,,17791,CHEMBL622087,,Compound was evaluated for oral bioavailability in rats; peptide,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9880,1,10116.0,N,,,7768,CHEMBL622088,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9881,1,10116.0,N,,,7768,CHEMBL622089,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9882,1,10116.0,N,,,7768,CHEMBL623685,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9883,1,10116.0,N,,,7768,CHEMBL623686,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9884,1,10116.0,N,,,8677,CHEMBL623687,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9885,1,10116.0,N,,,8677,CHEMBL623688,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9886,1,10116.0,N,,,8677,CHEMBL623689,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9887,1,10116.0,N,,,8677,CHEMBL622485,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Stomach,A,50597,1,,945.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9888,1,10116.0,N,,,8677,CHEMBL622486,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9889,1,10116.0,N,,,8677,CHEMBL877613,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9890,1,10116.0,N,,,8677,CHEMBL622487,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9891,1,10116.0,N,,,8677,CHEMBL622488,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9892,1,10116.0,N,,,8677,CHEMBL622489,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9893,1,10116.0,N,,,6899,CHEMBL622490,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9894,1,10116.0,N,,,6899,CHEMBL622491,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9895,1,10116.0,N,,,6899,CHEMBL622492,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9896,1,10116.0,N,,,6899,CHEMBL622493,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9897,1,10116.0,N,,,6899,CHEMBL622494,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9898,1,10116.0,N,,,8677,CHEMBL622495,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9899,1,10116.0,N,,,6899,CHEMBL622496,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9900,1,10116.0,N,,,6899,CHEMBL622497,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9901,1,10116.0,N,,,2189,CHEMBL622498,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9902,1,10116.0,N,,,2189,CHEMBL624918,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9903,1,10116.0,N,,,2189,CHEMBL624919,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Urine,A,50597,1,,1088.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9904,1,10116.0,N,,,10839,CHEMBL624920,,Biodistribution of compound in rat blood after 5 min of administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9905,1,10116.0,N,,,10839,CHEMBL624921,,Biodistribution of compound in rat blood after 5 min of administration.,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9906,1,10116.0,N,,,10839,CHEMBL624922,,Biodistribution of compound in rat brain after 5 min of administration,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9907,1,10116.0,N,,,10839,CHEMBL624923,,Biodistribution of compound in rat heart after 5 min of administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9908,1,10116.0,N,,,10839,CHEMBL624924,,Biodistribution of compound in rat heart after 5 min of administration.,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9909,1,10116.0,N,,,10839,CHEMBL624925,,Biodistribution of compound in rat kidney after 5 min of administration,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9910,1,10116.0,N,,,10839,CHEMBL624926,,Biodistribution of compound in rat kidney after 5 min of administration.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9911,1,10116.0,N,,,10839,CHEMBL624927,,Biodistribution of compound in rat liver after 5 min of administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9912,1,10116.0,N,,,10839,CHEMBL874402,,Biodistribution of compound in rat liver after 5 min of administration.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9913,1,10116.0,N,,,10839,CHEMBL624928,,Biodistribution of compound in rat lung after 5 min of administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9914,1,10116.0,N,,,10839,CHEMBL624929,,Biodistribution of compound in rat lung after 5 min of administration.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9915,1,10116.0,N,,,10839,CHEMBL624930,,Biodistribution of compound in rat muscle after 5 min of administration,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9916,1,10116.0,N,,,10839,CHEMBL624931,,Biodistribution of compound in rat muscle after 5 min of administration.,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9917,1,10116.0,N,,,4043,CHEMBL624932,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9918,1,10116.0,N,,,4043,CHEMBL624933,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9919,1,10116.0,N,,,4043,CHEMBL624934,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9920,1,10116.0,N,,,4043,CHEMBL624935,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9921,1,10116.0,N,,,4043,CHEMBL624936,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9922,1,10116.0,N,,,4043,CHEMBL624937,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9923,1,10116.0,N,,,4043,CHEMBL624938,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9924,1,10116.0,N,,,4043,CHEMBL624939,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9925,1,10116.0,N,,,4043,CHEMBL624940,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9926,1,10116.0,N,,,4043,CHEMBL874403,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9927,1,10116.0,N,,,1446,CHEMBL624941,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9928,1,10116.0,N,,,9971,CHEMBL624942,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9929,1,10116.0,N,,,9971,CHEMBL624943,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Urine,A,50597,1,,1088.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9930,1,10116.0,N,,,5765,CHEMBL624944,,% Bioavailability after 1 day of the drug administration in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9931,1,10116.0,N,,,5765,CHEMBL624945,,% Bioavailability after 4 day of the drug administration in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9932,1,10116.0,N,,,4257,CHEMBL624946,,Absolute bioavailability was evaluated in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9933,1,10116.0,N,,,13091,CHEMBL624947,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9934,1,10116.0,N,,,13091,CHEMBL624948,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9935,1,10116.0,N,,,13091,CHEMBL624949,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9936,1,10116.0,N,,,13091,CHEMBL622025,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9937,1,10116.0,N,,,13091,CHEMBL622026,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9938,1,10116.0,N,,,13091,CHEMBL622027,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9939,1,10116.0,N,,,13091,CHEMBL622028,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9940,1,10116.0,N,,,13091,CHEMBL622029,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9941,1,10116.0,N,,,13091,CHEMBL622208,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9942,1,10116.0,N,,,13091,CHEMBL622209,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9943,1,10116.0,N,,,13091,CHEMBL622210,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9944,1,10116.0,N,,,13091,CHEMBL622211,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9945,1,10116.0,N,,,13091,CHEMBL622212,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9946,1,10116.0,N,,,13091,CHEMBL622213,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9947,1,10116.0,N,,,13091,CHEMBL874404,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9948,1,10116.0,N,,,13091,CHEMBL620452,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9949,1,10116.0,N,,,13091,CHEMBL620453,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9950,1,10116.0,N,,,13091,CHEMBL620454,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9951,1,10116.0,N,,,13091,CHEMBL624067,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9952,1,10116.0,N,,,13091,CHEMBL624068,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9953,1,10116.0,N,,,13091,CHEMBL624069,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Female gonad,A,50597,1,,992.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9954,1,10116.0,N,,,13091,CHEMBL624070,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Female gonad,A,50597,1,,992.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9955,1,10116.0,N,,,13091,CHEMBL624071,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Female gonad,A,50597,1,,992.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9956,1,10116.0,N,,,13091,CHEMBL624072,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9957,1,10116.0,N,,,13091,CHEMBL624073,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9958,1,10116.0,N,,,13091,CHEMBL624788,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9959,1,10116.0,N,,,13091,CHEMBL624789,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9960,1,10116.0,N,,,13091,CHEMBL624790,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9961,1,10116.0,N,,,13091,CHEMBL624791,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9962,1,10116.0,N,,,13091,CHEMBL624792,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9963,1,10116.0,N,,,13091,CHEMBL624793,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9964,1,10116.0,N,,,13091,CHEMBL877491,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9965,1,10116.0,N,,,13091,CHEMBL624957,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9966,1,10116.0,N,,,13091,CHEMBL624958,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9967,1,10116.0,N,,,13091,CHEMBL624959,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9968,1,10116.0,N,,,11977,CHEMBL624960,,Dissociation constant was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9969,1,10116.0,N,,,14941,CHEMBL624961,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9970,1,10116.0,N,,,15078,CHEMBL624962,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9971,1,10116.0,N,,,15078,CHEMBL624963,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9972,1,10116.0,N,,,4755,CHEMBL624964,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9973,1,10116.0,N,,,589,CHEMBL624965,,LogP value was evaluated in the in situ rat gut perfusion assay,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9974,1,10116.0,N,,,17582,CHEMBL624966,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9975,1,10116.0,N,,,5031,CHEMBL624967,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9976,1,10116.0,N,,,17764,CHEMBL624968,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9977,1,10116.0,N,,,17720,CHEMBL624969,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,A,50597,1,,,Rattus norvegicus
,,,,Expert,BAO_0000218,9978,1,10116.0,N,,,2862,CHEMBL624970,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9979,1,10116.0,N,,,16423,CHEMBL624971,,Half-life was evaluated after 10 uM/kg of intra arterial administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9980,1,10116.0,N,,,16423,CHEMBL624972,,Half-life was evaluated after 20 uM/kg of peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9981,1,10116.0,N,,,6005,CHEMBL624973,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9982,1,10116.0,N,,,2938,CHEMBL624974,,Half-life was evaluated in plasma of rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9983,1,10116.0,N,,,6410,CHEMBL624975,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9984,1,10116.0,N,,,6410,CHEMBL877492,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9985,1,10116.0,N,,,6062,CHEMBL624976,,Half-life was measured in rat after an iv dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9986,1,10116.0,N,,,6571,CHEMBL624977,,Half-life period of compound in rats after peroral administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9987,1,10116.0,N,,,3136,CHEMBL626848,,Half-life period of compound was measured in rat plasma.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9988,1,10116.0,N,,,3136,CHEMBL626849,,Half-life period of compound was measured in rat plasma; ND is not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9989,1,10116.0,N,,,3136,CHEMBL626850,,Half-life period of compound was measured in rat plasma; not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9990,1,10116.0,N,,,4521,CHEMBL626851,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9991,1,10116.0,N,,,5871,CHEMBL626852,,Half-life period in rat by iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9992,1,10116.0,N,,,6077,CHEMBL626853,,Half-life period in rats following intravenous administration at 2 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9993,1,10116.0,N,,,6679,CHEMBL626854,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,9994,1,10116.0,N,,,5144,CHEMBL627486,,Half-life period was determined for the compound in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9995,1,10116.0,N,,,4498,CHEMBL627487,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9996,1,10116.0,N,,,4498,CHEMBL627488,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9997,1,10116.0,N,,,1908,CHEMBL627489,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9998,1,10116.0,N,,,6211,CHEMBL627490,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,9999,1,10116.0,N,,,5529,CHEMBL873829,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10000,1,10116.0,N,,,6444,CHEMBL627655,,Half-life was determined in rat at a dose of 1 mpk i.v.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10001,1,10116.0,N,,,6444,CHEMBL625994,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10002,1,10116.0,N,,,6444,CHEMBL625995,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10003,1,10116.0,N,,,5207,CHEMBL625996,,Half-life in rat,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,10004,1,10116.0,N,,,530,CHEMBL625850,,In vitro half life in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,10005,1,10116.0,N,,,1116,CHEMBL625851,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,10006,1,10116.0,N,,,3219,CHEMBL625852,,In vitro half life in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10007,1,10116.0,N,,,6109,CHEMBL625853,,In vivo half life period after intravenous administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10008,1,10116.0,N,,,17582,CHEMBL625854,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10009,1,10116.0,N,,,17582,CHEMBL874450,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10010,1,10116.0,N,,,5974,CHEMBL625855,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10011,1,10116.0,N,,,5974,CHEMBL625856,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10012,1,10116.0,N,,,5974,CHEMBL625857,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10013,1,10116.0,N,,,5974,CHEMBL873831,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10014,1,10116.0,N,,,17853,CHEMBL625858,,Longer half-life in rat (i.v.) at 0.5 mpk,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10015,1,10116.0,N,,,17853,CHEMBL625859,,Longer half-life in rat (p.o.) at 2.0 mpk,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10016,1,10116.0,N,,,3457,CHEMBL625860,,Pharmacokinetic property (half life) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10017,1,10116.0,N,,,2792,CHEMBL625861,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10018,1,10116.0,N,,,2792,CHEMBL625862,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10019,1,10116.0,N,,,2792,CHEMBL625863,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10020,1,10116.0,N,,,2792,CHEMBL625864,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10021,1,10116.0,N,,,5739,CHEMBL625865,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10022,1,10116.0,N,,,15765,CHEMBL625866,,Pharmacokinetic half time was determined intravenously in rats.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10023,1,10116.0,N,,,6567,CHEMBL625867,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10024,1,10116.0,N,,,2448,CHEMBL625868,,Plasma half life of hydrolysis of the compound,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10025,1,10116.0,N,,,5423,CHEMBL625869,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10026,1,10116.0,N,,,4853,CHEMBL874451,,Plasma half life period was calculated in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10027,1,10116.0,N,,,4514,CHEMBL625870,,Plasma half-life in Sprague-Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10028,1,10116.0,N,,,4514,CHEMBL625871,,Plasma half-life in Sprague-Dawley rats; Not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10029,1,10116.0,N,,,1500,CHEMBL625872,,Plasma half-life in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10030,1,10116.0,N,,,1500,CHEMBL625873,,Plasma half-life in rats; <MQL,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10031,1,10116.0,N,,,5334,CHEMBL625874,,Plasma half-life period (0-8 h) was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10032,1,10116.0,N,,,5334,CHEMBL625875,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10033,1,10116.0,N,,,5334,CHEMBL625876,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10034,1,10116.0,N,,,5334,CHEMBL631258,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10035,1,10116.0,N,,,4956,CHEMBL631259,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10036,1,10116.0,N,,,4956,CHEMBL631260,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10037,1,10116.0,N,,,7768,CHEMBL631261,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10038,1,10116.0,N,,,7768,CHEMBL631262,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10039,1,10116.0,N,,,7768,CHEMBL631263,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10040,1,10116.0,N,,,7768,CHEMBL631264,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10041,1,10116.0,N,,,7768,CHEMBL631265,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10042,1,10116.0,N,,,7768,CHEMBL631266,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10043,1,10116.0,N,,,7768,CHEMBL631267,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10044,1,10116.0,N,,,7768,CHEMBL631268,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10045,1,10116.0,N,,,7768,CHEMBL631269,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10046,1,10116.0,N,,,7768,CHEMBL631270,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10047,1,10116.0,N,,,7768,CHEMBL631271,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10048,1,10116.0,N,,,7768,CHEMBL631272,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10049,1,10116.0,N,,,7768,CHEMBL631273,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10050,1,10116.0,N,,,7768,CHEMBL631274,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10051,1,10116.0,N,,,7768,CHEMBL631275,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10052,1,10116.0,N,,,7768,CHEMBL626984,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10053,1,10116.0,N,,,7768,CHEMBL626985,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10054,1,10116.0,N,,,7768,CHEMBL626986,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10055,1,10116.0,N,,,7768,CHEMBL626987,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10056,1,10116.0,N,,,7768,CHEMBL626988,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10057,1,10116.0,N,,,7768,CHEMBL626989,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10058,1,10116.0,N,,,7768,CHEMBL626990,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10059,1,10116.0,N,,,7768,CHEMBL626991,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10060,1,10116.0,N,,,7768,CHEMBL626992,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10061,1,10116.0,N,,,7768,CHEMBL626993,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10062,1,10116.0,N,,,7768,CHEMBL874593,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10063,1,10116.0,N,,,7768,CHEMBL626994,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10064,1,10116.0,N,,,7768,CHEMBL626995,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10065,1,10116.0,N,,,7768,CHEMBL626190,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10066,1,10116.0,N,,,7768,CHEMBL626191,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10067,1,10116.0,N,,,7768,CHEMBL626364,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10068,1,10116.0,N,,,7768,CHEMBL626365,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10069,1,10116.0,N,,,7768,CHEMBL626366,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10070,1,10116.0,N,,,7768,CHEMBL626367,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10071,1,10116.0,N,,,7768,CHEMBL626368,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10072,1,10116.0,N,,,7768,CHEMBL626369,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10073,1,10116.0,N,,,7768,CHEMBL626370,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10074,1,10116.0,N,,,4498,CHEMBL626371,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10075,1,10116.0,N,,,4498,CHEMBL626372,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10076,1,10116.0,N,,,3603,CHEMBL626373,,Bioavailability after a dose of 10 mg/kg p.o.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10077,1,10116.0,N,,,6215,CHEMBL626374,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10078,1,10116.0,N,,,5710,CHEMBL626375,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10079,1,10116.0,N,,,5710,CHEMBL626376,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10080,1,10116.0,N,,,5676,CHEMBL626377,,Bioavailability in rat po was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10081,1,10116.0,N,,,17667,CHEMBL626378,,Bioavailability of compound at 10 mg/kg in rat after oral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10082,1,10116.0,N,,,17667,CHEMBL626379,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10083,1,10116.0,N,,,6848,CHEMBL626380,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10084,1,10116.0,N,,,6848,CHEMBL626381,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10085,1,10116.0,N,,,17267,CHEMBL626382,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10086,1,10116.0,N,,,6362,CHEMBL626383,,Bioavailability in rat (Sprague-Dawley) (female),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10087,1,10116.0,N,,,17671,CHEMBL874652,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10088,1,10116.0,N,,,17671,CHEMBL626384,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10089,1,10116.0,N,,,4333,CHEMBL626385,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10090,1,10116.0,N,,,6077,CHEMBL626386,,Bioavailability in rat at an oral dose of 2 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10091,1,10116.0,N,,,3278,CHEMBL626387,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10092,1,10116.0,N,,,5964,CHEMBL626388,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10093,1,10116.0,N,,,4884,CHEMBL626389,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10094,1,10116.0,N,,,4905,CHEMBL626390,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10095,1,10116.0,N,,,4884,CHEMBL626391,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10096,1,10116.0,N,,,6850,CHEMBL626392,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10097,1,10116.0,N,,,2864,CHEMBL626393,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10098,1,10116.0,N,,,5780,CHEMBL623026,,Bioavailability was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10099,1,10116.0,N,,,1465,CHEMBL623027,,Bioavailability,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10100,1,10116.0,N,,,5199,CHEMBL623028,,Bioavailability,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10101,1,10116.0,N,,,5765,CHEMBL623029,,Bioavailability in rat after 1 day dosing,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10102,1,10116.0,N,,,5765,CHEMBL623030,,Bioavailability in rat after 4 day dosing,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10103,1,10116.0,N,,,6518,CHEMBL623031,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10104,1,10116.0,N,,,6518,CHEMBL623032,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10105,1,10116.0,N,,,6518,CHEMBL623033,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10106,1,10116.0,N,,,6518,CHEMBL623034,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10107,1,10116.0,N,,,2083,CHEMBL623035,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10108,1,10116.0,N,,,17260,CHEMBL623036,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10109,1,10116.0,N,,,4956,CHEMBL623037,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10110,1,10116.0,N,,,4368,CHEMBL623038,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10111,1,10116.0,N,,,17752,CHEMBL874385,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10112,1,10116.0,N,,,1446,CHEMBL623039,,Bioavailability in rat (Fisher) (fasted),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10113,0,9443.0,U,,,2891,CHEMBL623040,,Bioavailability in monkey after po administration of 10 mg/kg dose,,A,22224,1,,,Primates
,In vivo,,,Intermediate,BAO_0000218,10114,0,9443.0,U,,,2891,CHEMBL623041,,Oral bioavailability in monkey (dose 10 mg/kg),,A,22224,1,,,Primates
,In vivo,,,Intermediate,BAO_0000218,10115,1,10116.0,N,,,6672,CHEMBL623741,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10116,1,10116.0,N,,,6673,CHEMBL623742,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10117,1,10116.0,N,,,17655,CHEMBL623743,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10118,1,10116.0,N,,,17796,CHEMBL623744,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10119,1,10116.0,N,,,17853,CHEMBL623745,,Bioavailability in rat (dose 2.0 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10120,1,10116.0,N,,,4521,CHEMBL623746,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10121,1,10116.0,N,,,4940,CHEMBL623747,,Oral bioavailability in rat (dose 5 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10122,0,10116.0,U,,,2891,CHEMBL623748,,Bioavailability in rat after po administration of 30 mg/kg dose,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10123,0,10116.0,U,,,2891,CHEMBL623916,,Bioavailability in rat after po administration of 30 mg/kg dose,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10124,1,10116.0,N,,,4521,CHEMBL623917,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10125,1,10116.0,N,,,17686,CHEMBL623918,,Bioavailability in rat (dose 2 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10126,1,10116.0,N,,,17796,CHEMBL874386,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10127,1,10116.0,N,,,17796,CHEMBL623919,,Bioavailability in rat; Only traces detected in rat plasma,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10128,1,10116.0,N,,,5064,CHEMBL623920,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10129,1,10116.0,N,,,5147,CHEMBL623148,,Bioavailability upon oral administration of compound,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10130,1,10116.0,N,,,1916,CHEMBL623149,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10131,1,10116.0,N,,,6049,CHEMBL623150,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10132,1,10116.0,N,,,1445,CHEMBL623151,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10133,1,10116.0,N,,,1445,CHEMBL623152,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,A,50597,1,,,Rattus norvegicus
,,,,Expert,BAO_0000218,10134,1,10116.0,N,,,2862,CHEMBL623153,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,F,50597,1,,,Rattus norvegicus
,,,,Expert,BAO_0000218,10135,1,10116.0,N,,,2862,CHEMBL623154,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10136,1,10116.0,N,,,4194,CHEMBL623155,,In vitro and metabolic stability was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10137,1,10116.0,N,,,4194,CHEMBL623156,,In vitro metabolic stability in rat hepatocytes,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10138,1,10116.0,N,,,5486,CHEMBL623157,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,A,50597,1,,,Rattus norvegicus
Hepatocyte,In vitro,,401.0,Intermediate,BAO_0000218,10139,1,10116.0,N,,,17582,CHEMBL623158,,Metabolic rate for compound was observed in rat hepatocytes,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10140,1,10116.0,N,,,5600,CHEMBL623159,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10141,1,10116.0,N,,,14294,CHEMBL874390,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10142,1,10116.0,N,,,14294,CHEMBL623160,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10143,1,10116.0,N,,,14294,CHEMBL623161,,Metabolism of compound in rat S9 microsomes; Trace,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10144,1,10116.0,N,,,17847,CHEMBL623162,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10145,1,10116.0,N,,,11020,CHEMBL623163,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10146,1,10116.0,N,,,11020,CHEMBL623164,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10147,1,10116.0,N,,,11020,CHEMBL623165,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10148,1,10116.0,N,,,11020,CHEMBL623166,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10149,1,10116.0,N,,,11020,CHEMBL624983,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10150,1,10116.0,N,,,11020,CHEMBL624984,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10151,1,10116.0,N,,,11020,CHEMBL624985,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10152,1,10116.0,N,,,11020,CHEMBL622970,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10153,1,10116.0,N,,,11020,CHEMBL622971,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10154,1,10116.0,N,,,11020,CHEMBL622972,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10155,1,10116.0,N,,,11020,CHEMBL622973,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10156,1,10116.0,N,,,11020,CHEMBL622974,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10157,1,10116.0,N,,,11020,CHEMBL622975,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10158,1,10116.0,N,,,11020,CHEMBL622976,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10159,1,10116.0,N,,,11020,CHEMBL622977,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10160,1,10116.0,N,,,11020,CHEMBL624351,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10161,1,10116.0,N,,,11020,CHEMBL624352,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10162,1,10116.0,N,,,11020,CHEMBL624353,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10163,1,10116.0,N,,,11020,CHEMBL622397,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10164,1,10116.0,N,,,11020,CHEMBL622398,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10165,1,10116.0,N,,,11020,CHEMBL622399,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10166,1,10116.0,N,,,11020,CHEMBL622400,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10167,1,10116.0,N,,,11020,CHEMBL628428,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10168,1,10116.0,N,,,11020,CHEMBL628590,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10169,1,10116.0,N,,,11020,CHEMBL628591,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10170,1,10116.0,N,,,11020,CHEMBL628592,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10171,1,10116.0,N,,,11020,CHEMBL628593,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10172,1,10116.0,N,,,11020,CHEMBL875333,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10173,1,10116.0,N,,,11020,CHEMBL628594,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10174,1,10116.0,N,,,4969,CHEMBL628595,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10175,1,10116.0,N,,,6737,CHEMBL628596,,Stability in rat plasma was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10176,1,10116.0,N,,,6737,CHEMBL628597,,Stability in rat plasma was determined; ND= no data,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10177,1,10116.0,N,,,5089,CHEMBL628598,,Tested for plasma half life period in rat (0-8 hr),Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10178,1,10116.0,N,,,5089,CHEMBL628599,,Tested for plasma half life period in rat (0-8 hr); Not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10179,1,10116.0,N,,,1466,CHEMBL628600,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10180,1,10116.0,N,,,1466,CHEMBL628601,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10181,1,10116.0,N,,,4950,CHEMBL628602,,Tested for the half life in rat,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,10182,1,10116.0,N,,,2412,CHEMBL628603,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,10183,1,10116.0,N,,,2412,CHEMBL628604,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,10184,1,10116.0,N,,,2412,CHEMBL628605,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,10185,1,10116.0,N,,,2412,CHEMBL628606,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,10186,1,10116.0,N,,,2412,CHEMBL628607,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10187,1,10116.0,N,,,15022,CHEMBL628608,,The biological half life the compound was measured at the dose of 100 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10188,1,10116.0,N,,,15022,CHEMBL628609,,The biological half life the compound was measured at the dose of 30 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10189,1,10116.0,N,,,406,CHEMBL628610,,The compound was evaluated for plasma half life period in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10190,1,10116.0,N,,,15078,CHEMBL873819,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10191,1,10116.0,N,,,15078,CHEMBL628611,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10192,1,10116.0,N,,,5247,CHEMBL628612,,The pharmacokinetic parameter half-life period in vivo in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10193,1,10116.0,N,,,5041,CHEMBL628613,,"The pharmacokinetic property, Half-life was determined",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10194,1,10116.0,N,,,5041,CHEMBL628614,,"The pharmacokinetic property, Half-life in rat in vivo",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10195,1,10116.0,N,,,5041,CHEMBL628615,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10196,1,10116.0,N,,,5041,CHEMBL628616,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10197,1,10116.0,N,,,3918,CHEMBL627924,,The plasma half life period in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10198,1,10116.0,N,,,2906,CHEMBL627925,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10199,1,10116.0,N,,,6467,CHEMBL627926,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10200,1,10116.0,N,,,5510,CHEMBL627927,,t1/2 (apparent elimination)of the compound was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10201,1,10116.0,N,,,3788,CHEMBL627928,,t1/2 value in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10202,1,10116.0,N,,,17796,CHEMBL627539,,Half life in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10203,1,10116.0,N,,,12873,CHEMBL876790,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10204,1,10116.0,N,,,5983,CHEMBL858186,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10205,1,10116.0,N,,,15765,CHEMBL627540,,Half-life period in fasted rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10206,1,10116.0,N,,,2661,CHEMBL627541,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10207,1,10116.0,N,,,2661,CHEMBL627715,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10208,1,10116.0,N,,,429,CHEMBL627716,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10209,1,10116.0,N,,,17655,CHEMBL627717,,Maximum time required to achieve Cmax was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10210,1,10116.0,N,,,17717,CHEMBL627718,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10211,1,10116.0,N,,,17717,CHEMBL627719,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10212,1,10116.0,N,,,17717,CHEMBL627720,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10213,1,10116.0,N,,,6570,CHEMBL627721,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10214,1,10116.0,N,,,6570,CHEMBL627722,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10215,1,10116.0,N,,,5978,CHEMBL627723,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10216,1,10116.0,N,,,5978,CHEMBL626058,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10217,1,10116.0,N,,,5978,CHEMBL626059,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10218,1,10116.0,N,,,5978,CHEMBL626060,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10219,1,10116.0,N,,,17720,CHEMBL626061,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10220,1,10116.0,N,,,4723,CHEMBL876791,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10221,1,10116.0,N,,,4723,CHEMBL626062,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10222,1,10116.0,N,,,4756,CHEMBL626063,,Tmax at the dose of 2 mg/Kg administered perorally in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10223,1,10116.0,N,,,4756,CHEMBL626064,,Tmax at the dose of 5 mg/Kg administered perorally in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10224,1,10116.0,N,,,17720,CHEMBL626065,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10225,1,10116.0,N,,,17720,CHEMBL626066,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10226,1,10116.0,N,,,1466,CHEMBL626067,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10227,1,10116.0,N,,,7449,CHEMBL626068,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10228,1,10116.0,N,,,7449,CHEMBL626069,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10229,1,10116.0,N,,,7449,CHEMBL626070,,Percent total excretion of 3-methoxyacetaminophen glucuronide,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10230,1,10116.0,N,,,7449,CHEMBL626071,,Percent total excretion of N-methoxyacetaminophen glucuronide,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10231,1,10116.0,N,,,7449,CHEMBL626072,,Percent total excretion of N-methoxyacetaminophen sulfate,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10232,1,10116.0,N,,,7449,CHEMBL626073,,Percent total excretion of acetaminophen,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10233,1,10116.0,N,,,7768,CHEMBL626741,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10234,1,10116.0,N,,,17655,CHEMBL626742,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10235,1,10116.0,N,,,17735,CHEMBL626743,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10236,1,10116.0,N,,,5960,CHEMBL876792,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10237,1,10116.0,N,,,17735,CHEMBL626744,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10238,1,10116.0,N,,,7116,CHEMBL626745,,Compound was tested for antidiuretic activity in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10239,1,10116.0,N,,,4878,CHEMBL626746,,AUC in rat after 3mg/kg oral dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10240,1,10116.0,N,,,5939,CHEMBL626747,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10241,1,10116.0,N,,,5939,CHEMBL626748,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10242,1,10116.0,N,,,16367,CHEMBL626749,,Bioavailability administered orally at a dose of 10 mg/kg to rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10243,1,10116.0,N,,,16366,CHEMBL626750,,Oral Bioavailability was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10244,1,10116.0,N,,,4426,CHEMBL626751,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10245,1,10116.0,N,,,4426,CHEMBL626913,,Oral bioavailability in rat; Not performed.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10246,1,10116.0,N,,,5041,CHEMBL626914,,Bioavailability,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10247,1,10116.0,N,,,5041,CHEMBL626915,,Bioavailability was determined; ND denotes no data,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10248,1,10116.0,N,,,1500,CHEMBL626916,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10249,1,10116.0,N,,,1500,CHEMBL626917,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10250,1,10116.0,N,,,17409,CHEMBL626918,,Binding towards rat plasma protein at 10 uM,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10251,1,10116.0,N,,,17409,CHEMBL626919,,Binding towards rat plasma protein at 100 uM,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10252,1,10116.0,N,,,2959,CHEMBL626920,,Bioavailability in rat (dose 20 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10253,1,10116.0,N,,,13501,CHEMBL621976,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10254,1,10116.0,N,,,6567,CHEMBL877599,,Bioavailability in rat after 5 mg/kg oral gavage,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10255,1,10116.0,N,,,6571,CHEMBL621977,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10256,1,10116.0,N,,,6715,CHEMBL621978,,Bioavailability in rat (dose 1 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10257,1,10116.0,N,,,6715,CHEMBL621979,,Bioavailability in rat (dose 3 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10258,1,10116.0,N,,,2932,CHEMBL621980,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10259,1,10116.0,N,,,4171,CHEMBL621981,,Bioavailability of the compound in rats after administration of 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10260,1,10116.0,N,,,17509,CHEMBL621982,,Bioavailability after administration of 10 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10261,1,10116.0,N,,,17509,CHEMBL882953,,Bioavailability after administration of 2 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10262,1,10116.0,N,,,4527,CHEMBL621983,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10263,1,10116.0,N,,,4026,CHEMBL621984,,Bioavailability in dogs was determined; high,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10264,1,10116.0,N,,,6659,CHEMBL621985,,Bioavailability in monkey after intravenous administration at 1 mpk,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10265,1,10116.0,N,,,6659,CHEMBL621986,,Bioavailability in monkey after peroral administration at 10 mpk,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10266,1,10116.0,N,,,6659,CHEMBL621987,,Bioavailability in rat after intravenous administration at 1 mpk,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10267,1,10116.0,N,,,6659,CHEMBL877600,,Bioavailability in rat after intravenous administration at 2 mpk,,F,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10268,1,10116.0,N,,,6659,CHEMBL621988,,Bioavailability in rat after peroral administration at 30 mpk,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10269,1,10116.0,N,,,6659,CHEMBL621989,,Bioavailability in rat after peroral administration at at 100 mpk,,F,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10270,1,10116.0,N,,,6597,CHEMBL621990,,Bioavailability in rats was evaluated,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10271,1,10116.0,N,,,1202,CHEMBL621991,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10272,1,10116.0,N,,,1202,CHEMBL621992,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10273,1,10116.0,N,,,1202,CHEMBL621993,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10274,1,10116.0,N,,,1202,CHEMBL621994,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10275,1,10116.0,N,,,5207,CHEMBL621995,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10276,1,10116.0,N,,,5970,CHEMBL621996,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10277,1,10116.0,N,,,17538,CHEMBL621997,,Oral bioavailability in rat (dose 10 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10278,1,10116.0,N,,,17538,CHEMBL621998,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10279,1,10116.0,N,,,1466,CHEMBL621999,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10280,1,10116.0,N,,,2879,CHEMBL622000,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10281,1,10116.0,N,,,2879,CHEMBL622001,,Bioavailability was measured in rat after oral administration; 2-4,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10282,1,10116.0,N,,,2879,CHEMBL622002,,Bioavailability was measured in rat after oral administration; 3-7,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10283,1,10116.0,N,,,3777,CHEMBL622003,,Bioavailability in rat (intraduodenal administration),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10284,1,10116.0,N,,,3777,CHEMBL877601,,Bioavailability in rat (intraduodenal administration),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10285,1,10116.0,N,,,3777,CHEMBL624871,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10286,1,10116.0,N,,,3777,CHEMBL622004,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10287,1,10116.0,N,,,5423,CHEMBL882954,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10288,1,10116.0,N,,,16365,CHEMBL622005,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10289,1,10116.0,N,,,16365,CHEMBL622006,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10290,1,10116.0,N,,,4239,CHEMBL622007,,Bioavailability was measured in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10291,1,10116.0,N,,,5438,CHEMBL622008,,Bioavailability was reported,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10292,1,10116.0,N,,,5334,CHEMBL622009,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10293,1,10116.0,N,,,5334,CHEMBL622010,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10294,1,10116.0,N,,,4199,CHEMBL622011,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10295,1,10116.0,N,,,4199,CHEMBL622012,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10296,1,10116.0,N,,,4199,CHEMBL622013,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10297,1,10116.0,N,,,4890,CHEMBL622014,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10298,1,10116.0,N,,,2792,CHEMBL624749,,Bioavailability was determined at 3 mg/kg po dose in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10299,1,10116.0,N,,,5529,CHEMBL624750,,Oral bioavailability in rat (dose 2 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10300,1,10116.0,N,,,6685,CHEMBL624751,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10301,1,10116.0,N,,,6685,CHEMBL624752,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10302,1,10116.0,N,,,6685,CHEMBL624753,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10303,1,10116.0,N,,,6005,CHEMBL624754,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10304,1,10116.0,N,,,6410,CHEMBL624755,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10305,1,10116.0,N,,,6410,CHEMBL624756,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10306,1,10116.0,N,,,6103,CHEMBL624757,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10307,1,10116.0,N,,,6410,CHEMBL624758,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10308,1,10116.0,N,,,6410,CHEMBL622270,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10309,1,10116.0,N,,,5353,CHEMBL622271,,Bioavailability in rat (Sprague-Dawley),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10310,1,10116.0,N,,,4727,CHEMBL622272,,Bioavailability in rat at the dose of 2 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10311,1,10116.0,N,,,17804,CHEMBL622273,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10312,1,10116.0,N,,,5809,CHEMBL622274,,Bioavailability in rat (cannulated) (dose 2 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10313,1,10116.0,N,,,17804,CHEMBL622275,,Bioavailability value of compound in rats was determined after peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10314,1,10116.0,N,,,3634,CHEMBL622276,,Oral bioavailability in rat (dose 20 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10315,1,10116.0,N,,,3341,CHEMBL622277,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10316,1,10116.0,N,,,2690,CHEMBL622278,,Oral bioavailability in rat (dose 5 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10317,1,10116.0,N,,,3184,CHEMBL622279,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10318,1,10116.0,N,,,740,CHEMBL622280,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10319,1,10116.0,N,,,1806,CHEMBL624083,,Compound was evaluated for oral bioavailability in rats; 15-27 %,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10320,1,10116.0,N,,,4891,CHEMBL624084,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10321,1,10116.0,N,,,3634,CHEMBL624085,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10322,1,10116.0,N,,,64,CHEMBL624086,,Compound was tested for bioavailability in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10323,1,10116.0,N,,,4839,CHEMBL624087,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10324,1,10116.0,N,,,1094,CHEMBL624088,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10325,0,9544.0,U,,,5005,CHEMBL624089,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,A,22224,1,,,Macaca mulatta
,In vivo,,,Intermediate,BAO_0000218,10326,0,10116.0,U,,,5005,CHEMBL624090,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10327,1,10116.0,N,,,4687,CHEMBL624091,,Evaluated for the bioavailability in rat (in vivo),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10328,1,10116.0,N,,,17804,CHEMBL624092,,F value of compound in rats was determined after peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10329,1,10116.0,N,,,5974,CHEMBL624093,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10330,1,10116.0,N,,,5974,CHEMBL624094,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10331,1,10116.0,N,,,5974,CHEMBL624095,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10332,1,10116.0,N,,,5974,CHEMBL624096,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10333,1,10116.0,N,,,1088,CHEMBL624097,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10334,1,10116.0,N,,,1742,CHEMBL624098,,Maximum fall in carotid flow in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10335,1,10116.0,N,,,4689,CHEMBL874392,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10336,1,10116.0,N,,,2463,CHEMBL624099,,Oral bioavailability in rat (dose 5 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10337,1,10116.0,N,,,5654,CHEMBL624100,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10338,1,10116.0,N,,,5654,CHEMBL624101,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10339,1,10116.0,N,,,6874,CHEMBL624102,,Oral bioavailability in rat (male Wistar),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10340,1,10116.0,N,,,5633,CHEMBL624103,,Oral bioavailability after administration (30 mg/kg) in rat; good,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10341,1,10116.0,N,,,5496,CHEMBL624104,,Oral bioavailability at the dose of 2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10342,1,10116.0,N,,,2358,CHEMBL624105,,Oral bioavailability determined in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10343,1,10116.0,N,,,16456,CHEMBL624106,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10344,1,10116.0,N,,,5302,CHEMBL624107,,Oral bioavailability in rat (dose single 10 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10345,1,10116.0,N,,,5302,CHEMBL623943,,Oral bioavailability in rat (dose single 10 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10346,1,10116.0,N,,,5302,CHEMBL623944,,Oral bioavailability in rat (dose 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10347,1,10116.0,N,,,11020,CHEMBL623945,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10348,1,10116.0,N,,,11020,CHEMBL623946,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10349,1,10116.0,N,,,11020,CHEMBL623947,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10350,1,10116.0,N,,,11020,CHEMBL623948,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10351,1,10116.0,N,,,11020,CHEMBL623949,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10352,1,10116.0,N,,,11020,CHEMBL623950,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10353,1,10116.0,N,,,11020,CHEMBL874398,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10354,1,10116.0,N,,,11020,CHEMBL623951,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10355,1,10116.0,N,,,11020,CHEMBL623952,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10356,1,10116.0,N,,,11020,CHEMBL623953,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10357,1,10116.0,N,,,11020,CHEMBL623954,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10358,1,10116.0,N,,,11020,CHEMBL623955,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10359,1,10116.0,N,,,11020,CHEMBL623956,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10360,1,10116.0,N,,,11020,CHEMBL627807,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10361,1,10116.0,N,,,11020,CHEMBL627808,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10362,1,10116.0,N,,,11020,CHEMBL627809,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10363,1,10116.0,N,,,11020,CHEMBL627810,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10364,1,10116.0,N,,,11020,CHEMBL627811,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10365,1,10116.0,N,,,11020,CHEMBL627812,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10366,1,10116.0,N,,,11020,CHEMBL627813,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10367,1,10116.0,N,,,11020,CHEMBL627814,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10368,1,10116.0,N,,,11020,CHEMBL875336,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10369,1,10116.0,N,,,11020,CHEMBL627815,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10370,1,10116.0,N,,,11020,CHEMBL627816,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10371,1,10116.0,N,,,11020,CHEMBL627817,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10372,1,10116.0,N,,,11020,CHEMBL627818,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10373,1,10116.0,N,,,11020,CHEMBL627819,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10374,1,10116.0,N,,,11020,CHEMBL627820,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10375,1,10116.0,N,,,11020,CHEMBL627821,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10376,1,10116.0,N,,,11020,CHEMBL628464,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10377,1,10116.0,N,,,11020,CHEMBL626239,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10378,1,10116.0,N,,,11020,CHEMBL626240,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10379,1,10116.0,N,,,11020,CHEMBL626241,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10380,1,10116.0,N,,,11020,CHEMBL626242,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10381,1,10116.0,N,,,11020,CHEMBL626243,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10382,1,10116.0,N,,,11020,CHEMBL626244,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10383,1,10116.0,N,,,11020,CHEMBL626907,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10384,1,10116.0,N,,,11020,CHEMBL626908,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10385,1,10116.0,N,,,11020,CHEMBL626909,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10386,1,10116.0,N,,,11020,CHEMBL626910,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10387,1,10116.0,N,,,7449,CHEMBL875342,,Percent total excretion of acetaminophen cysteine conjugate,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10388,1,10116.0,N,,,7449,CHEMBL626911,,Percent total excretion of acetaminophen glucuronide,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10389,1,10116.0,N,,,7449,CHEMBL626912,,Percent total excretion of acetaminophen sulfate,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10390,1,10116.0,N,,,7449,CHEMBL627065,,Percent total excretion of acetaminophen-mercapturic acid,,F,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10391,1,10116.0,N,,,3172,CHEMBL627066,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Urine,A,50597,1,,1088.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10392,1,10116.0,N,,,16456,CHEMBL627067,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,10393,0,8656.0,U,,,10839,CHEMBL627068,,Biodistribution of compound in rat muscle after 5 min of administration,Muscle tissue,A,22224,1,,2385.0,ratrat
,In vivo,,,Autocuration,BAO_0000218,10394,0,8656.0,U,,,10839,CHEMBL627069,,Biodistribution of compound in rat muscle after 5 min of administration.,Muscle tissue,A,22224,1,,2385.0,ratrat
,In vivo,,,Autocuration,BAO_0000218,10395,0,9940.0,U,,,5334,CHEMBL627070,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,A,22224,1,,,Ovis aries
,In vivo,,,Autocuration,BAO_0000218,10396,0,9940.0,U,,,5334,CHEMBL627071,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,A,22224,1,,,Ovis aries
,In vivo,,,Autocuration,BAO_0000218,10397,0,9940.0,U,,,5334,CHEMBL627072,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,A,22224,1,,,Ovis aries
,In vivo,,,Autocuration,BAO_0000218,10398,0,9940.0,U,,,5334,CHEMBL627073,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,A,22224,1,,,Ovis aries
,In vivo,,,Autocuration,BAO_0000218,10399,0,9940.0,U,,,5334,CHEMBL625387,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,A,22224,1,,,Ovis aries
,In vivo,,,Autocuration,BAO_0000218,10400,0,9940.0,U,,,5334,CHEMBL625388,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,A,22224,1,,,Ovis aries
,In vivo,,,Autocuration,BAO_0000218,10401,0,9940.0,U,,,5334,CHEMBL625389,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Plasma,A,22224,1,,1969.0,Ovis aries
,In vivo,,,Autocuration,BAO_0000218,10402,0,9940.0,U,,,5334,CHEMBL875343,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Plasma,A,22224,1,,1969.0,Ovis aries
,,,,Intermediate,BAO_0000218,10403,1,8570.0,N,,,1735,CHEMBL876795,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,A,50497,1,,,Serpentes
,,,,Intermediate,BAO_0000218,10404,1,8570.0,N,,,1469,CHEMBL626552,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,A,50497,1,,,Serpentes
,,,,Intermediate,BAO_0000218,10405,1,8570.0,N,,,1336,CHEMBL626553,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,A,50497,1,,,Serpentes
,,,,Autocuration,BAO_0000366,10406,0,9606.0,U,,,12403,CHEMBL626554,,The human biological plasma half life of the compound,Plasma,A,22224,1,,1969.0,Homo sapiens
,,,,Intermediate,BAO_0000218,10407,1,10116.0,N,,,8151,CHEMBL626555,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10408,1,10116.0,N,,,8004,CHEMBL626556,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10409,1,10116.0,N,,,8004,CHEMBL626557,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10410,1,10116.0,N,,,8004,CHEMBL626558,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10411,1,10116.0,N,,,8004,CHEMBL626559,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10412,1,10116.0,N,,,8004,CHEMBL626560,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10413,1,10116.0,N,,,8004,CHEMBL876803,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10414,1,10116.0,N,,,8004,CHEMBL627964,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10415,1,10116.0,N,,,8004,CHEMBL627965,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10416,1,10116.0,N,,,8004,CHEMBL627966,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10417,1,10116.0,N,,,8004,CHEMBL627967,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10418,1,10116.0,N,,,8004,CHEMBL627968,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10419,1,10116.0,N,,,8004,CHEMBL627969,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10420,1,10116.0,N,,,8004,CHEMBL627970,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10421,1,10116.0,N,,,8004,CHEMBL627971,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10422,1,10116.0,N,,,8004,CHEMBL627972,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Expert,BAO_0000357,10423,9,9606.0,D,,,15917,CHEMBL856029,,Dissociation constant against binding to human cyclophilin A,,B,180,1,,,Homo sapiens
,,,,Expert,BAO_0000019,10424,8,9913.0,H,,,12396,CHEMBL627973,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,B,11591,1,,,Bos taurus
,,,,Autocuration,BAO_0000019,10425,0,,U,,,7065,CHEMBL627974,,-Log C was determined by performing the electroshock minimum test,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10426,0,,U,,,7065,CHEMBL627975,,-Log C was determined by performing the foot shock test,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10427,0,,U,,,7065,CHEMBL627976,,-Log C was determined by performing the incl screen test,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10428,0,,U,,,7065,CHEMBL627977,,-Log C was determined by performing the maximum electroshock test,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10429,0,,U,,,7065,CHEMBL627978,,-Log C was determined by performing the pentylenetetrazole test,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10430,0,,U,,,12415,CHEMBL627979,,Tested for experimental arotinoid inhibitory dose,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10431,0,,U,,,10256,CHEMBL876804,,Negative log transformed activity,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10432,0,,U,,,7991,CHEMBL627980,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,A,22224,1,,,
,,,,Intermediate,BAO_0000218,10433,1,10141.0,N,,,14342,CHEMBL627981,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,A,50512,1,,,Cavia porcellus
,,,,Intermediate,BAO_0000218,10434,1,10141.0,N,,,14342,CHEMBL627982,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,A,50512,1,,,Cavia porcellus
,,,,Intermediate,BAO_0000218,10435,1,10141.0,N,,,14342,CHEMBL627983,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,A,50512,1,,,Cavia porcellus
,,,,Intermediate,BAO_0000218,10436,1,10141.0,N,,,14342,CHEMBL627984,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Ileum,A,50512,1,,2116.0,Cavia porcellus
,,,,Autocuration,BAO_0000100,10437,0,,U,,,6047,CHEMBL627985,,Solubility in water was determined; values expressed as -log,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,10438,0,,U,,,17269,CHEMBL627986,,Ratio of Kcat to that of Km was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10439,0,,U,,,10026,CHEMBL627987,,Observed first order rate constant,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10440,0,,U,,,14583,CHEMBL627988,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,10441,1,10116.0,N,,,2661,CHEMBL627989,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10442,1,10116.0,N,,,2661,CHEMBL627990,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10443,1,10116.0,N,,,4029,CHEMBL876805,,Oral Bioavailability after administration of 10 mg/kg in male rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10444,1,10116.0,N,,,17735,CHEMBL627991,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10445,1,10116.0,N,,,4576,CHEMBL627992,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10446,1,10116.0,N,,,17582,CHEMBL627993,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10447,1,10116.0,N,,,17651,CHEMBL622817,,Oral bioavailability at 1 mg/kg was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10448,1,10116.0,N,,,17651,CHEMBL622818,,Oral bioavailability at 10 mg/kg was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10449,1,10116.0,N,,,17670,CHEMBL622819,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10450,1,10116.0,N,,,5045,CHEMBL872267,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10451,1,10116.0,N,,,1696,CHEMBL622820,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10452,1,10116.0,N,,,17764,CHEMBL622821,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10453,1,10116.0,N,,,6448,CHEMBL622822,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10454,1,10116.0,N,,,6596,CHEMBL622823,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10455,1,10116.0,N,,,17547,CHEMBL622824,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10456,1,10116.0,N,,,17771,CHEMBL622825,,Oral bioavailability in rat at a dose of 3 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10457,1,10116.0,N,,,6495,CHEMBL622901,,Oral bioavailability in rat after oral administration at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10458,1,10116.0,N,,,4558,CHEMBL622902,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10459,1,10116.0,N,,,17596,CHEMBL621844,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10460,1,10116.0,N,,,6827,CHEMBL621845,,Oral bioavailability in Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10461,1,10116.0,N,,,4026,CHEMBL621846,,Oral bioavailability,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10462,1,10116.0,N,,,10,CHEMBL621847,,Oral bioavailability in rat (dose 30 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10463,1,10116.0,N,,,17717,CHEMBL877609,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10464,1,10116.0,N,,,17717,CHEMBL621848,,Bioavailability in rat (dose 3 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10465,1,10116.0,N,,,17717,CHEMBL621849,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10466,1,10116.0,N,,,17717,CHEMBL622030,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10467,1,10116.0,N,,,4796,CHEMBL622031,,Percent oral bioavailability determined in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10468,1,10116.0,N,,,4883,CHEMBL622032,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10469,1,10116.0,N,,,2137,CHEMBL622033,,The compound was evaluated for bioavailability in rats; 32-51,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10470,1,10116.0,N,,,2959,CHEMBL622034,,Bioavailability in rat (dose 20 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10471,1,10116.0,N,,,1361,CHEMBL622035,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10472,1,10116.0,N,,,4727,CHEMBL882966,,Bioavailability percent in rat at the dose of 2 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10473,1,10116.0,N,,,16423,CHEMBL622036,,Bioavailability was evaluated after 20 uM/kg of peroral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10474,1,10116.0,N,,,5206,CHEMBL622037,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10475,1,10116.0,N,,,6448,CHEMBL622038,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10476,1,10116.0,N,,,17723,CHEMBL622039,,Bioavailability in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10477,1,10116.0,N,,,17738,CHEMBL622040,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10478,1,10116.0,N,,,17738,CHEMBL622041,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10479,1,10116.0,N,,,17738,CHEMBL622042,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10480,1,10116.0,N,,,17738,CHEMBL622043,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10481,1,10116.0,N,,,17738,CHEMBL622044,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10482,1,10116.0,N,,,17738,CHEMBL622045,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10483,1,10116.0,N,,,17738,CHEMBL622046,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10484,1,10116.0,N,,,17738,CHEMBL622047,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10485,1,10116.0,N,,,17738,CHEMBL877610,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10486,1,10116.0,N,,,17738,CHEMBL622048,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10487,1,10116.0,N,,,17738,CHEMBL622049,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10488,1,10116.0,N,,,17738,CHEMBL622050,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10489,1,10116.0,N,,,17738,CHEMBL622051,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10490,1,10116.0,N,,,17738,CHEMBL622052,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10491,1,10116.0,N,,,17738,CHEMBL622053,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10492,1,10116.0,N,,,17738,CHEMBL622054,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10493,1,10116.0,N,,,17738,CHEMBL622055,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10494,1,10116.0,N,,,5237,CHEMBL622056,,Oral bioavailability in rats was determined; High,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10495,1,10116.0,N,,,5503,CHEMBL622057,,Oral bioavailability in the rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10496,1,10116.0,N,,,15765,CHEMBL628008,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10497,1,10116.0,N,,,15660,CHEMBL622058,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10498,1,10116.0,N,,,5978,CHEMBL622059,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10499,1,10116.0,N,,,5978,CHEMBL622060,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10500,1,10116.0,N,,,5978,CHEMBL622061,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10501,1,10116.0,N,,,5978,CHEMBL622062,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10502,1,10116.0,N,,,5656,CHEMBL622063,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Expert,BAO_0000218,10503,1,10116.0,N,,,3598,CHEMBL877611,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10504,1,10116.0,N,,,4216,CHEMBL622064,,Oral bioavailability of compound in Sprague Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10505,1,10116.0,N,,,17839,CHEMBL622065,,Oral bioavailability of compound in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10506,1,10116.0,N,,,6570,CHEMBL622066,,Oral bioavailability in rat (dose 2 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10507,1,10116.0,N,,,5334,CHEMBL622067,,Oral bioavailability of compound in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10508,1,10116.0,N,,,6886,CHEMBL622068,,Oral bioavailability of compound in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10509,1,10116.0,N,,,5210,CHEMBL622069,,Oral bioavailability of compound was determined in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10510,1,10116.0,N,,,4170,CHEMBL624796,,Oral bioavailability at a dose of 30 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10511,1,10116.0,N,,,6028,CHEMBL624797,,Oral bioavailability in rat (dose 10 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10512,1,10116.0,N,,,6028,CHEMBL623053,,Oral bioavailability in rat (dose 10 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10513,1,10116.0,N,,,6078,CHEMBL623054,,Oral bioavailability evaluated in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10514,1,10116.0,N,,,6168,CHEMBL623055,,Oral bioavailability in fasted rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10515,1,10116.0,N,,,6168,CHEMBL623056,,Oral bioavailability in fed rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10516,1,10116.0,N,,,5160,CHEMBL623057,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10517,1,10116.0,N,,,6057,CHEMBL623058,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10518,1,10116.0,N,,,6535,CHEMBL623059,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10519,1,10116.0,N,,,6535,CHEMBL623060,,Oral bioavailability in rat after administration of 10 mg/kg po,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10520,1,10116.0,N,,,4194,CHEMBL623061,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10521,1,10116.0,N,,,6230,CHEMBL623062,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10522,1,10116.0,N,,,6619,CHEMBL623063,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10523,1,10116.0,N,,,17607,CHEMBL623064,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10524,1,10116.0,N,,,4942,CHEMBL623065,,Oral bioavailability in ratrs,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10525,1,10116.0,N,,,4942,CHEMBL623066,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10526,1,10116.0,N,,,6646,CHEMBL623067,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10527,1,10116.0,N,,,5237,CHEMBL623068,,Oral bioavailability in rats was determined; High,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10528,1,10116.0,N,,,6646,CHEMBL623069,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10529,1,10116.0,N,,,4449,CHEMBL623070,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10530,1,10116.0,N,,,6057,CHEMBL623071,,Oral bioavailability was calculated in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10531,1,10116.0,N,,,2552,CHEMBL623072,,Oral bioavailability,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10532,1,10116.0,N,,,5496,CHEMBL623073,,Oral bioavailability,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10533,1,10116.0,N,,,6484,CHEMBL623074,,Oral bioavailability,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10534,1,10116.0,N,,,6485,CHEMBL623075,,Oral bioavailability,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10535,1,10116.0,N,,,6616,CHEMBL623076,,Oral bioavailability after i.v. administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10536,1,10116.0,N,,,4969,CHEMBL623077,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10537,1,10116.0,N,,,5862,CHEMBL623078,,Oral bioavailability in rat (Sprague-Dawley),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10538,1,10116.0,N,,,4514,CHEMBL623079,,Oral bioavailability in Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10539,1,10116.0,N,,,4514,CHEMBL623080,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10540,1,10116.0,N,,,4514,CHEMBL623081,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10541,1,10116.0,N,,,5546,CHEMBL623082,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10542,1,10116.0,N,,,6168,CHEMBL874400,,Oral bioavailability in fasted rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10543,1,10116.0,N,,,6168,CHEMBL623083,,Oral bioavailability in fed rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10544,1,10116.0,N,,,3624,CHEMBL623084,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10545,1,10116.0,N,,,5213,CHEMBL623085,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10546,1,10116.0,N,,,5496,CHEMBL623086,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10547,1,10116.0,N,,,5553,CHEMBL623087,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10548,1,10116.0,N,,,5833,CHEMBL623088,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10549,1,10116.0,N,,,5836,CHEMBL623089,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10550,1,10116.0,N,,,5865,CHEMBL623090,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10551,1,10116.0,N,,,5960,CHEMBL623091,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10552,1,10116.0,N,,,6249,CHEMBL623092,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10553,1,10116.0,N,,,6448,CHEMBL623093,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10554,1,10116.0,N,,,6453,CHEMBL874401,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10555,1,10116.0,N,,,6640,CHEMBL623094,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10556,1,10116.0,N,,,17607,CHEMBL623095,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10557,1,10116.0,N,,,5939,CHEMBL623096,,Oral bioavailability in rat after peroral administration at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10558,1,10116.0,N,,,5939,CHEMBL624913,,Oral bioavailability in rat after peroral administration at 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10559,1,10116.0,N,,,6281,CHEMBL624914,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10560,1,10116.0,N,,,5874,CHEMBL624915,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10561,1,10116.0,N,,,5213,CHEMBL624916,,Oral bioavailability in rat; Not measured,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10562,1,10116.0,N,,,4964,CHEMBL624917,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10563,1,10116.0,N,,,11020,CHEMBL625157,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10564,1,10116.0,N,,,6251,CHEMBL625158,,In vitro metabolic potential in rat liver microsomes,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10565,1,10116.0,N,,,1568,CHEMBL625159,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10566,1,10116.0,N,,,3032,CHEMBL625160,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10567,1,10116.0,N,,,3748,CHEMBL625161,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10568,1,10116.0,N,,,401,CHEMBL625162,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10569,1,10116.0,N,,,6512,CHEMBL625163,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10570,1,10116.0,N,,,17617,CHEMBL625164,,Oral bioavailability in rats at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10571,1,10116.0,N,,,6679,CHEMBL625165,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10572,1,10116.0,N,,,6742,CHEMBL625166,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10573,1,10116.0,N,,,589,CHEMBL625167,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10574,1,10116.0,N,,,589,CHEMBL625168,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10575,1,10116.0,N,,,3185,CHEMBL625169,,Plasma clearance of the compound,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10576,1,10116.0,N,,,17596,CHEMBL626264,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10577,1,10116.0,N,,,2713,CHEMBL626265,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10578,1,10116.0,N,,,12500,CHEMBL626266,,The compound was tested for plasma clearance in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10579,1,10116.0,N,,,12500,CHEMBL626267,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10580,1,10116.0,N,,,2713,CHEMBL626268,,Plasma concentration upon oral administration of 1 mg/Kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10581,1,10116.0,N,,,1446,CHEMBL626269,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10582,1,10116.0,N,,,6227,CHEMBL626270,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10583,1,10116.0,N,,,4709,CHEMBL626271,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10584,1,10116.0,N,,,5510,CHEMBL626272,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10585,1,10116.0,N,,,5510,CHEMBL626273,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10586,1,10116.0,N,,,5510,CHEMBL875346,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10587,1,10116.0,N,,,5510,CHEMBL626274,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10588,1,10116.0,N,,,4514,CHEMBL626275,,Compound was tested for protein binding in rat plasma,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10589,1,10116.0,N,,,2713,CHEMBL624646,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10590,1,10116.0,N,,,2713,CHEMBL624647,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10591,1,10116.0,N,,,5340,CHEMBL624648,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10592,1,10116.0,N,,,12058,CHEMBL624649,,Area under curve ratio was determined (po/iv) in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10593,1,10116.0,N,,,11195,CHEMBL624650,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10594,1,10116.0,N,,,11195,CHEMBL624651,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10595,1,10116.0,N,,,11195,CHEMBL624652,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10596,1,10116.0,N,,,6495,CHEMBL624653,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10597,1,10116.0,N,,,6078,CHEMBL624654,,Ratio of AUCbrain to AUCplasma,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10598,1,10116.0,N,,,5656,CHEMBL624655,,Ratio of brain to plasma,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10599,1,10116.0,N,,,4910,CHEMBL624656,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10600,1,10116.0,N,,,4910,CHEMBL624657,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10601,1,10116.0,N,,,4910,CHEMBL624658,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10602,1,10116.0,N,,,10130,CHEMBL624659,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10603,1,10116.0,N,,,10130,CHEMBL624660,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10604,1,10116.0,N,,,10130,CHEMBL624661,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10605,1,10116.0,N,,,5213,CHEMBL624662,,Steady state brain :blood ratio was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10606,1,10116.0,N,,,4910,CHEMBL625199,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10607,1,10116.0,N,,,4910,CHEMBL625200,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10608,1,10116.0,N,,,4910,CHEMBL625201,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10609,1,10116.0,N,,,4910,CHEMBL625202,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10610,1,10116.0,N,,,2083,CHEMBL625203,,Percentage recovery after 3h incubation with rat hapatocytes was determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10611,1,10116.0,N,,,2082,CHEMBL625204,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10612,1,10116.0,N,,,2082,CHEMBL625205,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10613,1,10116.0,N,,,6351,CHEMBL625206,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,10614,0,,U,,,14583,CHEMBL625207,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10615,0,,U,,,14583,CHEMBL625208,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,A,22224,1,,,
Caco-2,,,495.0,Intermediate,BAO_0000218,10616,1,9606.0,N,,,4608,CHEMBL625209,,In vivo absorption in Caco-2 cell line monolayers was determined,,A,50587,1,,,Homo sapiens
,,,,Autocuration,BAO_0000100,10617,0,,U,,,13668,CHEMBL625210,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Intermediate,BAO_0000218,10618,1,10116.0,N,,,5669,CHEMBL625211,,Area under curve was determine after peroral administration at 10 mpk in Rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10619,1,9544.0,N,,,5669,CHEMBL625212,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,A,50797,1,,,Macaca mulatta
,,,,Intermediate,BAO_0000218,10620,1,10116.0,N,,,5669,CHEMBL625213,,Area under curve was determine after peroral administration at 160 mpk in Rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10621,1,10116.0,N,,,5669,CHEMBL625214,,Area under curve was determine after peroral administration at 20 mpk in Rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10622,1,10116.0,N,,,5669,CHEMBL874542,,Area under curve was determine after peroral administration at 50 mpk in Rat,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000100,10623,0,,U,,,6472,CHEMBL625215,,Calculated partition coefficient (clogP) (AlogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,10624,0,,U,,,15106,CHEMBL625216,,Activated partial thromboplastin time measured,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,10625,0,,U,,,15207,CHEMBL625217,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,P,22224,1,,,
,,,,Autocuration,BAO_0000100,10626,0,,U,,,15207,CHEMBL625218,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,P,22224,1,,,
,,,,Intermediate,BAO_0000218,10627,1,9615.0,N,,,13941,CHEMBL622864,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10628,1,10116.0,N,,,13941,CHEMBL622865,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10629,1,10116.0,N,,,13941,CHEMBL622866,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10630,1,9615.0,N,,,13941,CHEMBL622867,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10631,1,10141.0,N,,,15240,CHEMBL876808,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Plasma,A,50512,1,,1969.0,Cavia porcellus
,,,,Autocuration,BAO_0000019,10632,0,,U,,,10655,CHEMBL627725,,AUC in brain,Brain,A,22224,1,,955.0,
,,,,Autocuration,BAO_0000019,10633,0,,U,,,10655,CHEMBL627726,,AUC in serum,Serum,A,22224,1,,1977.0,
,,,,Autocuration,BAO_0000019,10634,0,,U,,,6504,CHEMBL627727,,AUC was determined,Plasma,A,22224,1,,1969.0,
,,,,Autocuration,BAO_0000019,10635,0,,U,,,10615,CHEMBL627728,,AUC of the compound.,Plasma,A,22224,1,,1969.0,
,,,,Autocuration,BAO_0000019,10636,0,,U,,,10353,CHEMBL627729,,AUC value (0-4 hr),Plasma,A,22224,1,,1969.0,
,,,,Autocuration,BAO_0000019,10637,0,,U,,,14907,CHEMBL627730,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",Plasma,A,22224,1,,1969.0,
,,,,Autocuration,BAO_0000019,10638,0,,U,,,14907,CHEMBL627731,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,Plasma,A,22224,1,,1969.0,
,,,,Autocuration,BAO_0000019,10639,0,,U,,,14907,CHEMBL627732,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",Plasma,A,22224,1,,1969.0,
,,,,Autocuration,BAO_0000019,10640,0,,U,,,14907,CHEMBL627733,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",Plasma,A,22224,1,,1969.0,
,,,,Intermediate,BAO_0000218,10641,1,10116.0,N,,,16359,CHEMBL627734,,AUC(area under curve) was determined after intravenous administration in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10642,1,10116.0,N,,,16359,CHEMBL627735,,AUC(area under curve) was determined after oral administration in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10643,1,10141.0,N,,,15240,CHEMBL627736,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Plasma,A,50512,1,,1969.0,Cavia porcellus
,,,,Intermediate,BAO_0000218,10644,1,10116.0,N,,,15240,CHEMBL876809,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,10645,0,,U,,,15469,CHEMBL627737,,Area Under Curve after oral dosing of 100 uM/Kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10646,0,,U,,,15469,CHEMBL627738,,Area Under Curve after oral dosing of 30 uM/Kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10647,0,,U,,,13520,CHEMBL627739,,Area Under Curve was measured by ploting the graph between concentration verses time,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,10648,1,9615.0,N,,,17025,CHEMBL626143,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,10649,0,314293.0,U,,,17025,CHEMBL626144,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,10650,1,9986.0,N,,,17025,CHEMBL626145,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,10651,1,10116.0,N,,,17025,CHEMBL626146,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10652,1,10116.0,N,,,12032,CHEMBL626147,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,10653,0,,U,,,10291,CHEMBL626148,,Area under curve (AUC) was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,10654,0,,U,,,5767,CHEMBL626149,,Area under curve (AUC) following ip administration at 1 mg/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10655,0,,U,,,1434,CHEMBL626150,,Area under curve (AUC) was determined; ND is Not determined,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,10656,1,9615.0,N,,,14925,CHEMBL626151,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10657,1,9615.0,N,,,14925,CHEMBL626152,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10658,1,9615.0,N,,,14925,CHEMBL626153,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000019,10659,0,,U,,,1434,CHEMBL626154,,Area under curve (AUR) was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10660,0,,U,,,11883,CHEMBL626155,,Area under curve at 1 uM/dg administered intravenously,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10661,0,,U,,,11883,CHEMBL626156,,Area under curve at 10 uM/dg administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10662,0,,U,,,11883,CHEMBL626157,,Area under curve at 2 uM/dg administered intravenously,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10663,0,,U,,,11883,CHEMBL626158,,Area under curve at 20 uM/dg administered perorally,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,10664,1,9615.0,N,,,15233,CHEMBL626159,,Area under curve at a peroral dose of 3 mg/kg in dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10665,1,10116.0,N,,,15233,CHEMBL626160,,Area under curve at a peroral dose of 3 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10666,1,9615.0,N,,,15233,CHEMBL626161,,Area under curve at an iv dose of 1 mg/kg in dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10667,1,10116.0,N,,,15233,CHEMBL626162,,Area under curve at an iv dose of 1 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,10668,0,,U,,,12978,CHEMBL626163,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,10669,0,,U,,,12978,CHEMBL626164,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,10670,1,10090.0,N,,,11355,CHEMBL626165,,Area under curve measured as conc vs time after intravenous administration to mice.,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,10671,1,10090.0,N,,,11355,CHEMBL626166,,Area under curve measured as conc vs time after peroral administration to mice.,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,10672,1,9615.0,N,,,12923,CHEMBL626167,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10673,1,9615.0,N,,,12923,CHEMBL626168,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10674,1,9615.0,N,,,12923,CHEMBL877463,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10675,1,9615.0,N,,,12923,CHEMBL626169,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10676,1,10116.0,N,,,17738,CHEMBL626170,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10677,1,10116.0,N,,,17738,CHEMBL626171,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10678,1,10116.0,N,,,17738,CHEMBL626172,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10679,1,10116.0,N,,,17738,CHEMBL626173,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10680,1,10116.0,N,,,17738,CHEMBL626174,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10681,1,10116.0,N,,,17738,CHEMBL626175,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10682,1,10116.0,N,,,17738,CHEMBL626176,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10683,1,10116.0,N,,,17738,CHEMBL626177,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10684,1,10116.0,N,,,17738,CHEMBL622499,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10685,1,10116.0,N,,,17738,CHEMBL622500,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10686,1,10116.0,N,,,17738,CHEMBL622501,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10687,1,10116.0,N,,,17738,CHEMBL622502,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10688,1,10116.0,N,,,17738,CHEMBL622503,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10689,1,10116.0,N,,,17738,CHEMBL877614,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10690,1,10116.0,N,,,17738,CHEMBL624839,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10691,1,10116.0,N,,,17738,CHEMBL624840,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10692,1,10116.0,N,,,17738,CHEMBL624841,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10693,1,10116.0,N,,,17738,CHEMBL624842,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10694,1,10116.0,N,,,17738,CHEMBL624843,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10695,1,10116.0,N,,,17738,CHEMBL624844,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10696,1,10116.0,N,,,17738,CHEMBL624845,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10697,1,10116.0,N,,,17738,CHEMBL621904,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10698,1,10116.0,N,,,11195,CHEMBL621905,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10699,1,10116.0,N,,,11195,CHEMBL874382,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10700,1,10116.0,N,,,11195,CHEMBL621906,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10701,1,10116.0,N,,,11195,CHEMBL621907,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10702,1,10116.0,N,,,11195,CHEMBL622096,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10703,1,10116.0,N,,,11195,CHEMBL622097,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10704,1,10116.0,N,,,11195,CHEMBL622098,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10705,1,10116.0,N,,,11195,CHEMBL622099,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10706,1,10116.0,N,,,11195,CHEMBL622100,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10707,1,10116.0,N,,,11195,CHEMBL622101,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10708,1,10116.0,N,,,11195,CHEMBL622102,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10709,1,10116.0,N,,,11195,CHEMBL622103,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10710,1,10116.0,N,,,11195,CHEMBL622104,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10711,1,10116.0,N,,,11195,CHEMBL622105,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10712,1,10116.0,N,,,11195,CHEMBL622106,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10713,1,10116.0,N,,,11195,CHEMBL622107,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10714,1,10116.0,N,,,11195,CHEMBL622108,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10715,1,10116.0,N,,,11195,CHEMBL622109,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10716,1,10116.0,N,,,11195,CHEMBL622110,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10717,1,10116.0,N,,,11195,CHEMBL622111,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10718,1,10116.0,N,,,11195,CHEMBL874383,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10719,1,10116.0,N,,,11195,CHEMBL622112,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10720,1,10116.0,N,,,11195,CHEMBL622113,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10721,1,10116.0,N,,,11195,CHEMBL622114,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10722,1,10116.0,N,,,11195,CHEMBL622115,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10723,1,10116.0,N,,,11195,CHEMBL622116,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10724,1,10116.0,N,,,6193,CHEMBL622117,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10725,1,10116.0,N,,,6803,CHEMBL622118,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10726,1,10116.0,N,,,6647,CHEMBL622119,,Oral bioavailability in rats at 6 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10727,1,10116.0,N,,,6647,CHEMBL622120,,Oral bioavailability in rat (dose 6 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10728,1,10116.0,N,,,6647,CHEMBL622121,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10729,1,10116.0,N,,,6640,CHEMBL622122,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10730,1,10116.0,N,,,6641,CHEMBL622123,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10731,1,10116.0,N,,,6641,CHEMBL622124,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10732,1,10116.0,N,,,6642,CHEMBL622125,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10733,1,10116.0,N,,,5472,CHEMBL622126,,Oral bioavailability,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10734,1,10116.0,N,,,6141,CHEMBL620455,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10735,1,10116.0,N,,,4390,CHEMBL620456,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10736,1,10116.0,N,,,5472,CHEMBL620457,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10737,1,10116.0,N,,,5472,CHEMBL620458,,Oral bioavailability was evaluated; Not tested,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10738,1,10116.0,N,,,5438,CHEMBL620459,,Oral bioavailability,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10739,1,10116.0,N,,,4883,CHEMBL620460,,Oral bioavailability in rat by oral dosing,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10740,1,10116.0,N,,,1908,CHEMBL620461,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10741,1,10116.0,N,,,4853,CHEMBL620462,,Oral bioavailability in rat (Sprague-Dawley),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10742,1,10116.0,N,,,4853,CHEMBL620463,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10743,1,10116.0,N,,,4853,CHEMBL620464,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10744,1,10116.0,N,,,4853,CHEMBL620465,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10745,1,10116.0,N,,,4853,CHEMBL620466,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10746,1,10116.0,N,,,4853,CHEMBL620467,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10747,1,10116.0,N,,,4853,CHEMBL620468,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10748,1,10116.0,N,,,12873,CHEMBL620469,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10749,1,10116.0,N,,,12873,CHEMBL620470,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10750,1,10116.0,N,,,3169,CHEMBL620471,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10751,1,10116.0,N,,,6305,CHEMBL620472,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10752,1,10116.0,N,,,4762,CHEMBL620473,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10753,1,10116.0,N,,,17847,CHEMBL620474,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10754,1,10116.0,N,,,6211,CHEMBL620475,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10755,1,10116.0,N,,,6011,CHEMBL620476,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10756,1,10116.0,N,,,6317,CHEMBL620477,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10757,1,10116.0,N,,,6644,CHEMBL620478,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10758,1,10116.0,N,,,6644,CHEMBL618768,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10759,1,10116.0,N,,,6644,CHEMBL618769,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10760,1,10116.0,N,,,6644,CHEMBL618770,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10761,1,10116.0,N,,,6113,CHEMBL618771,,Oral bioavailability (dose 20 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10762,1,10116.0,N,,,5937,CHEMBL618772,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10763,1,10116.0,N,,,5711,CHEMBL618773,,Oral bioavailability in rat at 10 mg/kg of the compound,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10764,1,10116.0,N,,,17717,CHEMBL875842,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10765,1,10116.0,N,,,17717,CHEMBL618774,,Bioavailability in rat (dose 3 mg/kg i.v.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10766,1,10116.0,N,,,17717,CHEMBL618775,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10767,1,10116.0,N,,,17717,CHEMBL618776,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10768,1,10116.0,N,,,4722,CHEMBL618777,,Percent bioavailability (F) in rats after iv administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10769,1,10116.0,N,,,4722,CHEMBL618778,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10770,1,10116.0,N,,,4353,CHEMBL618779,,Bioavailability in rat (dose 5 uM/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10771,1,10116.0,N,,,15662,CHEMBL618780,,Oral bioavailability,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10772,1,10116.0,N,,,4756,CHEMBL618781,,Bioavailability in rat (dose 2 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10773,1,10116.0,N,,,4756,CHEMBL618782,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10774,1,10116.0,N,,,3436,CHEMBL618783,,Oral bioavailability in rat (dose 20 mg/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10775,1,10116.0,N,,,17800,CHEMBL618784,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10776,1,10116.0,N,,,15762,CHEMBL618785,,Percent oral bioavailability evaluated in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10777,1,10116.0,N,,,5089,CHEMBL618786,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10778,1,10116.0,N,,,5089,CHEMBL618787,,Percent oral bioavailability in rat; Not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10779,1,10116.0,N,,,3185,CHEMBL618788,,Oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10780,1,10116.0,N,,,5145,CHEMBL618789,,Bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10781,1,10116.0,N,,,3457,CHEMBL618790,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10782,1,10116.0,N,,,3457,CHEMBL618791,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10783,1,10116.0,N,,,5983,CHEMBL875843,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10784,1,10116.0,N,,,5739,CHEMBL618792,,Oral bioavailability in rat (dose 20 mg/kg p.o.),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10785,1,10116.0,N,,,3579,CHEMBL623395,,Cmax at a dose of 30 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,10786,0,314293.0,U,,,17788,CHEMBL623396,,Cmax in monkeys at a dose of 1 mg/kg,,A,22224,1,,,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,10787,1,10116.0,N,,,14956,CHEMBL623397,,Cmax in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10788,1,10116.0,N,,,17788,CHEMBL623398,,Cmax in rats at a dose of 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10789,1,10090.0,N,,,9750,CHEMBL623399,,Cmax was measured in mice after an oral dose of 50 mg/kg.,,A,50594,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,10790,0,,U,,,12767,CHEMBL623400,,"Cmax value at a dose of 12.7 uM/kg, po",,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,10791,0,,U,,,12767,CHEMBL623401,,"Cmax value at a dose of 6.3 uM/kg, iv",,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,10792,0,,U,,,12767,CHEMBL623402,,"Cmax value at a dose of 7.1 uM/kg, iv",,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,10793,0,,U,,,12703,CHEMBL623403,,Cmax value of compound was determined after 1 hr,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,10794,0,,U,,,15778,CHEMBL623404,,Cmax value of the compound,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,10795,1,10116.0,N,,,12818,CHEMBL625997,,Cmax value administered intraintestinal in rats.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10796,1,10116.0,N,,,14964,CHEMBL625998,,Cmax value administered perorally was determined in rat; Not determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,10797,0,,U,,,15808,CHEMBL625999,,Cmax value at the dose of 2.3 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,10798,0,,U,,,15808,CHEMBL626000,,Cmax value at the dose of 5 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,10799,0,,U,,,15778,CHEMBL626001,,Cmax value in the period of 8 hr after dosing. ,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,10800,0,,U,,,3715,CHEMBL626002,,Cmax value at a oral dose of 20 mg/kg; Not tested,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,10801,0,,U,,,3715,CHEMBL626003,,Cmax value at a oral dose of 20 mg/kg,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,10802,1,10116.0,N,,,1446,CHEMBL626004,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10803,1,10141.0,N,,,15240,CHEMBL626005,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,A,50512,1,,,Cavia porcellus
,In vivo,,,Intermediate,BAO_0000218,10804,1,10116.0,N,,,15240,CHEMBL626006,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10805,1,10116.0,N,,,14810,CHEMBL626007,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10806,1,10090.0,N,,,14239,CHEMBL626008,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10807,1,9615.0,N,,,12555,CHEMBL626009,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Liver,A,50588,1,,2107.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10808,1,9615.0,N,,,10754,CHEMBL626010,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10809,1,10090.0,N,,,10754,CHEMBL626011,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10810,1,10090.0,N,,,10754,CHEMBL626012,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10811,1,10090.0,N,,,10754,CHEMBL626013,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10812,1,10090.0,N,,,10754,CHEMBL626014,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10813,1,10090.0,N,,,10754,CHEMBL877496,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10814,1,9615.0,N,,,14600,CHEMBL626015,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,F,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10815,1,9615.0,N,,,14600,CHEMBL626016,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,F,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10816,1,9615.0,N,,,14600,CHEMBL626017,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,F,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10817,1,9615.0,N,,,13543,CHEMBL626018,,Bioavailability as maximal plasma concentration in dogs,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10818,1,9615.0,N,,,13543,CHEMBL626692,,Bioavailability as maximal plasma concentration in dogs,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10819,1,10116.0,N,,,13543,CHEMBL626693,,Bioavailability as maximal plasma concentration in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,10820,0,10116.0,U,,,13543,CHEMBL626694,,Bioavailability as maximal plasma concentration in rats,Plasma,A,22224,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10821,1,9615.0,N,,,14600,CHEMBL626695,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Blood,A,50588,1,,178.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10822,1,9615.0,N,,,14600,CHEMBL626696,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Blood,A,50588,1,,178.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10823,1,9615.0,N,,,14600,CHEMBL626697,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Blood,A,50588,1,,178.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10824,1,9615.0,N,,,14600,CHEMBL626859,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Blood,A,50588,1,,178.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10825,1,9615.0,N,,,14600,CHEMBL626860,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Blood,A,50588,1,,178.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10826,1,9615.0,N,,,14600,CHEMBL626861,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Blood,A,50588,1,,178.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10827,1,10116.0,N,,,14681,CHEMBL626296,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,10828,0,,U,,,15905,CHEMBL626297,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,10829,0,,U,,,15905,CHEMBL626298,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,10830,1,10116.0,N,,,13304,CHEMBL626299,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10831,1,10116.0,N,,,15137,CHEMBL626300,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10832,1,10116.0,N,,,15137,CHEMBL626301,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10833,1,10116.0,N,,,15137,CHEMBL626962,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10834,1,10116.0,N,,,15137,CHEMBL626963,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10835,1,10116.0,N,,,15137,CHEMBL626964,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10836,1,9541.0,N,,,14839,CHEMBL626965,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Plasma,A,100710,1,,1969.0,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,10837,1,10090.0,N,,,14839,CHEMBL626966,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10838,1,10090.0,N,,,14839,CHEMBL626967,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10839,1,9541.0,N,,,14839,CHEMBL626968,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Plasma,A,100710,1,,1969.0,Macaca fascicularis
,,,,Intermediate,BAO_0000218,10840,1,10116.0,N,,,8418,CHEMBL626969,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10841,1,10116.0,N,,,8418,CHEMBL627126,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10842,1,10116.0,N,,,8418,CHEMBL631276,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10843,1,10116.0,N,,,8418,CHEMBL631277,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10844,1,10116.0,N,,,8418,CHEMBL631278,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10845,1,10116.0,N,,,8418,CHEMBL874457,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10846,1,10116.0,N,,,8418,CHEMBL631279,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10847,1,10116.0,N,,,8418,CHEMBL631280,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10848,1,10116.0,N,,,8418,CHEMBL631281,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10849,1,10116.0,N,,,8418,CHEMBL631968,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10850,1,10116.0,N,,,8418,CHEMBL631969,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10851,1,10116.0,N,,,8418,CHEMBL631970,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10852,1,10116.0,N,,,8418,CHEMBL631971,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10853,1,10116.0,N,,,8418,CHEMBL631972,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10854,1,10116.0,N,,,8418,CHEMBL630435,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10855,1,10116.0,N,,,8418,CHEMBL630436,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10856,1,10116.0,N,,,8418,CHEMBL630437,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10857,1,10116.0,N,,,8418,CHEMBL630438,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10858,1,10116.0,N,,,8418,CHEMBL630439,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10859,1,10116.0,N,,,8418,CHEMBL630440,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10860,1,10116.0,N,,,8418,CHEMBL630441,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10861,1,10116.0,N,,,8418,CHEMBL630442,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10862,1,10116.0,N,,,8418,CHEMBL625234,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10863,1,10116.0,N,,,8418,CHEMBL625235,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10864,1,10116.0,N,,,8418,CHEMBL625236,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10865,1,10116.0,N,,,8418,CHEMBL625237,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10866,1,10116.0,N,,,8418,CHEMBL626125,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10867,1,10116.0,N,,,8418,CHEMBL626126,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10868,1,10116.0,N,,,8418,CHEMBL626127,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10869,1,10116.0,N,,,8418,CHEMBL626128,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10870,1,10116.0,N,,,8418,CHEMBL626129,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10871,1,10116.0,N,,,8418,CHEMBL626130,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10872,1,10116.0,N,,,8418,CHEMBL626131,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10873,1,10116.0,N,,,8418,CHEMBL626132,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10874,1,10116.0,N,,,8418,CHEMBL626752,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10875,1,10116.0,N,,,8418,CHEMBL626753,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10876,1,10116.0,N,,,8418,CHEMBL626754,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10877,1,10116.0,N,,,8418,CHEMBL626755,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10878,1,10116.0,N,,,8418,CHEMBL626756,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10879,1,10116.0,N,,,8418,CHEMBL626757,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10880,1,10116.0,N,,,8418,CHEMBL626758,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10881,1,10116.0,N,,,8418,CHEMBL626759,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10882,1,10116.0,N,,,8418,CHEMBL626760,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10883,1,9615.0,N,,,6996,CHEMBL626394,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10884,1,9615.0,N,,,6996,CHEMBL626395,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10885,1,9615.0,N,,,6996,CHEMBL626396,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10886,1,9615.0,N,,,6996,CHEMBL626397,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10887,1,9615.0,N,,,6996,CHEMBL626398,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10888,1,9615.0,N,,,6996,CHEMBL626399,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10889,1,10116.0,N,,,6996,CHEMBL874653,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10890,1,10116.0,N,,,6996,CHEMBL626400,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10891,1,10116.0,N,,,6996,CHEMBL626401,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10892,1,10116.0,N,,,6996,CHEMBL626402,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10893,1,10116.0,N,,,6996,CHEMBL626403,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10894,1,10116.0,N,,,6996,CHEMBL626404,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10895,1,10116.0,N,,,6996,CHEMBL626405,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10896,1,10116.0,N,,,6996,CHEMBL625529,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10897,1,10116.0,N,,,6996,CHEMBL625530,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10898,1,10116.0,N,,,6996,CHEMBL625531,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10899,1,10116.0,N,,,6996,CHEMBL625532,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10900,1,10116.0,N,,,6996,CHEMBL625533,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10901,1,10116.0,N,,,6996,CHEMBL875474,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10902,1,10116.0,N,,,6996,CHEMBL625534,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10903,1,10116.0,N,,,6996,CHEMBL625535,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10904,1,10116.0,N,,,6996,CHEMBL625536,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10905,1,10116.0,N,,,6996,CHEMBL625537,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10906,1,10116.0,N,,,6996,CHEMBL625538,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10907,1,10116.0,N,,,6996,CHEMBL625539,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10908,1,10116.0,N,,,6996,CHEMBL625540,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10909,1,10116.0,N,,,6996,CHEMBL625541,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10910,1,10116.0,N,,,6996,CHEMBL625542,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10911,1,10116.0,N,,,6996,CHEMBL625543,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10912,1,10116.0,N,,,6996,CHEMBL625544,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,10913,1,9615.0,N,,,6996,CHEMBL625545,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10914,1,9615.0,N,,,6996,CHEMBL625546,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10915,1,9615.0,N,,,6996,CHEMBL625547,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10916,1,9615.0,N,,,6996,CHEMBL625548,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10917,1,9615.0,N,,,6996,CHEMBL625549,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10918,1,9615.0,N,,,6996,CHEMBL625550,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10919,1,9615.0,N,,,6996,CHEMBL625551,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10920,1,9615.0,N,,,6996,CHEMBL875475,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10921,1,9615.0,N,,,6996,CHEMBL625552,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10922,1,9615.0,N,,,6996,CHEMBL625553,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10923,1,9615.0,N,,,6996,CHEMBL625554,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10924,1,9615.0,N,,,6996,CHEMBL625555,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10925,1,9615.0,N,,,6996,CHEMBL625556,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10926,1,9615.0,N,,,6996,CHEMBL624986,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10927,1,9615.0,N,,,6996,CHEMBL624987,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,10928,1,9615.0,N,,,6996,CHEMBL624988,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10929,1,9615.0,N,,,9025,CHEMBL624989,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10930,1,9615.0,N,,,9025,CHEMBL624990,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10931,1,9615.0,N,,,9025,CHEMBL874391,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10932,1,9615.0,N,,,9025,CHEMBL624991,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10933,1,9615.0,N,,,9025,CHEMBL624992,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10934,1,9615.0,N,,,9025,CHEMBL624993,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10935,1,9615.0,N,,,9025,CHEMBL624994,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10936,1,9615.0,N,,,9025,CHEMBL624995,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10937,1,9615.0,N,,,9025,CHEMBL624996,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10938,1,9615.0,N,,,9025,CHEMBL624997,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10939,1,9615.0,N,,,9025,CHEMBL624998,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10940,1,9615.0,N,,,9025,CHEMBL624999,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10941,1,9615.0,N,,,9025,CHEMBL882955,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10942,1,9615.0,N,,,9025,CHEMBL625000,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10943,1,9615.0,N,,,9025,CHEMBL625001,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10944,1,9615.0,N,,,9025,CHEMBL625089,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10945,1,9615.0,N,,,9025,CHEMBL625090,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10946,1,9615.0,N,,,9025,CHEMBL625091,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10947,1,9615.0,N,,,9025,CHEMBL625092,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10948,1,9615.0,N,,,9025,CHEMBL625093,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10949,1,9615.0,N,,,9025,CHEMBL625094,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10950,1,9615.0,N,,,9025,CHEMBL625095,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10951,1,9615.0,N,,,2249,CHEMBL625096,,Compound was evaluated for its bioavailability in the dogs,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10952,1,10116.0,N,,,2249,CHEMBL625097,,Compound was evaluated for its bioavailability in the rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,10953,0,,U,,,17515,CHEMBL882956,,Compound was evaluated for oral bioavailability,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,10954,1,10116.0,N,,,14541,CHEMBL625098,,Compound was evaluated for percentage of Oral bioavailability in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,10955,0,10141.0,U,,,12797,CHEMBL625099,,Bioavailability in guinea pig,,A,22224,1,,,Cavia porcellus
,In vivo,,,Intermediate,BAO_0000218,10956,1,10116.0,N,,,12797,CHEMBL625100,,Compound was evaluated for the oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10957,1,9615.0,N,,,12797,CHEMBL625101,,Compound was evaluated for the oral bioavailability in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10958,1,10116.0,N,,,12797,CHEMBL874396,,Compound was evaluated for the oral bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,10959,0,9615.0,U,,,11727,CHEMBL625102,,Bioavailability in dog (dosed i.v.),,F,22224,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10960,1,9615.0,N,,,13249,CHEMBL625103,,Compound was tested for in vivo bioavailability in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,10961,1,10026.0,N,,,13249,CHEMBL625104,,Compound was tested for in vivo bioavailability in hamsters,,A,100712,1,,,Cricetinae
,In vivo,,,Autocuration,BAO_0000218,10962,0,314293.0,U,,,13249,CHEMBL625105,,Compound was tested for in vivo bioavailability in monkey,,A,22224,1,,,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,10963,1,10116.0,N,,,13249,CHEMBL625106,,Compound was tested for in vivo bioavailability in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,10964,0,10090.0,U,,,9552,CHEMBL625107,,Oral bioavailability in mouse,,A,22224,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10965,1,10090.0,N,,,9552,CHEMBL625108,,Compound was tested for percent of oral bioavailability in mice; 56-74,,A,50594,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,10966,0,10090.0,U,,,14839,CHEMBL625109,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,A,22224,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,10967,0,9541.0,U,,,14839,CHEMBL625110,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,A,22224,1,,,Macaca fascicularis
,In vivo,,,Autocuration,BAO_0000218,10968,0,9541.0,U,,,14839,CHEMBL625111,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,A,22224,1,,,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,10969,1,10090.0,N,,,14839,CHEMBL625112,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10970,1,10090.0,N,,,14839,CHEMBL875334,,Oral bioavailability in nude mice,,A,50594,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,10971,0,9443.0,U,,,11219,CHEMBL628617,,Bioavailability in monkey (i.d. dosing),,A,22224,1,,,Primates
,In vivo,,,Autocuration,BAO_0000218,10972,0,10116.0,U,,,9552,CHEMBL628618,,Bioavailability in rat,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,10973,0,,U,,,11732,CHEMBL628619,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,10974,0,,U,,,11732,CHEMBL628620,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,10975,1,9541.0,N,,,14839,CHEMBL628621,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,A,100710,1,,,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,10976,1,9541.0,N,,,14839,CHEMBL628622,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,A,100710,1,,,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,10977,1,9541.0,N,,,14839,CHEMBL628623,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,A,100710,1,,,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,10978,1,9541.0,N,,,14839,CHEMBL628624,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Plasma,A,100710,1,,1969.0,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,10979,1,10090.0,N,,,14839,CHEMBL628625,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10980,1,9541.0,N,,,14839,CHEMBL628626,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Plasma,A,100710,1,,1969.0,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,10981,1,10090.0,N,,,14839,CHEMBL627041,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10982,1,10090.0,N,,,14839,CHEMBL627042,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10983,1,10090.0,N,,,14839,CHEMBL627043,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,10984,0,,U,,,13932,CHEMBL627044,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,10985,1,10090.0,N,,,11637,CHEMBL627045,,Cmax in mouse plasma,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,10986,0,,U,,,11637,CHEMBL627046,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,10987,1,10116.0,N,,,13960,CHEMBL627047,,Maximal plasma concentration in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10988,1,10116.0,N,,,15905,CHEMBL627048,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10989,1,10116.0,N,,,14062,CHEMBL627049,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10990,1,10116.0,N,,,14062,CHEMBL627050,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10991,1,10116.0,N,,,14062,CHEMBL627051,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10992,1,10116.0,N,,,14062,CHEMBL627052,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10993,1,10116.0,N,,,14062,CHEMBL627053,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10994,1,10116.0,N,,,14062,CHEMBL627054,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,10995,1,10090.0,N,,,15011,CHEMBL627055,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10996,1,10090.0,N,,,15011,CHEMBL627056,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10997,1,10090.0,N,,,15011,CHEMBL627057,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10998,1,10090.0,N,,,15011,CHEMBL627058,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,10999,1,10090.0,N,,,15011,CHEMBL626211,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,A,50594,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,11000,0,,U,,,10291,CHEMBL626212,,Maximum Concentration of the compound.,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,11001,1,9615.0,N,,,14599,CHEMBL626213,,Maximum Concentration was measured after iv administration into Beagle dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11002,1,9615.0,N,,,14599,CHEMBL626214,,Maximum Concentration was measured after iv administration into Beagle dog.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11003,1,9615.0,N,,,14599,CHEMBL626215,,Maximum Concentration was measured after po administration into Beagle dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11004,1,9615.0,N,,,14599,CHEMBL626216,,Maximum Concentration was measured after po administration into Beagle dog.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11005,0,,U,,,12767,CHEMBL626217,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,11006,0,,U,,,12767,CHEMBL626218,,Maximum blood level reached after an iv dose of 12.2 uM/kg,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,11007,0,,U,,,12767,CHEMBL626219,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,11008,0,,U,,,12767,CHEMBL626220,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,11009,0,,U,,,12767,CHEMBL626221,,Maximum blood level reached after an oral dose of 5.0 mg/kg,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,11010,0,,U,,,12767,CHEMBL626222,,Maximum blood level reached at dose of 10.6 uM/kg orally,Blood,A,22224,1,,178.0,
,In vivo,,,Intermediate,BAO_0000218,11011,1,10141.0,N,,,14706,CHEMBL626223,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,A,50512,1,,,Cavia porcellus
,In vivo,,,Intermediate,BAO_0000218,11012,1,10141.0,N,,,14706,CHEMBL626224,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,A,50512,1,,,Cavia porcellus
,In vivo,,,Intermediate,BAO_0000218,11013,1,10116.0,N,,,14793,CHEMBL626225,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11014,1,10116.0,N,,,14793,CHEMBL626226,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11015,1,10116.0,N,,,14793,CHEMBL626227,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11016,1,10116.0,N,,,14793,CHEMBL626228,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11017,1,10116.0,N,,,14793,CHEMBL626229,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11018,1,10116.0,N,,,14793,CHEMBL626921,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11019,1,10116.0,N,,,14793,CHEMBL876793,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11020,1,10116.0,N,,,14793,CHEMBL625309,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11021,1,1423.0,N,,,10524,CHEMBL625310,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,A,50278,1,,,Bacillus subtilis
,In vivo,,,Autocuration,BAO_0000218,11022,0,314293.0,U,,,11871,CHEMBL625311,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,A,22224,1,,,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,11023,1,10116.0,N,,,11871,CHEMBL625312,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11024,0,,U,,,3437,CHEMBL625313,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,11025,1,10090.0,N,,,12038,CHEMBL625314,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11026,1,10116.0,N,,,12038,CHEMBL625315,,Maximum concentration in male rats after iv administration of 20 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11027,1,10116.0,N,,,8418,CHEMBL625316,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11028,1,10116.0,N,,,8418,CHEMBL625317,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11029,1,10116.0,N,,,8418,CHEMBL625318,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11030,1,10116.0,N,,,8418,CHEMBL625319,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11031,1,10116.0,N,,,8418,CHEMBL625320,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11032,1,10116.0,N,,,8418,CHEMBL625321,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11033,1,10116.0,N,,,8418,CHEMBL625322,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11034,1,10116.0,N,,,8418,CHEMBL876801,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11035,1,10116.0,N,,,8418,CHEMBL625323,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11036,1,10116.0,N,,,8418,CHEMBL625324,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11037,1,10116.0,N,,,8418,CHEMBL625325,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11038,1,10116.0,N,,,8418,CHEMBL625326,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11039,1,10116.0,N,,,8418,CHEMBL625327,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11040,1,10116.0,N,,,8418,CHEMBL625328,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11041,1,10116.0,N,,,8418,CHEMBL625329,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11042,1,10116.0,N,,,8418,CHEMBL625330,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11043,1,10116.0,N,,,8418,CHEMBL627774,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11044,1,10116.0,N,,,8418,CHEMBL627775,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11045,1,10116.0,N,,,8418,CHEMBL627949,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11046,1,10116.0,N,,,8418,CHEMBL627950,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11047,1,10116.0,N,,,8418,CHEMBL627951,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11048,1,10116.0,N,,,8418,CHEMBL627952,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11049,1,10116.0,N,,,8418,CHEMBL627953,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11050,1,10116.0,N,,,8418,CHEMBL627954,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11051,1,10116.0,N,,,8418,CHEMBL627955,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11052,1,10116.0,N,,,8418,CHEMBL627956,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11053,1,10116.0,N,,,8418,CHEMBL876802,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11054,1,10116.0,N,,,8418,CHEMBL627957,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11055,1,10116.0,N,,,8418,CHEMBL627958,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11056,1,10116.0,N,,,8418,CHEMBL627959,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11057,1,10116.0,N,,,8418,CHEMBL627960,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11058,1,10116.0,N,,,8418,CHEMBL627961,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11059,1,10116.0,N,,,8418,CHEMBL627962,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11060,1,10116.0,N,,,9796,CHEMBL627963,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11061,1,10116.0,N,,,9796,CHEMBL624759,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11062,1,10116.0,N,,,9796,CHEMBL624760,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11063,1,10116.0,N,,,9796,CHEMBL624761,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11064,1,10116.0,N,,,9796,CHEMBL877607,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11065,1,10116.0,N,,,9796,CHEMBL624762,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11066,1,10116.0,N,,,9796,CHEMBL624763,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11067,1,10116.0,N,,,9796,CHEMBL624764,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11068,1,10116.0,N,,,9796,CHEMBL624765,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11069,1,10116.0,N,,,9796,CHEMBL624766,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11070,1,9615.0,N,,,6996,CHEMBL624767,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11071,1,9615.0,N,,,6996,CHEMBL624768,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11072,1,9615.0,N,,,6996,CHEMBL624769,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11073,1,9615.0,N,,,6996,CHEMBL624770,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11074,1,9615.0,N,,,6996,CHEMBL624771,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11075,1,9615.0,N,,,6996,CHEMBL624772,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11076,1,10116.0,N,,,6996,CHEMBL624773,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11077,1,10116.0,N,,,6996,CHEMBL624774,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11078,1,10116.0,N,,,6996,CHEMBL624775,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11079,1,10116.0,N,,,6996,CHEMBL624776,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11080,1,10116.0,N,,,6996,CHEMBL624777,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11081,1,10116.0,N,,,6996,CHEMBL624778,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11082,1,10116.0,N,,,6996,CHEMBL624779,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11083,1,10116.0,N,,,6996,CHEMBL624780,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11084,1,10116.0,N,,,6996,CHEMBL624781,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11085,1,10116.0,N,,,6996,CHEMBL877608,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11086,1,10116.0,N,,,6996,CHEMBL624782,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11087,1,10116.0,N,,,6996,CHEMBL624783,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11088,1,10116.0,N,,,6996,CHEMBL624784,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11089,1,10116.0,N,,,6996,CHEMBL624785,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11090,1,10116.0,N,,,6996,CHEMBL624786,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11091,1,10116.0,N,,,6996,CHEMBL624787,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11092,1,10116.0,N,,,6996,CHEMBL628676,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11093,1,10116.0,N,,,6996,CHEMBL621842,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11094,1,10116.0,N,,,6996,CHEMBL621843,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11095,1,10116.0,N,,,6996,CHEMBL623873,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11096,1,10116.0,N,,,6996,CHEMBL623874,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11097,1,10116.0,N,,,6996,CHEMBL623875,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11098,1,10116.0,N,,,6996,CHEMBL623876,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11099,1,9615.0,N,,,6996,CHEMBL623877,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11100,1,9615.0,N,,,6996,CHEMBL623878,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11101,1,9615.0,N,,,6996,CHEMBL623879,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11102,1,9615.0,N,,,6996,CHEMBL623880,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11103,1,9615.0,N,,,6996,CHEMBL623881,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11104,1,9615.0,N,,,6996,CHEMBL623957,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11105,1,9615.0,N,,,6996,CHEMBL623958,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11106,1,9615.0,N,,,6996,CHEMBL623959,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11107,1,9615.0,N,,,6996,CHEMBL623960,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11108,1,9615.0,N,,,6996,CHEMBL623961,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11109,1,9615.0,N,,,6996,CHEMBL623962,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11110,1,9615.0,N,,,6996,CHEMBL624676,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11111,1,9615.0,N,,,6996,CHEMBL624677,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11112,1,9615.0,N,,,6996,CHEMBL624678,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11113,1,9615.0,N,,,6996,CHEMBL624679,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11114,1,9615.0,N,,,6996,CHEMBL624680,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11115,0,,U,,,11732,CHEMBL624849,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11116,0,,U,,,11732,CHEMBL624850,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11117,0,,U,,,11732,CHEMBL874399,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11118,0,,U,,,11732,CHEMBL624851,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11119,0,,U,,,11732,CHEMBL624852,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11120,0,10116.0,U,,,13359,CHEMBL624853,,Oral bioavailability in rat (dose 10 mg/kg),,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11121,0,10116.0,U,,,16618,CHEMBL624854,,Oral bioavailability in rat (Sprague-Dawley),,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11122,0,10116.0,U,,,13960,CHEMBL624855,,Oral bioavailability in rat,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11123,0,10116.0,U,,,13917,CHEMBL624856,,Oral bioavailability in rats was determined in vivo,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11124,0,9615.0,U,,,14266,CHEMBL882957,,Oral bioavailability in dog,,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11125,0,314293.0,U,,,12359,CHEMBL624857,,Oral bioavailability of compound in monkey,,A,22224,1,,,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,11126,1,10116.0,N,,,12359,CHEMBL622202,,Oral bioavailability of compound in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11127,0,10116.0,U,,,12359,CHEMBL622203,,Bioavailability in rat of PMEA prodrug,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11128,1,10116.0,N,,,12359,CHEMBL625522,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11129,0,9544.0,U,,,10791,CHEMBL622868,,Serum conc at 3 hours following 25 mg/kg dose,,A,22224,1,,,Macaca mulatta
,In vivo,,,Autocuration,BAO_0000218,11130,0,9544.0,U,,,10791,CHEMBL622869,,Urine conc 0-5 hours following 25 mg/kg dose,Urine,A,22224,1,,1088.0,Macaca mulatta
,In vivo,,,Autocuration,BAO_0000218,11131,0,9544.0,U,,,10791,CHEMBL622870,,Urine conc 0-24 hours following 25 mg/kg dose,Urine,A,22224,1,,1088.0,Macaca mulatta
,In vivo,,,Autocuration,BAO_0000218,11132,0,9534.0,U,,,138,CHEMBL622871,,Oral bioavailability in African green monkeys; 20-25,,A,22224,1,,,Chlorocebus aethiops
,In vivo,,,Intermediate,BAO_0000218,11133,1,9541.0,N,,,14521,CHEMBL620560,,Oral bioavailability in cynomolgus monkey.,,A,100710,1,,,Macaca fascicularis
,In vivo,,,Autocuration,BAO_0000218,11134,0,9615.0,U,,,13953,CHEMBL620561,,Oral bioavailability in dog,,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11135,1,9615.0,N,,,12836,CHEMBL620562,,Oral bioavailability in dog at 10 mg/kg oral dose,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11136,1,10026.0,N,,,12836,CHEMBL620563,,Oral bioavailability in hamster at 10 mg/kg oral dose,,A,100712,1,,,Cricetinae
,In vivo,,,Intermediate,BAO_0000218,11137,1,10116.0,N,,,12836,CHEMBL620564,,Oral bioavailability in rat at 10 mg/kg oral dose,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11138,0,10116.0,U,,,14521,CHEMBL872265,,Oral bioavailability in rat,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11139,0,10116.0,U,,,13953,CHEMBL620565,,Oral bioavailability in rat,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11140,0,9347.0,U,,,6799,CHEMBL620566,,Oral bioavailability,,A,22224,1,,,Eutheria
,In vivo,,,Autocuration,BAO_0000218,11141,0,,U,,,11311,CHEMBL620567,,Oral bioavailability was determined; range 49-102%,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,11142,1,9615.0,N,,,4013,CHEMBL620568,,Oral bioavailability was determined in dogs,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11143,0,10116.0,U,,,4013,CHEMBL620569,,Oral bioavailability in rat,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11144,0,9347.0,U,,,17591,CHEMBL620570,,Oral bioavailability,,A,22224,1,,,Eutheria
,In vivo,,,Autocuration,BAO_0000218,11145,0,,U,,,17591,CHEMBL620571,,Oral bioavailability was determined; Not orally available,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,11146,1,10090.0,N,,,15011,CHEMBL620572,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,A,50594,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,11147,0,10090.0,U,,,15011,CHEMBL620573,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,A,22224,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,11148,0,10090.0,U,,,15011,CHEMBL620574,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,A,22224,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,11149,0,9544.0,U,,,9552,CHEMBL620575,,Oral bioavailability in Rhesus monkey,,A,22224,1,,,Macaca mulatta
,In vivo,,,Autocuration,BAO_0000218,11150,0,9615.0,U,,,9552,CHEMBL620576,,Oral bioavailability in dog (female mongrel),,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11151,0,,U,,,3639,CHEMBL875846,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11152,0,9615.0,U,,,13397,CHEMBL620577,,Oral bioavailability in dog,,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11153,0,,U,,,3031,CHEMBL620578,,Percentage Bioavailability was evaluated.,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11154,0,10116.0,U,,,12818,CHEMBL620579,,Bioavailability in rat administered i.d.,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11155,0,9347.0,U,,,4847,CHEMBL621248,,Bioavailability,,A,22224,1,,,Eutheria
,In vivo,,,Autocuration,BAO_0000218,11156,0,9615.0,U,,,12421,CHEMBL625390,,Bioavailability in dog (male Beagle) i.v. administration,,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11157,0,10116.0,U,,,11966,CHEMBL625391,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11158,0,9443.0,U,,,11218,CHEMBL872266,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,A,22224,1,,,Primates
,In vivo,,,Autocuration,BAO_0000218,11159,0,10116.0,U,,,13129,CHEMBL625392,,Oral bioavailability in rat (Sprague-Dawley) (male),,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11160,1,10116.0,N,,,12350,CHEMBL625393,,The oral bioavailability was measured on rats after oral administration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11161,1,10116.0,N,,,2231,CHEMBL625394,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11162,1,9544.0,N,,,2231,CHEMBL625395,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,A,50797,1,,,Macaca mulatta
,In vivo,,,Autocuration,BAO_0000218,11163,0,10116.0,U,,,12187,CHEMBL625396,,Bioavailability in rat (dose 10 mg/kg i.d.),,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11164,0,9615.0,U,,,12421,CHEMBL625397,,Bioavailability in dog (male Beagle) i.v. administration,,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11165,1,10090.0,N,,,13256,CHEMBL625398,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11166,1,10090.0,N,,,13256,CHEMBL625399,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11167,1,10090.0,N,,,13256,CHEMBL626074,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Cerebellum,A,50594,1,,2037.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11168,1,10090.0,N,,,13256,CHEMBL626075,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11169,1,10116.0,N,,,2231,CHEMBL626076,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11170,1,9544.0,N,,,2231,CHEMBL626077,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Plasma,A,50797,1,,1969.0,Macaca mulatta
,In vivo,,,Intermediate,BAO_0000218,11171,1,10116.0,N,,,12178,CHEMBL626078,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11172,0,,U,,,12178,CHEMBL625846,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,11173,0,,U,,,12178,CHEMBL625847,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),Blood,A,22224,1,,178.0,
,In vivo,,,Expert,BAO_0000218,11174,1,10116.0,N,,,15633,CHEMBL625848,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11175,1,10116.0,N,,,14258,CHEMBL625849,,Maximum concentration of compound in plasma administered orally to rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11176,1,9615.0,N,,,14224,CHEMBL626023,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11177,1,9615.0,N,,,14224,CHEMBL626024,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11178,1,9615.0,N,,,14224,CHEMBL626025,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11179,0,,U,,,5566,CHEMBL626026,,Maximum concentration after 10 mg/kg by oral administration,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11180,0,,U,,,16935,CHEMBL626027,,Maximum concentration at a dose of 1.5 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11181,0,,U,,,16935,CHEMBL626028,,Maximum concentration at a dose of 2.0 mg/kg,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,11182,1,9615.0,N,,,14224,CHEMBL626029,,Maximum concentration in dog plasma,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11183,0,,U,,,12536,CHEMBL626030,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11184,0,,U,,,12536,CHEMBL626031,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11185,0,,U,,,12536,CHEMBL626032,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11186,0,,U,,,12536,CHEMBL626033,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11187,0,,U,,,12536,CHEMBL626034,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,11188,1,9615.0,N,,,9994,CHEMBL626035,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11189,0,,U,,,1434,CHEMBL626036,,Maximum concentration in plasma at Tmax,Plasma,A,22224,1,,1969.0,
,In vivo,,,Expert,BAO_0000218,11190,1,9615.0,N,,,12836,CHEMBL626037,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11191,1,10026.0,N,,,12836,CHEMBL626038,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Plasma,A,100712,1,,1969.0,Cricetinae
,In vivo,,,Intermediate,BAO_0000218,11192,1,10116.0,N,,,12836,CHEMBL626039,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11193,1,10116.0,N,,,12545,CHEMBL626040,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11194,1,9986.0,N,,,13856,CHEMBL626041,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Plasma,A,50592,1,,1969.0,Oryctolagus cuniculus
,In vivo,,,Autocuration,BAO_0000218,11195,0,,U,,,3550,CHEMBL626042,,Maximum concentration was calculated,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11196,0,,U,,,2632,CHEMBL626043,,Maximum concentration was calculated.,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11197,0,,U,,,5566,CHEMBL626044,,Maximum concentration at a peroral dose of 10 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11198,0,,U,,,11883,CHEMBL626045,,Maximum concentration of the drug at 10 uM/dg administered perorally,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11199,0,,U,,,11883,CHEMBL626046,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,11200,1,9615.0,N,,,14122,CHEMBL626047,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11201,1,10026.0,N,,,14122,CHEMBL626048,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Plasma,A,100712,1,,1969.0,Cricetinae
,In vivo,,,Intermediate,BAO_0000218,11202,1,10116.0,N,,,14122,CHEMBL626049,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11203,1,10116.0,N,,,12542,CHEMBL626050,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11204,1,9615.0,N,,,12542,CHEMBL874541,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11205,1,10026.0,N,,,12542,CHEMBL622826,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Plasma,A,100712,1,,1969.0,Cricetinae
,In vivo,,,Intermediate,BAO_0000218,11206,1,10026.0,N,,,12542,CHEMBL622827,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Plasma,A,100712,1,,1969.0,Cricetinae
,In vivo,,,Intermediate,BAO_0000218,11207,1,10116.0,N,,,12542,CHEMBL622828,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11208,1,10116.0,N,,,14080,CHEMBL622829,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11209,1,10116.0,N,,,11911,CHEMBL876806,,Maximum concentration reached following intravenous administration in male rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11210,1,9615.0,N,,,13204,CHEMBL622830,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11211,1,10116.0,N,,,13204,CHEMBL622831,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11212,1,9615.0,N,,,14346,CHEMBL626794,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11213,1,10116.0,N,,,14346,CHEMBL626795,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11214,1,10116.0,N,,,14346,CHEMBL626796,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11215,1,10116.0,N,,,14346,CHEMBL626797,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11216,1,10116.0,N,,,14127,CHEMBL626798,,Maximum drug concentration is determined after oral dosing in rats.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11217,1,9615.0,N,,,14339,CHEMBL626799,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11218,1,9615.0,N,,,14339,CHEMBL626800,,Maximum observed concentration in oral (5 mg/kg) fed dogs,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11219,0,,U,,,13494,CHEMBL626801,,Maximum plasma concentration,Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,11220,1,10116.0,N,,,14925,CHEMBL876816,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11221,1,10116.0,N,,,14474,CHEMBL626802,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11222,1,9615.0,N,,,14474,CHEMBL626803,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11223,0,,U,,,13917,CHEMBL626804,,Maximum plasma concentration following oral administration of 30 umol/kg,Plasma,A,22224,1,,1969.0,
,,,,Intermediate,BAO_0000218,11224,1,10116.0,N,,,9796,CHEMBL626805,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11225,1,10116.0,N,,,9796,CHEMBL626309,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11226,1,10116.0,N,,,9796,CHEMBL626310,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11227,1,10116.0,N,,,9796,CHEMBL626311,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11228,1,10116.0,N,,,9796,CHEMBL626312,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11229,1,10116.0,N,,,9796,CHEMBL626313,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11230,1,10116.0,N,,,9796,CHEMBL626314,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11231,1,10116.0,N,,,9796,CHEMBL626315,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11232,1,10116.0,N,,,9796,CHEMBL626316,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11233,1,10116.0,N,,,9796,CHEMBL626317,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11234,1,10116.0,N,,,8363,CHEMBL626318,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11235,1,10116.0,N,,,8363,CHEMBL626319,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11236,1,10116.0,N,,,8363,CHEMBL626320,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11237,1,10116.0,N,,,8363,CHEMBL875053,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11238,1,10116.0,N,,,8363,CHEMBL626321,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11239,1,10116.0,N,,,8363,CHEMBL626322,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11240,1,10116.0,N,,,8363,CHEMBL626323,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11241,1,10116.0,N,,,8363,CHEMBL626324,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11242,1,10116.0,N,,,8363,CHEMBL626325,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11243,1,10116.0,N,,,8363,CHEMBL626326,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11244,1,10116.0,N,,,8363,CHEMBL626327,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11245,1,10116.0,N,,,8363,CHEMBL626328,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11246,1,10116.0,N,,,8684,CHEMBL626329,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11247,1,10116.0,N,,,8684,CHEMBL626330,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11248,1,10116.0,N,,,8684,CHEMBL626331,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11249,1,10116.0,N,,,8684,CHEMBL626332,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11250,1,10116.0,N,,,8684,CHEMBL626333,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11251,1,10116.0,N,,,8684,CHEMBL626334,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11252,1,10116.0,N,,,8684,CHEMBL626335,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11253,1,10116.0,N,,,8684,CHEMBL624798,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11254,1,10116.0,N,,,8684,CHEMBL624799,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11255,1,10116.0,N,,,8684,CHEMBL624800,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11256,1,10116.0,N,,,8684,CHEMBL624801,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11257,1,10116.0,N,,,8684,CHEMBL624802,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11258,1,10116.0,N,,,8684,CHEMBL624803,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11259,1,10116.0,N,,,8684,CHEMBL624804,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11260,1,10116.0,N,,,8684,CHEMBL624805,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11261,1,10116.0,N,,,8684,CHEMBL624806,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11262,1,10116.0,N,,,8684,CHEMBL624807,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11263,1,10116.0,N,,,8684,CHEMBL624808,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11264,1,10116.0,N,,,8684,CHEMBL624809,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11265,1,10116.0,N,,,8684,CHEMBL624810,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11266,1,10116.0,N,,,8684,CHEMBL877618,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11267,1,10116.0,N,,,8684,CHEMBL624811,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11268,1,10116.0,N,,,8684,CHEMBL624812,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11269,1,10116.0,N,,,8684,CHEMBL624813,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11270,1,10116.0,N,,,8684,CHEMBL624814,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11271,1,10116.0,N,,,8684,CHEMBL624815,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11272,1,10116.0,N,,,8684,CHEMBL624816,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11273,1,10116.0,N,,,8684,CHEMBL624817,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11274,1,9615.0,N,,,6996,CHEMBL624818,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11275,1,9615.0,N,,,6996,CHEMBL624819,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11276,1,9615.0,N,,,6996,CHEMBL624820,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11277,1,9615.0,N,,,6996,CHEMBL624821,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11278,1,9615.0,N,,,6996,CHEMBL624822,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11279,1,9615.0,N,,,6996,CHEMBL624823,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11280,1,562.0,N,,,15599,CHEMBL624824,,Observed diffusion coefficient in organic solvent for Escherichia coli,,A,50212,1,,,Escherichia coli
,,,,Intermediate,BAO_0000218,11281,1,10116.0,N,,,9614,CHEMBL624825,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11282,1,10116.0,N,,,9614,CHEMBL624826,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11283,1,10116.0,N,,,9614,CHEMBL876817,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Cardiac atrium,A,50597,1,,2081.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11284,1,10116.0,N,,,9614,CHEMBL624827,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Cardiac atrium,A,50597,1,,2081.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11285,1,10116.0,N,,,9614,CHEMBL624828,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11286,1,10116.0,N,,,9614,CHEMBL624829,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11287,1,10116.0,N,,,9614,CHEMBL624830,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11288,1,10116.0,N,,,9614,CHEMBL624831,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11289,1,10116.0,N,,,9614,CHEMBL624832,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Cardiac atrium,A,50597,1,,2081.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11290,1,10116.0,N,,,9614,CHEMBL624833,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Cardiac atrium,A,50597,1,,2081.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11291,1,10116.0,N,,,9614,CHEMBL624834,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11292,1,10116.0,N,,,9614,CHEMBL624835,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11293,1,10116.0,N,,,9614,CHEMBL624836,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11294,1,10116.0,N,,,9614,CHEMBL624837,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11295,1,10116.0,N,,,9071,CHEMBL624838,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11296,1,10116.0,N,,,9071,CHEMBL622188,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11297,1,10116.0,N,,,9071,CHEMBL622189,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11298,1,10116.0,N,,,9071,CHEMBL622190,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11299,1,10116.0,N,,,9071,CHEMBL625170,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11300,1,10116.0,N,,,9071,CHEMBL625171,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11301,1,10116.0,N,,,9071,CHEMBL625172,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11302,1,10116.0,N,,,9071,CHEMBL625173,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11303,1,10116.0,N,,,9071,CHEMBL625174,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11304,1,10116.0,N,,,9071,CHEMBL625175,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11305,1,10116.0,N,,,9071,CHEMBL625176,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11306,1,10116.0,N,,,9071,CHEMBL625177,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11307,1,10116.0,N,,,9071,CHEMBL625178,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11308,1,10116.0,N,,,9071,CHEMBL625179,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11309,1,10116.0,N,,,9071,CHEMBL625180,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Autocuration,BAO_0000218,11310,0,,U,,,10677,CHEMBL625181,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,A,22224,1,,,
,,,,Intermediate,BAO_0000218,11311,1,10090.0,N,,,9750,CHEMBL625182,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,11312,1,10116.0,N,,,8319,CHEMBL625183,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11313,1,10116.0,N,,,8319,CHEMBL875848,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11314,1,10116.0,N,,,8319,CHEMBL622260,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11315,1,10116.0,N,,,8319,CHEMBL622261,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11316,1,10116.0,N,,,8319,CHEMBL622262,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11317,1,10116.0,N,,,8319,CHEMBL622263,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11318,1,10116.0,N,,,8319,CHEMBL622418,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11319,1,10116.0,N,,,8319,CHEMBL622419,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11320,1,10090.0,N,,,13256,CHEMBL623388,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11321,1,10090.0,N,,,13256,CHEMBL623389,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11322,1,10090.0,N,,,13256,CHEMBL623390,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11323,1,10090.0,N,,,13256,CHEMBL623391,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11324,1,10090.0,N,,,13256,CHEMBL623392,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11325,1,10090.0,N,,,13256,CHEMBL623393,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Cerebellum,A,50594,1,,2037.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11326,1,10090.0,N,,,13256,CHEMBL623394,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11327,1,10090.0,N,,,13256,CHEMBL618885,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11328,1,10090.0,N,,,13256,CHEMBL618886,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11329,1,10090.0,N,,,13256,CHEMBL618887,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11330,1,10090.0,N,,,13256,CHEMBL619535,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11331,1,10090.0,N,,,13256,CHEMBL619536,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11332,1,10090.0,N,,,13256,CHEMBL619537,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Cerebellum,A,50594,1,,2037.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11333,1,10090.0,N,,,13256,CHEMBL619705,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11334,1,10090.0,N,,,13256,CHEMBL619706,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11335,1,10090.0,N,,,13256,CHEMBL619707,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11336,1,10090.0,N,,,13256,CHEMBL619708,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11337,1,10090.0,N,,,13256,CHEMBL625219,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11338,1,10090.0,N,,,13256,CHEMBL625220,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11339,1,10090.0,N,,,13256,CHEMBL625221,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Cerebellum,A,50594,1,,2037.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11340,1,10090.0,N,,,13256,CHEMBL625222,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11341,1,10090.0,N,,,13256,CHEMBL625223,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11342,1,10090.0,N,,,13256,CHEMBL625224,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11343,1,10090.0,N,,,13256,CHEMBL625225,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11344,1,10116.0,N,,,8829,CHEMBL625226,,Biodistribution in Rat blood after 24 hours of iv administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11345,1,10116.0,N,,,8829,CHEMBL625227,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11346,1,10116.0,N,,,8829,CHEMBL625228,,Biodistribution in Rat blood after 30 minutes of iv administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11347,1,10116.0,N,,,8829,CHEMBL875354,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11348,1,10116.0,N,,,8829,CHEMBL625229,,Biodistribution in Rat blood after 5 minutes of iv administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11349,1,10116.0,N,,,8829,CHEMBL625230,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11350,1,10116.0,N,,,8829,CHEMBL625231,,Biodistribution in Rat heart after 24 hours of iv administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11351,1,10116.0,N,,,8829,CHEMBL625900,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11352,1,10116.0,N,,,8829,CHEMBL625901,,Biodistribution in Rat heart after 30 minutes of iv administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11353,1,10116.0,N,,,8829,CHEMBL625902,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11354,1,10116.0,N,,,8829,CHEMBL625903,,Biodistribution in Rat heart after 5 minutes of iv administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11355,1,10116.0,N,,,8829,CHEMBL625904,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11356,1,10116.0,N,,,8829,CHEMBL625905,,Biodistribution in Rat liver after 24 hours of iv administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11357,1,10116.0,N,,,8829,CHEMBL627861,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11358,1,10116.0,N,,,8829,CHEMBL627862,,Biodistribution in Rat liver after 30 minutes of iv administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11359,1,10116.0,N,,,8829,CHEMBL627863,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11360,1,10116.0,N,,,8829,CHEMBL627769,,Biodistribution in Rat liver after 30 minutes of iv administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11361,1,9615.0,N,,,13249,CHEMBL627770,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11362,1,9541.0,N,,,13622,CHEMBL627771,,Cmax in cynomolgus monkey (PO dose),,A,100710,1,,,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,11363,1,10116.0,N,,,13622,CHEMBL627772,,Cmax in rat (PO dose),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11364,1,10116.0,N,,,13622,CHEMBL627773,,Cmax in rat (PO dose),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11365,1,10116.0,N,,,13494,CHEMBL621922,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11366,1,10116.0,N,,,12170,CHEMBL621923,,Cmax in rat plasma after oral dose (10 mg/kg),Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11367,0,,U,,,12170,CHEMBL621924,,Cmax in plasma after oral dose (10 mg/kg),Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,11368,1,9615.0,N,,,17025,CHEMBL621925,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11369,0,314293.0,U,,,17025,CHEMBL621926,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Plasma,A,22224,1,,1969.0,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,11370,1,9986.0,N,,,17025,CHEMBL621927,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Plasma,A,50592,1,,1969.0,Oryctolagus cuniculus
,In vivo,,,Intermediate,BAO_0000218,11371,1,10116.0,N,,,17025,CHEMBL621928,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11372,1,10116.0,N,,,14187,CHEMBL621929,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11373,1,10090.0,N,,,14816,CHEMBL621930,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11374,1,10116.0,N,,,17820,CHEMBL621931,,Maximum plasma concentration after oral dosing in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11375,0,,U,,,14380,CHEMBL621932,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11376,0,,U,,,14380,CHEMBL621933,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,11377,1,9615.0,N,,,14691,CHEMBL621934,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11378,1,9615.0,N,,,14691,CHEMBL621935,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11379,1,10116.0,N,,,13375,CHEMBL621936,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11380,0,,U,,,6236,CHEMBL621937,,Maximum plasma concentration was determined,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11381,0,,U,,,14380,CHEMBL621938,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11382,0,,U,,,14380,CHEMBL621939,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11383,0,,U,,,14380,CHEMBL621940,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11384,0,,U,,,14380,CHEMBL621941,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11385,0,,U,,,14380,CHEMBL621942,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11386,0,,U,,,14380,CHEMBL626178,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11387,0,,U,,,14380,CHEMBL626179,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,11388,0,,U,,,14380,CHEMBL626180,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,11389,1,10116.0,N,,,13622,CHEMBL626181,,Plasma Cmax in rat (PO dose),Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11390,1,10116.0,N,,,15372,CHEMBL626182,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11391,1,10116.0,N,,,15372,CHEMBL626183,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11392,1,10116.0,N,,,15372,CHEMBL626184,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11393,1,10116.0,N,,,15372,CHEMBL626185,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11394,1,9615.0,N,,,14925,CHEMBL626186,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11395,1,9615.0,N,,,14925,CHEMBL877589,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11396,0,,U,,,11883,CHEMBL626187,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11397,0,,U,,,11883,CHEMBL626188,,Maximum concentration of the drug at 20 uM/dg administered perorally,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11398,0,,U,,,13391,CHEMBL626189,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,11399,0,,U,,,13391,CHEMBL626855,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,11400,0,,U,,,13391,CHEMBL623781,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,11401,0,,U,,,13391,CHEMBL623782,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Blood,A,22224,1,,178.0,
,In vivo,,,Intermediate,BAO_0000218,11402,1,10116.0,N,,,16360,CHEMBL623783,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11403,1,9615.0,N,,,3673,CHEMBL623784,,Cmax in dog plasma after 1mg/kg oral dose,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11404,1,9615.0,N,,,14431,CHEMBL623785,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11405,1,10116.0,N,,,14431,CHEMBL623786,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11406,1,10116.0,N,,,14964,CHEMBL623787,,Oral maximum concentration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11407,1,10116.0,N,,,14964,CHEMBL623788,,Oral maximum concentration in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11408,1,10090.0,N,,,14209,CHEMBL623789,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11409,1,10090.0,N,,,11355,CHEMBL623790,,Peak concentration in blood after intravenous administration to mice,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11410,1,10090.0,N,,,11355,CHEMBL623791,,Peak concentration in blood after peroral administration to mice,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11411,1,10116.0,N,,,11966,CHEMBL623792,,Peak concentration in rat plasma was determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11412,0,314293.0,U,,,8918,CHEMBL623793,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Plasma,A,22224,1,,1969.0,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,11413,1,10090.0,N,,,8918,CHEMBL623794,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11414,1,10116.0,N,,,8918,CHEMBL623795,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11415,1,10116.0,N,,,8684,CHEMBL623796,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11416,1,10116.0,N,,,8684,CHEMBL623797,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11417,1,10116.0,N,,,8684,CHEMBL623798,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11418,1,10116.0,N,,,8684,CHEMBL623799,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11419,1,10116.0,N,,,8684,CHEMBL624490,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Intestine,A,50597,1,,160.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11420,1,10116.0,N,,,8684,CHEMBL624491,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Intestine,A,50597,1,,160.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11421,1,10116.0,N,,,8684,CHEMBL624492,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Intestine,A,50597,1,,160.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11422,1,10116.0,N,,,8684,CHEMBL624493,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Intestine,A,50597,1,,160.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11423,1,10116.0,N,,,8684,CHEMBL877595,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Intestine,A,50597,1,,160.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11424,1,10116.0,N,,,8684,CHEMBL624494,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Intestine,A,50597,1,,160.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11425,1,10116.0,N,,,8684,CHEMBL624495,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Intestine,A,50597,1,,160.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11426,1,10116.0,N,,,8684,CHEMBL624681,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Intestine,A,50597,1,,160.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11427,1,10116.0,N,,,8684,CHEMBL624682,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11428,1,10116.0,N,,,8684,CHEMBL624683,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11429,1,10116.0,N,,,8684,CHEMBL624684,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11430,1,10116.0,N,,,8684,CHEMBL624685,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11431,1,10116.0,N,,,8684,CHEMBL624686,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11432,1,10116.0,N,,,8684,CHEMBL624687,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11433,1,10116.0,N,,,8684,CHEMBL624688,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11434,1,10116.0,N,,,8684,CHEMBL627161,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11435,1,10116.0,N,,,8684,CHEMBL622127,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11436,1,10116.0,N,,,8684,CHEMBL622128,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11437,1,10116.0,N,,,8684,CHEMBL874384,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11438,1,10116.0,N,,,8684,CHEMBL624898,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11439,1,10116.0,N,,,8684,CHEMBL624899,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11440,1,10116.0,N,,,8684,CHEMBL624900,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11441,1,10116.0,N,,,8684,CHEMBL624901,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11442,1,10116.0,N,,,8684,CHEMBL624902,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11443,1,10116.0,N,,,8684,CHEMBL624903,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11444,1,10116.0,N,,,8684,CHEMBL624904,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11445,1,10116.0,N,,,8684,CHEMBL624905,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11446,1,10116.0,N,,,8684,CHEMBL624906,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11447,1,10116.0,N,,,8684,CHEMBL624907,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11448,1,10116.0,N,,,8684,CHEMBL624908,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11449,1,10116.0,N,,,8684,CHEMBL624909,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11450,1,10116.0,N,,,8684,CHEMBL624910,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11451,1,10116.0,N,,,8684,CHEMBL624911,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11452,1,10116.0,N,,,8684,CHEMBL874388,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11453,1,10116.0,N,,,8684,CHEMBL624912,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11454,1,10116.0,N,,,8684,CHEMBL622930,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11455,1,10116.0,N,,,8684,CHEMBL623121,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11456,1,10116.0,N,,,8684,CHEMBL623122,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11457,1,10116.0,N,,,8684,CHEMBL623123,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11458,1,10116.0,N,,,8684,CHEMBL623124,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11459,1,10116.0,N,,,8684,CHEMBL623125,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11460,1,10116.0,N,,,8684,CHEMBL623126,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11461,1,10116.0,N,,,8684,CHEMBL623127,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11462,1,10116.0,N,,,8684,CHEMBL623128,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11463,1,10116.0,N,,,8684,CHEMBL623129,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11464,1,10116.0,N,,,8684,CHEMBL623130,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11465,1,10116.0,N,,,8684,CHEMBL623131,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11466,1,10116.0,N,,,8684,CHEMBL623132,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11467,1,10116.0,N,,,8319,CHEMBL623133,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11468,1,10116.0,N,,,8319,CHEMBL623134,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11469,1,10116.0,N,,,8319,CHEMBL874389,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11470,1,10116.0,N,,,8319,CHEMBL623135,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11471,1,10116.0,N,,,8319,CHEMBL623136,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11472,1,10116.0,N,,,8319,CHEMBL623137,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11473,1,10116.0,N,,,8319,CHEMBL623138,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11474,1,10116.0,N,,,8319,CHEMBL623139,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11475,1,10116.0,N,,,8319,CHEMBL623140,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11476,1,10116.0,N,,,8319,CHEMBL623141,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11477,1,10116.0,N,,,8319,CHEMBL623142,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11478,1,10116.0,N,,,8319,CHEMBL623143,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11479,1,10090.0,N,,,14571,CHEMBL623144,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,11480,1,10116.0,N,,,14571,CHEMBL623405,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11481,1,10116.0,N,,,8319,CHEMBL624074,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11482,1,10116.0,N,,,8319,CHEMBL624075,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11483,1,10116.0,N,,,8319,CHEMBL624076,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11484,1,10116.0,N,,,8319,CHEMBL624077,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11485,1,10116.0,N,,,8319,CHEMBL624078,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11486,1,10116.0,N,,,8319,CHEMBL624079,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11487,1,10116.0,N,,,8319,CHEMBL624261,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11488,1,10116.0,N,,,8319,CHEMBL624262,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11489,1,10116.0,N,,,8319,CHEMBL624263,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11490,1,10116.0,N,,,8319,CHEMBL624264,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11491,1,10116.0,N,,,8319,CHEMBL624265,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11492,1,10116.0,N,,,8319,CHEMBL624266,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11493,1,10116.0,N,,,8319,CHEMBL624267,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11494,1,10116.0,N,,,8319,CHEMBL624268,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11495,1,10116.0,N,,,8319,CHEMBL875227,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11496,1,10116.0,N,,,8319,CHEMBL624269,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11497,1,10116.0,N,,,8319,CHEMBL624270,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11498,1,10116.0,N,,,8319,CHEMBL624271,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11499,1,10116.0,N,,,8319,CHEMBL624272,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11500,1,10116.0,N,,,8319,CHEMBL624273,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11501,1,10116.0,N,,,12064,CHEMBL624274,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11502,1,10116.0,N,,,12064,CHEMBL624275,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11503,1,10116.0,N,,,12064,CHEMBL624276,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11504,1,10116.0,N,,,12038,CHEMBL624277,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,11505,0,,U,,,14314,CHEMBL624278,,% dose converted to 2-amino-5-chlorophenyl sulfate,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11506,0,,U,,,14314,CHEMBL624279,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,A,22224,1,,,
,,,,Intermediate,BAO_0000218,11507,1,10116.0,N,,,11488,CHEMBL624280,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Feces,A,50597,1,,1988.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11508,1,10116.0,N,,,11488,CHEMBL624281,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Feces,A,50597,1,,1988.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11509,1,10116.0,N,,,11488,CHEMBL622933,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Feces,A,50597,1,,1988.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11510,1,10116.0,N,,,11488,CHEMBL622934,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Feces,A,50597,1,,1988.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11511,1,10116.0,N,,,8829,CHEMBL622935,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11512,1,10116.0,N,,,8829,CHEMBL622936,,Biodistribution in Rat liver after 5 minutes of iv administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11513,1,10116.0,N,,,8829,CHEMBL875228,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11514,1,10116.0,N,,,8829,CHEMBL622937,,Biodistribution in Rat lung after 24 hours of iv administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11515,1,10116.0,N,,,8829,CHEMBL622938,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11516,1,10116.0,N,,,8829,CHEMBL619736,,Biodistribution in Rat lung after 30 minutes of iv administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11517,1,10116.0,N,,,8829,CHEMBL625117,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11518,1,10116.0,N,,,8829,CHEMBL625118,,Biodistribution in Rat lung after 5 minutes of iv administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11519,1,10116.0,N,,,8829,CHEMBL625119,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11520,1,10116.0,N,,,14972,CHEMBL625120,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11521,1,10116.0,N,,,14972,CHEMBL625121,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11522,1,10116.0,N,,,14972,CHEMBL625122,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Thalamus,A,50597,1,,10000006.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11523,1,10116.0,N,,,14608,CHEMBL622204,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11524,1,10116.0,N,,,14608,CHEMBL877503,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11525,1,10116.0,N,,,14608,CHEMBL627127,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11526,0,,U,,,14608,CHEMBL627128,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,Hippocampus,A,22224,1,,10000000.0,
,In vivo,,,Autocuration,BAO_0000218,11527,0,,U,,,14608,CHEMBL627129,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,Hippocampus,A,22224,1,,10000000.0,
,In vivo,,,Autocuration,BAO_0000218,11528,0,,U,,,14608,CHEMBL627130,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,Hippocampus,A,22224,1,,10000000.0,
,In vivo,,,Intermediate,BAO_0000218,11529,1,10116.0,N,,,14608,CHEMBL627131,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11530,1,10116.0,N,,,14608,CHEMBL627132,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11531,1,10116.0,N,,,14608,CHEMBL627133,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11532,1,10116.0,N,,,14608,CHEMBL627134,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11533,1,10116.0,N,,,14608,CHEMBL627135,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11534,1,10116.0,N,,,14608,CHEMBL627136,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11535,1,10116.0,N,,,14608,CHEMBL628435,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11536,1,10116.0,N,,,14608,CHEMBL628436,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11537,1,10116.0,N,,,14608,CHEMBL628437,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11538,1,10116.0,N,,,14608,CHEMBL628438,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11539,1,10116.0,N,,,14608,CHEMBL628439,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11540,1,10116.0,N,,,14608,CHEMBL628440,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11541,1,10116.0,N,,,14608,CHEMBL628441,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11542,1,10116.0,N,,,14608,CHEMBL628442,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11543,1,10116.0,N,,,14608,CHEMBL628443,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11544,1,10116.0,N,,,14608,CHEMBL628444,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11545,1,10116.0,N,,,14608,CHEMBL628445,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11546,1,10116.0,N,,,14608,CHEMBL877504,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11547,1,10116.0,N,,,14608,CHEMBL628446,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11548,1,10116.0,N,,,14608,CHEMBL626874,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11549,1,10116.0,N,,,14608,CHEMBL626875,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11550,1,10116.0,N,,,14608,CHEMBL626876,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11551,1,10116.0,N,,,14608,CHEMBL626877,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11552,1,10116.0,N,,,14608,CHEMBL626878,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11553,1,10116.0,N,,,14608,CHEMBL626879,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11554,0,314293.0,U,,,8918,CHEMBL626880,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Plasma,A,22224,1,,1969.0,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,11555,1,10090.0,N,,,8918,CHEMBL626881,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11556,1,10116.0,N,,,8918,CHEMBL626882,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11557,1,9615.0,N,,,14470,CHEMBL626883,,Peak plasma concentration was measured in dogs,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11558,1,10116.0,N,,,14393,CHEMBL626884,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11559,1,10116.0,N,,,14886,CHEMBL626885,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11560,1,10116.0,N,,,14886,CHEMBL626886,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11561,1,10116.0,N,,,14886,CHEMBL626887,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11562,1,10116.0,N,,,14393,CHEMBL626888,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11563,1,9615.0,N,,,13465,CHEMBL626889,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11564,0,314293.0,U,,,13465,CHEMBL626761,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,A,22224,1,,,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,11565,1,9615.0,N,,,13465,CHEMBL626762,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11566,1,9615.0,N,,,13465,CHEMBL626763,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11567,1,10116.0,N,,,13465,CHEMBL626764,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11568,1,10116.0,N,,,13465,CHEMBL626765,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11569,1,9615.0,N,,,13465,CHEMBL626766,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11570,1,10116.0,N,,,13465,CHEMBL626767,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11571,1,10116.0,N,,,13465,CHEMBL626768,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11572,1,9615.0,N,,,13465,CHEMBL626769,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11573,1,9615.0,N,,,13465,CHEMBL874463,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11574,0,314293.0,U,,,13465,CHEMBL626770,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,A,22224,1,,,Simiiformes
,In vivo,,,Autocuration,BAO_0000218,11575,0,314293.0,U,,,13465,CHEMBL626771,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,A,22224,1,,,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,11576,1,10116.0,N,,,13465,CHEMBL626772,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11577,1,9541.0,N,,,14731,CHEMBL626773,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,A,100710,1,,,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,11578,1,10090.0,N,,,14731,CHEMBL626774,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11579,1,9615.0,N,,,13376,CHEMBL626775,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11580,1,9615.0,N,,,13376,CHEMBL626776,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11581,1,10116.0,N,,,14443,CHEMBL626777,,Maximum concentration (Cmax) in rat when administered orally,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11582,0,314293.0,U,,,13465,CHEMBL626778,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Plasma,A,22224,1,,1969.0,Simiiformes
,In vivo,,,Autocuration,BAO_0000218,11583,0,10116.0,U,,,16359,CHEMBL626779,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11584,0,10116.0,U,,,16359,CHEMBL626780,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11585,0,,U,,,15618,CHEMBL626781,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,11586,1,10116.0,N,,,14554,CHEMBL632164,,Pharmacokinetic profile Cmax was evaluated in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11587,1,9615.0,N,,,11537,CHEMBL632165,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11588,1,10090.0,N,,,11537,CHEMBL632166,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11589,1,9615.0,N,,,11537,CHEMBL632167,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11590,1,10090.0,N,,,11537,CHEMBL632168,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,A,50594,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,11591,0,10116.0,U,,,2021,CHEMBL632169,,Cmax in rat plasma,Plasma,A,22224,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11592,1,9615.0,N,,,5932,CHEMBL632170,,Cmax in dog plasma after 30mg/kg oral dose,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11593,1,10116.0,N,,,5932,CHEMBL632171,,Cmax in rat plasma after 30mg/kg oral dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11594,1,10116.0,N,,,17320,CHEMBL632172,,Plasma level in rats at 30 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11595,1,10090.0,N,,,15831,CHEMBL632173,,Tested for maximum plasma concentration in mice,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11596,1,10116.0,N,,,15078,CHEMBL632174,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11597,1,10116.0,N,,,14941,CHEMBL632175,,The Cmax values in female wistar rats.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11598,1,9615.0,N,,,15343,CHEMBL632176,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11599,1,10116.0,N,,,15343,CHEMBL632177,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11600,1,10116.0,N,,,14856,CHEMBL632178,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11601,1,10116.0,N,,,13129,CHEMBL632179,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11602,1,10116.0,N,,,13098,CHEMBL632180,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11603,1,10116.0,N,,,13098,CHEMBL632181,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11604,1,10116.0,N,,,13098,CHEMBL632182,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11605,0,10090.0,U,,,15478,CHEMBL632183,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Blood,A,22224,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11606,1,9615.0,N,,,15341,CHEMBL632184,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11607,1,10116.0,N,,,15341,CHEMBL874470,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11608,1,10116.0,N,,,8684,CHEMBL631302,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11609,1,10116.0,N,,,8684,CHEMBL631303,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11610,1,10116.0,N,,,8684,CHEMBL631304,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11611,1,10116.0,N,,,8684,CHEMBL631305,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11612,1,10116.0,N,,,8684,CHEMBL631306,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11613,1,10116.0,N,,,8684,CHEMBL631307,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11614,1,10116.0,N,,,8684,CHEMBL631308,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11615,1,10116.0,N,,,8684,CHEMBL625557,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11616,1,10116.0,N,,,8684,CHEMBL625558,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11617,1,10116.0,N,,,8684,CHEMBL625559,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11618,1,10116.0,N,,,8684,CHEMBL625560,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11619,1,10116.0,N,,,8684,CHEMBL625561,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11620,1,10116.0,N,,,8684,CHEMBL625562,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11621,1,10116.0,N,,,8684,CHEMBL875320,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11622,1,10116.0,N,,,8684,CHEMBL625563,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11623,1,10116.0,N,,,8684,CHEMBL625564,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11624,1,10116.0,N,,,8684,CHEMBL625565,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11625,1,10116.0,N,,,8684,CHEMBL625566,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11626,1,10116.0,N,,,8684,CHEMBL625567,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11627,1,10116.0,N,,,8684,CHEMBL625568,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11628,1,10116.0,N,,,8684,CHEMBL628217,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11629,1,10116.0,N,,,8684,CHEMBL628218,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11630,1,10116.0,N,,,8684,CHEMBL628219,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11631,1,10116.0,N,,,8684,CHEMBL628220,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,11632,0,,U,,,8926,CHEMBL628221,,Distribution in the blood after 120 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11633,0,,U,,,8926,CHEMBL628222,,Distribution in the blood after 15 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11634,0,,U,,,8926,CHEMBL628223,,Distribution in the blood after 30 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11635,0,,U,,,8926,CHEMBL628224,,Distribution in the blood after 5 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11636,0,,U,,,8926,CHEMBL628225,,Distribution in the blood after 60 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11637,0,,U,,,8926,CHEMBL628226,,Distribution in the blood after 90 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11638,0,,U,,,8926,CHEMBL628227,,Distribution in the bone after 120 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11639,0,,U,,,8926,CHEMBL875481,,Distribution in the bone after 15 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11640,0,,U,,,8926,CHEMBL628228,,Distribution in the bone after 30 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11641,0,,U,,,8926,CHEMBL628229,,Distribution in the bone after 5 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11642,0,,U,,,8926,CHEMBL628230,,Distribution in the bone after 60 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11643,0,,U,,,8926,CHEMBL628231,,Distribution in the bone after 90 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11644,0,,U,,,8926,CHEMBL628232,,Distribution in the heart after 120 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11645,0,,U,,,8926,CHEMBL628233,,Distribution in the heart after 15 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11646,0,,U,,,8926,CHEMBL628234,,Distribution in the heart after 30 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11647,0,,U,,,8926,CHEMBL628235,,Distribution in the heart after 5 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11648,0,,U,,,8926,CHEMBL628236,,Distribution in the heart after 60 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11649,0,,U,,,8926,CHEMBL628237,,Distribution in the heart after 90 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11650,0,,U,,,8926,CHEMBL628238,,Distribution in the kidneys after 120 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11651,0,,U,,,8926,CHEMBL628239,,Distribution in the kidneys after 15 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11652,0,,U,,,8926,CHEMBL628240,,Distribution in the kidneys after 30 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11653,0,,U,,,8926,CHEMBL628241,,Distribution in the kidneys after 5 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11654,0,,U,,,8926,CHEMBL628242,,Distribution in the kidneys after 60 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11655,0,,U,,,8926,CHEMBL875482,,Distribution in the kidneys after 90 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11656,0,,U,,,8926,CHEMBL628243,,Distribution in the liver after 120 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11657,0,,U,,,8926,CHEMBL628244,,Distribution in the liver after 15 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11658,0,,U,,,8926,CHEMBL628245,,Distribution in the liver after 30 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11659,0,,U,,,8926,CHEMBL628246,,Distribution in the liver after 5 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11660,0,,U,,,8926,CHEMBL628247,,Distribution in the liver after 60 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11661,0,,U,,,8926,CHEMBL628248,,Distribution in the liver after 90 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11662,0,,U,,,8926,CHEMBL628249,,Distribution in the lung after 120 min of intravenous administration,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,11663,1,10090.0,N,,,14839,CHEMBL625452,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11664,1,10090.0,N,,,14839,CHEMBL625453,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11665,1,10090.0,N,,,14839,CHEMBL625454,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11666,1,10090.0,N,,,14839,CHEMBL623844,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11667,1,10116.0,N,,,12178,CHEMBL623845,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11668,1,10116.0,N,,,12178,CHEMBL623846,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,11669,0,,U,,,12178,CHEMBL623847,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,11670,1,9541.0,N,,,12186,CHEMBL623848,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,11671,1,9541.0,N,,,12186,CHEMBL623849,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,11672,1,9541.0,N,,,12186,CHEMBL623850,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,11673,1,9541.0,N,,,12186,CHEMBL623851,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,A,100710,1,,,Macaca fascicularis
,,,,Autocuration,BAO_0000218,11674,0,314293.0,U,,,12187,CHEMBL623852,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,11675,1,9669.0,N,,,12187,CHEMBL624551,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,A,50506,1,,,Mustela putorius furo
,,,,Intermediate,BAO_0000218,11676,1,9669.0,N,,,12187,CHEMBL624552,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,A,50506,1,,,Mustela putorius furo
,,,,Autocuration,BAO_0000218,11677,0,314293.0,U,,,12187,CHEMBL624553,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,A,22224,1,,,Simiiformes
,,,,Autocuration,BAO_0000218,11678,0,314293.0,U,,,12187,CHEMBL624554,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,11679,1,10116.0,N,,,12187,CHEMBL624555,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11680,1,10116.0,N,,,12187,CHEMBL624741,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11681,1,9615.0,N,,,14122,CHEMBL624742,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11682,1,10026.0,N,,,14122,CHEMBL624743,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,A,100712,1,,,Cricetinae
,,,,Intermediate,BAO_0000218,11683,1,10116.0,N,,,14122,CHEMBL877606,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,11684,0,,U,,,13391,CHEMBL624744,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,11685,0,,U,,,13391,CHEMBL624745,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Blood,A,22224,1,,178.0,
,,,,Autocuration,BAO_0000218,11686,0,,U,,,13391,CHEMBL624746,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Blood,A,22224,1,,178.0,
,,,,Autocuration,BAO_0000218,11687,0,,U,,,13391,CHEMBL624747,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Blood,A,22224,1,,178.0,
,,,,Autocuration,BAO_0000019,11688,0,,U,,,16360,CHEMBL624748,,Oral absorption expressed as Area under curve was determined,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,11689,1,9615.0,N,,,3673,CHEMBL622504,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11690,1,9615.0,N,,,14122,CHEMBL622505,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11691,1,10026.0,N,,,14122,CHEMBL622506,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,A,100712,1,,,Cricetinae
,,,,Intermediate,BAO_0000218,11692,1,10026.0,N,,,14122,CHEMBL622507,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,A,100712,1,,,Cricetinae
,,,,Intermediate,BAO_0000218,11693,1,10116.0,N,,,14122,CHEMBL622508,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,11694,0,,U,,,13889,CHEMBL622509,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,11695,1,10116.0,N,,,14393,CHEMBL622510,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11696,1,10116.0,N,,,17279,CHEMBL622511,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11697,1,9541.0,N,,,14548,CHEMBL622512,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,11698,1,9541.0,N,,,14548,CHEMBL622513,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,11699,1,9541.0,N,,,14548,CHEMBL622514,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,11700,1,9615.0,N,,,14548,CHEMBL622515,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11701,1,9615.0,N,,,14548,CHEMBL622516,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11702,1,10116.0,N,,,14548,CHEMBL622517,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11703,1,10116.0,N,,,14548,CHEMBL622518,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11704,1,10116.0,N,,,14548,CHEMBL622519,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11705,1,10116.0,N,,,14608,CHEMBL622520,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11706,1,10116.0,N,,,14608,CHEMBL622521,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11707,1,10090.0,N,,,14608,CHEMBL625113,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Zone of skin,A,50594,1,,14.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11708,1,10116.0,N,,,14608,CHEMBL625114,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11709,1,10116.0,N,,,14608,CHEMBL874397,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11710,1,10116.0,N,,,14608,CHEMBL625115,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11711,1,10116.0,N,,,14608,CHEMBL625116,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11712,1,10116.0,N,,,14608,CHEMBL623932,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11713,1,10116.0,N,,,14608,CHEMBL623933,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11714,1,10116.0,N,,,14608,CHEMBL623934,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11715,1,10116.0,N,,,14608,CHEMBL623935,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11716,1,10116.0,N,,,14608,CHEMBL623936,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11717,1,10116.0,N,,,14608,CHEMBL623937,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11718,1,10116.0,N,,,14608,CHEMBL623938,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11719,1,10090.0,N,,,15383,CHEMBL623939,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11720,1,10090.0,N,,,15383,CHEMBL623940,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11721,1,10090.0,N,,,15383,CHEMBL623941,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11722,1,10090.0,N,,,15383,CHEMBL627216,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11723,1,10090.0,N,,,15383,CHEMBL623942,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11724,1,10090.0,N,,,15383,CHEMBL618793,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,11725,1,10090.0,N,,,15383,CHEMBL618794,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,11726,1,10090.0,N,,,15383,CHEMBL618795,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,11727,1,10090.0,N,,,15383,CHEMBL618796,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11728,1,10090.0,N,,,15383,CHEMBL618797,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11729,1,10090.0,N,,,15383,CHEMBL618798,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Kidney,A,50594,1,,2113.0,Mus musculus
,,,,Intermediate,BAO_0000218,11730,1,10090.0,N,,,15383,CHEMBL618799,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Kidney,A,50594,1,,2113.0,Mus musculus
,,,,Intermediate,BAO_0000218,11731,1,10090.0,N,,,15383,CHEMBL618800,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Kidney,A,50594,1,,2113.0,Mus musculus
,,,,Intermediate,BAO_0000218,11732,1,10090.0,N,,,15383,CHEMBL618801,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Kidney,A,50594,1,,2113.0,Mus musculus
,,,,Intermediate,BAO_0000218,11733,1,10090.0,N,,,15383,CHEMBL618802,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Kidney,A,50594,1,,2113.0,Mus musculus
,,,,Intermediate,BAO_0000218,11734,1,10090.0,N,,,15383,CHEMBL618803,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Kidney,A,50594,1,,2113.0,Mus musculus
,,,,Intermediate,BAO_0000218,11735,1,10090.0,N,,,15383,CHEMBL618804,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Liver,A,50594,1,,2107.0,Mus musculus
,,,,Intermediate,BAO_0000218,11736,1,10090.0,N,,,15383,CHEMBL618805,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Liver,A,50594,1,,2107.0,Mus musculus
,,,,Intermediate,BAO_0000218,11737,1,10090.0,N,,,15383,CHEMBL618806,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Liver,A,50594,1,,2107.0,Mus musculus
,,,,Intermediate,BAO_0000218,11738,1,10090.0,N,,,15383,CHEMBL618807,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Liver,A,50594,1,,2107.0,Mus musculus
,,,,Intermediate,BAO_0000218,11739,1,10090.0,N,,,15383,CHEMBL618808,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Liver,A,50594,1,,2107.0,Mus musculus
,,,,Intermediate,BAO_0000218,11740,1,10090.0,N,,,15383,CHEMBL618809,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Liver,A,50594,1,,2107.0,Mus musculus
,,,,Intermediate,BAO_0000218,11741,1,10090.0,N,,,15383,CHEMBL618810,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Muscle tissue,A,50594,1,,2385.0,Mus musculus
,,,,Intermediate,BAO_0000218,11742,1,10090.0,N,,,15383,CHEMBL618811,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Muscle tissue,A,50594,1,,2385.0,Mus musculus
,,,,Intermediate,BAO_0000218,11743,1,10090.0,N,,,15383,CHEMBL875844,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Muscle tissue,A,50594,1,,2385.0,Mus musculus
,,,,Intermediate,BAO_0000218,11744,1,10090.0,N,,,15383,CHEMBL618812,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Muscle tissue,A,50594,1,,2385.0,Mus musculus
,,,,Intermediate,BAO_0000218,11745,1,10090.0,N,,,15383,CHEMBL618813,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Muscle tissue,A,50594,1,,2385.0,Mus musculus
,,,,Intermediate,BAO_0000218,11746,1,10090.0,N,,,15383,CHEMBL618814,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11747,1,10090.0,N,,,15383,CHEMBL618815,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11748,1,10090.0,N,,,15383,CHEMBL618816,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11749,1,10090.0,N,,,15383,CHEMBL618817,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11750,1,10090.0,N,,,15383,CHEMBL620544,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11751,1,10116.0,N,,,15341,CHEMBL626230,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11752,1,10116.0,N,,,15341,CHEMBL626231,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11753,1,10116.0,N,,,15341,CHEMBL626232,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11754,1,9615.0,N,,,14906,CHEMBL626233,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11755,1,10116.0,N,,,14906,CHEMBL626234,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11756,1,10116.0,N,,,14906,CHEMBL875341,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11757,1,9606.0,N,,,14215,CHEMBL626235,,The maximum plasma concentration (100 mg/kg) administered orally in human,Plasma,A,50587,1,,1969.0,Homo sapiens
,In vivo,,,Autocuration,BAO_0000218,11758,0,9481.0,U,,,14215,CHEMBL626236,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Plasma,A,22224,1,,1969.0,Callithrix
,In vivo,,,Autocuration,BAO_0000218,11759,0,314293.0,U,,,14215,CHEMBL626237,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Plasma,A,22224,1,,1969.0,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,11760,1,9615.0,N,,,14215,CHEMBL626238,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11761,1,9606.0,N,,,14215,CHEMBL622412,,The maximum plasma concentration (200 mg/kg) administered orally in human,Plasma,A,50587,1,,1969.0,Homo sapiens
,In vivo,,,Intermediate,BAO_0000218,11762,1,10116.0,N,,,14215,CHEMBL623114,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11763,0,9481.0,U,,,14215,CHEMBL623115,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Plasma,A,22224,1,,1969.0,Callithrix
,In vivo,,,Autocuration,BAO_0000218,11764,0,314293.0,U,,,14215,CHEMBL623116,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Plasma,A,22224,1,,1969.0,Simiiformes
,In vivo,,,Autocuration,BAO_0000218,11765,0,9615.0,U,,,14215,CHEMBL623117,,The maximum plasma concentration (30 mg/kg) administered orally in dog,Plasma,A,22224,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11766,1,9606.0,N,,,14215,CHEMBL623118,,The maximum plasma concentration (400 mg/kg) administered orally in human,Plasma,A,50587,1,,1969.0,Homo sapiens
,In vivo,,,Intermediate,BAO_0000218,11767,1,10116.0,N,,,14215,CHEMBL623119,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11768,1,10116.0,N,,,14215,CHEMBL623120,,The maximum plasma concentration (50 mg/kg) administered orally in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11769,1,9606.0,N,,,14215,CHEMBL623286,,The maximum plasma concentration (800 mg/kg) administered orally in human,Plasma,A,50587,1,,1969.0,Homo sapiens
,In vivo,,,Intermediate,BAO_0000218,11770,1,10116.0,N,,,14067,CHEMBL623287,,The maximum plasma concentration was measured on rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11771,1,10116.0,N,,,12350,CHEMBL623288,,The maximum plasma concentration was measured on rats after oral administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11772,1,10116.0,N,,,14813,CHEMBL623289,,Plasma drug Cmax in rat (PO dose),Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,11773,0,,U,,,12536,CHEMBL623290,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,11774,1,9615.0,N,,,14169,CHEMBL623291,,maximum Plasma concentration in Dog was determined after Peroral administration,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,11775,1,10116.0,N,,,14169,CHEMBL623292,,maximum Plasma concentration in Rats was determined after Peroral administration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11776,1,9615.0,N,,,15604,CHEMBL623293,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,11777,0,314293.0,U,,,15604,CHEMBL623294,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Plasma,A,22224,1,,1969.0,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,11778,1,10116.0,N,,,15604,CHEMBL623295,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11779,1,10090.0,N,,,14387,CHEMBL623296,,maximum concentration was measured when administered through oral route in mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11780,1,10090.0,N,,,15115,CHEMBL875349,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000019,11781,0,314293.0,U,,,15115,CHEMBL623297,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,A,22224,1,,,Simiiformes
,,,,Autocuration,BAO_0000019,11782,0,314293.0,U,,,15115,CHEMBL623298,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,A,22224,1,,,Simiiformes
,,,,Autocuration,BAO_0000019,11783,0,314293.0,U,,,15115,CHEMBL623299,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,11784,1,10116.0,N,,,16359,CHEMBL623300,,Pharmacokinetic parameter was evaluated in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11785,1,10090.0,N,,,12829,CHEMBL623301,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11786,1,10090.0,N,,,12829,CHEMBL623302,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11787,1,10090.0,N,,,12829,CHEMBL623303,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11788,1,10090.0,N,,,12829,CHEMBL623304,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11789,1,10090.0,N,,,12829,CHEMBL623305,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11790,1,10116.0,N,,,15137,CHEMBL623306,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11791,1,10116.0,N,,,15137,CHEMBL623307,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11792,1,10116.0,N,,,15137,CHEMBL623308,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11793,1,10090.0,N,,,15137,CHEMBL623309,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Plasma,A,50594,1,,1969.0,Mus musculus
,,,,Intermediate,BAO_0000218,11794,1,10090.0,N,,,13509,CHEMBL623310,,Plasma Concentration after 120 min of oral administration to mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11795,1,10090.0,N,,,13509,CHEMBL623311,,Plasma Concentration after 30 min of oral administration to mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11796,1,9541.0,N,,,13509,CHEMBL623312,,Plasma Concentration after 60 min of oral administration to mice,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,11797,1,10090.0,N,,,13509,CHEMBL875350,,Plasma Concentration after 60 min of oral administration to mice; Not determined,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11798,1,10090.0,N,,,13509,CHEMBL628635,,Plasma Concentration after 90 min of oral administration to mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11799,1,10116.0,N,,,12064,CHEMBL628636,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11800,1,10116.0,N,,,12064,CHEMBL628637,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11801,1,10116.0,N,,,12064,CHEMBL628058,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11802,1,10116.0,N,,,10677,CHEMBL628059,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11803,1,10116.0,N,,,10677,CHEMBL628060,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,11804,0,,U,,,8926,CHEMBL628061,,Distribution in the lung after 15 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11805,0,,U,,,8926,CHEMBL628062,,Distribution in the lung after 30 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11806,0,,U,,,8926,CHEMBL628063,,Distribution in the lung after 5 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11807,0,,U,,,8926,CHEMBL628064,,Distribution in the lung after 60 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11808,0,,U,,,8926,CHEMBL628065,,Distribution in the lung after 90 min of intravenous administration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11809,0,,U,,,8926,CHEMBL628066,,Distribution in the muscle after 120 min of intravenous administration,Muscle tissue,A,22224,1,,2385.0,
,,,,Autocuration,BAO_0000019,11810,0,,U,,,8926,CHEMBL628067,,Distribution in the muscle after 15 min of intravenous administration,Muscle tissue,A,22224,1,,2385.0,
,,,,Intermediate,BAO_0000218,11811,1,10090.0,N,,,8926,CHEMBL874646,,Distribution in the muscle after 30 min of intravenous administration,Muscle tissue,A,50594,1,,2385.0,Mus musculus
,,,,Autocuration,BAO_0000019,11812,0,,U,,,8926,CHEMBL628068,,Distribution in the muscle after 5 min of intravenous administration,Muscle tissue,A,22224,1,,2385.0,
,,,,Autocuration,BAO_0000019,11813,0,,U,,,8926,CHEMBL628069,,Distribution in the muscle after 60 min of intravenous administration,Muscle tissue,A,22224,1,,2385.0,
,,,,Autocuration,BAO_0000019,11814,0,,U,,,8926,CHEMBL628070,,Distribution in the muscle after 90 min of intravenous administration,Muscle tissue,A,22224,1,,2385.0,
,,,,Autocuration,BAO_0000019,11815,0,,U,,,8926,CHEMBL628071,,Distribution in the spleen after 120 min of intravenous administration,Spleen,A,22224,1,,2106.0,
,,,,Autocuration,BAO_0000019,11816,0,,U,,,8926,CHEMBL628072,,Distribution in the spleen after 15 min of intravenous administration,Spleen,A,22224,1,,2106.0,
,,,,Autocuration,BAO_0000019,11817,0,,U,,,8926,CHEMBL628073,,Distribution in the spleen after 30 min of intravenous administration,Spleen,A,22224,1,,2106.0,
,,,,Autocuration,BAO_0000019,11818,0,,U,,,8926,CHEMBL628074,,Distribution in the spleen after 5 min of intravenous administration,Spleen,A,22224,1,,2106.0,
,,,,Autocuration,BAO_0000019,11819,0,,U,,,8926,CHEMBL628075,,Distribution in the spleen after 60 min of intravenous administration,Spleen,A,22224,1,,2106.0,
,,,,Autocuration,BAO_0000019,11820,0,,U,,,8926,CHEMBL628076,,Distribution in the spleen after 90 min of intravenous administration,Spleen,A,22224,1,,2106.0,
,,,,Intermediate,BAO_0000218,11821,1,10116.0,N,,,7570,CHEMBL628077,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Adrenal cortex,A,50597,1,,1235.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11822,1,10116.0,N,,,7570,CHEMBL628078,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11823,1,10116.0,N,,,7570,CHEMBL628079,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11824,1,10116.0,N,,,7570,CHEMBL628080,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Female gonad,A,50597,1,,992.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11825,1,10116.0,N,,,7570,CHEMBL628081,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11826,1,10116.0,N,,,7570,CHEMBL628082,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Adrenal cortex,A,50597,1,,1235.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11827,1,10116.0,N,,,7570,CHEMBL874647,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11828,1,10116.0,N,,,7570,CHEMBL626406,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11829,1,10116.0,N,,,7570,CHEMBL626407,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Female gonad,A,50597,1,,992.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11830,1,10116.0,N,,,7570,CHEMBL626408,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11831,1,10116.0,N,,,8608,CHEMBL626409,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11832,1,10116.0,N,,,8608,CHEMBL626410,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11833,1,10116.0,N,,,8608,CHEMBL626411,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11834,1,10116.0,N,,,8608,CHEMBL626412,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11835,1,10116.0,N,,,8608,CHEMBL626413,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11836,1,10116.0,N,,,8608,CHEMBL626414,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11837,1,10116.0,N,,,8608,CHEMBL626415,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11838,1,10116.0,N,,,8608,CHEMBL626416,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11839,1,10116.0,N,,,8608,CHEMBL627062,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11840,1,10116.0,N,,,8608,CHEMBL627063,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11841,1,10116.0,N,,,8608,CHEMBL627064,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11842,1,10116.0,N,,,8608,CHEMBL627227,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11843,1,10116.0,N,,,8608,CHEMBL627228,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11844,1,10116.0,N,,,8608,CHEMBL627229,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11845,1,10116.0,N,,,8608,CHEMBL625792,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11846,1,10116.0,N,,,8608,CHEMBL625793,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11847,1,10116.0,N,,,8608,CHEMBL625794,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11848,1,10116.0,N,,,8608,CHEMBL625795,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11849,1,10090.0,N,,,13792,CHEMBL625796,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11850,1,9615.0,N,,,13376,CHEMBL625797,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,11851,1,9615.0,N,,,13376,CHEMBL625798,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,11852,0,,U,,,14380,CHEMBL875613,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,11853,0,,U,,,14380,CHEMBL625799,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,11854,0,,U,,,14380,CHEMBL625800,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,11855,0,,U,,,14380,CHEMBL625801,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,11856,0,,U,,,14380,CHEMBL625802,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,11857,0,,U,,,14380,CHEMBL625803,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,11858,0,,U,,,14380,CHEMBL625804,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,11859,0,,U,,,14380,CHEMBL622530,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,11860,1,10090.0,N,,,13701,CHEMBL622531,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11861,1,10090.0,N,,,13701,CHEMBL622532,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11862,1,10090.0,N,,,13701,CHEMBL623176,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11863,1,10090.0,N,,,13701,CHEMBL623177,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11864,1,10090.0,N,,,13701,CHEMBL623178,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11865,1,10090.0,N,,,13701,CHEMBL623179,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11866,1,10090.0,N,,,13701,CHEMBL623180,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11867,1,10090.0,N,,,13701,CHEMBL623181,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11868,1,10090.0,N,,,13701,CHEMBL624131,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11869,1,10090.0,N,,,13701,CHEMBL624132,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11870,1,10090.0,N,,,13701,CHEMBL624133,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11871,1,10090.0,N,,,13701,CHEMBL624846,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11872,1,10090.0,N,,,13701,CHEMBL624847,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11873,1,10090.0,N,,,13701,CHEMBL624848,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11874,1,10090.0,N,,,13701,CHEMBL625012,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11875,1,10090.0,N,,,13701,CHEMBL625013,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11876,1,10090.0,N,,,13701,CHEMBL625014,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11877,1,10090.0,N,,,13701,CHEMBL625015,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11878,1,10090.0,N,,,13701,CHEMBL625016,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11879,1,10090.0,N,,,13701,CHEMBL625017,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11880,1,10090.0,N,,,13701,CHEMBL625018,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11881,1,10090.0,N,,,13701,CHEMBL625019,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11882,1,10090.0,N,,,13701,CHEMBL625020,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11883,1,10090.0,N,,,13701,CHEMBL625021,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11884,1,10116.0,N,,,14393,CHEMBL625022,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11885,1,10090.0,N,,,14731,CHEMBL625023,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11886,1,9541.0,N,,,14731,CHEMBL625024,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,11887,1,9541.0,N,,,14731,CHEMBL627626,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,A,100710,1,,,Macaca fascicularis
,,,,Autocuration,BAO_0000218,11888,0,,U,,,13758,CHEMBL627627,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Brain,A,22224,1,,955.0,
,,,,Autocuration,BAO_0000218,11889,0,,U,,,13758,CHEMBL627628,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,Serum,A,22224,1,,1977.0,
,,,,Autocuration,BAO_0000218,11890,0,,U,,,13758,CHEMBL627629,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Brain,A,22224,1,,955.0,
,,,,Autocuration,BAO_0000218,11891,0,,U,,,13758,CHEMBL627630,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,Serum,A,22224,1,,1977.0,
,,,,Autocuration,BAO_0000019,11892,0,,U,,,16359,CHEMBL627631,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,A,22224,1,,,
,,,,Autocuration,BAO_0000218,11893,0,,U,,,16359,CHEMBL629515,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,A,22224,1,,,
,,,,Intermediate,BAO_0000218,11894,1,10090.0,N,,,15383,CHEMBL629516,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Spleen,A,50594,1,,2106.0,Mus musculus
,,,,Intermediate,BAO_0000218,11895,1,10090.0,N,,,15383,CHEMBL629517,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Spleen,A,50594,1,,2106.0,Mus musculus
,,,,Intermediate,BAO_0000218,11896,1,10090.0,N,,,15383,CHEMBL629518,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Spleen,A,50594,1,,2106.0,Mus musculus
,,,,Intermediate,BAO_0000218,11897,1,10090.0,N,,,15383,CHEMBL877499,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11898,1,10090.0,N,,,15383,CHEMBL629519,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11899,1,10090.0,N,,,15383,CHEMBL629520,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11900,1,10090.0,N,,,15383,CHEMBL629521,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11901,1,10090.0,N,,,14439,CHEMBL629522,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11902,1,10090.0,N,,,14439,CHEMBL629523,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11903,1,10090.0,N,,,14439,CHEMBL629524,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11904,1,10090.0,N,,,14439,CHEMBL629525,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11905,1,10090.0,N,,,14439,CHEMBL629526,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11906,1,10090.0,N,,,14439,CHEMBL629527,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11907,1,10090.0,N,,,14439,CHEMBL629528,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11908,1,10090.0,N,,,14439,CHEMBL629529,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11909,1,10090.0,N,,,14439,CHEMBL629530,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11910,1,10090.0,N,,,14439,CHEMBL629531,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11911,1,10090.0,N,,,14439,CHEMBL628656,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,11912,1,10090.0,N,,,14439,CHEMBL628657,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,11913,1,10116.0,N,,,13751,CHEMBL628658,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11914,1,10116.0,N,,,13751,CHEMBL628659,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11915,1,10116.0,N,,,13751,CHEMBL877500,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11916,1,10116.0,N,,,13751,CHEMBL628660,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11917,1,10116.0,N,,,13751,CHEMBL628661,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11918,1,10116.0,N,,,13751,CHEMBL628662,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11919,1,10116.0,N,,,13751,CHEMBL628663,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11920,1,10116.0,N,,,13751,CHEMBL628664,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11921,1,10116.0,N,,,13751,CHEMBL628665,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11922,1,10116.0,N,,,13751,CHEMBL628666,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11923,1,10116.0,N,,,13751,CHEMBL628667,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11924,1,10116.0,N,,,13751,CHEMBL628668,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11925,1,10116.0,N,,,13751,CHEMBL628669,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11926,1,10116.0,N,,,13751,CHEMBL628670,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11927,1,10116.0,N,,,13751,CHEMBL628671,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11928,1,10116.0,N,,,13751,CHEMBL628672,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11929,1,10116.0,N,,,13751,CHEMBL630300,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11930,1,10116.0,N,,,13751,CHEMBL629787,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11931,1,10116.0,N,,,13751,CHEMBL629788,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11932,1,10116.0,N,,,13751,CHEMBL629789,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11933,1,10116.0,N,,,13751,CHEMBL629790,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11934,1,10116.0,N,,,13751,CHEMBL629791,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11935,1,10116.0,N,,,13751,CHEMBL629792,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11936,1,10116.0,N,,,13751,CHEMBL629793,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11937,1,10116.0,N,,,13751,CHEMBL629794,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11938,1,10116.0,N,,,10677,CHEMBL874459,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11939,1,10116.0,N,,,10677,CHEMBL629795,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11940,1,10116.0,N,,,10677,CHEMBL629796,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11941,1,10116.0,N,,,10677,CHEMBL629797,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11942,1,10116.0,N,,,10677,CHEMBL629798,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11943,1,10116.0,N,,,10911,CHEMBL629799,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Adrenal gland,A,50597,1,,2369.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11944,1,10116.0,N,,,10911,CHEMBL629800,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Adrenal gland,A,50597,1,,2369.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11945,1,10116.0,N,,,10911,CHEMBL629801,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Adrenal gland,A,50597,1,,2369.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11946,1,10116.0,N,,,10911,CHEMBL629802,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Adrenal gland,A,50597,1,,2369.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11947,1,10116.0,N,,,10911,CHEMBL629803,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Adrenal gland,A,50597,1,,2369.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11948,1,10116.0,N,,,10911,CHEMBL629804,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11949,1,10116.0,N,,,10911,CHEMBL629805,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11950,1,10116.0,N,,,10911,CHEMBL629806,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11951,1,10116.0,N,,,10911,CHEMBL629807,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11952,1,10116.0,N,,,10911,CHEMBL629808,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11953,1,10116.0,N,,,10911,CHEMBL629809,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11954,1,10116.0,N,,,10911,CHEMBL629810,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11955,1,10116.0,N,,,10911,CHEMBL629811,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11956,1,10116.0,N,,,10911,CHEMBL629812,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11957,1,10116.0,N,,,10911,CHEMBL629813,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11958,1,10116.0,N,,,10911,CHEMBL874460,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11959,1,10116.0,N,,,10911,CHEMBL629814,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11960,1,10116.0,N,,,10911,CHEMBL629815,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11961,1,10116.0,N,,,10911,CHEMBL629816,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11962,1,10116.0,N,,,10911,CHEMBL629817,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11963,1,10116.0,N,,,10911,CHEMBL626643,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11964,1,10116.0,N,,,10911,CHEMBL626644,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11965,1,10116.0,N,,,10911,CHEMBL626806,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11966,1,10116.0,N,,,10911,CHEMBL626807,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11967,1,10116.0,N,,,10911,CHEMBL627261,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11968,1,10116.0,N,,,10911,CHEMBL627262,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11969,1,10116.0,N,,,10911,CHEMBL627263,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11970,1,10116.0,N,,,10911,CHEMBL627264,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11971,1,10116.0,N,,,10911,CHEMBL627265,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11972,1,10116.0,N,,,10911,CHEMBL627266,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11973,1,10116.0,N,,,10911,CHEMBL627267,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11974,1,10116.0,N,,,10911,CHEMBL627268,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11975,1,10116.0,N,,,10911,CHEMBL627269,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,11976,1,10116.0,N,,,10911,CHEMBL627270,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11977,1,10116.0,N,,,8608,CHEMBL627271,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11978,1,10116.0,N,,,8608,CHEMBL627946,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11979,1,10116.0,N,,,8608,CHEMBL875472,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11980,1,10116.0,N,,,8608,CHEMBL627947,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11981,1,10116.0,N,,,8608,CHEMBL627948,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11982,1,10116.0,N,,,8608,CHEMBL628113,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11983,1,10116.0,N,,,8608,CHEMBL628114,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11984,1,10116.0,N,,,8608,CHEMBL628115,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11985,1,10116.0,N,,,8608,CHEMBL628116,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11986,1,10116.0,N,,,8608,CHEMBL628117,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11987,1,10116.0,N,,,8608,CHEMBL628118,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11988,1,10116.0,N,,,8608,CHEMBL628119,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11989,1,10116.0,N,,,8608,CHEMBL628120,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11990,1,10116.0,N,,,8608,CHEMBL628121,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11991,1,10116.0,N,,,8608,CHEMBL628122,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11992,1,10116.0,N,,,8608,CHEMBL627297,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11993,1,10116.0,N,,,8608,CHEMBL627298,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11994,1,10116.0,N,,,8608,CHEMBL627299,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11995,1,10116.0,N,,,8608,CHEMBL627300,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11996,1,10116.0,N,,,8608,CHEMBL627301,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11997,1,10116.0,N,,,8608,CHEMBL627302,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11998,1,10116.0,N,,,8608,CHEMBL627303,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,11999,1,10116.0,N,,,8608,CHEMBL627304,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12000,1,10116.0,N,,,8608,CHEMBL627305,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12001,1,10116.0,N,,,8608,CHEMBL627306,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12002,1,10116.0,N,,,8608,CHEMBL623982,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12003,1,10116.0,N,,,8608,CHEMBL623983,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12004,1,10116.0,N,,,8608,CHEMBL623984,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12005,1,10116.0,N,,,8608,CHEMBL623985,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12006,1,10116.0,N,,,8608,CHEMBL623986,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12007,1,10116.0,N,,,8608,CHEMBL623987,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12008,1,10116.0,N,,,8608,CHEMBL623988,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12009,1,10116.0,N,,,8608,CHEMBL623989,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12010,1,10116.0,N,,,8608,CHEMBL622215,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12011,1,10116.0,N,,,8608,CHEMBL622216,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12012,1,10116.0,N,,,8608,CHEMBL877481,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,12013,0,,U,,,16359,CHEMBL622217,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12014,1,10090.0,N,,,13701,CHEMBL622218,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12015,1,10116.0,N,,,14554,CHEMBL622219,,Pharmacokinetic profile AUC was evaluated in rats,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12016,0,,U,,,6241,CHEMBL622220,,Pharmacokinetic property (Area under curve),,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12017,1,9615.0,N,,,11537,CHEMBL622221,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12018,1,10090.0,N,,,11537,CHEMBL622222,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12019,1,9615.0,N,,,11537,CHEMBL622223,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12020,1,10090.0,N,,,11537,CHEMBL622224,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000019,12021,0,,U,,,13118,CHEMBL622225,,Plasma concentration (AUC) was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12022,0,,U,,,13118,CHEMBL622226,,Plasma concentration (AUC) was determined; Not detectable,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12023,1,10141.0,N,,,9562,CHEMBL624154,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,A,50512,1,,,Cavia porcellus
,,,,Intermediate,BAO_0000218,12024,1,10116.0,N,,,10363,CHEMBL624155,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12025,1,10116.0,N,,,10363,CHEMBL624156,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12026,1,10116.0,N,,,10363,CHEMBL624157,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12027,1,10116.0,N,,,10363,CHEMBL624158,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12028,1,10116.0,N,,,12504,CHEMBL624159,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12029,1,10116.0,N,,,12504,CHEMBL624160,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12030,1,10116.0,N,,,12504,CHEMBL624161,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12031,1,10116.0,N,,,12504,CHEMBL624162,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12032,1,9615.0,N,,,13317,CHEMBL624163,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12033,1,10116.0,N,,,15078,CHEMBL624164,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12034,1,10116.0,N,,,14941,CHEMBL624165,,The AUC(0-infinity) values in female wistar rats.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12035,1,10116.0,N,,,15078,CHEMBL624166,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12036,1,10116.0,N,,,15078,CHEMBL624167,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12037,1,10116.0,N,,,14941,CHEMBL624168,,The AUC(0-t)values in female wistar rats.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12038,1,10116.0,N,,,14067,CHEMBL624169,,The Area under the concentration time curve of compound was measured on rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12039,1,9606.0,N,,,14215,CHEMBL624170,,The area under curve (100 mg/kg) administered orally in humans,,A,50587,1,,,Homo sapiens
,,,,Autocuration,BAO_0000218,12040,0,9481.0,U,,,14215,CHEMBL624171,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,A,22224,1,,,Callithrix
,,,,Autocuration,BAO_0000218,12041,0,314293.0,U,,,14215,CHEMBL624172,,The area under curve (12.5 mg/kg) administered intravenously in monkey,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,12042,1,9615.0,N,,,14215,CHEMBL624173,,The area under curve (15 mg/kg) administered intravenously in dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12043,1,9606.0,N,,,14215,CHEMBL877488,,The area under curve (200 mg/kg) administered orally in humans,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,12044,1,10116.0,N,,,14215,CHEMBL624174,,The area under curve (25 mg/kg) administered intravenously in rat,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,12045,0,9481.0,U,,,14215,CHEMBL624175,,The area under curve (25 mg/kg) administered orally in marmoset,,A,22224,1,,,Callithrix
,,,,Autocuration,BAO_0000218,12046,0,314293.0,U,,,14215,CHEMBL624176,,The area under curve (25 mg/kg) administered orally in monkey,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,12047,1,9615.0,N,,,14215,CHEMBL624177,,The area under curve (30 mg/kg) administered orally in dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12048,1,9606.0,N,,,14215,CHEMBL624178,,The area under curve (400 mg/kg) administered orally in humans,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,12049,1,10116.0,N,,,14215,CHEMBL624179,,The area under curve (50 mg/kg) administered orally in fasted rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12050,1,10116.0,N,,,14215,CHEMBL627689,,The area under curve (50 mg/kg) administered orally in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12051,1,9606.0,N,,,14215,CHEMBL627690,,The area under curve (800 mg/kg) administered orally in humans,,A,50587,1,,,Homo sapiens
,,,,Autocuration,BAO_0000019,12052,0,,U,,,11324,CHEMBL627691,,The compound was evaluated for area under the curve,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12053,0,9481.0,U,,,11324,CHEMBL627692,,The compound was evaluated for area under the curve in marmosets,,A,22224,1,,,Callithrix
,,,,Autocuration,BAO_0000019,12054,0,9481.0,U,,,11324,CHEMBL627693,,The compound was evaluated for area under the curve in marmosets,,A,22224,1,,,Callithrix
,,,,Intermediate,BAO_0000218,12055,1,10116.0,N,,,13875,CHEMBL627694,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12056,1,10116.0,N,,,13875,CHEMBL627695,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,12057,0,,U,,,13875,CHEMBL627696,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12058,1,10116.0,N,,,13875,CHEMBL627697,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12059,1,10116.0,N,,,13875,CHEMBL627698,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12060,1,10116.0,N,,,13875,CHEMBL627699,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12061,1,10116.0,N,,,13807,CHEMBL627700,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12062,1,10116.0,N,,,14127,CHEMBL627701,,Total drug exposure is determined after oral dosing in rats.,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,12063,0,,U,,,15116,CHEMBL627702,,Total drug exposure (5 mg/kg) when administered intravenously,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12064,0,,U,,,15116,CHEMBL627703,,Total drug exposure (5 mg/kg) when administered orally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12065,0,314293.0,U,,,15604,CHEMBL626873,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,12066,1,10116.0,N,,,15604,CHEMBL629583,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12067,1,9615.0,N,,,15604,CHEMBL629584,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12068,1,9615.0,N,,,15604,CHEMBL629585,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12069,1,10116.0,N,,,13751,CHEMBL629586,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12070,1,10116.0,N,,,13751,CHEMBL629587,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12071,1,10116.0,N,,,13751,CHEMBL629588,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12072,1,10116.0,N,,,13751,CHEMBL629589,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12073,1,10116.0,N,,,13751,CHEMBL629590,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12074,1,10116.0,N,,,13751,CHEMBL629591,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12075,1,10116.0,N,,,13751,CHEMBL629592,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12076,1,10116.0,N,,,13751,CHEMBL629593,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12077,1,10116.0,N,,,13751,CHEMBL629594,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12078,1,10116.0,N,,,13751,CHEMBL629595,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12079,1,10116.0,N,,,13751,CHEMBL630290,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12080,1,10116.0,N,,,13751,CHEMBL627137,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12081,1,10116.0,N,,,13751,CHEMBL627138,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12082,1,10116.0,N,,,13751,CHEMBL627139,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12083,1,10116.0,N,,,13751,CHEMBL627140,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12084,1,10116.0,N,,,13751,CHEMBL627141,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12085,1,10116.0,N,,,13751,CHEMBL627142,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12086,1,10116.0,N,,,13751,CHEMBL627143,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12087,1,10116.0,N,,,13751,CHEMBL874449,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12088,1,10116.0,N,,,13751,CHEMBL627144,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12089,1,10116.0,N,,,13751,CHEMBL627145,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12090,1,10116.0,N,,,13751,CHEMBL627146,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12091,1,10116.0,N,,,13751,CHEMBL627147,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12092,1,10116.0,N,,,13751,CHEMBL627148,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12093,1,10116.0,N,,,13751,CHEMBL627149,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12094,1,10116.0,N,,,13751,CHEMBL632160,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12095,1,10116.0,N,,,13751,CHEMBL632161,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12096,1,10116.0,N,,,13751,CHEMBL632162,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12097,1,10116.0,N,,,13751,CHEMBL632163,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12098,1,10116.0,N,,,13751,CHEMBL874469,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12099,1,10116.0,N,,,13751,CHEMBL627182,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12100,1,10116.0,N,,,13751,CHEMBL627183,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12101,1,10116.0,N,,,13751,CHEMBL627184,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12102,1,10116.0,N,,,13751,CHEMBL627185,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12103,1,10116.0,N,,,13751,CHEMBL627186,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12104,1,10116.0,N,,,13751,CHEMBL627187,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12105,1,10116.0,N,,,13751,CHEMBL627188,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12106,1,10116.0,N,,,13751,CHEMBL627189,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12107,1,10116.0,N,,,13751,CHEMBL627190,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12108,1,10116.0,N,,,13751,CHEMBL627191,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12109,1,10116.0,N,,,13751,CHEMBL627192,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12110,1,10116.0,N,,,13751,CHEMBL627193,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12111,1,10116.0,N,,,10911,CHEMBL874590,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12112,1,10116.0,N,,,10911,CHEMBL627194,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12113,1,10116.0,N,,,10911,CHEMBL627195,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12114,1,10116.0,N,,,10911,CHEMBL627196,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Female gonad,A,50597,1,,992.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12115,1,10116.0,N,,,10911,CHEMBL627197,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Female gonad,A,50597,1,,992.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12116,1,10116.0,N,,,10911,CHEMBL627198,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Female gonad,A,50597,1,,992.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12117,1,10116.0,N,,,10911,CHEMBL627199,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Female gonad,A,50597,1,,992.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12118,1,10116.0,N,,,10911,CHEMBL627200,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Female gonad,A,50597,1,,992.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12119,1,10116.0,N,,,10911,CHEMBL627201,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12120,1,10116.0,N,,,10911,CHEMBL627202,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12121,1,10116.0,N,,,10911,CHEMBL627203,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12122,1,10116.0,N,,,10911,CHEMBL627204,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12123,1,10116.0,N,,,10911,CHEMBL627205,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12124,1,10116.0,N,,,10911,CHEMBL627206,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12125,1,10116.0,N,,,10911,CHEMBL627207,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12126,1,10116.0,N,,,10911,CHEMBL627208,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12127,1,10116.0,N,,,10911,CHEMBL627209,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12128,1,10116.0,N,,,10911,CHEMBL627210,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12129,1,10116.0,N,,,10911,CHEMBL627211,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12130,1,10116.0,N,,,10911,CHEMBL627212,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12131,1,10116.0,N,,,10911,CHEMBL627213,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Uterus,A,50597,1,,995.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12132,1,10116.0,N,,,10911,CHEMBL626599,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Uterus,A,50597,1,,995.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12133,1,10116.0,N,,,10911,CHEMBL626600,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Uterus,A,50597,1,,995.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12134,1,10116.0,N,,,10911,CHEMBL626601,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12135,0,,U,,,8081,CHEMBL627484,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12136,1,9541.0,N,,,17248,CHEMBL627485,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Plasma,A,100710,1,,1969.0,Macaca fascicularis
,,,,Intermediate,BAO_0000218,12137,1,9541.0,N,,,17248,CHEMBL628147,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Plasma,A,100710,1,,1969.0,Macaca fascicularis
,,,,Intermediate,BAO_0000218,12138,1,9541.0,N,,,17248,CHEMBL628148,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Plasma,A,100710,1,,1969.0,Macaca fascicularis
,,,,Intermediate,BAO_0000218,12139,1,9615.0,N,,,17248,CHEMBL628149,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12140,1,9615.0,N,,,17248,CHEMBL628150,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12141,1,9615.0,N,,,17248,CHEMBL628318,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12142,1,9615.0,N,,,17248,CHEMBL628319,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12143,1,9615.0,N,,,15592,CHEMBL875609,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000019,12144,0,,U,,,7040,CHEMBL628320,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12145,0,,U,,,7040,CHEMBL628321,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12146,0,,U,,,7040,CHEMBL628322,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12147,0,,U,,,7040,CHEMBL628323,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12148,0,,U,,,7040,CHEMBL628324,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12149,0,,U,,,7040,CHEMBL628325,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12150,0,,U,,,7040,CHEMBL628326,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12151,1,9615.0,N,,,9614,CHEMBL628327,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Adrenal medulla,A,50588,1,,1236.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12152,1,9615.0,N,,,9614,CHEMBL628328,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Adrenal medulla,A,50588,1,,1236.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12153,1,9615.0,N,,,9614,CHEMBL628329,,"Concentration of compound in blood of dog 1, after administering intravenously",Blood,A,50588,1,,178.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12154,1,10116.0,N,,,8608,CHEMBL628330,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12155,1,10116.0,N,,,8608,CHEMBL628331,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12156,1,10116.0,N,,,8608,CHEMBL628332,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12157,1,10116.0,N,,,8608,CHEMBL628333,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12158,1,10116.0,N,,,8608,CHEMBL628334,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12159,1,10116.0,N,,,8608,CHEMBL628335,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12160,1,10116.0,N,,,8608,CHEMBL628336,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12161,1,10116.0,N,,,8608,CHEMBL628337,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12162,1,10116.0,N,,,8608,CHEMBL628338,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12163,1,10116.0,N,,,8608,CHEMBL875610,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12164,1,10116.0,N,,,8608,CHEMBL628339,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12165,1,10116.0,N,,,8608,CHEMBL628340,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12166,1,10116.0,N,,,8608,CHEMBL628341,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12167,1,10116.0,N,,,8608,CHEMBL622214,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12168,1,10116.0,N,,,8608,CHEMBL623167,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12169,1,10116.0,N,,,8608,CHEMBL623168,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12170,1,10116.0,N,,,8608,CHEMBL623169,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12171,1,10116.0,N,,,8608,CHEMBL623170,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12172,1,10116.0,N,,,8608,CHEMBL627224,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12173,1,10116.0,N,,,8608,CHEMBL875634,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12174,1,10116.0,N,,,8608,CHEMBL627225,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12175,1,10116.0,N,,,8608,CHEMBL627226,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12176,1,10116.0,N,,,8608,CHEMBL626083,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12177,1,10116.0,N,,,8608,CHEMBL626084,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12178,1,10116.0,N,,,8608,CHEMBL626085,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12179,1,10116.0,N,,,8608,CHEMBL626086,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12180,1,10116.0,N,,,8608,CHEMBL626087,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12181,1,10116.0,N,,,8608,CHEMBL626088,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12182,1,10116.0,N,,,8608,CHEMBL626089,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12183,1,10116.0,N,,,8608,CHEMBL626090,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12184,1,10116.0,N,,,8608,CHEMBL626091,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12185,1,10116.0,N,,,8608,CHEMBL626092,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12186,1,10116.0,N,,,8608,CHEMBL626093,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12187,1,10116.0,N,,,8608,CHEMBL626094,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12188,1,10116.0,N,,,8608,CHEMBL626095,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12189,1,10116.0,N,,,8608,CHEMBL626096,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Autocuration,BAO_0000218,12190,0,314293.0,U,,,15604,CHEMBL626097,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,12191,1,10116.0,N,,,15604,CHEMBL626098,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,12192,0,,U,,,1806,CHEMBL626099,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,Plasma,A,22224,1,,1969.0,
,,,,Autocuration,BAO_0000218,12193,0,,U,,,1806,CHEMBL626100,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,Plasma,A,22224,1,,1969.0,
,,,,Intermediate,BAO_0000218,12194,1,9615.0,N,,,17237,CHEMBL626101,,AUC 0-inf in dog,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12195,1,10141.0,N,,,17237,CHEMBL626102,,AUC 0-inf in guinea pig,Plasma,A,50512,1,,1969.0,Cavia porcellus
,,,,Intermediate,BAO_0000218,12196,1,9615.0,N,,,17237,CHEMBL626103,,AUC 0-t in dog,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12197,1,10141.0,N,,,17237,CHEMBL628391,,AUC 0-t in guinea pig,Plasma,A,50512,1,,1969.0,Cavia porcellus
,,,,Intermediate,BAO_0000218,12198,1,10116.0,N,,,15194,CHEMBL628392,,The compound was tested for brain to plasma partition in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12199,1,10116.0,N,,,15194,CHEMBL628393,,The compound was tested for brain to plasma partition in rat.,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12200,0,,U,,,8787,CHEMBL628394,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,Blood,A,22224,1,,178.0,
,,,,Intermediate,BAO_0000218,12201,1,9615.0,N,,,17025,CHEMBL628395,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,12202,0,314293.0,U,,,17025,CHEMBL628396,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,12203,1,9986.0,N,,,17025,CHEMBL628397,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12204,1,10116.0,N,,,17025,CHEMBL628398,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12205,1,9544.0,N,,,4236,CHEMBL628399,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,A,50797,1,,,Macaca mulatta
,,,,Intermediate,BAO_0000218,12206,1,9615.0,N,,,15343,CHEMBL628400,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12207,1,10116.0,N,,,15343,CHEMBL874907,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12208,0,,U,,,17720,CHEMBL628401,,Area under curve of the compound was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12209,0,314293.0,U,,,17788,CHEMBL628402,,AUC in monkeys at a dose of 1 mg/kg,Plasma,A,22224,1,,1969.0,Simiiformes
,,,,Intermediate,BAO_0000218,12210,1,10116.0,N,,,17788,CHEMBL628403,,AUC in rats at a dose of 1 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12211,0,,U,,,8778,CHEMBL628404,,Compound was evaluated for the overall absorbance loss at pH of 2,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12212,0,,U,,,8778,CHEMBL628405,,Compound was evaluated for the overall absorbance loss at pH of 4,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12213,0,,U,,,8778,CHEMBL628406,,Compound was evaluated for the overall absorbance loss at pH of 7,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12214,1,10116.0,N,,,2249,CHEMBL628407,,Compound was evaluated for its absorption in the rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12215,1,10116.0,N,,,8881,CHEMBL628408,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12216,1,10116.0,N,,,8881,CHEMBL629171,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12217,1,10116.0,N,,,8881,CHEMBL629172,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12218,1,10116.0,N,,,8881,CHEMBL629173,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12219,1,10116.0,N,,,15286,CHEMBL629174,,In vitro percent permeability into rat ileum,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12220,1,10116.0,N,,,15286,CHEMBL629175,,In vitro percent permeability into rat ileum; Range is 10-17,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12221,1,10116.0,N,,,15286,CHEMBL629176,,In vitro percent permeability into rat ileum; Range is 10-18,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12222,1,10116.0,N,,,15286,CHEMBL629177,,In vitro percent permeability into rat ileum; Range is 10-19,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12223,1,10116.0,N,,,15286,CHEMBL629178,,In vitro percent permeability into rat ileum; Range is 12-15,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12224,1,10116.0,N,,,15286,CHEMBL631869,,In vitro percent permeability into rat ileum; Range is 13-19,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12225,1,10116.0,N,,,15286,CHEMBL631870,,In vitro percent permeability into rat ileum; Range is 14-17,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12226,1,10116.0,N,,,15286,CHEMBL631871,,In vitro percent permeability into rat ileum; Range is 15-18,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12227,1,10116.0,N,,,15286,CHEMBL631872,,In vitro percent permeability into rat ileum; Range is 2-5,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000221,12228,0,,U,,,15286,CHEMBL875775,,In vitro percent permeability into rat ileum; Range is 23-42,Ileum,A,22224,1,,2116.0,
,,,,Intermediate,BAO_0000218,12229,1,10116.0,N,,,15286,CHEMBL631873,,In vitro percent permeability into rat ileum; Range is 28-36,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12230,1,10116.0,N,,,15286,CHEMBL631874,,In vitro percent permeability into rat ileum; Range is 29-35,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12231,1,10116.0,N,,,15286,CHEMBL631875,,In vitro percent permeability into rat ileum; Range is 46-66,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12232,1,10116.0,N,,,15286,CHEMBL631876,,In vitro percent permeability into rat ileum; Range is 50-68,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12233,1,10116.0,N,,,15286,CHEMBL631877,,In vitro percent permeability into rat ileum; Range is 78-81,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12234,1,10116.0,N,,,15286,CHEMBL631878,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12235,1,10116.0,N,,,15286,CHEMBL631879,,In vitro percent permeability into rat ileum; nd indicates not detected,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12236,1,10116.0,N,,,15286,CHEMBL631880,,In vitro percent permeability into rat ileum; nt indicates not detected,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12237,1,10116.0,N,,,15286,CHEMBL631881,,In vitro percent permeability into rat ileum; nt indicates not tested,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12238,1,10116.0,N,,,13770,CHEMBL631882,,Compound was tested for oral absorption in bile-duct cannulated rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12239,1,10116.0,N,,,13770,CHEMBL630749,,Compound was tested for oral absorption in bile-duct cannulated rats.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12240,1,9606.0,N,,,5202,CHEMBL630750,,Oral absorption using Caco-2 cell monolayers.,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,12241,1,9606.0,N,,,14920,CHEMBL630253,,Percent of the drug absorbed after administration to humans was determined,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,12242,1,10116.0,N,,,14103,CHEMBL630254,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12243,1,10116.0,N,,,14103,CHEMBL630255,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12244,1,10116.0,N,,,14103,CHEMBL630256,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12245,1,10116.0,N,,,13751,CHEMBL875781,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12246,1,10116.0,N,,,13751,CHEMBL630257,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12247,1,10116.0,N,,,13751,CHEMBL630258,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12248,1,10116.0,N,,,15807,CHEMBL630259,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12249,1,10116.0,N,,,15807,CHEMBL630260,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Striatum,A,50597,1,,2435.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12250,1,10116.0,N,,,15807,CHEMBL630261,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Striatum,A,50597,1,,2435.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12251,1,10116.0,N,,,14950,CHEMBL630262,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12252,1,10116.0,N,,,14950,CHEMBL630263,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12253,1,10116.0,N,,,14950,CHEMBL630264,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12254,1,10116.0,N,,,14950,CHEMBL630265,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12255,1,10116.0,N,,,14950,CHEMBL630266,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12256,1,10116.0,N,,,14950,CHEMBL630267,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12257,1,10116.0,N,,,14950,CHEMBL630268,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12258,1,10116.0,N,,,14950,CHEMBL630269,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12259,1,10116.0,N,,,14950,CHEMBL630270,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12260,1,10116.0,N,,,14950,CHEMBL630141,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12261,1,10116.0,N,,,14950,CHEMBL630142,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12262,1,10116.0,N,,,14950,CHEMBL630143,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12263,1,10116.0,N,,,14950,CHEMBL630144,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12264,1,10116.0,N,,,14950,CHEMBL630145,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Prostate gland,A,50597,1,,2367.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12265,1,10116.0,N,,,14950,CHEMBL630146,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Prostate gland,A,50597,1,,2367.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12266,1,10116.0,N,,,14950,CHEMBL630147,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12267,1,10116.0,N,,,14950,CHEMBL630148,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12268,1,10116.0,N,,,14950,CHEMBL630149,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12269,1,10116.0,N,,,14950,CHEMBL630150,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12270,1,10116.0,N,,,14950,CHEMBL630151,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12271,1,10116.0,N,,,14950,CHEMBL632031,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12272,1,10116.0,N,,,14950,CHEMBL632032,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12273,1,10116.0,N,,,14950,CHEMBL632033,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12274,1,10116.0,N,,,14950,CHEMBL632034,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12275,1,10116.0,N,,,14950,CHEMBL632035,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12276,1,10116.0,N,,,14950,CHEMBL632036,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12277,1,10116.0,N,,,14950,CHEMBL632037,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12278,1,10116.0,N,,,8631,CHEMBL632038,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12279,1,10116.0,N,,,8631,CHEMBL632039,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12280,1,10116.0,N,,,8631,CHEMBL632040,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12281,1,10116.0,N,,,8631,CHEMBL632041,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12282,1,9615.0,N,,,9614,CHEMBL632042,,"Concentration of compound in blood of dog 2, after administering intravenously",Blood,A,50588,1,,178.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12283,1,9615.0,N,,,9614,CHEMBL632043,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12284,1,9615.0,N,,,9614,CHEMBL632044,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12285,1,9615.0,N,,,9614,CHEMBL632045,,"Concentration of compound in liver of dog 1, after administering intravenously",Liver,A,50588,1,,2107.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12286,1,9615.0,N,,,9614,CHEMBL632046,,"Concentration of compound in liver of dog 2, after administering intravenously",Liver,A,50588,1,,2107.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12287,1,9615.0,N,,,9614,CHEMBL632047,,"Concentration of compound in lung of dog 1, after administering intravenously",Lung,A,50588,1,,2048.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12288,1,9615.0,N,,,9614,CHEMBL632048,,"Concentration of compound in lung of dog 2, after administering intravenously",Lung,A,50588,1,,2048.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12289,1,9615.0,N,,,9614,CHEMBL632049,,"Concentration of compound in muscle of dog 1, after administering intravenously",Muscle tissue,A,50588,1,,2385.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12290,1,9615.0,N,,,9614,CHEMBL876418,,"Concentration of compound in muscle of dog 2, after administering intravenously",Muscle tissue,A,50588,1,,2385.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12291,1,9615.0,N,,,9614,CHEMBL632050,,"Concentration of compound in spleen of dog 1,after administering intravenously",Spleen,A,50588,1,,2106.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12292,1,9615.0,N,,,9614,CHEMBL632051,,"Concentration of compound in spleen of dog 2, after administering intravenously",Spleen,A,50588,1,,2106.0,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,12293,0,,U,,,10353,CHEMBL632052,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,F,22224,1,,,
,,,,Autocuration,BAO_0000218,12294,0,,U,,,10353,CHEMBL632053,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,F,22224,1,,,
,,,,Autocuration,BAO_0000218,12295,0,,U,,,10353,CHEMBL632054,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12296,0,,U,,,10353,CHEMBL632055,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,F,22224,1,,,
,,,,Autocuration,BAO_0000218,12297,0,,U,,,10353,CHEMBL631181,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,F,22224,1,,,
,,,,Autocuration,BAO_0000218,12298,0,,U,,,9196,CHEMBL631182,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12299,0,,U,,,9196,CHEMBL631183,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12300,0,,U,,,9196,CHEMBL631184,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12301,0,,U,,,9196,CHEMBL629774,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12302,0,,U,,,9196,CHEMBL629775,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12303,0,,U,,,9196,CHEMBL876549,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12304,0,,U,,,9196,CHEMBL628172,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12305,0,,U,,,9196,CHEMBL628173,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12306,0,,U,,,9196,CHEMBL628174,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12307,0,,U,,,9196,CHEMBL628175,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12308,0,,U,,,9196,CHEMBL628176,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12309,0,,U,,,9196,CHEMBL628177,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12310,0,,U,,,9196,CHEMBL628178,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12311,0,,U,,,9196,CHEMBL628179,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12312,0,,U,,,9196,CHEMBL628180,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12313,0,,U,,,9196,CHEMBL628181,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12314,0,,U,,,9196,CHEMBL628182,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12315,0,,U,,,9196,CHEMBL628183,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12316,0,,U,,,9196,CHEMBL628184,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12317,0,,U,,,9196,CHEMBL628185,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12318,0,,U,,,9196,CHEMBL875617,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12319,0,,U,,,9196,CHEMBL628186,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12320,0,,U,,,9196,CHEMBL628187,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12321,0,,U,,,9196,CHEMBL628188,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12322,0,,U,,,9196,CHEMBL628189,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12323,0,,U,,,9196,CHEMBL628190,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12324,0,,U,,,9196,CHEMBL628191,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12325,0,,U,,,9196,CHEMBL626513,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12326,1,10116.0,N,,,8608,CHEMBL626514,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12327,1,10116.0,N,,,8608,CHEMBL626515,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12328,1,10116.0,N,,,8608,CHEMBL626516,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12329,1,10116.0,N,,,8608,CHEMBL626517,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12330,1,10116.0,N,,,8608,CHEMBL626518,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12331,1,10116.0,N,,,8608,CHEMBL626519,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12332,1,10116.0,N,,,8608,CHEMBL626520,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12333,1,10116.0,N,,,8608,CHEMBL626521,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12334,1,10116.0,N,,,8608,CHEMBL626522,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12335,1,10116.0,N,,,8608,CHEMBL626523,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12336,1,10116.0,N,,,8608,CHEMBL626524,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12337,1,10116.0,N,,,8608,CHEMBL626688,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12338,1,10116.0,N,,,8608,CHEMBL626689,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12339,1,10116.0,N,,,8608,CHEMBL626690,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12340,1,10116.0,N,,,8608,CHEMBL626691,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12341,1,10116.0,N,,,8608,CHEMBL627319,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12342,1,10116.0,N,,,8608,CHEMBL624052,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12343,1,10116.0,N,,,8608,CHEMBL624053,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12344,1,10116.0,N,,,8085,CHEMBL624054,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12345,1,10116.0,N,,,8085,CHEMBL624055,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12346,1,10116.0,N,,,8085,CHEMBL624056,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12347,1,10116.0,N,,,8085,CHEMBL624057,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12348,1,10116.0,N,,,8085,CHEMBL622281,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12349,1,10116.0,N,,,8085,CHEMBL622282,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12350,1,10116.0,N,,,8085,CHEMBL622283,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12351,1,10116.0,N,,,8085,CHEMBL622284,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12352,1,10116.0,N,,,8085,CHEMBL622285,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12353,1,10116.0,N,,,8085,CHEMBL622286,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Autocuration,BAO_0000100,12354,0,,U,,,7657,CHEMBL622287,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,P,22224,1,,,
,,,,Intermediate,BAO_0000218,12355,1,10090.0,N,,,8935,CHEMBL622288,,Partition coefficient (logD7.4),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12356,1,10090.0,N,,,13792,CHEMBL622289,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12357,1,10090.0,N,,,13792,CHEMBL622290,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,12358,1,10090.0,N,,,13792,CHEMBL622291,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12359,1,10090.0,N,,,13792,CHEMBL622292,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,12360,1,10090.0,N,,,13792,CHEMBL622293,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12361,1,10090.0,N,,,13792,CHEMBL622294,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,12362,1,10090.0,N,,,13792,CHEMBL622295,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12363,1,10116.0,N,,,13792,CHEMBL622296,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12364,1,10116.0,N,,,14103,CHEMBL874409,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12365,1,10116.0,N,,,14103,CHEMBL622297,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12366,1,10116.0,N,,,14103,CHEMBL622298,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12367,1,10116.0,N,,,14103,CHEMBL622299,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12368,1,10116.0,N,,,14103,CHEMBL622300,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12369,1,10116.0,N,,,14103,CHEMBL622301,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12370,1,10116.0,N,,,14103,CHEMBL622302,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12371,1,10116.0,N,,,14103,CHEMBL622303,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12372,1,10116.0,N,,,14103,CHEMBL622304,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12373,1,10116.0,N,,,14103,CHEMBL622305,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12374,1,10116.0,N,,,14103,CHEMBL622306,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12375,1,10116.0,N,,,14103,CHEMBL626864,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12376,1,10116.0,N,,,14103,CHEMBL626865,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12377,1,10116.0,N,,,14103,CHEMBL626866,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12378,1,10116.0,N,,,14103,CHEMBL626867,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12379,1,10116.0,N,,,14103,CHEMBL626868,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12380,1,10116.0,N,,,14103,CHEMBL626869,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12381,1,10116.0,N,,,14103,CHEMBL626870,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12382,1,10116.0,N,,,14103,CHEMBL626871,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12383,1,10116.0,N,,,14103,CHEMBL626872,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12384,1,10116.0,N,,,14103,CHEMBL632185,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12385,1,10116.0,N,,,14103,CHEMBL632186,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12386,0,,U,,,12904,CHEMBL629310,,Amount of acetic acid produced by the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12387,0,,U,,,12904,CHEMBL629311,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12388,1,10116.0,N,,,9663,CHEMBL629312,,Log of (Cbrain/Cblood) in rats,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000221,12389,0,,U,,,7652,CHEMBL629313,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000221,12390,0,,U,,,7652,CHEMBL629314,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000221,12391,0,,U,,,7652,CHEMBL629315,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000219,12392,0,,U,,,7652,CHEMBL629316,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,B,22224,1,,,
,,,,Autocuration,BAO_0000221,12393,0,,U,,,7652,CHEMBL629317,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12394,0,,U,,,7652,CHEMBL629318,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12395,0,,U,,,7652,CHEMBL877497,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12396,0,,U,,,7652,CHEMBL629319,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12397,0,,U,,,7652,CHEMBL629320,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12398,0,,U,,,7652,CHEMBL629496,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12399,0,,U,,,7652,CHEMBL629497,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12400,0,,U,,,7652,CHEMBL629498,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12401,0,,U,,,7652,CHEMBL629499,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12402,0,,U,,,7652,CHEMBL629500,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12403,0,,U,,,7652,CHEMBL629501,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12404,0,,U,,,7652,CHEMBL629502,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,12405,0,,U,,,8267,CHEMBL629503,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,F,22224,1,,,
,,,,Intermediate,BAO_0000218,12406,1,9615.0,N,,,8267,CHEMBL629504,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000019,12407,0,,U,,,14479,CHEMBL629505,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12408,0,,U,,,17515,CHEMBL629506,,Compound was evaluated for total body clearance,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12409,0,,U,,,17515,CHEMBL629507,,Compound was evaluated for volume of distribution at steady state,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12410,0,,U,,,8142,CHEMBL877498,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12411,0,,U,,,14849,CHEMBL629508,,Percentage of the diamine which is monoprotonated at pH 7.4,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12412,0,,U,,,7653,CHEMBL629509,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12413,1,10116.0,N,,,8631,CHEMBL629510,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12414,1,10116.0,N,,,8631,CHEMBL629511,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12415,1,10116.0,N,,,8631,CHEMBL629512,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12416,1,10116.0,N,,,8631,CHEMBL629513,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12417,1,10116.0,N,,,8631,CHEMBL629514,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12418,1,10116.0,N,,,8631,CHEMBL628447,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12419,1,10116.0,N,,,8631,CHEMBL628448,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12420,1,10116.0,N,,,8631,CHEMBL628449,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12421,1,10116.0,N,,,8631,CHEMBL631119,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12422,1,10116.0,N,,,8631,CHEMBL631120,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12423,1,10116.0,N,,,8631,CHEMBL631121,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12424,1,10116.0,N,,,8631,CHEMBL874458,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12425,1,10116.0,N,,,8631,CHEMBL631122,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12426,1,10116.0,N,,,8631,CHEMBL631123,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12427,1,10116.0,N,,,8631,CHEMBL631124,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12428,1,10116.0,N,,,8631,CHEMBL631125,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12429,1,10116.0,N,,,8631,CHEMBL631290,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12430,1,10116.0,N,,,8631,CHEMBL631291,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12431,1,10116.0,N,,,8631,CHEMBL631292,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12432,1,10116.0,N,,,8631,CHEMBL631293,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12433,1,10116.0,N,,,8631,CHEMBL631294,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12434,1,10116.0,N,,,8631,CHEMBL631295,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12435,1,10116.0,N,,,8631,CHEMBL631296,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12436,1,10116.0,N,,,8631,CHEMBL631297,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Autocuration,BAO_0000218,12437,0,,U,,,10263,CHEMBL631298,,Maximum biodistribution (Bmax) was determined.,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12438,1,10090.0,N,,,12364,CHEMBL631299,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12439,1,10090.0,N,,,12364,CHEMBL631300,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12440,1,10090.0,N,,,12364,CHEMBL631301,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12441,1,10090.0,N,,,12364,CHEMBL630291,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000218,12442,0,,U,,,14793,CHEMBL630292,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12443,0,,U,,,14793,CHEMBL630293,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12444,0,,U,,,14793,CHEMBL630294,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12445,0,,U,,,14793,CHEMBL630295,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12446,0,,U,,,14793,CHEMBL630296,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12447,0,,U,,,14793,CHEMBL626782,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12448,0,,U,,,14793,CHEMBL626783,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12449,0,,U,,,14793,CHEMBL626784,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12450,0,,U,,,14793,CHEMBL626785,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12451,0,,U,,,14793,CHEMBL626786,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12452,0,,U,,,9196,CHEMBL626787,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12453,0,,U,,,9196,CHEMBL626788,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12454,0,,U,,,9196,CHEMBL625927,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12455,1,10116.0,N,,,8374,CHEMBL625928,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12456,1,10116.0,N,,,8374,CHEMBL625929,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12457,1,10116.0,N,,,8374,CHEMBL625930,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12458,1,10116.0,N,,,8374,CHEMBL625931,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12459,1,10116.0,N,,,8374,CHEMBL627230,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12460,1,10116.0,N,,,8374,CHEMBL627231,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12461,1,10116.0,N,,,8374,CHEMBL627232,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12462,1,10116.0,N,,,8374,CHEMBL627233,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12463,1,10116.0,N,,,8374,CHEMBL875470,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12464,1,10116.0,N,,,8374,CHEMBL627234,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12465,1,10116.0,N,,,8374,CHEMBL627235,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12466,1,10116.0,N,,,8374,CHEMBL627236,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12467,1,10116.0,N,,,8374,CHEMBL627237,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12468,1,10116.0,N,,,8374,CHEMBL627238,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12469,1,10116.0,N,,,8374,CHEMBL627239,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12470,1,10116.0,N,,,8374,CHEMBL627240,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12471,1,10116.0,N,,,8374,CHEMBL627241,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12472,1,10116.0,N,,,8374,CHEMBL627242,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12473,1,10116.0,N,,,8374,CHEMBL627243,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12474,1,10116.0,N,,,8374,CHEMBL627244,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12475,1,10116.0,N,,,8374,CHEMBL627245,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12476,1,10116.0,N,,,8374,CHEMBL627246,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12477,1,10116.0,N,,,8374,CHEMBL627247,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12478,1,10116.0,N,,,8374,CHEMBL627248,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12479,1,10116.0,N,,,8374,CHEMBL627249,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12480,1,10116.0,N,,,8374,CHEMBL625569,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12481,1,10116.0,N,,,8374,CHEMBL625570,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12482,1,10116.0,N,,,8374,CHEMBL625571,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12483,1,10116.0,N,,,8374,CHEMBL625572,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12484,1,10116.0,N,,,8374,CHEMBL625573,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12485,1,10116.0,N,,,8374,CHEMBL625574,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12486,1,10116.0,N,,,8374,CHEMBL626245,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12487,1,10116.0,N,,,8374,CHEMBL626246,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Autocuration,BAO_0000218,12488,0,,U,,,9196,CHEMBL626247,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12489,0,,U,,,9196,CHEMBL626248,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12490,0,,U,,,9196,CHEMBL626249,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12491,0,,U,,,9196,CHEMBL626420,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12492,0,,U,,,9196,CHEMBL626421,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12493,0,,U,,,9196,CHEMBL626422,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12494,0,,U,,,9196,CHEMBL626423,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12495,0,,U,,,9196,CHEMBL626424,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12496,1,9615.0,N,,,12023,CHEMBL626425,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12497,1,10116.0,N,,,12023,CHEMBL875476,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12498,1,9541.0,N,,,12023,CHEMBL626426,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,A,100710,1,,,Macaca fascicularis
,,,,Autocuration,BAO_0000100,12499,0,,U,,,10580,CHEMBL626427,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,12500,0,,U,,,10580,CHEMBL626428,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,P,22224,1,,,
,,,,Autocuration,BAO_0000019,12501,0,,U,,,16032,CHEMBL626429,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12502,0,,U,,,16032,CHEMBL625025,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,Urine,A,22224,1,,1088.0,
,,,,Intermediate,BAO_0000218,12503,1,10116.0,N,,,8594,CHEMBL625026,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12504,1,10116.0,N,,,8594,CHEMBL625027,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12505,1,10116.0,N,,,8594,CHEMBL874410,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12506,1,10116.0,N,,,8594,CHEMBL625028,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12507,1,10116.0,N,,,8594,CHEMBL625029,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12508,1,10116.0,N,,,8594,CHEMBL625030,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12509,1,10116.0,N,,,8594,CHEMBL625031,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12510,1,10116.0,N,,,8594,CHEMBL625032,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12511,1,10116.0,N,,,8594,CHEMBL625033,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12512,1,10116.0,N,,,8594,CHEMBL625034,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12513,1,10116.0,N,,,8594,CHEMBL624872,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12514,1,10116.0,N,,,8594,CHEMBL624873,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12515,1,10116.0,N,,,8594,CHEMBL624874,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12516,1,10116.0,N,,,8594,CHEMBL624875,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12517,1,10116.0,N,,,8594,CHEMBL624876,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12518,1,10116.0,N,,,8594,CHEMBL624877,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12519,1,10116.0,N,,,8594,CHEMBL624878,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12520,1,10116.0,N,,,8594,CHEMBL624879,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12521,1,10116.0,N,,,8594,CHEMBL624880,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12522,1,10116.0,N,,,8594,CHEMBL624881,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12523,1,10116.0,N,,,8594,CHEMBL624882,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12524,1,10116.0,N,,,8594,CHEMBL624883,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12525,1,10116.0,N,,,8594,CHEMBL624884,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12526,1,10116.0,N,,,8594,CHEMBL624885,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12527,1,10116.0,N,,,8594,CHEMBL624886,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12528,1,10116.0,N,,,8594,CHEMBL624887,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12529,1,10116.0,N,,,8594,CHEMBL624888,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12530,1,10116.0,N,,,8594,CHEMBL624889,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12531,1,10116.0,N,,,8594,CHEMBL624890,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12532,1,10116.0,N,,,8594,CHEMBL621964,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12533,1,10116.0,N,,,8594,CHEMBL621965,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12534,1,10116.0,N,,,8594,CHEMBL621966,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12535,1,10116.0,N,,,8594,CHEMBL621967,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12536,1,10116.0,N,,,8594,CHEMBL622164,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12537,0,,U,,,7653,CHEMBL623097,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12538,0,,U,,,7653,CHEMBL623098,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12539,0,,U,,,7653,CHEMBL623099,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12540,0,,U,,,7653,CHEMBL623100,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12541,1,10116.0,N,,,9104,CHEMBL628673,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12542,1,10116.0,N,,,9104,CHEMBL628674,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12543,1,10116.0,N,,,9104,CHEMBL628675,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12544,1,10116.0,N,,,9104,CHEMBL627644,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12545,1,10116.0,N,,,9104,CHEMBL627645,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12546,1,10116.0,N,,,9104,CHEMBL627646,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12547,1,10116.0,N,,,9104,CHEMBL627647,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12548,1,10116.0,N,,,9104,CHEMBL627648,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12549,1,10116.0,N,,,12902,CHEMBL627649,,Free level in rat plasma,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12550,0,,U,,,6614,CHEMBL628313,,Level reaching in blood plasma of rat or human was determined,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12551,1,10116.0,N,,,9663,CHEMBL628314,,Log (Cbrain/Cblood) in rats,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12552,0,,U,,,17658,CHEMBL628315,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12553,0,,U,,,17658,CHEMBL628316,,Mean percentage of compound transport through membrane; expressed as membrane transport,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12554,0,,U,,,14314,CHEMBL628317,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12555,0,,U,,,7385,CHEMBL628473,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12556,0,,U,,,7385,CHEMBL628474,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12557,0,,U,,,7385,CHEMBL628475,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12558,0,,U,,,1329,CHEMBL628476,,Net water uptake by a carrier mediated transport (%cm) mechanism,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12559,0,314293.0,U,,,12187,CHEMBL628477,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,12560,1,9669.0,N,,,12187,CHEMBL628478,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,A,50506,1,,,Mustela putorius furo
,,,,Intermediate,BAO_0000218,12561,1,9669.0,N,,,12187,CHEMBL628479,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,A,50506,1,,,Mustela putorius furo
,,,,Autocuration,BAO_0000218,12562,0,314293.0,U,,,12187,CHEMBL628480,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,A,22224,1,,,Simiiformes
,,,,Autocuration,BAO_0000218,12563,0,314293.0,U,,,12187,CHEMBL628481,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,12564,1,10116.0,N,,,12187,CHEMBL628482,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12565,1,10116.0,N,,,12187,CHEMBL628483,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12566,1,10116.0,N,,,9278,CHEMBL628484,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12567,1,10116.0,N,,,9278,CHEMBL628485,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12568,1,9541.0,N,,,9278,CHEMBL628486,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Plasma,A,100710,1,,1969.0,Macaca fascicularis
,,,,Intermediate,BAO_0000218,12569,1,9606.0,N,,,9278,CHEMBL628487,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Plasma,A,50587,1,,1969.0,Homo sapiens
,,,,Intermediate,BAO_0000218,12570,1,10116.0,N,,,9278,CHEMBL628488,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12571,1,10116.0,N,,,9278,CHEMBL628489,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12572,1,10116.0,N,,,9278,CHEMBL628490,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12573,1,9541.0,N,,,12186,CHEMBL628491,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,12574,1,9541.0,N,,,12186,CHEMBL877507,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,A,100710,1,,,Macaca fascicularis
,,,,Autocuration,BAO_0000218,12575,0,,U,,,12186,CHEMBL628492,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12576,0,314293.0,U,,,12041,CHEMBL628493,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,A,22224,1,,,Simiiformes
,,,,Autocuration,BAO_0000019,12577,0,314293.0,U,,,12041,CHEMBL628494,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,A,22224,1,,,Simiiformes
,,,,Autocuration,BAO_0000019,12578,0,314293.0,U,,,12041,CHEMBL628495,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,12579,1,9606.0,N,,,6737,CHEMBL628496,,Permeability in Caco-2 assay at 10E-6,,A,50587,1,,,Homo sapiens
,,,,Autocuration,BAO_0000218,12580,0,,U,,,13758,CHEMBL628497,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Brain,A,22224,1,,955.0,
,,,,Autocuration,BAO_0000218,12581,0,,U,,,13758,CHEMBL628498,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Brain,A,22224,1,,955.0,
,,,,Autocuration,BAO_0000019,12582,0,,U,,,5676,CHEMBL628499,,Plasma protein binding was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12583,0,,U,,,14793,CHEMBL627656,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12584,0,,U,,,14793,CHEMBL627657,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12585,0,,U,,,14793,CHEMBL626808,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12586,0,,U,,,14793,CHEMBL626809,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12587,0,,U,,,14793,CHEMBL626810,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12588,0,,U,,,14793,CHEMBL626811,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12589,0,,U,,,14793,CHEMBL874465,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12590,0,,U,,,14793,CHEMBL626812,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12591,0,,U,,,14793,CHEMBL626813,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12592,0,,U,,,14793,CHEMBL626814,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12593,0,,U,,,14000,CHEMBL626815,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12594,0,,U,,,5948,CHEMBL628566,,Partition coefficient (logP),,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12595,0,,U,,,13824,CHEMBL628567,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12596,0,,U,,,10778,CHEMBL628568,,Calculated partition coefficient (clogP),,P,22229,1,,,
,In vivo,,,Intermediate,BAO_0000218,12597,1,9615.0,N,,,17237,CHEMBL628569,,C max in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12598,1,10141.0,N,,,17237,CHEMBL628570,,C max in guinea pig,,A,50512,1,,,Cavia porcellus
,In vivo,,,Autocuration,BAO_0000218,12599,0,,U,,,2809,CHEMBL628571,,C max value was evaluated,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,12600,0,,U,,,11954,CHEMBL628572,,Cmax value after oral dose of 0.1 mg//kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,12601,0,,U,,,11954,CHEMBL628573,,Cmax value after oral dose of 0.3 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,12602,0,,U,,,11954,CHEMBL628574,,Cmax value after oral dose of 1 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,12603,0,,U,,,11954,CHEMBL628575,,Cmax value after oral dose of 10 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,12604,0,,U,,,11954,CHEMBL628576,,Cmax value after oral dose of 23.4 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,12605,0,,U,,,11954,CHEMBL628577,,Cmax value after oral dose of 3 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,12606,0,,U,,,11954,CHEMBL628578,,Cmax value after oral dose of 3.87 mg/kg,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,12607,1,9615.0,N,,,12768,CHEMBL874466,,Cmax value in female Beagle dogs,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12608,1,10116.0,N,,,12768,CHEMBL628579,,Cmax value in male rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12609,1,10116.0,N,,,12780,CHEMBL628580,,Cmax value in rat plasma when administered 20 mg/kg perorally,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12610,1,9615.0,N,,,15592,CHEMBL628581,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12611,1,9615.0,N,,,15592,CHEMBL628582,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12612,1,9615.0,N,,,17025,CHEMBL628583,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,12613,0,314293.0,U,,,17025,CHEMBL625782,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,A,22224,1,,,Simiiformes
,,,,Intermediate,BAO_0000218,12614,1,9986.0,N,,,17025,CHEMBL625783,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12615,1,10116.0,N,,,17025,CHEMBL625784,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12616,1,9544.0,N,,,4236,CHEMBL625785,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Plasma,A,50797,1,,1969.0,Macaca mulatta
,,,,Intermediate,BAO_0000218,12617,1,10116.0,N,,,15791,CHEMBL625786,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12618,0,,U,,,11149,CHEMBL874467,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12619,1,9615.0,N,,,15592,CHEMBL625787,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12620,1,12721.0,N,,,15778,CHEMBL625964,,cytotoxicity against HIV protease enzyme.,,A,50677,1,,,Human immunodeficiency virus
,,,,Intermediate,BAO_0000218,12621,1,10090.0,N,,,12745,CHEMBL625965,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12622,1,10090.0,N,,,12745,CHEMBL625966,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,12623,1,9615.0,N,,,13941,CHEMBL625967,,The plasma clearance in dog.,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12624,1,10116.0,N,,,13941,CHEMBL625968,,The plasma clearance in rat.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12625,1,10116.0,N,,,16449,CHEMBL625969,,Clearance from plasma in male Sprague-Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12626,1,9541.0,N,,,16449,CHEMBL625970,,Clearance from plasma in male cynomolgus monkeys,Plasma,A,100710,1,,1969.0,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,12627,1,9615.0,N,,,14224,CHEMBL625971,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12628,1,9615.0,N,,,14224,CHEMBL625972,,Clearance of compound in dog plasma,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12629,1,9606.0,N,,,14224,CHEMBL625973,,Clearance of compound in human plasma,Plasma,A,50587,1,,1969.0,Homo sapiens
,In vivo,,,Intermediate,BAO_0000218,12630,1,9615.0,N,,,14317,CHEMBL625974,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12631,1,9615.0,N,,,14317,CHEMBL625975,,Clearance of compound when administered intravenously as an individual dose to a single dog.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12632,1,9615.0,N,,,14224,CHEMBL625976,,"Clearance (10 mg/kg, intravenously) in dog plasma",Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12633,1,9615.0,N,,,17237,CHEMBL625977,,Clearance value in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12634,1,10141.0,N,,,17237,CHEMBL625978,,Clearance value in guinea pig,,A,50512,1,,,Cavia porcellus
,In vivo,,,Intermediate,BAO_0000218,12635,1,10116.0,N,,,14187,CHEMBL874468,,Clearance values in rats after iv administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,12636,0,,U,,,4806,CHEMBL625421,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,12637,1,9986.0,N,,,15025,CHEMBL625422,,In vivo clearance (5 mg/kg) was determined in rabbits,,A,50592,1,,,Oryctolagus cuniculus
,In vivo,,,Intermediate,BAO_0000218,12638,1,10116.0,N,,,13197,CHEMBL625423,,Plasma Clearance rate was determined for the compound in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,12639,0,9520.0,U,,,13197,CHEMBL625424,,Plasma Clearance rate was determined for the compound in squirrel monkeys,,A,22224,1,,,Saimiri
,In vivo,,,Intermediate,BAO_0000218,12640,1,10116.0,N,,,13960,CHEMBL625425,,Plasma clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,12641,0,,U,,,17820,CHEMBL625426,,Plasma clearance of the compound,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,12642,1,10141.0,N,,,14706,CHEMBL625427,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,A,50512,1,,,Cavia porcellus
,In vivo,,,Intermediate,BAO_0000218,12643,1,10141.0,N,,,14706,CHEMBL625428,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,A,50512,1,,,Cavia porcellus
,In vivo,,,Autocuration,BAO_0000218,12644,0,,U,,,6504,CHEMBL625429,,Plasma clearance was determined,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,12645,1,9615.0,N,,,14925,CHEMBL625430,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12646,1,10116.0,N,,,13197,CHEMBL625431,,Plasma clearance rate was determined for the compound in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,12647,0,9520.0,U,,,13197,CHEMBL627307,,Plasma clearance rate was determined for the compound in squirrel monkeys,,A,22224,1,,,Saimiri
,In vivo,,,Autocuration,BAO_0000218,12648,0,,U,,,3437,CHEMBL627308,,Slow clearance (CL) was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12649,0,,U,,,9196,CHEMBL627309,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12650,0,,U,,,9196,CHEMBL627310,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12651,0,,U,,,9196,CHEMBL627311,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12652,0,,U,,,9196,CHEMBL627312,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12653,0,,U,,,9196,CHEMBL627313,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12654,0,,U,,,9196,CHEMBL627314,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12655,0,,U,,,9196,CHEMBL627315,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12656,0,,U,,,9196,CHEMBL627316,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12657,0,,U,,,9196,CHEMBL627317,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12658,0,,U,,,9196,CHEMBL627318,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12659,0,,U,,,9196,CHEMBL627999,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12660,0,,U,,,9196,CHEMBL628000,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12661,0,,U,,,9196,CHEMBL628001,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12662,0,,U,,,9196,CHEMBL628002,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12663,0,,U,,,9196,CHEMBL625610,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12664,0,,U,,,9196,CHEMBL625611,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12665,0,,U,,,9196,CHEMBL625612,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12666,0,,U,,,9196,CHEMBL625613,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12667,0,,U,,,9196,CHEMBL875479,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12668,0,,U,,,9196,CHEMBL625614,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12669,0,,U,,,9196,CHEMBL625615,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,12670,0,,U,,,9196,CHEMBL626302,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12671,1,10116.0,N,,,8374,CHEMBL626303,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12672,1,10116.0,N,,,8374,CHEMBL627420,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12673,1,10116.0,N,,,13477,CHEMBL627421,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12674,1,10116.0,N,,,13477,CHEMBL625695,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12675,1,10116.0,N,,,13477,CHEMBL625696,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12676,1,10090.0,N,,,10009,CHEMBL875606,,Distribution of compound in mice brain was measured after 1 hr,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,12677,1,10090.0,N,,,10009,CHEMBL625697,,Distribution of compound in mice brain was measured after 24 hr r,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,12678,1,10090.0,N,,,10009,CHEMBL625698,,Distribution of compound in mice brain was measured after 2 hr,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,12679,1,10090.0,N,,,10009,CHEMBL625699,,Distribution of compound in mice brain was measured after 3 hr,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,12680,1,10090.0,N,,,10009,CHEMBL625700,,Distribution of compound in mice brain was measured after 6 hr,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,12681,1,10090.0,N,,,10009,CHEMBL625701,,Distribution of compound in mice liver was measured after 1 hr,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12682,1,10090.0,N,,,10009,CHEMBL625702,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12683,1,10090.0,N,,,10009,CHEMBL625703,,Distribution of compound in mice liver was measured after 2 hr,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12684,1,10090.0,N,,,10009,CHEMBL625704,,Distribution of compound in mice liver was measured after 3 hr,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12685,1,10090.0,N,,,10009,CHEMBL625705,,Distribution of compound in mice liver was measured after 6 hr,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12686,1,9615.0,N,,,8170,CHEMBL625706,,Distribution in dog adrenal medulla 30 min after administration.,Adrenal medulla,A,50588,1,,1236.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12687,1,9615.0,N,,,8170,CHEMBL625707,,Distribution in dog adrenal medulla 72 hours after administration.,Adrenal medulla,A,50588,1,,1236.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12688,1,9615.0,N,,,8170,CHEMBL625708,,Distribution in female dog Ovary 24 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12689,1,9615.0,N,,,8170,CHEMBL625709,,Distribution in female dog Ovary 72 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12690,1,9615.0,N,,,8170,CHEMBL624180,,Distribution in female dog adipose 24 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12691,1,9615.0,N,,,8170,CHEMBL624181,,Distribution in female dog adipose 72 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12692,1,9615.0,N,,,8170,CHEMBL624182,,Distribution in female dog adrenal cortex 72 hours after administration.,Adrenal cortex,A,50588,1,,1235.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12693,1,9615.0,N,,,8170,CHEMBL624183,,Distribution in female dog adrenal cortex 72 hours after administration.,Adrenal cortex,A,50588,1,,1235.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12694,1,10116.0,N,,,8594,CHEMBL624184,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12695,1,10116.0,N,,,8594,CHEMBL877489,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12696,1,10116.0,N,,,8594,CHEMBL624185,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12697,1,10116.0,N,,,8594,CHEMBL624186,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12698,1,10116.0,N,,,8594,CHEMBL624187,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12699,1,10116.0,N,,,8594,CHEMBL624188,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12700,1,10116.0,N,,,8594,CHEMBL624189,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12701,1,10116.0,N,,,8594,CHEMBL624190,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12702,1,10116.0,N,,,8594,CHEMBL624191,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12703,1,10116.0,N,,,8594,CHEMBL624192,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12704,1,10116.0,N,,,8594,CHEMBL624193,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12705,1,10116.0,N,,,8594,CHEMBL624194,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12706,1,10116.0,N,,,8594,CHEMBL624891,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12707,1,10116.0,N,,,8594,CHEMBL624892,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12708,1,10116.0,N,,,8594,CHEMBL624893,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12709,1,10116.0,N,,,8594,CHEMBL627632,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12710,1,10116.0,N,,,8594,CHEMBL627633,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12711,1,10116.0,N,,,8594,CHEMBL627634,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12712,1,10116.0,N,,,8594,CHEMBL627635,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12713,1,10116.0,N,,,8594,CHEMBL627636,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12714,1,10116.0,N,,,8594,CHEMBL626816,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12715,1,10116.0,N,,,8594,CHEMBL626817,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12716,1,10116.0,N,,,8594,CHEMBL626818,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12717,1,10116.0,N,,,8594,CHEMBL626819,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12718,1,10116.0,N,,,8594,CHEMBL626820,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12719,1,10116.0,N,,,8594,CHEMBL626821,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12720,1,10116.0,N,,,8594,CHEMBL626822,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12721,1,10116.0,N,,,8594,CHEMBL626823,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12722,1,10116.0,N,,,8594,CHEMBL626824,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12723,1,10116.0,N,,,8594,CHEMBL626825,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12724,1,10116.0,N,,,8594,CHEMBL626826,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12725,1,10116.0,N,,,8594,CHEMBL626827,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12726,1,10116.0,N,,,8594,CHEMBL626828,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12727,1,10116.0,N,,,8594,CHEMBL626829,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12728,1,10116.0,N,,,8594,CHEMBL626830,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12729,1,10116.0,N,,,8594,CHEMBL627150,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12730,1,10116.0,N,,,8594,CHEMBL627151,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12731,1,10116.0,N,,,8594,CHEMBL627152,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12732,1,10116.0,N,,,8594,CHEMBL627153,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12733,0,,U,,,12904,CHEMBL627154,,Rate of acetate production by the compound was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12734,0,,U,,,12904,CHEMBL627155,,Rate of acetate production by the compound was determined; Not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12735,0,,U,,,3730,CHEMBL627156,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12736,0,,U,,,3627,CHEMBL627157,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12737,1,9986.0,N,,,13799,CHEMBL627158,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12738,1,9986.0,N,,,13799,CHEMBL627159,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Plasma,A,50592,1,,1969.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12739,1,10090.0,N,,,13799,CHEMBL627160,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,12740,1,10116.0,N,,,13799,CHEMBL628540,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12741,1,10116.0,N,,,13799,CHEMBL628541,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12742,1,10116.0,N,,,13799,CHEMBL628542,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Autocuration,BAO_0000100,12743,0,,U,,,6629,CHEMBL628543,,Solubility after at a pH 1.2,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12744,0,,U,,,6629,CHEMBL628544,,Solubility after at pH 1.2,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12745,0,,U,,,6629,CHEMBL628545,,Solubility after injection of water,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,12746,0,,U,,,14000,CHEMBL628546,,Statistical significance of IC 50 values; Expressed as R value,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12747,0,,U,,,8267,CHEMBL874455,,Systemic availability with respect to methyldopa was determined,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12748,1,10116.0,N,,,13799,CHEMBL628547,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12749,1,10116.0,N,,,13799,CHEMBL628548,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12750,1,9986.0,N,,,7132,CHEMBL628549,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12751,1,9986.0,N,,,7132,CHEMBL628550,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12752,1,9986.0,N,,,7132,CHEMBL628551,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12753,1,9986.0,N,,,7132,CHEMBL628552,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12754,1,9986.0,N,,,7132,CHEMBL628553,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12755,1,9986.0,N,,,7132,CHEMBL628554,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12756,1,9986.0,N,,,7132,CHEMBL628555,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12757,1,9986.0,N,,,7132,CHEMBL628556,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12758,1,9986.0,N,,,7132,CHEMBL628557,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Kidney,A,50592,1,,2113.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12759,1,9986.0,N,,,7132,CHEMBL628558,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12760,1,9986.0,N,,,7132,CHEMBL628559,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12761,1,9986.0,N,,,7132,CHEMBL628560,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12762,1,9986.0,N,,,7132,CHEMBL874456,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12763,1,9986.0,N,,,7132,CHEMBL628561,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12764,1,9986.0,N,,,7132,CHEMBL628562,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12765,1,9986.0,N,,,7132,CHEMBL628563,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12766,1,9986.0,N,,,7132,CHEMBL628564,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12767,1,9986.0,N,,,7132,CHEMBL628565,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12768,1,9986.0,N,,,7132,CHEMBL631248,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12769,1,9986.0,N,,,7132,CHEMBL631249,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12770,1,9986.0,N,,,7132,CHEMBL627214,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Kidney,A,50592,1,,2113.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12771,1,9986.0,N,,,7132,CHEMBL874591,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12772,1,9986.0,N,,,7132,CHEMBL627215,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12773,1,9986.0,N,,,7132,CHEMBL625471,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12774,1,9986.0,N,,,7132,CHEMBL625472,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12775,1,9986.0,N,,,7132,CHEMBL625473,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,A,50592,1,,,Oryctolagus cuniculus
,In vivo,,,Intermediate,BAO_0000218,12776,1,9615.0,N,,,13317,CHEMBL625474,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12777,1,9615.0,N,,,15341,CHEMBL625475,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12778,1,10116.0,N,,,15341,CHEMBL625476,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12779,1,10116.0,N,,,15341,CHEMBL625477,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12780,1,10116.0,N,,,15341,CHEMBL625478,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,12781,1,10116.0,N,,,12801,CHEMBL625479,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,esophageal tunica muscularis mucosae,A,50597,1,,,Rattus norvegicus
,In vitro,,,Intermediate,BAO_0000218,12782,1,10116.0,N,,,12801,CHEMBL625480,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,esophageal tunica muscularis mucosae,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12783,1,10116.0,N,,,14856,CHEMBL625481,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12784,1,10116.0,N,,,14062,CHEMBL625482,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12785,1,10116.0,N,,,14062,CHEMBL625483,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12786,1,10116.0,N,,,14062,CHEMBL625484,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12787,1,10116.0,N,,,14062,CHEMBL625485,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12788,1,9615.0,N,,,14346,CHEMBL625486,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12789,1,10116.0,N,,,14346,CHEMBL625487,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12790,1,10116.0,N,,,14346,CHEMBL625488,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12791,1,10116.0,N,,,14346,CHEMBL625489,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12792,1,10116.0,N,,,14346,CHEMBL625490,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12793,1,9615.0,N,,,14346,CHEMBL625491,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12794,1,10116.0,N,,,14346,CHEMBL625492,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12795,1,9606.0,N,,,15711,CHEMBL625493,,plasma clearance in human,Plasma,A,50587,1,,1969.0,Homo sapiens
,In vivo,,,Intermediate,BAO_0000218,12796,1,10116.0,N,,,14886,CHEMBL625494,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12797,1,10116.0,N,,,14886,CHEMBL625495,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,12798,1,10116.0,N,,,14886,CHEMBL625496,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000100,12799,0,,U,,,4115,CHEMBL625497,,1-Octanol/water partition coefficient measured at 7.4,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12800,0,,U,,,13733,CHEMBL625498,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,12801,0,,U,,,12102,CHEMBL625499,,Partition coefficient (logP),,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12802,0,,U,,,12676,CHEMBL625500,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12803,0,,U,,,13733,CHEMBL625501,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12804,0,,U,,,13740,CHEMBL625502,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12805,0,,U,,,12766,CHEMBL625503,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12806,0,,U,,,2764,CHEMBL625504,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12807,0,,U,,,12355,CHEMBL625505,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12808,0,,U,,,11314,CHEMBL625506,,Calculated partition coefficient of the compound,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,12809,0,,U,,,12706,CHEMBL625507,,Partition coefficient (logP),,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12810,0,,U,,,12645,CHEMBL625508,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12811,0,,U,,,13668,CHEMBL625509,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12812,0,,U,,,12819,CHEMBL625510,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12813,0,,U,,,13668,CHEMBL883125,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12814,0,,U,,,13017,CHEMBL625511,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,12815,0,,U,,,2448,CHEMBL874650,,Partition coefficient of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12816,0,,U,,,11526,CHEMBL625512,,Partition coefficient of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12817,0,,U,,,12426,CHEMBL625513,,Partition coefficient of compound was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12818,0,,U,,,2448,CHEMBL625514,,Partition coefficient was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12819,0,,U,,,12001,CHEMBL625515,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12820,0,,U,,,12426,CHEMBL625516,,partition coefficient of compound was determined,,P,22229,1,,,
,In vivo,,,Intermediate,BAO_0000218,12821,1,9615.0,N,,,13204,CHEMBL625517,,The total body administered intravenously in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,12822,1,10116.0,N,,,13204,CHEMBL625518,,The total body administered intravenously in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12823,1,10090.0,N,,,13889,CHEMBL625519,,Time taken for the administration to female NIH mice weighing 25-30 g.,,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000019,12824,0,,U,,,13889,CHEMBL625520,,Time taken for the administration,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,12825,1,9615.0,N,,,17025,CHEMBL874651,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,12826,0,314293.0,U,,,17025,CHEMBL625521,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,A,22224,1,,,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,12827,1,9986.0,N,,,17025,CHEMBL623171,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,A,50592,1,,,Oryctolagus cuniculus
,In vivo,,,Intermediate,BAO_0000218,12828,1,10116.0,N,,,17025,CHEMBL623853,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12829,0,,U,,,15067,CHEMBL623854,,Plasma clearance for the compound was determined.,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12830,0,,U,,,3091,CHEMBL874405,,CLog P value of the compound,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,12831,0,,U,,,15592,CHEMBL623855,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12832,0,,U,,,14738,CHEMBL623856,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12833,0,,U,,,14738,CHEMBL623857,,ClogP value of the compound; nd ='no data',,P,22224,1,,,
,,,,Autocuration,BAO_0000100,12834,0,,U,,,14738,CHEMBL623858,,ClogP value of the compound; nd ='not determined',,P,22224,1,,,
,,,,Autocuration,BAO_0000100,12835,0,,U,,,6076,CHEMBL623859,,CLog P was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,12836,0,,U,,,17840,CHEMBL839829,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,12837,0,,U,,,13589,CHEMBL623860,,CLogP was calculated,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12838,0,,U,,,17655,CHEMBL623861,,CLogP value was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12839,0,,U,,,5867,CHEMBL623862,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12840,0,,U,,,5867,CHEMBL874406,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12841,0,,U,,,10783,CHEMBL623863,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12842,0,,U,,,14849,CHEMBL624021,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Intermediate,BAO_0000218,12843,1,9615.0,N,,,8170,CHEMBL624022,,Distribution in female dog adrenal medulla 24 hours after administration.,Adrenal medulla,A,50588,1,,1236.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12844,1,9615.0,N,,,8170,CHEMBL624023,,Distribution in female dog adrenal medulla 72 hours after administration.,Adrenal medulla,A,50588,1,,1236.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12845,1,9615.0,N,,,8170,CHEMBL624024,,Distribution in female dog bile 24 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12846,1,9615.0,N,,,8170,CHEMBL624025,,Distribution in female dog bile 72 hr after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12847,1,9615.0,N,,,8170,CHEMBL624026,,Distribution in female dog blood 24 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12848,1,9615.0,N,,,8170,CHEMBL624027,,Distribution in female dog blood 72 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12849,1,9615.0,N,,,8170,CHEMBL624028,,Distribution in female dog heart 24 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12850,1,9615.0,N,,,8170,CHEMBL624029,,Distribution in female dog heart 72 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12851,1,9615.0,N,,,8170,CHEMBL624030,,Distribution in female dog kidney 24 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12852,1,9615.0,N,,,8170,CHEMBL624031,,Distribution in female dog kidney 72 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12853,1,9615.0,N,,,8170,CHEMBL624032,,Distribution in female dog large intestine 24 hours after administration.,Intestine,A,50588,1,,160.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12854,1,9615.0,N,,,8170,CHEMBL874407,,Distribution in female dog large intestine 72 hours after administration.,Intestine,A,50588,1,,160.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12855,1,9615.0,N,,,8170,CHEMBL624033,,Distribution in female dog liver 24 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12856,1,9615.0,N,,,8170,CHEMBL624034,,Distribution in female dog liver 72 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12857,1,9615.0,N,,,8170,CHEMBL624035,,Distribution in female dog lung 24 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12858,1,9615.0,N,,,8170,CHEMBL624036,,Distribution in female dog lung 72 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12859,1,9615.0,N,,,8170,CHEMBL624037,,Distribution in female dog muscle 24 hours after administration.,Muscle tissue,A,50588,1,,2385.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12860,1,9615.0,N,,,8170,CHEMBL624038,,Distribution in female dog muscle 72 hours after administration.,Muscle tissue,A,50588,1,,2385.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12861,1,9615.0,N,,,8170,CHEMBL624039,,Distribution in female dog pancreas 24 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12862,1,9615.0,N,,,8170,CHEMBL624040,,Distribution in female dog pancreas 72 hours after administration.,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12863,1,9615.0,N,,,8170,CHEMBL624041,,Distribution in female dog small intestine 24 hours after administration.,Intestine,A,50588,1,,160.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12864,1,9615.0,N,,,8170,CHEMBL624042,,Distribution in female dog small intestine 72 hours after administration.,Intestine,A,50588,1,,160.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12865,1,9615.0,N,,,8170,CHEMBL624043,,Distribution in female dog spleen 24 hours after administration.,Spleen,A,50588,1,,2106.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12866,1,9615.0,N,,,8170,CHEMBL624044,,Distribution in female dog spleen 72 hours after administration.,Spleen,A,50588,1,,2106.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12867,1,9615.0,N,,,8170,CHEMBL624045,,Distribution in female dog stomach 24 hours after administration.,Stomach,A,50588,1,,945.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12868,1,9615.0,N,,,8170,CHEMBL624046,,Distribution in female dog stomach 72 hours after administration.,Stomach,A,50588,1,,945.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12869,1,9615.0,N,,,8170,CHEMBL624047,,Distribution in female dog thyroid 24 hours after administration.,Thyroid gland,A,50588,1,,2046.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12870,1,9615.0,N,,,8170,CHEMBL624048,,Distribution in female dog thyroid 72 hours after administration.,Thyroid gland,A,50588,1,,2046.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12871,1,9615.0,N,,,8170,CHEMBL874408,,Distribution in female dog urine 24 hours after administration.,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12872,1,9615.0,N,,,8170,CHEMBL624049,,Distribution in female dog urine 72 hr after administration.,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,12873,0,,U,,,14283,CHEMBL624050,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,Plasma,A,22224,1,,1969.0,
,,,,Autocuration,BAO_0000019,12874,0,,U,,,5623,CHEMBL624051,,Plasma concentration at 7 hr after intravenous dosing,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12875,1,10116.0,N,,,13477,CHEMBL623278,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12876,1,10116.0,N,,,13477,CHEMBL623279,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12877,1,10116.0,N,,,13477,CHEMBL623280,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12878,1,10116.0,N,,,13477,CHEMBL623963,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12879,1,10116.0,N,,,13477,CHEMBL623964,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12880,1,10116.0,N,,,13477,CHEMBL623965,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12881,1,10116.0,N,,,13477,CHEMBL623966,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12882,1,10116.0,N,,,13477,CHEMBL874415,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12883,1,10116.0,N,,,13477,CHEMBL623967,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12884,1,10116.0,N,,,13477,CHEMBL623968,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12885,1,10116.0,N,,,13477,CHEMBL623969,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12886,1,10116.0,N,,,13477,CHEMBL628409,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12887,1,10116.0,N,,,13477,CHEMBL628410,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12888,1,10116.0,N,,,13477,CHEMBL628411,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12889,1,10116.0,N,,,13477,CHEMBL628412,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12890,0,,U,,,12553,CHEMBL628413,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12891,0,,U,,,14548,CHEMBL628414,,The concentration in plasmat; Not determined,Plasma,A,22224,1,,1969.0,
,,,,Intermediate,BAO_0000218,12892,1,10116.0,N,,,14393,CHEMBL628415,,Tissue level at 10 mg/kg/po in wistar rats in blood,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12893,1,10116.0,N,,,14393,CHEMBL628416,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12894,1,10116.0,N,,,14393,CHEMBL628417,,Tissue level at 10 mg/kg/po in wistar rats in heart,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12895,1,10116.0,N,,,14393,CHEMBL874908,,Tissue level at 10 mg/kg/po in wistar rats in liver,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12896,1,10116.0,N,,,14393,CHEMBL628418,,Tissue level at 10 mg/kg/po in wistar rats in plasma,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12897,1,10116.0,N,,,14393,CHEMBL628419,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12898,1,10116.0,N,,,14393,CHEMBL628420,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12899,0,,U,,,1629,CHEMBL628421,,Water solubility at 37 degree C.,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12900,0,,U,,,8194,CHEMBL626726,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12901,0,,U,,,8194,CHEMBL626727,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,P,22229,1,,,
,,,,Intermediate,BAO_0000218,12902,1,10116.0,N,,,8594,CHEMBL626728,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12903,1,10116.0,N,,,8594,CHEMBL626729,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12904,1,10116.0,N,,,8594,CHEMBL626730,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12905,1,10116.0,N,,,8594,CHEMBL626731,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12906,1,10116.0,N,,,8594,CHEMBL626732,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12907,1,10116.0,N,,,8594,CHEMBL626733,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12908,1,10116.0,N,,,8594,CHEMBL626734,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12909,1,10116.0,N,,,8594,CHEMBL626735,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12910,1,10116.0,N,,,8594,CHEMBL874909,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12911,1,10116.0,N,,,8594,CHEMBL626736,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Heart,A,50597,1,,948.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12912,1,10116.0,N,,,8594,CHEMBL626737,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12913,1,10116.0,N,,,8594,CHEMBL630999,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12914,1,10116.0,N,,,8594,CHEMBL631000,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12915,1,10116.0,N,,,8594,CHEMBL631001,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12916,1,10116.0,N,,,8594,CHEMBL631002,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12917,1,10116.0,N,,,8594,CHEMBL631003,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12918,1,10116.0,N,,,8594,CHEMBL631004,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12919,1,10116.0,N,,,8594,CHEMBL631005,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12920,1,10116.0,N,,,8594,CHEMBL631006,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12921,1,10116.0,N,,,8594,CHEMBL631007,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12922,1,10116.0,N,,,8594,CHEMBL631008,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12923,1,10116.0,N,,,8594,CHEMBL631009,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12924,1,10116.0,N,,,8594,CHEMBL631010,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12925,1,10116.0,N,,,8594,CHEMBL631011,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12926,1,10116.0,N,,,8594,CHEMBL631012,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12927,1,10116.0,N,,,8594,CHEMBL630271,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12928,1,10116.0,N,,,8594,CHEMBL630272,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12929,1,10116.0,N,,,8594,CHEMBL630273,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12930,1,10116.0,N,,,8594,CHEMBL630274,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12931,1,10116.0,N,,,8594,CHEMBL630275,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12932,1,10116.0,N,,,8594,CHEMBL875782,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12933,1,10116.0,N,,,8594,CHEMBL630276,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12934,1,10116.0,N,,,8594,CHEMBL630277,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12935,1,10116.0,N,,,8594,CHEMBL630278,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12936,1,10116.0,N,,,8594,CHEMBL630279,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12937,0,,U,,,8151,CHEMBL630280,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12938,0,,U,,,8151,CHEMBL630281,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12939,1,9986.0,N,,,7132,CHEMBL630282,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12940,1,9986.0,N,,,7132,CHEMBL630283,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,A,50592,1,,,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000019,12941,0,,U,,,5797,CHEMBL630284,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12942,0,,U,,,7849,CHEMBL630285,,Alkylating activity was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000251,12943,0,,U,,,14220,CHEMBL630286,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,A,22224,1,Microsomes,,
,,,,Intermediate,BAO_0000218,12944,1,9986.0,N,,,8650,CHEMBL630069,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12945,1,9986.0,N,,,8650,CHEMBL630070,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12946,1,9986.0,N,,,8650,CHEMBL630071,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12947,1,9986.0,N,,,8650,CHEMBL630072,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12948,1,9986.0,N,,,8650,CHEMBL875110,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12949,1,10116.0,N,,,7116,CHEMBL630073,,Compound was tested for antidiuretic activity in rats,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,12950,0,,U,,,14131,CHEMBL630074,,Compound was tested for inactivation kinetic values,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,12951,0,,U,,,7415,CHEMBL630075,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12952,0,,U,,,13178,CHEMBL630076,,Dissociation rate calculated from the first-order equation using the t1/2 value,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12953,0,,U,,,8815,CHEMBL630077,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12954,0,,U,,,1450,CHEMBL630078,,Aqueous solubility was measured,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12955,0,,U,,,1450,CHEMBL630079,,Aqueous solubility was measured at a pH 4,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12956,0,,U,,,1450,CHEMBL630080,,Aqueous solubility (pH 7),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12957,0,,U,,,1450,CHEMBL630081,,Aqueous solubility was measured at a pH 9,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,12958,0,,U,,,12711,CHEMBL630082,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12959,0,,U,,,12711,CHEMBL630083,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12960,0,,U,,,12711,CHEMBL630084,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12961,0,,U,,,15032,CHEMBL629198,,Aqueous solubility of the compound,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12962,0,,U,,,9964,CHEMBL629199,,Aqueous solubility at 37 degree Celsius at pH 7.38,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12963,0,,U,,,14962,CHEMBL629200,,Aqueous solubility in pH 7.4 phosphate buffer,,P,22229,1,,,
,,,,Intermediate,BAO_0000218,12964,1,9615.0,N,,,12487,CHEMBL629201,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12965,1,9615.0,N,,,12487,CHEMBL629202,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,12966,1,9606.0,N,,,10026,CHEMBL875111,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,12967,1,9606.0,N,,,10026,CHEMBL629203,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,12968,1,9606.0,N,,,10026,CHEMBL629204,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,12969,1,9606.0,N,,,10026,CHEMBL629205,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,12970,1,9606.0,N,,,10026,CHEMBL629206,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,A,50587,1,,,Homo sapiens
,,,,Autocuration,BAO_0000019,12971,0,,U,,,10026,CHEMBL631185,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12972,1,10116.0,N,,,7415,CHEMBL631186,,Compound was evaluated for the average bile flow rat in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,12973,1,9986.0,N,,,17025,CHEMBL631187,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,A,50592,1,,,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,12974,1,9986.0,N,,,17025,CHEMBL631188,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,A,50592,1,,,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000019,12975,0,,U,,,10184,CHEMBL876419,,Average half life period was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,12976,0,,U,,,10184,CHEMBL631189,,Average half life period was determined,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,12977,1,10298.0,N,,,8613,CHEMBL631190,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,12978,1,10298.0,N,,,8613,CHEMBL631191,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,12979,1,10298.0,N,,,8613,CHEMBL631192,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,12980,1,10298.0,N,,,8613,CHEMBL632400,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,12981,1,10298.0,N,,,8613,CHEMBL630564,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,12982,1,10298.0,N,,,8613,CHEMBL630565,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,12983,1,10298.0,N,,,8613,CHEMBL630566,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,12984,1,10298.0,N,,,8613,CHEMBL631229,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,12985,1,10298.0,N,,,8613,CHEMBL631230,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,A,50602,1,,,Human herpesvirus 1
,,,,Autocuration,BAO_0000100,12986,0,,U,,,6030,CHEMBL876428,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12987,0,,U,,,6147,CHEMBL631231,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12988,0,,U,,,14556,CHEMBL631232,,Calculated partition coefficient (clogP) (MacLogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,12989,0,,U,,,768,CHEMBL631233,,Hydrophilicity was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12990,0,,U,,,14452,CHEMBL631234,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,12991,0,,U,,,5237,CHEMBL883126,,Increased absorption was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12992,0,,U,,,14378,CHEMBL631235,,Lipophilicity value was evaluated,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,12993,0,,U,,,14418,CHEMBL631236,,Log P value of the compound.,,P,22224,1,,,
,,,,Autocuration,BAO_0000019,12994,0,,U,,,5249,CHEMBL631237,,Partition coefficient of compound was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12995,0,,U,,,14621,CHEMBL631238,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,12996,0,,U,,,12542,CHEMBL876429,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,12997,0,,U,,,12542,CHEMBL631414,,Partition coefficient was measured by medchem software; Not calculated,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,12998,0,,U,,,12542,CHEMBL631415,,Partition coefficient was measured by octanol-water using standard shake-flask method,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,12999,0,,U,,,15462,CHEMBL631416,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13000,0,,U,,,14884,CHEMBL631417,,Partition coefficient (logP),,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13001,0,,U,,,16526,CHEMBL631418,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13002,0,,U,,,13693,CHEMBL631419,,The Octanol/Water partition coefficient CLogP,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13003,0,,U,,,13693,CHEMBL631420,,The pharmacokinetic parameter C Log p was reported,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13004,0,,U,,,13779,CHEMBL631421,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13005,0,,U,,,14772,CHEMBL631422,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13006,0,,U,,,14393,CHEMBL631423,,Calculated partition coefficient (clogP),,P,22229,1,,,
,In vivo,,,Intermediate,BAO_0000218,13007,1,10116.0,N,,,14793,CHEMBL876430,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13008,1,10116.0,N,,,14793,CHEMBL631424,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13009,1,9615.0,N,,,13744,CHEMBL631425,,Compound was administered intravenously in dog to evaluate plasma clearance values,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,13010,0,314293.0,U,,,13744,CHEMBL631426,,Compound was administered intravenously in monkey to evaluate plasma clearance values,Plasma,A,22224,1,,1969.0,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,13011,1,10090.0,N,,,13744,CHEMBL631427,,Compound was administered intravenously in mouse to evaluate plasma clearance values,Plasma,A,50594,1,,1969.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13012,1,9615.0,N,,,13207,CHEMBL631428,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vitro,,,Intermediate,BAO_0000218,13013,1,9544.0,N,,,5669,CHEMBL631429,,Intrinsic clearance in Rhesus liver microsome,Liver,A,50797,1,Microsomes,2107.0,Macaca mulatta
,In vitro,,,Intermediate,BAO_0000218,13014,1,9615.0,N,,,5669,CHEMBL631430,,Intrinsic clearance in dog liver microsome,Liver,A,50588,1,Microsomes,2107.0,Canis lupus familiaris
,In vitro,,,Intermediate,BAO_0000218,13015,1,10116.0,N,,,5669,CHEMBL631431,,Intrinsic clearance in rat liver microsome,Liver,A,50597,1,Microsomes,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13016,1,9544.0,N,,,4853,CHEMBL631432,,Low plasma clearance was calculated in rhesus monkey,Plasma,A,50797,1,,1969.0,Macaca mulatta
,In vivo,,,Intermediate,BAO_0000218,13017,1,9615.0,N,,,16452,CHEMBL631433,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,13018,0,,U,,,11954,CHEMBL631434,,Plasma clearance after intravenous dose of 0.3 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13019,0,,U,,,11954,CHEMBL631435,,Plasma clearance after intravenous dose of 1 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13020,0,,U,,,11954,CHEMBL631436,,Plasma clearance after intravenous dose of 3 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13021,0,,U,,,11954,CHEMBL631437,,Plasma clearance after intravenous dose of 3.87 mg/kg,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13022,1,10116.0,N,,,5669,CHEMBL631438,,Plasma clearance after peroral administration at 10 mpk in Rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13023,1,9544.0,N,,,5669,CHEMBL876431,,Plasma clearance after peroral administration at 10 mpk in Rhesus,,A,50797,1,,,Macaca mulatta
,In vivo,,,Intermediate,BAO_0000218,13024,1,9615.0,N,,,5669,CHEMBL631439,,Plasma clearance after peroral administration at 10 mpk in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13025,1,10116.0,N,,,13662,CHEMBL631440,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,13026,0,,U,,,8272,CHEMBL631441,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13027,0,,U,,,13410,CHEMBL631442,,Critical Micellar concentration was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13028,0,,U,,,13410,CHEMBL626525,,Critical Micellar concentration of the compound. was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13029,0,,U,,,12628,CHEMBL627168,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13030,0,,U,,,9675,CHEMBL875618,,Critical micellar concentration was measured in water by the dye solubilization method,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13031,0,,U,,,12628,CHEMBL626612,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,B,22224,1,,,
,,,,Autocuration,BAO_0000019,13032,0,,U,,,12766,CHEMBL626613,,CMR value (relative to BAY K 8644),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13033,0,,U,,,7849,CHEMBL626614,,Carbamoylating activity was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,13034,0,314293.0,U,,,12187,CHEMBL626615,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,A,22224,1,,,Simiiformes
,,,,Autocuration,BAO_0000019,13035,0,,U,,,2040,CHEMBL626616,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13036,0,,U,,,2040,CHEMBL626617,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13037,1,9615.0,N,,,14180,CHEMBL626618,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13038,1,10116.0,N,,,14180,CHEMBL626619,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13039,1,9615.0,N,,,14474,CHEMBL626620,,"Clearance rate at 0.46 mg/kg, iv, in dogs",,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13040,1,10116.0,N,,,14474,CHEMBL626621,,"Clearance rate at 5.5 mg/kg, iv, in rat",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13041,1,9541.0,N,,,14548,CHEMBL626622,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,A,100710,1,,,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,13042,1,9541.0,N,,,14548,CHEMBL626623,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,A,100710,1,,,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,13043,1,9615.0,N,,,14548,CHEMBL626624,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13044,1,10116.0,N,,,14548,CHEMBL626625,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,Ex vivo,,,Intermediate,BAO_0000218,13045,1,10116.0,N,,,6125,CHEMBL626626,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13046,0,,U,,,6874,CHEMBL626627,,Tested for the total clearance of the compound,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13047,1,9615.0,N,,,15343,CHEMBL626628,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,13048,0,,U,,,6236,CHEMBL626629,,Total body clearance was determined,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13049,1,10116.0,N,,,11510,CHEMBL626630,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13050,1,10116.0,N,,,11510,CHEMBL626631,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000100,13051,0,,U,,,8194,CHEMBL626632,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13052,0,,U,,,8194,CHEMBL626633,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13053,0,,U,,,8194,CHEMBL626634,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13054,0,,U,,,8194,CHEMBL626635,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13055,0,,U,,,8194,CHEMBL626636,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13056,0,,U,,,8194,CHEMBL626637,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,P,22229,1,,,
,,,,Intermediate,BAO_0000218,13057,1,4754.0,N,,,13273,CHEMBL626638,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13058,1,4754.0,N,,,13273,CHEMBL626639,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13059,1,4754.0,N,,,13273,CHEMBL626640,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13060,1,4754.0,N,,,13273,CHEMBL626641,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13061,1,4754.0,N,,,13273,CHEMBL627272,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13062,1,4754.0,N,,,13273,CHEMBL627273,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13063,1,4754.0,N,,,13273,CHEMBL627441,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13064,1,4754.0,N,,,13273,CHEMBL628355,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13065,1,4754.0,N,,,13273,CHEMBL628356,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13066,1,4754.0,N,,,13273,CHEMBL628357,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13067,1,4754.0,N,,,13273,CHEMBL628358,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,A,50339,1,,,Pneumocystis carinii
,,,,Intermediate,BAO_0000218,13068,1,4754.0,N,,,13273,CHEMBL622307,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,A,50339,1,,,Pneumocystis carinii
,,,,Autocuration,BAO_0000019,13069,0,,U,,,13118,CHEMBL622527,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13070,0,,U,,,13118,CHEMBL622528,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13071,0,,U,,,13118,CHEMBL622529,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13072,0,,U,,,13118,CHEMBL622992,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13073,0,,U,,,13118,CHEMBL622993,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13074,0,,U,,,13118,CHEMBL622994,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13075,1,10116.0,N,,,10633,CHEMBL622995,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13076,1,10116.0,N,,,10633,CHEMBL622996,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13077,1,10116.0,N,,,10633,CHEMBL622997,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13078,1,10116.0,N,,,10633,CHEMBL622998,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,13079,0,,U,,,5767,CHEMBL622999,,Cp max following ip administration at 1 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13080,0,,U,,,3302,CHEMBL623000,,Maximum concentration in plasma was reported at 0.5 hour,Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,13081,0,,U,,,3302,CHEMBL623001,,Maximum concentration in plasma was reported at 2 hour,Plasma,A,22224,1,,1969.0,
,,,,Intermediate,BAO_0000218,13082,1,10090.0,N,,,12467,CHEMBL623002,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000100,13083,0,,U,,,11778,CHEMBL623003,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13084,0,,U,,,4321,CHEMBL623004,,Steady state concentration was evaluated,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13085,0,,U,,,14884,CHEMBL623005,,Partition coefficient (logP),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13086,0,,U,,,15234,CHEMBL623006,,Partition coefficient (logD7.4),,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13087,1,10116.0,N,,,14198,CHEMBL623007,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13088,1,10116.0,N,,,14198,CHEMBL623008,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13089,1,10116.0,N,,,14198,CHEMBL876654,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13090,1,10116.0,N,,,14198,CHEMBL623009,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13091,1,10116.0,N,,,14198,CHEMBL623010,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13092,1,10116.0,N,,,14198,CHEMBL623011,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13093,1,10116.0,N,,,14198,CHEMBL623012,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Intestine,A,50597,1,,160.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,13094,0,,U,,,8151,CHEMBL623013,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13095,0,,U,,,8151,CHEMBL623014,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13096,0,,U,,,8151,CHEMBL623015,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13097,0,,U,,,8151,CHEMBL623016,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13098,0,,U,,,8151,CHEMBL624858,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,Urine,A,22224,1,,1088.0,
,,,,Intermediate,BAO_0000218,13099,1,10116.0,N,,,8151,CHEMBL624859,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13100,1,10116.0,N,,,8151,CHEMBL624860,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13101,1,10116.0,N,,,8151,CHEMBL624861,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13102,1,10116.0,N,,,8151,CHEMBL624862,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13103,1,10116.0,N,,,8151,CHEMBL624863,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13104,1,10116.0,N,,,8151,CHEMBL876655,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13105,1,9615.0,N,,,6996,CHEMBL624864,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13106,1,9615.0,N,,,6996,CHEMBL624865,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13107,1,9615.0,N,,,6996,CHEMBL624866,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,A,50588,1,,,Canis lupus familiaris
,,,,Expert,BAO_0000218,13108,1,9615.0,N,,,6996,CHEMBL624867,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,F,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13109,1,9615.0,N,,,6996,CHEMBL624868,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13110,1,9615.0,N,,,6996,CHEMBL628450,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13111,1,9615.0,N,,,6996,CHEMBL628451,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13112,1,9615.0,N,,,6996,CHEMBL628452,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13113,1,9615.0,N,,,6996,CHEMBL628453,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13114,1,9615.0,N,,,6996,CHEMBL628454,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13115,1,9615.0,N,,,6996,CHEMBL628455,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13116,1,9615.0,N,,,6996,CHEMBL628456,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13117,1,9615.0,N,,,6996,CHEMBL628457,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13118,1,9615.0,N,,,6996,CHEMBL877505,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13119,1,9615.0,N,,,6996,CHEMBL628458,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13120,1,9615.0,N,,,6996,CHEMBL628459,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13121,1,9615.0,N,,,6996,CHEMBL628460,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13122,1,9615.0,N,,,6996,CHEMBL628461,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,13123,0,,U,,,6996,CHEMBL628462,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,B,22224,1,,,
,,,,Intermediate,BAO_0000218,13124,1,9615.0,N,,,6996,CHEMBL628463,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,A,50588,1,,,Canis lupus familiaris
,,,,Expert,BAO_0000218,13125,1,10116.0,N,,,6996,CHEMBL625666,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,F,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,13126,0,,U,,,6996,CHEMBL625667,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,B,22224,1,,,
,,,,Expert,BAO_0000218,13127,1,10116.0,N,,,6996,CHEMBL625668,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13128,1,10116.0,N,,,6996,CHEMBL625669,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,13129,0,,U,,,7114,CHEMBL625670,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13130,1,10116.0,N,,,7114,CHEMBL625671,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13131,1,10298.0,N,,,8613,CHEMBL625672,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13132,1,10298.0,N,,,8613,CHEMBL625673,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13133,1,10298.0,N,,,8613,CHEMBL625674,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13134,1,10298.0,N,,,8613,CHEMBL625675,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13135,1,10298.0,N,,,8613,CHEMBL627637,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13136,1,10298.0,N,,,8613,CHEMBL627638,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13137,1,10298.0,N,,,8613,CHEMBL627639,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13138,1,10298.0,N,,,8613,CHEMBL627640,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13139,1,10298.0,N,,,8613,CHEMBL627641,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13140,1,10298.0,N,,,8613,CHEMBL627642,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13141,1,10298.0,N,,,8613,CHEMBL877506,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,13142,1,10090.0,N,,,8613,CHEMBL627275,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13143,1,9669.0,N,,,11219,CHEMBL627643,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,A,50506,1,,,Mustela putorius furo
,,,,Intermediate,BAO_0000218,13144,1,9669.0,N,,,11219,CHEMBL631246,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,A,50506,1,,,Mustela putorius furo
,,,,Intermediate,BAO_0000218,13145,1,9669.0,N,,,11219,CHEMBL631247,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,A,50506,1,,,Mustela putorius furo
,,,,Intermediate,BAO_0000218,13146,1,9669.0,N,,,11219,CHEMBL629532,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,A,50506,1,,,Mustela putorius furo
,,,,Intermediate,BAO_0000218,13147,1,9669.0,N,,,11219,CHEMBL629533,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,A,50506,1,,,Mustela putorius furo
,,,,Intermediate,BAO_0000218,13148,1,9669.0,N,,,11219,CHEMBL629534,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,A,50506,1,,,Mustela putorius furo
,,,,Intermediate,BAO_0000218,13149,1,9669.0,N,,,11219,CHEMBL629535,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,A,50506,1,,,Mustela putorius furo
,,,,Autocuration,BAO_0000019,13150,0,,U,,,14837,CHEMBL625932,,Pharmacokinetic parameter :drug bound to plasma was reported,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13151,0,,U,,,14837,CHEMBL625933,,compound was evaluated for drug bound in plasma,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13152,1,10116.0,N,,,15343,CHEMBL625934,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000218,13153,0,9347.0,U,,,13761,CHEMBL625935,,Bioavailability,,A,22224,1,,,Eutheria
,,,,Intermediate,BAO_0000218,13154,1,10116.0,N,,,14810,CHEMBL625936,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13155,1,10116.0,N,,,14810,CHEMBL625937,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13156,1,9615.0,N,,,13249,CHEMBL625938,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13157,1,10116.0,N,,,9267,CHEMBL625939,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Bile,A,50597,1,,1970.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13158,1,10116.0,N,,,9267,CHEMBL625940,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Bile,A,50597,1,,1970.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13159,1,10116.0,N,,,9267,CHEMBL874464,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Bile,A,50597,1,,1970.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13160,1,10116.0,N,,,9267,CHEMBL625941,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Bile,A,50597,1,,1970.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13161,1,10116.0,N,,,9267,CHEMBL625942,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Bile,A,50597,1,,1970.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13162,1,10116.0,N,,,9267,CHEMBL625943,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Bile,A,50597,1,,1970.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13163,1,9606.0,N,,,15549,CHEMBL625944,,In vitro protein binding in human serum at 5 ug/ml,Serum,A,50587,1,,1977.0,Homo sapiens
,,,,Autocuration,BAO_0000019,13164,0,,U,,,10929,CHEMBL625945,,Serum protein binding ability was measured,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13165,0,,U,,,15444,CHEMBL625946,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13166,0,9615.0,U,,,12860,CHEMBL625947,,Oral bioavailability in dog,,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13167,1,10116.0,N,,,12170,CHEMBL625948,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13168,0,,U,,,15173,CHEMBL625949,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13169,0,,U,,,15173,CHEMBL625950,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13170,0,9347.0,U,,,15173,CHEMBL625951,,Oral bioavailability (dose 15 mg/kg i.v.),,A,22224,1,,,Eutheria
,In vivo,,,Autocuration,BAO_0000218,13171,0,,U,,,15173,CHEMBL625952,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13172,0,,U,,,15173,CHEMBL625953,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13173,0,,U,,,15173,CHEMBL625954,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13174,0,,U,,,15173,CHEMBL882959,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13175,1,9615.0,N,,,11767,CHEMBL625955,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,13176,0,9669.0,U,,,11219,CHEMBL625956,,Bioavailability in ferret,,A,22224,1,,,Mustela putorius furo
,In vivo,,,Intermediate,BAO_0000218,13177,1,9541.0,N,,,12186,CHEMBL625957,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,A,100710,1,,,Macaca fascicularis
,,,,Intermediate,BAO_0000218,13178,1,10116.0,N,,,11510,CHEMBL625958,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13179,1,10116.0,N,,,11510,CHEMBL625959,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13180,1,10116.0,N,,,11510,CHEMBL626642,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13181,1,10116.0,N,,,11510,CHEMBL631330,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13182,1,10116.0,N,,,11510,CHEMBL631331,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13183,1,10116.0,N,,,11510,CHEMBL631332,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13184,1,10116.0,N,,,11510,CHEMBL631333,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13185,1,10116.0,N,,,11510,CHEMBL632018,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13186,1,10116.0,N,,,11510,CHEMBL632019,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13187,1,10116.0,N,,,11510,CHEMBL632020,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13188,1,10116.0,N,,,11510,CHEMBL632021,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13189,1,10116.0,N,,,11510,CHEMBL632022,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13190,1,10116.0,N,,,11510,CHEMBL632023,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13191,1,10116.0,N,,,11510,CHEMBL632024,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13192,1,10116.0,N,,,11510,CHEMBL874472,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13193,1,10116.0,N,,,11510,CHEMBL632025,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13194,1,10116.0,N,,,11510,CHEMBL632026,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13195,1,10116.0,N,,,11510,CHEMBL632027,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13196,1,10116.0,N,,,11510,CHEMBL632028,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13197,1,10116.0,N,,,11510,CHEMBL626430,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13198,1,10116.0,N,,,11510,CHEMBL626431,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13199,1,10116.0,N,,,11510,CHEMBL626432,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13200,1,10116.0,N,,,11510,CHEMBL626433,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13201,1,10116.0,N,,,11510,CHEMBL626434,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13202,1,10116.0,N,,,11510,CHEMBL627280,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13203,1,10116.0,N,,,11510,CHEMBL627281,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13204,1,10116.0,N,,,11510,CHEMBL627282,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,13205,0,,U,,,7199,CHEMBL627283,,Total body clearance was measured at given dose,,A,22224,1,,,
,,,,Autocuration,BAO_0000218,13206,0,,U,,,7199,CHEMBL627284,,Total body clearance was measured at given dose.,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13207,1,10116.0,N,,,7095,CHEMBL627285,,Metabolic clearance from the body in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13208,0,,U,,,7095,CHEMBL627286,,Renal clearance from the body,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13209,1,10116.0,N,,,7095,CHEMBL875477,,Renal clearance from the body in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13210,1,10116.0,N,,,12528,CHEMBL627287,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13211,1,9615.0,N,,,12528,CHEMBL627288,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13212,1,10116.0,N,,,7095,CHEMBL627289,,Total clearance from the body in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13213,1,10116.0,N,,,14223,CHEMBL627290,,Clearance into cortex from rat plasma or PBS,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13214,0,,U,,,13569,CHEMBL627291,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13215,0,,U,,,13569,CHEMBL627292,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13216,0,,U,,,13569,CHEMBL627293,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13217,0,,U,,,13569,CHEMBL627294,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13218,0,,U,,,13569,CHEMBL875478,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13219,0,,U,,,13979,CHEMBL627295,,Clearance was determined,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13220,1,10090.0,N,,,14315,CHEMBL627296,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13221,1,9986.0,N,,,14315,CHEMBL626119,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,A,50592,1,,,Oryctolagus cuniculus
,In vivo,,,Intermediate,BAO_0000218,13222,1,10116.0,N,,,14315,CHEMBL626120,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13223,1,10116.0,N,,,12174,CHEMBL626121,,Clearance in rat after iv dose (100 ug/kg),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13224,0,10141.0,U,,,12797,CHEMBL626122,,Clearance in guinea pig,,A,22224,1,,,Cavia porcellus
,In vivo,,,Intermediate,BAO_0000218,13225,1,10116.0,N,,,12797,CHEMBL626123,,Compound was evaluated for clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13226,1,9615.0,N,,,12797,CHEMBL623456,,Compound was evaluated for the clearance in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13227,1,10116.0,N,,,12797,CHEMBL623457,,Compound was evaluated for the clearance in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13228,1,10116.0,N,,,11500,CHEMBL623458,,Compound was tested in vivo for clearance after iv administration in the rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13229,0,,U,,,15173,CHEMBL623459,,IV clearance determined at an iv dose of 14 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13230,0,,U,,,15173,CHEMBL875484,,IV clearance determined at an iv dose of 15.2 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13231,0,,U,,,15173,CHEMBL623460,,IV clearance determined at an iv dose of 15 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13232,0,,U,,,15173,CHEMBL623461,,IV clearance determined at an peroral dose of 30 mg/kg.,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13233,0,,U,,,15173,CHEMBL623462,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13234,0,,U,,,15173,CHEMBL627386,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13235,1,10116.0,N,,,14198,CHEMBL627387,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13236,1,10116.0,N,,,14198,CHEMBL627388,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13237,1,10116.0,N,,,14198,CHEMBL627389,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13238,1,10116.0,N,,,14198,CHEMBL627390,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13239,1,10116.0,N,,,14198,CHEMBL627391,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13240,1,10116.0,N,,,14198,CHEMBL627392,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13241,1,10116.0,N,,,14198,CHEMBL627393,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13242,1,10116.0,N,,,14198,CHEMBL627394,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Trachea,A,50597,1,,3126.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13243,1,10116.0,N,,,14198,CHEMBL627395,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13244,1,10116.0,N,,,14198,CHEMBL875485,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13245,1,10116.0,N,,,14198,CHEMBL627396,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13246,1,10116.0,N,,,14198,CHEMBL627397,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13247,1,10116.0,N,,,14198,CHEMBL627398,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13248,1,10116.0,N,,,14198,CHEMBL627399,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13249,1,10116.0,N,,,14198,CHEMBL627400,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13250,1,10116.0,N,,,14198,CHEMBL627401,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13251,1,10116.0,N,,,14198,CHEMBL627402,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13252,1,10116.0,N,,,14198,CHEMBL627403,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13253,1,10116.0,N,,,14198,CHEMBL627404,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13254,1,10116.0,N,,,14198,CHEMBL623101,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13255,1,10116.0,N,,,14198,CHEMBL877480,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13256,1,10116.0,N,,,14198,CHEMBL623102,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Trachea,A,50597,1,,3126.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13257,1,10116.0,N,,,14198,CHEMBL623103,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13258,1,10116.0,N,,,14198,CHEMBL623104,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13259,1,10116.0,N,,,14198,CHEMBL623105,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13260,1,10116.0,N,,,14198,CHEMBL623106,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13261,1,10116.0,N,,,14198,CHEMBL623107,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13262,1,10116.0,N,,,14198,CHEMBL623108,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13263,1,10116.0,N,,,14198,CHEMBL623109,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13264,1,10116.0,N,,,14198,CHEMBL623110,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13265,1,10116.0,N,,,14198,CHEMBL623111,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13266,1,10116.0,N,,,14198,CHEMBL625060,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13267,1,10116.0,N,,,14198,CHEMBL625061,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13268,1,10116.0,N,,,14198,CHEMBL625062,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13269,1,10116.0,N,,,14198,CHEMBL625063,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13270,1,10116.0,N,,,14198,CHEMBL625064,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Trachea,A,50597,1,,3126.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13271,1,10116.0,N,,,14198,CHEMBL625065,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Bone,A,50597,1,,10000001.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13272,1,10116.0,N,,,14198,CHEMBL625066,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13273,1,10116.0,N,,,14198,CHEMBL625067,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13274,1,10116.0,N,,,14198,CHEMBL625068,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13275,1,10116.0,N,,,14198,CHEMBL622159,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13276,1,10116.0,N,,,14198,CHEMBL622160,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Intestine,A,50597,1,,160.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13277,1,10116.0,N,,,14198,CHEMBL622161,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13278,1,10116.0,N,,,14198,CHEMBL622162,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13279,1,10116.0,N,,,14198,CHEMBL622163,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13280,1,10116.0,N,,,14198,CHEMBL622313,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13281,1,10116.0,N,,,14198,CHEMBL622314,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13282,1,10116.0,N,,,14198,CHEMBL622315,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13283,1,10116.0,N,,,14198,CHEMBL622316,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Trachea,A,50597,1,,3126.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13284,1,562.0,N,,,15599,CHEMBL877486,,Normal diffusion coefficient in water for Escherichia coli,,A,50212,1,,,Escherichia coli
,,,,Autocuration,BAO_0000019,13285,0,,U,,,8204,CHEMBL622317,,Average max percent decrease in RVR (renal vascular resistance) was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13286,0,,U,,,8204,CHEMBL622318,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13287,0,,U,,,6154,CHEMBL622319,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13288,0,,U,,,6154,CHEMBL622320,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13289,0,,U,,,6154,CHEMBL622321,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13290,0,,U,,,6154,CHEMBL622322,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13291,0,,U,,,7114,CHEMBL622323,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13292,1,10116.0,N,,,7114,CHEMBL622324,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13293,1,9615.0,N,,,8133,CHEMBL622325,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13294,1,9615.0,N,,,8133,CHEMBL622326,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13295,1,9615.0,N,,,8133,CHEMBL877487,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13296,1,9615.0,N,,,8133,CHEMBL622327,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13297,1,9615.0,N,,,8133,CHEMBL622328,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13298,1,9615.0,N,,,8133,CHEMBL622329,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13299,1,9615.0,N,,,8133,CHEMBL622330,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13300,1,9615.0,N,,,8133,CHEMBL622331,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13301,1,9615.0,N,,,8133,CHEMBL622332,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13302,1,9615.0,N,,,8133,CHEMBL622333,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,13303,0,314293.0,U,,,8133,CHEMBL627658,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13304,0,314293.0,U,,,8133,CHEMBL630428,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13305,0,314293.0,U,,,8133,CHEMBL630429,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13306,0,314293.0,U,,,8133,CHEMBL630430,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13307,0,314293.0,U,,,8133,CHEMBL630431,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Intermediate,BAO_0000218,13308,1,10116.0,N,,,8133,CHEMBL630432,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13309,1,10116.0,N,,,8133,CHEMBL630433,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13310,1,10116.0,N,,,8133,CHEMBL630434,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13311,1,10116.0,N,,,8133,CHEMBL629372,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13312,1,10116.0,N,,,8133,CHEMBL629553,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13313,1,10116.0,N,,,8133,CHEMBL629554,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13314,1,10116.0,N,,,8133,CHEMBL874447,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13315,1,10116.0,N,,,8133,CHEMBL629555,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13316,1,10116.0,N,,,8133,CHEMBL629556,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13317,1,10116.0,N,,,8133,CHEMBL629557,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13318,1,10116.0,N,,,8133,CHEMBL629558,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13319,1,10116.0,N,,,8133,CHEMBL629559,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13320,1,10116.0,N,,,8133,CHEMBL629560,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13321,1,9615.0,N,,,8133,CHEMBL629561,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13322,1,9615.0,N,,,8133,CHEMBL629562,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13323,1,9615.0,N,,,8133,CHEMBL629563,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13324,1,9615.0,N,,,8133,CHEMBL629564,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13325,1,9615.0,N,,,8133,CHEMBL629565,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13326,1,9615.0,N,,,8133,CHEMBL629566,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13327,1,9615.0,N,,,8133,CHEMBL629567,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13328,1,9615.0,N,,,8133,CHEMBL629568,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13329,1,9615.0,N,,,8133,CHEMBL629569,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13330,1,9615.0,N,,,8133,CHEMBL629570,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,13331,0,314293.0,U,,,8133,CHEMBL629571,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,In vivo,,,Autocuration,BAO_0000218,13332,0,10116.0,U,,,12170,CHEMBL629572,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13333,0,10116.0,U,,,12170,CHEMBL629573,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13334,0,9347.0,U,,,4985,CHEMBL629574,,Bioavailability (dose 20 mg/kg),,A,22224,1,,,Eutheria
,In vivo,,,Autocuration,BAO_0000218,13335,0,9615.0,U,,,15145,CHEMBL629575,,Bioavailability in dog,,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,13336,0,10116.0,U,,,14080,CHEMBL874448,,Bioavailability in rat (Sprague-Dawley) (male),,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13337,0,9443.0,U,,,11219,CHEMBL629576,,Bioavailability in monkey (dose 10 mg/kg i.d.),,A,22224,1,,,Primates
,In vivo,,,Autocuration,BAO_0000218,13338,0,10116.0,U,,,15145,CHEMBL629577,,Bioavailability in rat,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13339,0,10116.0,U,,,15145,CHEMBL629578,,Bioavailability in rat,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13340,0,9615.0,U,,,1202,CHEMBL629579,,Bioavailability in dog (dose 3.0 mg/kg p.o.),,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,13341,0,9615.0,U,,,1202,CHEMBL882958,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13342,1,9598.0,N,,,1202,CHEMBL629580,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,A,50505,1,,,Pan troglodytes
,In vivo,,,Autocuration,BAO_0000218,13343,0,9347.0,U,,,4026,CHEMBL629581,,Bioavailability,,A,22224,1,,,Eutheria
,In vivo,,,Autocuration,BAO_0000218,13344,0,9520.0,U,,,1492,CHEMBL629582,,Bioavailability in squirrel monkey,,A,22224,1,,,Saimiri
,In vivo,,,Intermediate,BAO_0000218,13345,1,9615.0,N,,,12793,CHEMBL628522,,Bioavailability was evaluated in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13346,1,10026.0,N,,,12793,CHEMBL625432,,Bioavailability was evaluated in hamster,,A,100712,1,,,Cricetinae
,In vivo,,,Autocuration,BAO_0000218,13347,0,10116.0,U,,,12793,CHEMBL625433,,Bioavailability in rat,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13348,1,10116.0,N,,,14793,CHEMBL625434,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13349,1,10116.0,N,,,14793,CHEMBL625435,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13350,0,10116.0,U,,,14793,CHEMBL625436,,Bioavailability in rat (dose 10 mg/kg p.o.),,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13351,1,9541.0,N,,,14731,CHEMBL874588,,Bioavailability was measured in cynomolgus monkeys.,,A,100710,1,,,Macaca fascicularis
,In vivo,,,Intermediate,BAO_0000218,13352,1,10090.0,N,,,14731,CHEMBL625437,,Bioavailability was measured in nude mice.,,A,50594,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,13353,0,9669.0,U,,,12187,CHEMBL625438,,Bioavailability in ferret (dose 10 mg/kg i.d.),,A,22224,1,,,Mustela putorius furo
,In vivo,,,Autocuration,BAO_0000218,13354,0,314293.0,U,,,12187,CHEMBL625439,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,A,22224,1,,,Simiiformes
,In vivo,,,Autocuration,BAO_0000218,13355,0,314293.0,U,,,12187,CHEMBL625440,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,A,22224,1,,,Simiiformes
,In vivo,,,Autocuration,BAO_0000218,13356,0,314293.0,U,,,12187,CHEMBL625441,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,A,22224,1,,,Simiiformes
,In vivo,,,Autocuration,BAO_0000218,13357,0,10116.0,U,,,12187,CHEMBL625442,,Bioavailability in rat (dose 10 mg/kg i.d.),,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13358,1,10116.0,N,,,12187,CHEMBL625443,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13359,0,,U,,,17431,CHEMBL625444,,Bioavailability was determined; extremely poor,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13360,1,10090.0,N,,,13318,CHEMBL625445,,% bioavailability in mice after oral administration of prodrug,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13361,1,9615.0,N,,,9025,CHEMBL625446,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13362,1,9615.0,N,,,9025,CHEMBL882960,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13363,1,9615.0,N,,,9025,CHEMBL625447,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13364,1,9615.0,N,,,9025,CHEMBL625448,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13365,1,9615.0,N,,,9025,CHEMBL625449,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13366,1,9615.0,N,,,9025,CHEMBL874589,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13367,1,9615.0,N,,,9025,CHEMBL625450,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13368,1,9615.0,N,,,9025,CHEMBL625451,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13369,1,9615.0,N,,,9025,CHEMBL626584,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13370,1,9615.0,N,,,9025,CHEMBL626585,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13371,1,9615.0,N,,,9025,CHEMBL626586,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13372,1,9615.0,N,,,9025,CHEMBL626587,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13373,1,9615.0,N,,,9025,CHEMBL626588,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13374,1,9615.0,N,,,9025,CHEMBL626589,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13375,1,9615.0,N,,,9025,CHEMBL626590,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13376,1,9615.0,N,,,9025,CHEMBL626591,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13377,1,9615.0,N,,,9025,CHEMBL627181,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13378,1,9615.0,N,,,9025,CHEMBL628083,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,13379,0,,U,,,15173,CHEMBL628084,,IV clearance determined at an peroral dose of 15 mg/kg.,,A,22224,1,,,
,In vivo,,,Expert,BAO_0000218,13380,1,102285.0,N,,,7732,CHEMBL628085,,Mouse oral clearance was measured against Hymenolepiasis nana.,,F,50064,1,,,Hymenolepis nana
,In vivo,,,Expert,BAO_0000218,13381,1,6339.0,N,,,7732,CHEMBL628086,,Mouse oral clearance was measured against Nematospiroides dubius,,F,50545,1,,,Heligmosomoides polygyrus
,In vivo,,,Autocuration,BAO_0000218,13382,0,,U,,,7732,CHEMBL628087,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,F,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13383,1,10090.0,N,,,7732,CHEMBL628088,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,A,50594,1,,,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,13384,0,,U,,,7732,CHEMBL628089,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,B,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13385,0,,U,,,8328,CHEMBL628090,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13386,0,,U,,,8328,CHEMBL628091,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13387,0,,U,,,8328,CHEMBL628092,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13388,0,,U,,,8328,CHEMBL628093,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13389,0,,U,,,8328,CHEMBL875607,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13390,0,,U,,,8328,CHEMBL625710,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13391,0,,U,,,8328,CHEMBL625711,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13392,0,,U,,,8328,CHEMBL625712,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13393,0,,U,,,8328,CHEMBL625713,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13394,1,9615.0,N,,,13376,CHEMBL625714,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13395,1,9544.0,N,,,13477,CHEMBL625715,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,A,50797,1,,,Macaca mulatta
,In vivo,,,Intermediate,BAO_0000218,13396,1,10116.0,N,,,13477,CHEMBL625716,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13397,1,10116.0,N,,,13477,CHEMBL625717,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13398,1,10116.0,N,,,13313,CHEMBL625718,,Plasma clearance was determined for the compound in rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13399,1,10116.0,N,,,12504,CHEMBL625719,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13400,1,10116.0,N,,,12504,CHEMBL625720,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13401,1,10116.0,N,,,12504,CHEMBL625721,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13402,1,10116.0,N,,,12504,CHEMBL625722,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13403,1,10116.0,N,,,13129,CHEMBL625723,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13404,1,6339.0,N,,,7732,CHEMBL625724,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,A,50545,1,,,Heligmosomoides polygyrus
,In vivo,,,Intermediate,BAO_0000218,13405,1,6339.0,N,,,7732,CHEMBL625725,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,A,50545,1,,,Heligmosomoides polygyrus
,In vivo,,,Intermediate,BAO_0000218,13406,1,6339.0,N,,,7732,CHEMBL625726,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,A,50545,1,,,Heligmosomoides polygyrus
,In vivo,,,Intermediate,BAO_0000218,13407,1,6339.0,N,,,7732,CHEMBL875608,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,A,50545,1,,,Heligmosomoides polygyrus
,In vivo,,,Intermediate,BAO_0000218,13408,1,6339.0,N,,,7732,CHEMBL625727,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,A,50545,1,,,Heligmosomoides polygyrus
,In vivo,,,Autocuration,BAO_0000218,13409,0,10116.0,U,,,9278,CHEMBL625728,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Urine,A,22224,1,,1088.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13410,0,10116.0,U,,,9278,CHEMBL625729,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13411,0,10116.0,U,,,9278,CHEMBL625730,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13412,0,10116.0,U,,,9278,CHEMBL625731,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Urine,A,22224,1,,1088.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13413,0,10116.0,U,,,9278,CHEMBL626417,,Urinary clearance was determined in rat at 25 mg/kg os dosage,Urine,A,22224,1,,1088.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13414,1,9606.0,N,,,9278,CHEMBL626418,,Urinary clearance was determined at 100 mg/kg oral dosage in human,Urine,A,50587,1,,1088.0,Homo sapiens
,In vivo,,,Intermediate,BAO_0000218,13415,1,9615.0,N,,,9278,CHEMBL626419,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13416,1,9615.0,N,,,5932,CHEMBL626592,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13417,1,10116.0,N,,,5932,CHEMBL626593,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13418,1,10116.0,N,,,5182,CHEMBL626594,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13419,1,9615.0,N,,,10499,CHEMBL625035,,Clearance rate in dogs,,A,50588,1,,,Canis lupus familiaris
,In vitro,,,Autocuration,BAO_0000019,13420,0,,U,,,6051,CHEMBL625036,,Compound was measured for intrinsic clearance,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13421,0,,U,,,17508,CHEMBL625037,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13422,0,,U,,,6228,CHEMBL625038,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13423,0,,U,,,6231,CHEMBL625039,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13424,0,,U,,,17740,CHEMBL625040,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13425,0,,U,,,6495,CHEMBL625041,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13426,0,,U,,,2171,CHEMBL625042,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13427,0,,U,,,3255,CHEMBL874411,,Partition coefficient of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13428,0,,U,,,6821,CHEMBL625043,,Permeability,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13429,0,,U,,,2685,CHEMBL625044,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13430,0,,U,,,17584,CHEMBL625045,,Partition coefficient (logD),,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13431,0,,U,,,13824,CHEMBL625046,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13432,0,,U,,,13824,CHEMBL625047,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13433,0,,U,,,16479,CHEMBL625048,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13434,0,,U,,,11997,CHEMBL625049,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13435,0,,U,,,2988,CHEMBL625050,,Calculated logarithm of partition coefficient (P) was determined,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13436,0,,U,,,931,CHEMBL625051,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13437,0,,U,,,4381,CHEMBL874412,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13438,0,,U,,,4397,CHEMBL625052,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13439,0,,U,,,5889,CHEMBL625053,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13440,0,,U,,,6154,CHEMBL623250,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13441,0,,U,,,6154,CHEMBL623251,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13442,0,,U,,,6154,CHEMBL623252,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13443,0,,U,,,6154,CHEMBL623253,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13444,0,,U,,,6154,CHEMBL623254,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13445,0,,U,,,6154,CHEMBL623255,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13446,0,,U,,,6887,CHEMBL626831,,Percent degradation of compound at a pH of 1 over a 18 hr period,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13447,0,,U,,,6887,CHEMBL877494,,Percent degradation of compound at pH of 1 over an 18 hr period,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13448,0,,U,,,14116,CHEMBL626832,,Delta Logarithm of Partition Coefficient value was determined.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13449,0,,U,,,11137,CHEMBL626833,,Delta logPoct-cyc,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13450,0,,U,,,7230,CHEMBL626834,,Lipophilicity estimated on reversed phase TLC,,P,22224,1,,,
,,,,Autocuration,BAO_0000019,13451,0,,U,,,15741,CHEMBL626835,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13452,0,,U,,,9663,CHEMBL626836,,Delta logPoct-cyc,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13453,0,,U,,,9663,CHEMBL626837,,Change in logarithm of partition coefficient of the compound,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13454,0,,U,,,13807,CHEMBL626838,,Delta logD (pH 6.5),,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13455,0,,U,,,13807,CHEMBL626839,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,P,22224,1,,,
,,,,Autocuration,BAO_0000019,13456,0,,U,,,17425,CHEMBL626840,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13457,0,,U,,,12143,CHEMBL626841,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,A,22224,1,,,
,,,,Autocuration,BAO_0000219,13458,0,,U,,,12608,CHEMBL626842,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,A,22224,1,,,
,,,,Autocuration,BAO_0000219,13459,0,,U,,,12608,CHEMBL626843,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13460,1,10116.0,N,,,8649,CHEMBL626844,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13461,1,10116.0,N,,,8649,CHEMBL877495,,Amount of deuterium retained was reported after normal workup in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13462,1,10116.0,N,,,8649,CHEMBL626845,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13463,1,10116.0,N,,,8649,CHEMBL626846,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13464,1,10116.0,N,,,8649,CHEMBL626847,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13465,1,10116.0,N,,,8649,CHEMBL628677,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13466,1,10116.0,N,,,8649,CHEMBL628678,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,13467,0,,U,,,9659,CHEMBL628679,,Compound was subjected to electrochemical oxidation,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13468,0,,U,,,9659,CHEMBL628680,,Compound was subjected to photochemical oxidation,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13469,0,,U,,,9659,CHEMBL628681,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13470,0,,U,,,9659,CHEMBL628682,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13471,0,,U,,,9659,CHEMBL628683,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13472,1,10116.0,N,,,9607,CHEMBL628684,,Percent diffusion through fuzzy rat skin after 48 h of incubation,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000100,13473,0,,U,,,7057,CHEMBL877501,,Dissociation constant (pKa),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13474,0,,U,,,7057,CHEMBL628685,,Dissociation constant value of the compound; ND means not determined.,,P,22224,1,,,
,,,,Intermediate,BAO_0000218,13475,1,10116.0,N,,,7911,CHEMBL628686,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13476,1,10116.0,N,,,7911,CHEMBL628687,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13477,1,10116.0,N,,,7911,CHEMBL628688,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13478,1,10116.0,N,,,7911,CHEMBL628689,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13479,1,10116.0,N,,,7911,CHEMBL628690,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13480,1,10116.0,N,,,7911,CHEMBL629363,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13481,1,10116.0,N,,,7911,CHEMBL629364,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13482,1,10116.0,N,,,7911,CHEMBL629365,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13483,1,10116.0,N,,,7911,CHEMBL629366,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13484,1,10116.0,N,,,7911,CHEMBL629367,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13485,1,10116.0,N,,,7911,CHEMBL629368,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Feces,A,50597,1,,1988.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13486,1,10116.0,N,,,7911,CHEMBL877502,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13487,1,10090.0,N,,,13792,CHEMBL629369,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Cerebellum,A,50594,1,,2037.0,Mus musculus
,,,,Intermediate,BAO_0000218,13488,1,10090.0,N,,,13792,CHEMBL629370,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Brain,A,50594,1,,955.0,Mus musculus
,,,,Autocuration,BAO_0000218,13489,0,314293.0,U,,,8133,CHEMBL629371,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13490,0,314293.0,U,,,8133,CHEMBL626276,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13491,0,314293.0,U,,,8133,CHEMBL626277,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13492,0,314293.0,U,,,8133,CHEMBL631250,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Intermediate,BAO_0000218,13493,1,10116.0,N,,,8133,CHEMBL631251,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13494,1,10116.0,N,,,8133,CHEMBL631252,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13495,1,10116.0,N,,,8133,CHEMBL631253,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13496,1,10116.0,N,,,8133,CHEMBL631254,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13497,1,10116.0,N,,,8133,CHEMBL631255,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13498,1,10116.0,N,,,8133,CHEMBL631256,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13499,1,10116.0,N,,,8133,CHEMBL631257,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13500,1,10116.0,N,,,8133,CHEMBL628009,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13501,1,10116.0,N,,,8133,CHEMBL628010,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13502,1,10116.0,N,,,8133,CHEMBL628011,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13503,1,10116.0,N,,,8133,CHEMBL628012,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13504,1,10116.0,N,,,8133,CHEMBL628013,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13505,1,10116.0,N,,,8133,CHEMBL628014,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13506,1,9615.0,N,,,8133,CHEMBL628015,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13507,1,9615.0,N,,,8133,CHEMBL628016,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13508,1,9615.0,N,,,8133,CHEMBL874461,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13509,1,9615.0,N,,,8133,CHEMBL628017,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13510,1,9615.0,N,,,8133,CHEMBL628018,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13511,1,9615.0,N,,,8133,CHEMBL628019,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13512,1,9615.0,N,,,8133,CHEMBL628020,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13513,1,9615.0,N,,,8133,CHEMBL628021,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13514,1,9615.0,N,,,8133,CHEMBL628022,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13515,1,9615.0,N,,,8133,CHEMBL628023,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Autocuration,BAO_0000218,13516,0,314293.0,U,,,8133,CHEMBL628024,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13517,0,314293.0,U,,,8133,CHEMBL628025,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13518,0,314293.0,U,,,8133,CHEMBL628026,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13519,0,314293.0,U,,,8133,CHEMBL628027,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Autocuration,BAO_0000218,13520,0,314293.0,U,,,8133,CHEMBL628028,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Urine,A,22224,1,,1088.0,Simiiformes
,,,,Intermediate,BAO_0000218,13521,1,10116.0,N,,,8133,CHEMBL628029,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13522,1,10116.0,N,,,8133,CHEMBL628030,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13523,1,10116.0,N,,,8133,CHEMBL628031,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13524,1,10116.0,N,,,8133,CHEMBL628032,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13525,1,10116.0,N,,,8133,CHEMBL628033,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13526,1,10116.0,N,,,8133,CHEMBL628034,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13527,1,10116.0,N,,,8133,CHEMBL628035,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13528,1,10116.0,N,,,8133,CHEMBL628036,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13529,1,10116.0,N,,,8133,CHEMBL874462,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13530,1,9615.0,N,,,9025,CHEMBL628037,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13531,1,9615.0,N,,,9025,CHEMBL628123,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13532,1,9615.0,N,,,9025,CHEMBL628124,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13533,1,9615.0,N,,,9025,CHEMBL628125,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13534,1,9615.0,N,,,9025,CHEMBL628126,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13535,1,9615.0,N,,,9025,CHEMBL628127,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13536,1,9615.0,N,,,9025,CHEMBL628128,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13537,1,9615.0,N,,,9025,CHEMBL628129,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13538,1,9615.0,N,,,9025,CHEMBL628130,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13539,1,9615.0,N,,,9025,CHEMBL628131,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13540,1,9615.0,N,,,9025,CHEMBL628132,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13541,1,9615.0,N,,,9025,CHEMBL628133,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13542,1,9615.0,N,,,9025,CHEMBL628134,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13543,1,9615.0,N,,,9025,CHEMBL628135,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13544,1,9615.0,N,,,9025,CHEMBL628136,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13545,1,9615.0,N,,,9025,CHEMBL628137,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13546,1,9615.0,N,,,9025,CHEMBL628138,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13547,1,9615.0,N,,,9025,CHEMBL628139,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13548,1,9615.0,N,,,9025,CHEMBL628140,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13549,1,9615.0,N,,,9025,CHEMBL628141,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13550,1,9615.0,N,,,9025,CHEMBL628142,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13551,1,9615.0,N,,,9025,CHEMBL628143,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13552,1,9615.0,N,,,9025,CHEMBL628144,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13553,1,9615.0,N,,,9025,CHEMBL628145,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13554,1,9615.0,N,,,9025,CHEMBL628146,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13555,1,9615.0,N,,,9025,CHEMBL625355,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13556,1,9615.0,N,,,9025,CHEMBL625356,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13557,1,9615.0,N,,,9025,CHEMBL625357,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13558,1,9615.0,N,,,9025,CHEMBL625527,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13559,1,9615.0,N,,,9025,CHEMBL875473,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13560,1,9615.0,N,,,9025,CHEMBL625528,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13561,1,10116.0,N,,,9025,CHEMBL626304,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13562,1,9615.0,N,,,9025,CHEMBL624138,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Artery,A,50588,1,,1637.0,Canis lupus familiaris
,,,,Autocuration,BAO_0000100,13563,0,,U,,,6448,CHEMBL624139,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13564,0,,U,,,17221,CHEMBL624140,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13565,0,,U,,,6545,CHEMBL624141,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13566,0,,U,,,577,CHEMBL624142,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13567,0,,U,,,6285,CHEMBL624143,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13568,0,,U,,,6500,CHEMBL624144,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13569,0,,U,,,6716,CHEMBL624145,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13570,0,,U,,,13658,CHEMBL624146,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13571,0,,U,,,6549,CHEMBL624147,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13572,0,,U,,,14685,CHEMBL883123,,Calculated partition coefficient (clogP) (MacLogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13573,0,,U,,,6893,CHEMBL624148,,Partition coefficient (logP),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13574,0,,U,,,3687,CHEMBL874416,,Kinetic parameter was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13575,0,,U,,,4207,CHEMBL624149,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13576,0,,U,,,4626,CHEMBL624150,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13577,0,,U,,,1021,CHEMBL624151,,Lipophilicity was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,13578,0,,U,,,3777,CHEMBL624152,,Lipophilicity was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,13579,0,,U,,,17533,CHEMBL622139,,Lipophilicity was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,13580,0,,U,,,6524,CHEMBL622140,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13581,0,,U,,,17533,CHEMBL622141,,Lipophilicity was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,13582,0,,U,,,6480,CHEMBL622142,,Lipophilicity in octanol-water,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,13583,0,,U,,,17606,CHEMBL622143,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13584,0,,U,,,6863,CHEMBL622144,,Octanol-water partition coefficient was determined,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13585,0,,U,,,1356,CHEMBL877473,,Partition coefficient (logP),,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13586,0,,U,,,3326,CHEMBL622145,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13587,0,,U,,,1356,CHEMBL622146,,Partition coefficient was determined; ND means not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13588,0,,U,,,12984,CHEMBL622147,,Calculated partition coefficient (clogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13589,0,,U,,,17363,CHEMBL622148,,Partition coefficient of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13590,0,,U,,,6827,CHEMBL883124,,Permeability was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13591,0,,U,,,261,CHEMBL622149,,The compound was evaluated for the partition coefficient,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13592,0,,U,,,2685,CHEMBL622150,,Partition coefficient (logP),,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13593,0,,U,,,414,CHEMBL622151,,The lipophilicity was reported,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,13594,0,,U,,,15769,CHEMBL622152,,logarithm of the octanol-water partition coefficient for the compound,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13595,0,,U,,,17248,CHEMBL622153,,Clogp value was determined,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13596,0,,U,,,16935,CHEMBL877474,,Clp at a dose of 1.5 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13597,0,,U,,,16935,CHEMBL622154,,Clp at a dose of 2.0 mg/kg,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13598,0,,U,,,14832,CHEMBL622155,,"Clp, plasma clearance at a dose of 10 mg/kg",Plasma,A,22224,1,,1969.0,
,In vivo,,,Autocuration,BAO_0000218,13599,0,,U,,,14832,CHEMBL622156,,"Clp, plasma clearance at a dose of 50 mg/kg",Plasma,A,22224,1,,1969.0,
,In vivo,,,Intermediate,BAO_0000218,13600,1,10116.0,N,,,2399,CHEMBL622157,,Compound was tested for plasma clearance in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13601,1,10116.0,N,,,2399,CHEMBL622158,,Compound was tested for plasma clearance in rat; Not determined,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13602,1,10116.0,N,,,6227,CHEMBL622807,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13603,1,9544.0,N,,,6227,CHEMBL622808,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,A,50797,1,,,Macaca mulatta
,In vivo,,,Autocuration,BAO_0000218,13604,0,,U,,,5623,CHEMBL622809,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13605,0,,U,,,4854,CHEMBL622810,,Plasma clearance determined,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,13606,1,10026.0,N,,,4493,CHEMBL876653,,Plasma clearance after iv administration at 3 mg/kg in hamster,,A,100712,1,,,Cricetinae
,In vivo,,,Intermediate,BAO_0000218,13607,1,10026.0,N,,,4493,CHEMBL622811,,Plasma clearance after iv administration at 4 mg/kg in hamster,,A,100712,1,,,Cricetinae
,In vivo,,,Intermediate,BAO_0000218,13608,1,10116.0,N,,,14956,CHEMBL622986,,Rate of clearance in rat was determined,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13609,1,10116.0,N,,,15372,CHEMBL622987,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13610,1,10116.0,N,,,15372,CHEMBL622988,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13611,1,10116.0,N,,,15372,CHEMBL622989,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13612,1,10116.0,N,,,15372,CHEMBL622990,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13613,0,314293.0,U,,,15604,CHEMBL622991,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Plasma,A,22224,1,,1969.0,Simiiformes
,In vivo,,,Intermediate,BAO_0000218,13614,1,10116.0,N,,,15604,CHEMBL622227,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13615,1,9615.0,N,,,15604,CHEMBL622228,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13616,1,10116.0,N,,,14964,CHEMBL622229,,Clpl value in rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13617,1,10141.0,N,,,15240,CHEMBL622230,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,A,50512,1,,,Cavia porcellus
,In vivo,,,Intermediate,BAO_0000218,13618,1,10116.0,N,,,16449,CHEMBL622231,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13619,1,9541.0,N,,,16449,CHEMBL622232,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,A,100710,1,,,Macaca fascicularis
,In vivo,,,Autocuration,BAO_0000218,13620,0,,U,,,12902,CHEMBL622233,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13621,0,,U,,,12902,CHEMBL622234,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13622,0,,U,,,12902,CHEMBL622235,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13623,0,,U,,,12902,CHEMBL622236,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13624,0,,U,,,12902,CHEMBL622237,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13625,0,,U,,,12902,CHEMBL877482,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13626,0,,U,,,12902,CHEMBL622238,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13627,0,,U,,,12902,CHEMBL622239,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,13628,0,,U,,,11149,CHEMBL622240,,Cmax was calculated as maximum concentration reached in the blood,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,13629,0,,U,,,11149,CHEMBL622241,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,Blood,A,22224,1,,178.0,
,In vivo,,,Intermediate,BAO_0000218,13630,1,10116.0,N,,,5669,CHEMBL631013,,Cmax was determine after peroral administration at 10 mpk in Rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13631,1,9544.0,N,,,5669,CHEMBL631014,,Cmax was determine after peroral administration at 10 mpk in Rhesus,,A,50797,1,,,Macaca mulatta
,In vivo,,,Intermediate,BAO_0000218,13632,1,9615.0,N,,,5669,CHEMBL631015,,Cmax was determine after peroral administration at 10 mpk in dog,,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13633,1,10116.0,N,,,5669,CHEMBL631016,,Cmax was determine after peroral administration at 160 mpk in Rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13634,1,10116.0,N,,,5669,CHEMBL631017,,Cmax was determine after peroral administration at 20 mpk in Rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13635,1,10116.0,N,,,5669,CHEMBL631018,,Cmax was determine after peroral administration at 50 mpk in Rat,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,13636,0,,U,,,4236,CHEMBL631019,,Cmax was determined,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13637,1,10090.0,N,,,13792,CHEMBL875761,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,13638,1,10090.0,N,,,13792,CHEMBL631020,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,13639,1,10090.0,N,,,13792,CHEMBL631669,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,13640,1,10090.0,N,,,13792,CHEMBL631670,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,13641,1,10090.0,N,,,13792,CHEMBL631671,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Striatum,A,50594,1,,2435.0,Mus musculus
,,,,Intermediate,BAO_0000218,13642,1,10116.0,N,,,8418,CHEMBL631672,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13643,1,10116.0,N,,,8418,CHEMBL631673,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13644,1,10116.0,N,,,8418,CHEMBL631856,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13645,1,10116.0,N,,,8418,CHEMBL631857,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13646,1,10116.0,N,,,8418,CHEMBL631858,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13647,1,10116.0,N,,,8418,CHEMBL631859,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13648,1,10116.0,N,,,8418,CHEMBL631860,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13649,1,10116.0,N,,,8418,CHEMBL631861,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13650,1,10116.0,N,,,8418,CHEMBL631862,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13651,1,10116.0,N,,,8418,CHEMBL631863,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13652,1,10116.0,N,,,8418,CHEMBL631864,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13653,1,10116.0,N,,,8418,CHEMBL631865,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13654,1,10116.0,N,,,8418,CHEMBL631866,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13655,1,10116.0,N,,,8418,CHEMBL629360,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13656,1,10116.0,N,,,8418,CHEMBL629361,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13657,1,10116.0,N,,,8418,CHEMBL629362,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13658,1,10116.0,N,,,8418,CHEMBL630740,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13659,1,10116.0,N,,,8418,CHEMBL630741,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13660,1,10116.0,N,,,8418,CHEMBL630742,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13661,1,10116.0,N,,,8418,CHEMBL630743,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13662,1,10116.0,N,,,8418,CHEMBL630744,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13663,1,10116.0,N,,,8418,CHEMBL630745,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13664,1,10116.0,N,,,8418,CHEMBL630746,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13665,1,10116.0,N,,,8418,CHEMBL630747,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13666,1,10116.0,N,,,8418,CHEMBL630748,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13667,1,10116.0,N,,,8418,CHEMBL632056,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13668,1,10116.0,N,,,8418,CHEMBL632057,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13669,1,10116.0,N,,,8418,CHEMBL632058,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13670,1,10116.0,N,,,8418,CHEMBL632059,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13671,1,10116.0,N,,,8418,CHEMBL632060,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13672,1,10116.0,N,,,8418,CHEMBL632061,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13673,1,10116.0,N,,,8418,CHEMBL629207,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13674,1,10116.0,N,,,8418,CHEMBL629208,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13675,1,10116.0,N,,,8418,CHEMBL629209,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13676,1,10116.0,N,,,8418,CHEMBL629210,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13677,1,10116.0,N,,,8418,CHEMBL629211,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13678,1,10116.0,N,,,8418,CHEMBL629212,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13679,1,10116.0,N,,,8418,CHEMBL629213,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13680,1,10116.0,N,,,8133,CHEMBL629214,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13681,1,10116.0,N,,,8133,CHEMBL629215,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13682,1,10116.0,N,,,8133,CHEMBL635154,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13683,1,10116.0,N,,,6996,CHEMBL629216,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13684,1,10116.0,N,,,6996,CHEMBL629217,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13685,1,10116.0,N,,,6996,CHEMBL629218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13686,1,10116.0,N,,,6996,CHEMBL629219,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13687,1,10116.0,N,,,6996,CHEMBL629220,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13688,1,10116.0,N,,,6996,CHEMBL629221,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13689,1,10116.0,N,,,6996,CHEMBL631127,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13690,1,10116.0,N,,,6996,CHEMBL631128,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13691,1,10116.0,N,,,6996,CHEMBL631129,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13692,1,10116.0,N,,,6996,CHEMBL631130,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13693,1,10116.0,N,,,6996,CHEMBL631131,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13694,1,10116.0,N,,,6996,CHEMBL631132,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13695,1,10116.0,N,,,6996,CHEMBL631133,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13696,1,10116.0,N,,,6996,CHEMBL631134,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13697,1,10116.0,N,,,6996,CHEMBL875120,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13698,1,10116.0,N,,,6996,CHEMBL631135,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13699,1,10116.0,N,,,6996,CHEMBL631136,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13700,1,10116.0,N,,,6996,CHEMBL631137,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13701,1,10116.0,N,,,6996,CHEMBL631138,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13702,1,10116.0,N,,,6996,CHEMBL631139,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13703,1,10116.0,N,,,6996,CHEMBL631140,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13704,1,10116.0,N,,,6996,CHEMBL631141,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13705,1,10116.0,N,,,6996,CHEMBL631142,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13706,1,10116.0,N,,,6996,CHEMBL631143,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13707,1,10116.0,N,,,6996,CHEMBL631144,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13708,1,9615.0,N,,,6996,CHEMBL631145,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13709,1,9615.0,N,,,6996,CHEMBL631146,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13710,1,9615.0,N,,,6996,CHEMBL631147,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13711,1,9615.0,N,,,6996,CHEMBL631148,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13712,1,9615.0,N,,,6996,CHEMBL631149,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13713,1,9615.0,N,,,6996,CHEMBL631150,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13714,1,9615.0,N,,,6996,CHEMBL631151,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13715,1,9615.0,N,,,6996,CHEMBL631152,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13716,1,9615.0,N,,,6996,CHEMBL631443,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13717,1,9615.0,N,,,6996,CHEMBL631444,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13718,1,9615.0,N,,,6996,CHEMBL631445,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13719,1,9615.0,N,,,6996,CHEMBL631446,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13720,1,9615.0,N,,,6996,CHEMBL631447,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13721,1,9615.0,N,,,6996,CHEMBL631448,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13722,1,9615.0,N,,,6996,CHEMBL631449,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13723,1,9615.0,N,,,6996,CHEMBL631450,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13724,1,9615.0,N,,,6996,CHEMBL629724,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,A,50588,1,,,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13725,1,10090.0,N,,,9716,CHEMBL629725,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Zone of skin,A,50594,1,,14.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13726,1,10090.0,N,,,9716,CHEMBL629726,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Zone of skin,A,50594,1,,14.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13727,1,10090.0,N,,,9716,CHEMBL629727,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13728,1,10090.0,N,,,9716,CHEMBL630404,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13729,1,10090.0,N,,,9716,CHEMBL630405,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13730,1,10090.0,N,,,9716,CHEMBL630406,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13731,1,10090.0,N,,,9716,CHEMBL630407,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Stomach,A,50594,1,,945.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13732,1,10090.0,N,,,9716,CHEMBL630573,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Stomach,A,50594,1,,945.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13733,1,10090.0,N,,,9716,CHEMBL630574,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Stomach,A,50594,1,,945.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13734,1,10090.0,N,,,9716,CHEMBL630575,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Stomach,A,50594,1,,945.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13735,1,10090.0,N,,,9716,CHEMBL630576,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13736,1,10090.0,N,,,9716,CHEMBL630577,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13737,1,10090.0,N,,,9716,CHEMBL630578,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,13738,1,10090.0,N,,,9716,CHEMBL630579,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13739,1,10090.0,N,,,12192,CHEMBL630580,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Kidney,A,50594,1,,2113.0,Mus musculus
,,,,Intermediate,BAO_0000218,13740,1,10090.0,N,,,12192,CHEMBL630581,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Kidney,A,50594,1,,2113.0,Mus musculus
,,,,Intermediate,BAO_0000218,13741,1,10090.0,N,,,12192,CHEMBL630582,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Kidney,A,50594,1,,2113.0,Mus musculus
,,,,Intermediate,BAO_0000218,13742,1,10090.0,N,,,12192,CHEMBL630583,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13743,1,10090.0,N,,,12192,CHEMBL630584,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13744,1,10090.0,N,,,12192,CHEMBL630585,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13745,1,10090.0,N,,,12192,CHEMBL630586,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13746,1,10090.0,N,,,12192,CHEMBL630587,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13747,1,10090.0,N,,,12192,CHEMBL630588,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13748,1,10090.0,N,,,12192,CHEMBL630589,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13749,1,10090.0,N,,,12192,CHEMBL630590,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,A,50594,1,,,Mus musculus
,,,,Autocuration,BAO_0000019,13750,0,,U,,,12192,CHEMBL630591,,Removal of 238-Plutonium(IV) in feces at 24 h,Feces,A,22224,1,,1988.0,
,,,,Autocuration,BAO_0000019,13751,0,,U,,,12192,CHEMBL630592,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),Feces,A,22224,1,,1988.0,
,,,,Autocuration,BAO_0000019,13752,0,,U,,,12192,CHEMBL630593,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13753,0,,U,,,12192,CHEMBL630594,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13754,0,,U,,,12192,CHEMBL630595,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13755,0,,U,,,12192,CHEMBL630596,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13756,0,,U,,,12192,CHEMBL630597,,Removal of 238-Plutonium(IV) in urine after 0-24 h,Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13757,0,,U,,,12192,CHEMBL630598,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13758,0,,U,,,12192,CHEMBL630599,,Removal of 238-Plutonium(IV) in urine after 0-4 h,Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13759,0,,U,,,12192,CHEMBL630600,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13760,0,,U,,,12192,CHEMBL630601,,Removal of 238-Plutonium(IV) in urine after 4-24 h,Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13761,0,,U,,,12192,CHEMBL630602,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13762,0,,U,,,12192,CHEMBL630603,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),Urine,A,22224,1,,1088.0,
,,,,Autocuration,BAO_0000019,13763,0,,U,,,12192,CHEMBL630604,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),Urine,A,22224,1,,1088.0,
,In vivo,,,Intermediate,BAO_0000218,13764,1,10116.0,N,,,12017,CHEMBL624869,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13765,1,10116.0,N,,,12017,CHEMBL624870,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13766,1,10116.0,N,,,12017,CHEMBL623189,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13767,1,10116.0,N,,,12017,CHEMBL623190,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13768,1,10116.0,N,,,12017,CHEMBL623191,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13769,1,10116.0,N,,,12017,CHEMBL623192,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13770,1,10116.0,N,,,12017,CHEMBL623193,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13771,1,10116.0,N,,,12017,CHEMBL623194,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13772,1,10116.0,N,,,12017,CHEMBL623195,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13773,1,10116.0,N,,,12017,CHEMBL623196,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13774,1,10116.0,N,,,11836,CHEMBL623197,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13775,1,10116.0,N,,,11836,CHEMBL623198,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13776,1,10116.0,N,,,11836,CHEMBL623199,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13777,1,10116.0,N,,,11836,CHEMBL623200,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13778,1,10116.0,N,,,11836,CHEMBL623201,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13779,1,10116.0,N,,,11836,CHEMBL623202,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13780,1,10116.0,N,,,11836,CHEMBL623203,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13781,1,10116.0,N,,,11836,CHEMBL623204,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13782,1,10116.0,N,,,11836,CHEMBL623205,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13783,1,10116.0,N,,,11836,CHEMBL623206,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13784,1,10116.0,N,,,11836,CHEMBL623207,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13785,1,10116.0,N,,,11836,CHEMBL623208,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13786,1,10116.0,N,,,11836,CHEMBL623209,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13787,1,10116.0,N,,,11836,CHEMBL623210,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13788,1,10116.0,N,,,11836,CHEMBL623211,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13789,1,10116.0,N,,,11836,CHEMBL623212,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Uterus,A,50597,1,,995.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,13790,0,,U,,,12640,CHEMBL623213,,Tested in vitro for intrinsic activity relative to quinpirole,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13791,0,,U,,,14218,CHEMBL623214,,"Relative ion enhancement, determined in pulsed ultrafiltration",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13792,0,,U,,,11296,CHEMBL623215,,% ionization at the pH 7.4 at 37 degree Centigrade,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13793,0,,U,,,10929,CHEMBL623216,,Percentage ionization was measured,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13794,1,9913.0,N,,,13841,CHEMBL623217,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,A,50591,1,,,Bos taurus
,,,,Autocuration,BAO_0000019,13795,0,,U,,,10431,CHEMBL623218,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13796,0,,U,,,10431,CHEMBL623913,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13797,0,,U,,,10431,CHEMBL623914,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,13798,0,,U,,,8826,CHEMBL623915,,Compound was evaluated for the partition coefficient in octanol/water,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13799,0,,U,,,8826,CHEMBL624080,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,13800,0,,U,,,9884,CHEMBL624081,,Equilibrium constant measured by the pulse radiolysis at pH 7,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13801,1,9606.0,N,,,9827,CHEMBL624082,,In vitro hydrolytic rate constant determined in human blood,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,13802,1,9606.0,N,,,10009,CHEMBL625054,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,A,50587,1,,,Homo sapiens
,,,,Autocuration,BAO_0000019,13803,0,,U,,,10009,CHEMBL877485,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13804,1,10090.0,N,,,10009,CHEMBL625055,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13805,1,10090.0,N,,,10009,CHEMBL625056,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13806,1,9606.0,N,,,10009,CHEMBL625057,,In vitro oxidation of compound in presence of human plasma,,A,50587,1,,,Homo sapiens
,,,,Autocuration,BAO_0000019,13807,0,,U,,,10009,CHEMBL625058,,In vitro oxidation of compound in presence of hydrogen peroxide,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,13808,1,10090.0,N,,,10009,CHEMBL625059,,In vitro oxidation of compound in presence of mouse brain homogenate,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13809,1,10090.0,N,,,10009,CHEMBL629536,,In vitro oxidation of compound in presence of mouse liver homogenate,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13810,1,10116.0,N,,,11510,CHEMBL629537,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13811,1,10116.0,N,,,11510,CHEMBL629538,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13812,1,10116.0,N,,,11510,CHEMBL629539,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13813,1,10116.0,N,,,11510,CHEMBL874445,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13814,1,10116.0,N,,,11510,CHEMBL629540,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13815,1,10116.0,N,,,11510,CHEMBL629541,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13816,1,10116.0,N,,,11510,CHEMBL629542,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13817,1,10116.0,N,,,11510,CHEMBL630243,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13818,1,10116.0,N,,,11510,CHEMBL630244,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13819,1,10116.0,N,,,11510,CHEMBL630245,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13820,1,10116.0,N,,,11510,CHEMBL630246,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13821,1,10116.0,N,,,11510,CHEMBL630247,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13822,1,10116.0,N,,,11510,CHEMBL630248,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13823,1,10116.0,N,,,13100,CHEMBL630249,,Biodistribution in rat blood at 240 minutes after dose administration.,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13824,1,10116.0,N,,,13100,CHEMBL630250,,Biodistribution in rat blood at 30 minutes after dose administration.,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13825,1,10116.0,N,,,13100,CHEMBL630251,,Biodistribution in rat blood at 360 minutes after dose administration.,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13826,1,10116.0,N,,,13100,CHEMBL630252,,Biodistribution in rat blood at 3 hr after dose administration.,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13827,1,10116.0,N,,,13100,CHEMBL630408,,Biodistribution in rat blood at 60 minutes after dose administration.,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13828,1,10116.0,N,,,13100,CHEMBL630409,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13829,1,10116.0,N,,,13100,CHEMBL874446,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13830,1,10116.0,N,,,13100,CHEMBL630410,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13831,1,10116.0,N,,,13100,CHEMBL630411,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13832,1,10116.0,N,,,13100,CHEMBL630412,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13833,1,10116.0,N,,,13100,CHEMBL630413,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13834,1,10116.0,N,,,13100,CHEMBL630414,,Biodistribution in rat cerebellum at 3 hr after dose administration.,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13835,1,10116.0,N,,,13100,CHEMBL630415,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13836,1,10116.0,N,,,13100,CHEMBL630416,,Biodistribution in rat cortex at 120 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13837,1,10116.0,N,,,13100,CHEMBL630417,,Biodistribution in rat cortex at 1440 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13838,1,10116.0,N,,,13100,CHEMBL630418,,Biodistribution in rat cortex at 15 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13839,1,10116.0,N,,,13100,CHEMBL630419,,Biodistribution in rat cortex at 240 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13840,1,10116.0,N,,,13100,CHEMBL630420,,Biodistribution in rat cortex at 30 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13841,1,10116.0,N,,,13100,CHEMBL630421,,Biodistribution in rat cortex at 360 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13842,1,10116.0,N,,,13100,CHEMBL630422,,Biodistribution in rat cortex at 3 hr after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13843,1,10116.0,N,,,13100,CHEMBL630423,,Biodistribution in rat cortex at 60 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13844,1,10116.0,N,,,13100,CHEMBL630424,,Biodistribution in rat heart at 120 minutes after dose administration.,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13845,1,10116.0,N,,,13100,CHEMBL630425,,Biodistribution in rat heart at 15 minutes after dose administration.,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13846,1,10116.0,N,,,13100,CHEMBL629462,,Biodistribution in rat heart at 240 minutes after dose administration.,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13847,1,10116.0,N,,,13100,CHEMBL630426,,Biodistribution in rat heart at 30 minutes after dose administration.,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13848,1,10116.0,N,,,13100,CHEMBL630427,,Biodistribution in rat heart at 360 minutes after dose administration.,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13849,1,10116.0,N,,,13100,CHEMBL625877,,Biodistribution in rat heart at 3 hr after dose administration.,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13850,1,10116.0,N,,,13100,CHEMBL625878,,Biodistribution in rat heart at 60 minutes after dose administration.,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13851,1,10116.0,N,,,13100,CHEMBL625879,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13852,1,10116.0,N,,,13100,CHEMBL625880,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13853,1,10116.0,N,,,13100,CHEMBL625881,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13854,1,10116.0,N,,,13100,CHEMBL625882,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13855,1,10116.0,N,,,13100,CHEMBL625883,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13856,1,10116.0,N,,,13100,CHEMBL625884,,Biodistribution in rat kidney at 120 minutes after dose administration.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13857,1,10116.0,N,,,13100,CHEMBL625885,,Biodistribution in rat kidney at 1440 minutes after dose administration.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13858,1,10116.0,N,,,13100,CHEMBL628649,,Biodistribution in rat kidney at 15 minutes after dose administration.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13859,1,10116.0,N,,,13100,CHEMBL628650,,Biodistribution in rat kidney at 240 minutes after dose administration.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13860,1,10116.0,N,,,13100,CHEMBL628651,,Biodistribution in rat kidney at 30 minutes after dose administration.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13861,1,10116.0,N,,,13100,CHEMBL628652,,Biodistribution in rat kidney at 360 minutes after dose administration.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13862,1,10116.0,N,,,13100,CHEMBL628653,,Biodistribution in rat kidney at 60 minutes after dose administration.,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13863,1,10116.0,N,,,13100,CHEMBL628654,,Biodistribution in rat liver at 120 minutes after dose administration.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13864,1,10116.0,N,,,13100,CHEMBL628655,,Biodistribution in rat liver at 1440 minutes after dose administration.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13865,1,10116.0,N,,,13100,CHEMBL625238,,Biodistribution in rat liver at 15 minutes after dose administration.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13866,1,10116.0,N,,,13100,CHEMBL625239,,Biodistribution in rat liver at 240 minutes after dose administration.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13867,1,10116.0,N,,,13100,CHEMBL625240,,Biodistribution in rat liver at 30 minutes after dose administration.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13868,1,10116.0,N,,,13100,CHEMBL625241,,Biodistribution in rat liver at 360 minutes after dose administration.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13869,1,10116.0,N,,,13100,CHEMBL625242,,Biodistribution in rat liver at 60 minutes after dose administration.,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13870,1,10116.0,N,,,13100,CHEMBL874587,,Biodistribution in rat lung at 120 minutes after dose administration.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13871,1,10116.0,N,,,13100,CHEMBL625405,,Biodistribution in rat lung at 1440 minutes after dose administration.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13872,1,10116.0,N,,,13100,CHEMBL625406,,Biodistribution in rat lung at 15 minutes after dose administration.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13873,1,10116.0,N,,,13100,CHEMBL625407,,Biodistribution in rat lung at 240 minutes after dose administration.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13874,1,10116.0,N,,,13100,CHEMBL625408,,Biodistribution in rat lung at 30 minutes after dose administration.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13875,1,10116.0,N,,,13100,CHEMBL625409,,Biodistribution in rat lung at 360 minutes after dose administration.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13876,1,10116.0,N,,,12361,CHEMBL625410,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Thoracic aorta,A,50597,1,,1515.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13877,1,10116.0,N,,,12361,CHEMBL625411,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Thoracic aorta,A,50597,1,,1515.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13878,1,10116.0,N,,,12361,CHEMBL625412,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Thoracic aorta,A,50597,1,,1515.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13879,1,10116.0,N,,,12361,CHEMBL625413,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Thoracic aorta,A,50597,1,,1515.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13880,1,10116.0,N,,,12361,CHEMBL625414,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Thoracic aorta,A,50597,1,,1515.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13881,1,10116.0,N,,,12361,CHEMBL625415,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Thoracic aorta,A,50597,1,,1515.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13882,1,10116.0,N,,,12361,CHEMBL625416,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Thoracic aorta,A,50597,1,,1515.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13883,1,10116.0,N,,,12712,CHEMBL625417,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13884,1,10116.0,N,,,7415,CHEMBL625418,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Feces,A,50597,1,,1988.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13885,1,10116.0,N,,,7415,CHEMBL625419,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13886,1,10116.0,N,,,7415,CHEMBL625420,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13887,1,10116.0,N,,,7415,CHEMBL626996,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13888,1,10116.0,N,,,7415,CHEMBL626997,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Feces,A,50597,1,,1988.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13889,1,10116.0,N,,,7415,CHEMBL626998,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13890,1,10116.0,N,,,7415,CHEMBL626999,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13891,1,10090.0,N,,,8050,CHEMBL627000,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13892,1,10090.0,N,,,8050,CHEMBL627001,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13893,1,10090.0,N,,,8050,CHEMBL627002,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13894,1,10090.0,N,,,8050,CHEMBL627003,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,13895,1,10090.0,N,,,8050,CHEMBL627004,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13896,1,10090.0,N,,,8050,CHEMBL627005,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13897,1,10090.0,N,,,8050,CHEMBL874594,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13898,1,10090.0,N,,,8050,CHEMBL627006,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13899,1,10090.0,N,,,8050,CHEMBL627007,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13900,1,10090.0,N,,,8050,CHEMBL627884,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13901,1,10090.0,N,,,8050,CHEMBL627885,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13902,1,10090.0,N,,,8050,CHEMBL627886,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13903,1,10090.0,N,,,8050,CHEMBL627887,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13904,1,10090.0,N,,,8050,CHEMBL627888,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13905,1,10090.0,N,,,8050,CHEMBL628057,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13906,1,10090.0,N,,,8050,CHEMBL627405,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Urine,A,50594,1,,1088.0,Mus musculus
,,,,Intermediate,BAO_0000218,13907,1,9615.0,N,,,12582,CHEMBL627406,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13908,1,9615.0,N,,,12582,CHEMBL627407,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13909,1,9615.0,N,,,12582,CHEMBL627408,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13910,1,9615.0,N,,,12582,CHEMBL627409,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13911,1,9615.0,N,,,12582,CHEMBL875486,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13912,1,9615.0,N,,,12582,CHEMBL627410,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13913,1,9615.0,N,,,12582,CHEMBL627411,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13914,1,9615.0,N,,,12582,CHEMBL627412,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13915,1,9615.0,N,,,12582,CHEMBL627413,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13916,1,9615.0,N,,,12582,CHEMBL627414,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13917,1,9615.0,N,,,12582,CHEMBL627415,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13918,1,9615.0,N,,,12582,CHEMBL627416,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13919,1,9615.0,N,,,12582,CHEMBL627417,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13920,1,9615.0,N,,,12582,CHEMBL627418,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13921,1,9615.0,N,,,12582,CHEMBL627419,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13922,1,9615.0,N,,,12582,CHEMBL627320,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,13923,1,9615.0,N,,,12582,CHEMBL627321,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,In vivo,,,Intermediate,BAO_0000218,13924,1,10116.0,N,,,12017,CHEMBL627322,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13925,1,10116.0,N,,,12017,CHEMBL627323,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13926,1,10116.0,N,,,12017,CHEMBL627491,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13927,1,10116.0,N,,,12017,CHEMBL627492,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13928,1,10116.0,N,,,12017,CHEMBL627493,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13929,1,10116.0,N,,,12017,CHEMBL627494,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13930,1,10116.0,N,,,12017,CHEMBL627495,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13931,1,10116.0,N,,,12017,CHEMBL627496,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13932,1,10116.0,N,,,12017,CHEMBL627497,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13933,1,10116.0,N,,,12017,CHEMBL627498,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13934,1,10116.0,N,,,12017,CHEMBL627499,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13935,1,10116.0,N,,,12017,CHEMBL627500,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13936,1,10116.0,N,,,12017,CHEMBL627501,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13937,1,10116.0,N,,,12017,CHEMBL625616,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13938,1,10116.0,N,,,12017,CHEMBL625617,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13939,1,10116.0,N,,,12017,CHEMBL625618,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13940,1,10116.0,N,,,12017,CHEMBL625619,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13941,1,10116.0,N,,,12017,CHEMBL625620,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13942,1,10116.0,N,,,12017,CHEMBL625621,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13943,1,10116.0,N,,,12017,CHEMBL625622,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13944,1,10116.0,N,,,12017,CHEMBL625788,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13945,1,10116.0,N,,,12017,CHEMBL625789,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13946,1,10116.0,N,,,12017,CHEMBL625790,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13947,1,10116.0,N,,,12017,CHEMBL625791,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13948,1,10116.0,N,,,12017,CHEMBL622334,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13949,1,10116.0,N,,,12017,CHEMBL622335,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13950,1,10116.0,N,,,12017,CHEMBL622336,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13951,1,10116.0,N,,,12017,CHEMBL622337,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13952,1,10116.0,N,,,12017,CHEMBL622338,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13953,1,10116.0,N,,,12017,CHEMBL622339,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13954,1,10116.0,N,,,12017,CHEMBL624153,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13955,1,10116.0,N,,,12017,CHEMBL628430,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13956,1,10116.0,N,,,12017,CHEMBL628431,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13957,1,10116.0,N,,,12017,CHEMBL628432,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13958,1,10116.0,N,,,12017,CHEMBL628433,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13959,1,10116.0,N,,,12017,CHEMBL628434,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13960,1,10116.0,N,,,12017,CHEMBL626789,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13961,1,10116.0,N,,,12017,CHEMBL626790,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13962,1,10116.0,N,,,12017,CHEMBL626791,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13963,1,10116.0,N,,,12017,CHEMBL626792,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,13964,1,10116.0,N,,,12017,CHEMBL626793,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13965,1,10116.0,N,,,11510,CHEMBL627436,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13966,1,10116.0,N,,,11510,CHEMBL627437,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13967,1,10116.0,N,,,11510,CHEMBL627438,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13968,1,10116.0,N,,,11510,CHEMBL627439,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13969,1,10116.0,N,,,11510,CHEMBL627440,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13970,1,10116.0,N,,,11510,CHEMBL627602,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13971,1,10116.0,N,,,11510,CHEMBL627603,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13972,1,10116.0,N,,,11510,CHEMBL627604,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13973,1,10116.0,N,,,11510,CHEMBL627605,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13974,1,10116.0,N,,,11510,CHEMBL627606,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13975,1,10116.0,N,,,11510,CHEMBL627607,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13976,1,10116.0,N,,,11510,CHEMBL627608,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13977,1,10116.0,N,,,11510,CHEMBL627609,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13978,1,10116.0,N,,,11510,CHEMBL627610,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13979,1,10116.0,N,,,11510,CHEMBL627611,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,13980,1,10116.0,N,,,11510,CHEMBL627612,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000100,13981,0,,U,,,8362,CHEMBL627613,,Octanol:water partition coefficient is evaluated,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,13982,0,,U,,,8257,CHEMBL627614,,Partition coefficient in 1-octanol/water system,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,13983,0,,U,,,8257,CHEMBL627615,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,13984,0,,U,,,9468,CHEMBL627616,,Partition coefficient in octanol/water system was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,13985,0,,U,,,9468,CHEMBL627617,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,P,22224,1,,,
,,,,Autocuration,BAO_0000019,13986,0,,U,,,10568,CHEMBL627618,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13987,0,,U,,,10568,CHEMBL627619,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13988,0,,U,,,15359,CHEMBL627620,,Pseudo-first-order rate constant of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13989,0,,U,,,15359,CHEMBL627621,,Pseudo-first-order rate constant with 1-min time point,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13990,0,,U,,,15359,CHEMBL627622,,Pseudo-first-order rate constant without 1-min time point,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13991,0,,U,,,10431,CHEMBL627623,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13992,0,,U,,,10431,CHEMBL627624,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13993,0,,U,,,10431,CHEMBL627625,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13994,0,,U,,,15704,CHEMBL628523,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13995,0,,U,,,15287,CHEMBL628524,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13996,0,,U,,,7516,CHEMBL628525,,The efflux rate constant of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13997,0,,U,,,12973,CHEMBL625732,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13998,0,,U,,,12973,CHEMBL625733,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,13999,0,,U,,,12973,CHEMBL625734,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,F,22224,1,,,
,,,,Autocuration,BAO_0000019,14000,0,,U,,,12973,CHEMBL625913,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14001,0,,U,,,8696,CHEMBL625914,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14002,0,,U,,,15052,CHEMBL625915,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14003,0,,U,,,15052,CHEMBL625916,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14004,0,,U,,,10503,CHEMBL625917,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14005,0,,U,,,8354,CHEMBL625918,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14006,0,,U,,,8354,CHEMBL625919,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14007,0,,U,,,8354,CHEMBL625920,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14008,0,,U,,,8354,CHEMBL874453,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14009,0,,U,,,8354,CHEMBL625921,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14010,0,,U,,,10503,CHEMBL625922,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14011,0,,U,,,8354,CHEMBL625923,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14012,0,,U,,,8354,CHEMBL625924,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14013,0,,U,,,8354,CHEMBL625925,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14014,0,,U,,,8354,CHEMBL625926,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,14015,1,10116.0,N,,,13100,CHEMBL627704,,Biodistribution in rat lung at 60 minutes after dose administration.,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14016,1,10116.0,N,,,13100,CHEMBL627705,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14017,1,10116.0,N,,,13100,CHEMBL627706,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14018,1,10116.0,N,,,13100,CHEMBL627707,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14019,1,10116.0,N,,,13100,CHEMBL627708,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14020,1,10116.0,N,,,13100,CHEMBL628361,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14021,1,10116.0,N,,,13100,CHEMBL628362,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14022,1,10116.0,N,,,13100,CHEMBL628363,,Biodistribution in rat striatum at 120 minutes after dose administration.,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14023,1,10116.0,N,,,13100,CHEMBL628364,,Biodistribution in rat striatum at 1440 minutes after dose administration.,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14024,1,10116.0,N,,,13100,CHEMBL628365,,Biodistribution in rat striatum at 15 minutes after dose administration.,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14025,1,10116.0,N,,,13100,CHEMBL874454,,Biodistribution in rat striatum at 240 minutes after dose administration.,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14026,1,10116.0,N,,,13100,CHEMBL628531,,Biodistribution in rat striatum at 30 minutes after dose administration.,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14027,1,10116.0,N,,,13100,CHEMBL628532,,Biodistribution in rat striatum at 360 minutes after dose administration.,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14028,1,10116.0,N,,,13100,CHEMBL628533,,Biodistribution in rat striatum at 3 hr after dose administration.,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14029,1,10116.0,N,,,13100,CHEMBL628534,,Biodistribution in rat striatum at 60 minutes after dose administration.,Striatum,A,50597,1,,2435.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14030,1,10116.0,N,,,13100,CHEMBL628535,,Biodistribution in rat thyroid at 120 minutes after dose administration.,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14031,1,10116.0,N,,,13100,CHEMBL628536,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14032,1,10116.0,N,,,13100,CHEMBL628537,,Biodistribution in rat thyroid at 15 minutes after dose administration.,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14033,1,10116.0,N,,,13100,CHEMBL628538,,Biodistribution in rat thyroid at 240 minutes after dose administration.,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14034,1,10116.0,N,,,13100,CHEMBL628539,,Biodistribution in rat thyroid at 30 minutes after dose administration.,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14035,1,10116.0,N,,,13100,CHEMBL630297,,Biodistribution in rat thyroid at 360 minutes after dose administration.,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14036,1,10116.0,N,,,13100,CHEMBL630298,,Biodistribution in rat thyroid at 60 minutes after dose administration.,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14037,1,10116.0,N,,,13100,CHEMBL630299,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14038,1,10116.0,N,,,13100,CHEMBL628094,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14039,1,10116.0,N,,,13100,CHEMBL628095,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14040,1,10116.0,N,,,13100,CHEMBL874648,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14041,1,10116.0,N,,,13100,CHEMBL628096,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14042,1,10116.0,N,,,13100,CHEMBL628097,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14043,1,10116.0,N,,,13100,CHEMBL628098,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Brain,A,50597,1,,955.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14044,0,,U,,,13331,CHEMBL628099,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14045,0,,U,,,13331,CHEMBL628100,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14046,0,,U,,,13331,CHEMBL628101,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14047,0,,U,,,13331,CHEMBL628102,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14048,0,,U,,,13331,CHEMBL628103,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14049,0,,U,,,13331,CHEMBL628104,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14050,0,,U,,,13331,CHEMBL628105,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14051,0,,U,,,13331,CHEMBL628106,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14052,1,10116.0,N,,,10086,CHEMBL628107,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Autocuration,BAO_0000218,14053,0,,U,,,10086,CHEMBL628108,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Urine,F,22224,1,,1088.0,
,,,,Intermediate,BAO_0000218,14054,1,10116.0,N,,,10086,CHEMBL628109,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Autocuration,BAO_0000218,14055,0,,U,,,10086,CHEMBL625299,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Urine,F,22224,1,,1088.0,
,,,,Intermediate,BAO_0000218,14056,1,10116.0,N,,,10086,CHEMBL625300,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14057,1,10116.0,N,,,10086,CHEMBL625301,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14058,1,10116.0,N,,,10086,CHEMBL625302,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14059,1,10116.0,N,,,10086,CHEMBL874649,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14060,1,10116.0,N,,,13248,CHEMBL625303,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14061,1,10116.0,N,,,13248,CHEMBL625463,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14062,1,9606.0,N,,,14527,CHEMBL625464,,In vitro metabolism in human liver microsomes,Liver,A,50587,1,,2107.0,Homo sapiens
,,,,Intermediate,BAO_0000218,14063,1,9606.0,N,,,3008,CHEMBL625465,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,14064,1,9615.0,N,,,12582,CHEMBL625466,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14065,1,9615.0,N,,,12582,CHEMBL625467,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14066,1,10116.0,N,,,12582,CHEMBL625468,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14067,1,10116.0,N,,,12582,CHEMBL625469,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14068,1,10116.0,N,,,12582,CHEMBL625470,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14069,1,10116.0,N,,,12582,CHEMBL632418,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14070,1,10116.0,N,,,12582,CHEMBL627250,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14071,1,10116.0,N,,,12582,CHEMBL627251,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14072,1,10116.0,N,,,12582,CHEMBL627252,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14073,1,10116.0,N,,,12582,CHEMBL627253,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14074,1,10116.0,N,,,12582,CHEMBL627254,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14075,1,10116.0,N,,,12582,CHEMBL875471,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14076,1,10116.0,N,,,12582,CHEMBL627255,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14077,1,10116.0,N,,,12582,CHEMBL627256,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14078,1,10116.0,N,,,12582,CHEMBL627257,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14079,1,10116.0,N,,,12582,CHEMBL627258,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14080,1,10116.0,N,,,12582,CHEMBL627259,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14081,1,10116.0,N,,,12582,CHEMBL627260,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14082,1,10116.0,N,,,12582,CHEMBL623256,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14083,1,10116.0,N,,,12582,CHEMBL874413,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14084,1,10116.0,N,,,12582,CHEMBL623257,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14085,1,10116.0,N,,,12582,CHEMBL623258,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14086,1,10116.0,N,,,12582,CHEMBL623259,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14087,1,10116.0,N,,,12582,CHEMBL623260,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14088,1,10116.0,N,,,12582,CHEMBL623261,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14089,1,10116.0,N,,,12582,CHEMBL623262,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14090,1,10116.0,N,,,12582,CHEMBL623263,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14091,1,10116.0,N,,,12582,CHEMBL623264,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14092,1,10116.0,N,,,12582,CHEMBL623265,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14093,1,10116.0,N,,,12582,CHEMBL623266,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14094,1,10116.0,N,,,12582,CHEMBL623267,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14095,1,10116.0,N,,,12582,CHEMBL623268,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14096,1,10116.0,N,,,12582,CHEMBL623269,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14097,1,10116.0,N,,,12582,CHEMBL623270,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14098,1,10116.0,N,,,12582,CHEMBL623271,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14099,1,10116.0,N,,,12582,CHEMBL623272,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14100,1,10116.0,N,,,12582,CHEMBL623273,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14101,1,10116.0,N,,,12582,CHEMBL623274,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14102,1,10116.0,N,,,12582,CHEMBL874414,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14103,1,10116.0,N,,,12582,CHEMBL623275,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14104,1,10116.0,N,,,12582,CHEMBL629150,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14105,1,10116.0,N,,,12582,CHEMBL623276,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14106,1,10116.0,N,,,12582,CHEMBL623277,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14107,1,10116.0,N,,,12582,CHEMBL623112,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14108,1,10116.0,N,,,12582,CHEMBL623113,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14109,1,10116.0,N,,,12582,CHEMBL623800,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14110,1,10116.0,N,,,12582,CHEMBL623801,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14111,1,10116.0,N,,,12017,CHEMBL623802,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14112,1,10116.0,N,,,12017,CHEMBL623803,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Uterus,A,50597,1,,995.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14113,1,10116.0,N,,,12017,CHEMBL623970,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Uterus,A,50597,1,,995.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14114,1,10116.0,N,,,12017,CHEMBL623971,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Uterus,A,50597,1,,995.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14115,1,10116.0,N,,,14045,CHEMBL623972,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14116,1,10116.0,N,,,14045,CHEMBL623973,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14117,1,10116.0,N,,,14045,CHEMBL623974,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14118,1,10116.0,N,,,14045,CHEMBL623975,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14119,1,10116.0,N,,,14045,CHEMBL623976,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14120,1,10116.0,N,,,14045,CHEMBL623977,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14121,1,10116.0,N,,,14045,CHEMBL623978,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14122,1,10116.0,N,,,14045,CHEMBL623979,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14123,1,10116.0,N,,,14045,CHEMBL623980,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14124,1,10116.0,N,,,14045,CHEMBL623981,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14125,1,10116.0,N,,,14045,CHEMBL626278,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14126,1,10116.0,N,,,14045,CHEMBL626279,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14127,1,10090.0,N,,,14045,CHEMBL626280,,Biodistribution in mice bladder plus excreted urine was determined,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14128,1,10090.0,N,,,14045,CHEMBL626281,,"Percentage biodistribution in mouse blood, 10 minutes post injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14129,1,10090.0,N,,,14045,CHEMBL626282,,"Percentage biodistribution in mouse blood, 30 minutes post injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14130,1,10090.0,N,,,14045,CHEMBL626283,,"Percentage biodistribution in mouse blood, 5 minutes post injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14131,1,10090.0,N,,,14045,CHEMBL626284,,"Percentage biodistribution in mouse blood, 60 minutes post injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14132,1,10090.0,N,,,14045,CHEMBL626285,,"Percentage biodistribution in mouse brain, 10 minutes post injection",Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,14133,1,10090.0,N,,,14045,CHEMBL626286,,"Percentage biodistribution in mouse brain, 30 minutes post injection",Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,14134,1,10090.0,N,,,14045,CHEMBL626287,,"Percentage biodistribution in mouse brain, 5 minutes post injection",Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,14135,1,10090.0,N,,,14045,CHEMBL626288,,"Percentage biodistribution in mouse brain, 60 minutes post injection",Brain,A,50594,1,,955.0,Mus musculus
,,,,Intermediate,BAO_0000218,14136,1,10090.0,N,,,14045,CHEMBL626289,,"Percentage biodistribution in mouse heart, 10 minutes post injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14137,1,10090.0,N,,,14045,CHEMBL626290,,"Percentage biodistribution in mouse heart, 30 minutes post injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14138,1,10090.0,N,,,14045,CHEMBL626291,,"Percentage biodistribution in mouse heart, 5 minutes post injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14139,1,10090.0,N,,,14045,CHEMBL839888,,"Percentage biodistribution in mouse heart, 60 minutes post injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14140,1,10090.0,N,,,14045,CHEMBL626292,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Intestine,A,50594,1,,160.0,Mus musculus
,,,,Intermediate,BAO_0000218,14141,1,10090.0,N,,,14045,CHEMBL626293,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Intestine,A,50594,1,,160.0,Mus musculus
,,,,Intermediate,BAO_0000218,14142,1,10090.0,N,,,14045,CHEMBL626294,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Intestine,A,50594,1,,160.0,Mus musculus
,,,,Intermediate,BAO_0000218,14143,1,10090.0,N,,,14045,CHEMBL626295,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Intestine,A,50594,1,,160.0,Mus musculus
,,,,Intermediate,BAO_0000218,14144,1,10090.0,N,,,14045,CHEMBL627659,,"Percentage biodistribution in mouse liver, 10 minutes post injection",Liver,A,50594,1,,2107.0,Mus musculus
,,,,Intermediate,BAO_0000218,14145,1,10090.0,N,,,14045,CHEMBL627660,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Liver,A,50594,1,,2107.0,Mus musculus
,,,,Intermediate,BAO_0000218,14146,1,10090.0,N,,,14045,CHEMBL627661,,"Percentage biodistribution in mouse liver, 5 minutes post injection",Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14147,1,10090.0,N,,,14045,CHEMBL627662,,Biodistribution in mice liver at 60 minutes of post injection,Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14148,1,10090.0,N,,,14045,CHEMBL627663,,Biodistribution in mice lungs at 10 min of post injection,Lung,A,50594,1,,2048.0,Mus musculus
,,,,Intermediate,BAO_0000218,14149,1,10090.0,N,,,14045,CHEMBL627664,,"Percentage biodistribution in mouse lung, 30 minutes post injection",,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14150,1,10090.0,N,,,14045,CHEMBL627665,,"Percentage biodistribution in mousee lung, 5 minutes post injection",,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14151,1,10090.0,N,,,14045,CHEMBL627666,,Biodistribution in mice lungs at 60 min of post injection,Lung,A,50594,1,,2048.0,Mus musculus
,,,,Intermediate,BAO_0000218,14152,1,10090.0,N,,,14045,CHEMBL627667,,Percentage biodistribution in mouse spleen,Spleen,A,50594,1,,2106.0,Mus musculus
,,,,Intermediate,BAO_0000218,14153,1,10090.0,N,,,14045,CHEMBL627668,,Percentage biodistribution in mouse stomach,Stomach,A,50594,1,,945.0,Mus musculus
,,,,Intermediate,BAO_0000218,14154,1,10090.0,N,,,11745,CHEMBL627669,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Urine,A,50594,1,,1088.0,Mus musculus
,In vivo,,,Autocuration,BAO_0000218,14155,0,,U,,,13257,CHEMBL627670,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,Urinary bladder,A,22224,1,,1255.0,
,In vivo,,,Autocuration,BAO_0000218,14156,0,,U,,,13257,CHEMBL627671,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,14157,0,,U,,,13257,CHEMBL627672,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,Bone element,A,22224,1,,1474.0,
,In vivo,,,Autocuration,BAO_0000218,14158,0,,U,,,13257,CHEMBL627673,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14159,0,,U,,,13257,CHEMBL627674,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,Kidney,A,22224,1,,2113.0,
,In vivo,,,Autocuration,BAO_0000218,14160,0,,U,,,13257,CHEMBL627675,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,Liver,A,22224,1,,2107.0,
,In vivo,,,Autocuration,BAO_0000218,14161,0,,U,,,13257,CHEMBL627676,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,Lung,A,22224,1,,2048.0,
,In vivo,,,Autocuration,BAO_0000218,14162,0,,U,,,13257,CHEMBL627677,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,Muscle tissue,A,22224,1,,2385.0,
,,,,Autocuration,BAO_0000019,14163,0,,U,,,8354,CHEMBL627678,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14164,1,10116.0,N,,,7095,CHEMBL627679,,Affinity for protein binding expressed as association constant in fresh rat serum,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14165,0,,U,,,12185,CHEMBL627680,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14166,0,,U,,,12185,CHEMBL627681,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14167,0,,U,,,12185,CHEMBL627682,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14168,0,,U,,,12185,CHEMBL627683,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14169,0,,U,,,12686,CHEMBL627684,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14170,0,,U,,,12686,CHEMBL874441,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14171,0,,U,,,12686,CHEMBL627685,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14172,0,,U,,,12686,CHEMBL627686,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14173,0,,U,,,8057,CHEMBL627687,,Apparent rate constant Koff for inactivation of dTMP synthase.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14174,0,,U,,,15778,CHEMBL627688,,The irreversible inhibitor activity by second order rate equation.,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14175,1,10116.0,N,,,12375,CHEMBL628038,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14176,1,10116.0,N,,,12375,CHEMBL628039,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14177,1,10116.0,N,,,12375,CHEMBL628040,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14178,0,,U,,,13588,CHEMBL628041,,Dissociation rate calculated from the first-order equation using t1/2 value,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14179,0,,U,,,15039,CHEMBL630226,,The compound was tested for Binding constant against DNA,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14180,0,,U,,,9500,CHEMBL628042,,First order rate constant for cyclization of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14181,0,,U,,,10014,CHEMBL625232,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14182,0,,U,,,10014,CHEMBL625233,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14183,0,,U,,,568,CHEMBL625979,,Hydrolysis rate constant was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14184,0,,U,,,10026,CHEMBL625980,,Observed first order rate constant,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14185,0,,U,,,10281,CHEMBL625981,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14186,0,,U,,,10281,CHEMBL625982,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14187,0,,U,,,9680,CHEMBL625983,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14188,0,,U,,,13028,CHEMBL625984,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14189,0,,U,,,13028,CHEMBL625985,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14190,0,,U,,,13028,CHEMBL625986,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14191,0,,U,,,13028,CHEMBL625987,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14192,0,,U,,,13028,CHEMBL625988,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14193,0,,U,,,13028,CHEMBL625989,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14194,0,,U,,,13028,CHEMBL625990,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14195,0,,U,,,13028,CHEMBL625991,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14196,0,,U,,,13028,CHEMBL625992,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14197,0,,U,,,13028,CHEMBL625993,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14198,0,,U,,,13028,CHEMBL631973,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14199,0,,U,,,13028,CHEMBL632143,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14200,0,,U,,,13028,CHEMBL632144,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14201,0,,U,,,13028,CHEMBL632145,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14202,0,,U,,,13028,CHEMBL632146,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14203,0,,U,,,13028,CHEMBL632147,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14204,0,,U,,,13028,CHEMBL632148,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14205,0,,U,,,13028,CHEMBL632149,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14206,0,,U,,,13028,CHEMBL632150,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14207,0,,U,,,13028,CHEMBL632151,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14208,1,9606.0,N,,,3008,CHEMBL632152,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,14209,1,9606.0,N,,,4509,CHEMBL632153,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,14210,1,9606.0,N,,,4509,CHEMBL632154,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,A,50587,1,,,Homo sapiens
,,,,Intermediate,BAO_0000218,14211,1,10298.0,N,,,8613,CHEMBL632155,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,14212,1,10298.0,N,,,8613,CHEMBL632156,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,14213,1,10298.0,N,,,8613,CHEMBL632157,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,14214,1,10298.0,N,,,8613,CHEMBL632158,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,14215,1,10298.0,N,,,8613,CHEMBL632159,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,14216,1,10298.0,N,,,8613,CHEMBL626305,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,14217,1,10298.0,N,,,8613,CHEMBL626306,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,14218,1,10298.0,N,,,8613,CHEMBL626307,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,14219,1,10298.0,N,,,8613,CHEMBL626308,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,14220,1,10298.0,N,,,8613,CHEMBL626479,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,A,50602,1,,,Human herpesvirus 1
,,,,Intermediate,BAO_0000218,14221,1,10298.0,N,,,8613,CHEMBL626480,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,A,50602,1,,,Human herpesvirus 1
,,,,Autocuration,BAO_0000100,14222,0,,U,,,6021,CHEMBL626481,,Calculated partition coefficient (clogP) (MlogP),,P,22229,1,,,
,,,,Autocuration,BAO_0000019,14223,0,,U,,,9348,CHEMBL626482,,Equipotent potent ratio relative to carbachol (nicotinic activity),,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14224,1,9615.0,N,,,15592,CHEMBL626483,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14225,1,9615.0,N,,,15592,CHEMBL626484,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,A,50588,1,,,Canis lupus familiaris
,,,,Autocuration,BAO_0000100,14226,0,,U,,,15592,CHEMBL626485,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,14227,0,,U,,,15592,CHEMBL626486,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,P,22229,1,,,
,,,,Autocuration,BAO_0000100,14228,0,,U,,,15592,CHEMBL626487,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,P,22229,1,,,
,In vivo,,,Intermediate,BAO_0000218,14229,1,9615.0,N,,,15592,CHEMBL626488,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Plasma,A,50588,1,,1969.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14230,1,10116.0,N,,,7095,CHEMBL626489,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Serum,A,50597,1,,1977.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14231,0,,U,,,16618,CHEMBL626490,,Area under the MAP curve measured over 5 min; ND means Not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,14232,0,,U,,,16835,CHEMBL626491,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14233,0,,U,,,15284,CHEMBL626492,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,14234,0,,U,,,15750,CHEMBL626493,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,14235,1,10116.0,N,,,16618,CHEMBL626494,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,14236,0,,U,,,16618,CHEMBL626495,,Half life after oral tested,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14237,1,10116.0,N,,,15812,CHEMBL626496,,Half life was determined in plasma of rat; NT indicates not tested,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14238,1,10116.0,N,,,16618,CHEMBL626497,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,14239,0,,U,,,16618,CHEMBL626498,,Oral bioavailability after oral tested,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14240,1,10116.0,N,,,13098,CHEMBL626499,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14241,1,10116.0,N,,,13098,CHEMBL626500,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14242,1,10116.0,N,,,15812,CHEMBL626501,,half life was determined in plasma of rat; NT indicates not tested,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14243,1,10116.0,N,,,15812,CHEMBL626502,,half life was determined in plasma of rat; NT means not tested,Plasma,A,50597,1,,1969.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14244,1,10116.0,N,,,11510,CHEMBL626503,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14245,1,10116.0,N,,,11510,CHEMBL626504,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14246,1,10116.0,N,,,11510,CHEMBL626505,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14247,1,10116.0,N,,,11510,CHEMBL626506,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14248,1,10116.0,N,,,11510,CHEMBL626507,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14249,1,10116.0,N,,,11510,CHEMBL626508,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14250,1,10116.0,N,,,11510,CHEMBL626509,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14251,1,10116.0,N,,,11510,CHEMBL875480,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14252,1,10116.0,N,,,11510,CHEMBL626510,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14253,1,10116.0,N,,,11510,CHEMBL626511,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14254,1,10116.0,N,,,11510,CHEMBL626512,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14255,1,10116.0,N,,,11510,CHEMBL628208,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14256,1,10116.0,N,,,11510,CHEMBL628209,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14257,1,10116.0,N,,,11510,CHEMBL628210,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14258,1,10116.0,N,,,11510,CHEMBL628211,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14259,1,10116.0,N,,,11510,CHEMBL628212,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14260,1,10116.0,N,,,11510,CHEMBL628213,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14261,1,10116.0,N,,,12582,CHEMBL628214,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14262,1,10116.0,N,,,12582,CHEMBL628215,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14263,1,10116.0,N,,,12582,CHEMBL628216,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14264,1,10116.0,N,,,12582,CHEMBL626595,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14265,1,10116.0,N,,,12582,CHEMBL626596,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14266,1,10116.0,N,,,12582,CHEMBL626597,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14267,1,10116.0,N,,,12582,CHEMBL626598,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14268,1,10116.0,N,,,12582,CHEMBL622242,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14269,1,10116.0,N,,,12582,CHEMBL622243,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14270,1,10116.0,N,,,12582,CHEMBL622244,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14271,1,10116.0,N,,,12582,CHEMBL622245,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14272,1,10116.0,N,,,12582,CHEMBL622246,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14273,1,10116.0,N,,,12582,CHEMBL622247,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14274,1,10116.0,N,,,12582,CHEMBL622248,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14275,1,10116.0,N,,,12582,CHEMBL877483,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14276,1,10116.0,N,,,12582,CHEMBL622249,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14277,1,9615.0,N,,,12582,CHEMBL622250,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14278,1,9615.0,N,,,12582,CHEMBL622251,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14279,1,9615.0,N,,,12582,CHEMBL622252,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14280,1,9615.0,N,,,12582,CHEMBL622253,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14281,1,9615.0,N,,,12582,CHEMBL622254,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14282,1,9615.0,N,,,12582,CHEMBL622255,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14283,1,9615.0,N,,,12582,CHEMBL622256,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14284,1,9615.0,N,,,12582,CHEMBL622257,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14285,1,9615.0,N,,,12582,CHEMBL622258,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14286,1,9615.0,N,,,12582,CHEMBL622259,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14287,1,9615.0,N,,,12582,CHEMBL622927,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14288,1,9615.0,N,,,12582,CHEMBL622928,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14289,1,9615.0,N,,,12582,CHEMBL622929,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14290,1,9615.0,N,,,12582,CHEMBL623182,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14291,1,9615.0,N,,,12582,CHEMBL623183,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14292,1,10116.0,N,,,12582,CHEMBL623184,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14293,1,10116.0,N,,,12582,CHEMBL623185,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14294,1,10116.0,N,,,12582,CHEMBL877484,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14295,1,10116.0,N,,,12582,CHEMBL627274,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14296,1,10116.0,N,,,12582,CHEMBL623186,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14297,1,10116.0,N,,,12582,CHEMBL623187,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14298,1,10116.0,N,,,12582,CHEMBL623188,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14299,1,10116.0,N,,,12582,CHEMBL628055,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14300,1,10116.0,N,,,12582,CHEMBL628056,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14301,1,10116.0,N,,,12582,CHEMBL628200,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14302,1,10116.0,N,,,12582,CHEMBL628201,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14303,1,10116.0,N,,,12582,CHEMBL628202,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14304,1,10116.0,N,,,12582,CHEMBL628203,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14305,1,10116.0,N,,,12582,CHEMBL628204,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14306,1,10116.0,N,,,12582,CHEMBL628205,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14307,1,10116.0,N,,,12582,CHEMBL628206,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,In vivo,,,Autocuration,BAO_0000218,14308,0,,U,,,13257,CHEMBL628207,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14309,0,,U,,,13257,CHEMBL627220,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14310,0,,U,,,13257,CHEMBL627221,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14311,0,,U,,,13257,CHEMBL627222,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14312,0,,U,,,13257,CHEMBL627223,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14313,0,,U,,,13257,CHEMBL632062,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14314,0,,U,,,13257,CHEMBL632063,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,Spleen,A,22224,1,,2106.0,
,In vivo,,,Autocuration,BAO_0000218,14315,0,,U,,,13257,CHEMBL632064,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,Urinary bladder,A,22224,1,,1255.0,
,In vivo,,,Autocuration,BAO_0000218,14316,0,,U,,,13257,CHEMBL632065,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,14317,0,,U,,,13257,CHEMBL632066,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,Bone element,A,22224,1,,1474.0,
,In vivo,,,Autocuration,BAO_0000218,14318,0,,U,,,13257,CHEMBL632067,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14319,0,,U,,,13257,CHEMBL629188,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,Kidney,A,22224,1,,2113.0,
,In vivo,,,Autocuration,BAO_0000218,14320,0,,U,,,13257,CHEMBL629189,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,Liver,A,22224,1,,2107.0,
,In vivo,,,Autocuration,BAO_0000218,14321,0,,U,,,13257,CHEMBL629190,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,Lung,A,22224,1,,2048.0,
,In vivo,,,Autocuration,BAO_0000218,14322,0,,U,,,13257,CHEMBL629191,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14323,0,,U,,,13257,CHEMBL629192,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14324,0,,U,,,13257,CHEMBL629193,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14325,0,,U,,,13257,CHEMBL629194,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14326,0,,U,,,13257,CHEMBL629195,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14327,0,,U,,,13257,CHEMBL629373,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14328,0,,U,,,13257,CHEMBL629374,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,Spleen,A,22224,1,,2106.0,
,In vivo,,,Autocuration,BAO_0000218,14329,0,,U,,,13257,CHEMBL629375,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14330,0,,U,,,13257,CHEMBL629376,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,Urinary bladder,A,22224,1,,1255.0,
,In vivo,,,Autocuration,BAO_0000218,14331,0,,U,,,13257,CHEMBL629377,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,14332,0,,U,,,13257,CHEMBL629378,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,Bone element,A,22224,1,,1474.0,
,In vivo,,,Autocuration,BAO_0000218,14333,0,,U,,,13257,CHEMBL629379,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14334,0,,U,,,13257,CHEMBL629151,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,Kidney,A,22224,1,,2113.0,
,In vivo,,,Autocuration,BAO_0000218,14335,0,,U,,,13257,CHEMBL629152,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,Liver,A,22224,1,,2107.0,
,In vivo,,,Autocuration,BAO_0000218,14336,0,,U,,,13257,CHEMBL629153,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,Lung,A,22224,1,,2048.0,
,In vivo,,,Autocuration,BAO_0000218,14337,0,,U,,,13257,CHEMBL629154,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14338,0,,U,,,13257,CHEMBL629155,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14339,0,,U,,,13257,CHEMBL629156,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14340,0,,U,,,13257,CHEMBL629157,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14341,0,,U,,,13257,CHEMBL629158,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14342,0,,U,,,13257,CHEMBL629159,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14343,0,,U,,,13257,CHEMBL629160,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14344,0,,U,,,13257,CHEMBL629161,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,Spleen,A,22224,1,,2106.0,
,In vivo,,,Autocuration,BAO_0000218,14345,0,,U,,,13257,CHEMBL629162,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,Urinary bladder,A,22224,1,,1255.0,
,In vivo,,,Autocuration,BAO_0000218,14346,0,,U,,,13257,CHEMBL629163,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,14347,0,,U,,,13257,CHEMBL629164,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,Bone element,A,22224,1,,1474.0,
,In vivo,,,Autocuration,BAO_0000218,14348,0,,U,,,13257,CHEMBL629165,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14349,0,,U,,,13257,CHEMBL629166,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,Liver,A,22224,1,,2107.0,
,In vivo,,,Autocuration,BAO_0000218,14350,0,,U,,,13257,CHEMBL629167,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,Lung,A,22224,1,,2048.0,
,In vivo,,,Autocuration,BAO_0000218,14351,0,,U,,,13257,CHEMBL629168,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,Muscle tissue,A,22224,1,,2385.0,
,,,,Autocuration,BAO_0000019,14352,0,,U,,,2193,CHEMBL629169,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14353,0,,U,,,2193,CHEMBL629170,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14354,0,,U,,,2193,CHEMBL631153,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14355,0,,U,,,2193,CHEMBL875121,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14356,0,,U,,,2193,CHEMBL631154,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14357,0,,U,,,2193,CHEMBL631155,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14358,0,,U,,,568,CHEMBL631156,,Hydrolysis rate constant was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14359,0,,U,,,9680,CHEMBL631157,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14360,0,,U,,,9680,CHEMBL631158,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14361,0,,U,,,9680,CHEMBL631159,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14362,0,,U,,,10026,CHEMBL631160,,Observed second order rate constant,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14363,0,,U,,,10281,CHEMBL631161,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14364,0,,U,,,10014,CHEMBL631162,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14365,0,,U,,,10014,CHEMBL630313,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14366,0,,U,,,9680,CHEMBL630314,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14367,0,,U,,,9680,CHEMBL630315,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14368,0,,U,,,13028,CHEMBL630316,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14369,0,,U,,,13028,CHEMBL630986,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14370,0,,U,,,13028,CHEMBL630987,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14371,0,,U,,,13028,CHEMBL630988,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14372,0,,U,,,13028,CHEMBL630989,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14373,0,,U,,,13028,CHEMBL630990,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14374,0,,U,,,13028,CHEMBL630991,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14375,0,,U,,,13028,CHEMBL630992,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14376,0,,U,,,13028,CHEMBL630993,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14377,0,,U,,,13028,CHEMBL630994,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14378,1,10116.0,N,,,10014,CHEMBL630995,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14379,0,,U,,,9962,CHEMBL629252,,Association constant for compound at 31 degree C was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14380,0,,U,,,12029,CHEMBL629253,,Calculated antagonist equilibrium dissociation constant of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14381,0,,U,,,12029,CHEMBL629944,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14382,1,10141.0,N,,,10583,CHEMBL629945,,Dissociation constants vs LTE4 on guinea pig trachea,Trachea,A,50512,1,,3126.0,Cavia porcellus
,,,,Autocuration,BAO_0000019,14383,0,,U,,,568,CHEMBL629946,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14384,0,,U,,,568,CHEMBL629947,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14385,0,,U,,,568,CHEMBL629948,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14386,0,,U,,,568,CHEMBL856024,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14387,0,,U,,,7493,CHEMBL629949,,Affinity constant KD value was derived from TMP,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14388,0,,U,,,8371,CHEMBL629950,,Apparent dissociation (binding) rate constant was evaluated,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,14389,0,,U,,,13114,CHEMBL630127,,Dissociation constant (KD) of the compound,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14390,0,,U,,,15515,CHEMBL630128,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14391,0,,U,,,522,CHEMBL630129,,Dissociation constant from ESR titration experiments,,P,22224,1,,,
,,,,Autocuration,BAO_0000019,14392,0,,U,,,13888,CHEMBL630130,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,22224,1,,,
,,,,Autocuration,BAO_0000100,14393,0,,U,,,2616,CHEMBL875234,,Dissociation constant was evaluated.,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14394,0,,U,,,3798,CHEMBL630131,,Dissociation constant was reported,,P,22224,1,,,
,,,,Intermediate,BAO_0000218,14395,1,10116.0,N,,,8731,CHEMBL630132,,Dissociation constant was determined in rat pituitary cells.,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14396,0,,U,,,11892,CHEMBL630133,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14397,0,,U,,,11892,CHEMBL630134,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14398,0,,U,,,2582,CHEMBL630135,,Equilibrium dissociation constant of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14399,0,,U,,,11892,CHEMBL630136,,Equilibrium dissociation constant was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14400,0,,U,,,13396,CHEMBL630137,,Kinetic constant KD was evaluated,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14401,0,,U,,,603,CHEMBL630138,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14402,0,,U,,,15673,CHEMBL630139,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14403,0,,U,,,10368,CHEMBL630140,,Rate constant for hydrolysis in aqueous acetone.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14404,0,,U,,,14228,CHEMBL875235,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14405,1,10116.0,N,,,11510,CHEMBL876439,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14406,1,10116.0,N,,,11510,CHEMBL630605,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14407,1,10116.0,N,,,11510,CHEMBL630606,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14408,1,10116.0,N,,,11510,CHEMBL630607,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14409,1,10116.0,N,,,11510,CHEMBL630608,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14410,1,10116.0,N,,,11510,CHEMBL630609,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14411,1,10116.0,N,,,11510,CHEMBL630610,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14412,1,10116.0,N,,,11510,CHEMBL630611,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14413,1,10116.0,N,,,11510,CHEMBL629552,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14414,1,10116.0,N,,,11510,CHEMBL629733,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14415,1,10116.0,N,,,11510,CHEMBL629734,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14416,1,10116.0,N,,,11510,CHEMBL629735,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14417,1,10116.0,N,,,11510,CHEMBL629736,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14418,1,10116.0,N,,,11510,CHEMBL629737,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14419,1,10116.0,N,,,11510,CHEMBL629738,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14420,1,10116.0,N,,,11510,CHEMBL629739,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14421,1,10116.0,N,,,11510,CHEMBL629740,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14422,1,10116.0,N,,,11510,CHEMBL629741,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14423,1,10116.0,N,,,11510,CHEMBL629742,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14424,1,10116.0,N,,,11510,CHEMBL629743,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14425,1,10116.0,N,,,11510,CHEMBL629744,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14426,1,10116.0,N,,,11510,CHEMBL629745,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14427,1,10116.0,N,,,11510,CHEMBL629746,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14428,1,10116.0,N,,,11510,CHEMBL629747,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14429,1,10116.0,N,,,11510,CHEMBL629748,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14430,1,10116.0,N,,,11510,CHEMBL629749,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14431,1,10116.0,N,,,11510,CHEMBL629750,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14432,1,10116.0,N,,,11510,CHEMBL629751,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14433,1,10116.0,N,,,11510,CHEMBL629752,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14434,1,10116.0,N,,,11510,CHEMBL629753,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14435,1,10116.0,N,,,11510,CHEMBL629754,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14436,1,10116.0,N,,,11510,CHEMBL629755,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14437,1,10116.0,N,,,11510,CHEMBL629756,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14438,1,10116.0,N,,,11510,CHEMBL629757,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14439,1,10116.0,N,,,11510,CHEMBL629758,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14440,1,10116.0,N,,,11510,CHEMBL629759,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14441,1,10116.0,N,,,11510,CHEMBL629760,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14442,1,10116.0,N,,,11510,CHEMBL876443,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14443,1,9615.0,N,,,8310,CHEMBL629761,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14444,1,9615.0,N,,,8310,CHEMBL629762,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14445,1,10090.0,N,,,8310,CHEMBL629763,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14446,1,10090.0,N,,,8310,CHEMBL629764,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14447,1,10090.0,N,,,8310,CHEMBL629765,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14448,1,10090.0,N,,,8310,CHEMBL629766,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14449,1,10090.0,N,,,8310,CHEMBL629767,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14450,1,9615.0,N,,,8310,CHEMBL629768,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14451,1,10090.0,N,,,8310,CHEMBL629769,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14452,1,9615.0,N,,,8310,CHEMBL629770,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14453,1,9615.0,N,,,8310,CHEMBL629771,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,A,50588,1,,,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14454,1,10090.0,N,,,8310,CHEMBL629772,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14455,1,10090.0,N,,,8310,CHEMBL629773,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14456,1,10090.0,N,,,8310,CHEMBL625455,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14457,1,10090.0,N,,,8310,CHEMBL625456,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14458,1,10090.0,N,,,8310,CHEMBL625457,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14459,1,10116.0,N,,,12582,CHEMBL625458,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14460,1,10116.0,N,,,12582,CHEMBL625459,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14461,1,10116.0,N,,,12582,CHEMBL875483,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14462,1,10116.0,N,,,12582,CHEMBL634779,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14463,1,10116.0,N,,,12582,CHEMBL625460,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14464,1,10116.0,N,,,12582,CHEMBL626117,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14465,1,10116.0,N,,,12582,CHEMBL626118,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14466,1,10116.0,N,,,12582,CHEMBL628342,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14467,1,10116.0,N,,,12582,CHEMBL628343,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14468,1,10116.0,N,,,12582,CHEMBL628344,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14469,1,10116.0,N,,,12582,CHEMBL628345,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14470,1,10116.0,N,,,12582,CHEMBL628346,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14471,1,10116.0,N,,,12582,CHEMBL628347,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14472,1,10116.0,N,,,12582,CHEMBL628348,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14473,1,10116.0,N,,,12582,CHEMBL628349,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14474,1,10116.0,N,,,12582,CHEMBL875611,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14475,1,10116.0,N,,,12582,CHEMBL628350,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14476,1,10116.0,N,,,12582,CHEMBL628351,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14477,1,10116.0,N,,,12582,CHEMBL628352,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14478,1,10116.0,N,,,12582,CHEMBL628353,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14479,1,10116.0,N,,,12582,CHEMBL628354,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14480,1,10116.0,N,,,12582,CHEMBL626667,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14481,1,10116.0,N,,,12582,CHEMBL626668,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14482,1,10116.0,N,,,12582,CHEMBL626669,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14483,1,10116.0,N,,,12582,CHEMBL626670,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14484,1,10116.0,N,,,12582,CHEMBL626671,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14485,1,10116.0,N,,,12582,CHEMBL626672,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14486,1,10116.0,N,,,12582,CHEMBL626673,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14487,1,10116.0,N,,,12582,CHEMBL626674,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14488,1,10116.0,N,,,12582,CHEMBL626675,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14489,1,10116.0,N,,,12582,CHEMBL626676,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14490,1,10116.0,N,,,12582,CHEMBL626677,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14491,1,10116.0,N,,,12582,CHEMBL626678,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14492,1,10116.0,N,,,12582,CHEMBL626679,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14493,1,10116.0,N,,,12582,CHEMBL875612,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14494,1,10116.0,N,,,12582,CHEMBL626680,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14495,1,10116.0,N,,,12582,CHEMBL626681,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14496,1,10116.0,N,,,12582,CHEMBL626682,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14497,1,10116.0,N,,,12582,CHEMBL626683,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14498,1,10116.0,N,,,12582,CHEMBL626684,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14499,1,10116.0,N,,,12582,CHEMBL626685,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14500,1,10116.0,N,,,12582,CHEMBL626686,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14501,1,10116.0,N,,,12582,CHEMBL626687,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14502,1,10116.0,N,,,12582,CHEMBL624978,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14503,1,10116.0,N,,,12582,CHEMBL624979,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14504,1,10116.0,N,,,12582,CHEMBL624980,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14505,1,10116.0,N,,,12582,CHEMBL624981,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14506,1,9615.0,N,,,12582,CHEMBL624982,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,14507,0,,U,,,13257,CHEMBL627564,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14508,0,,U,,,13257,CHEMBL627565,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14509,0,,U,,,13257,CHEMBL627566,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14510,0,,U,,,13257,CHEMBL627567,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14511,0,,U,,,13257,CHEMBL627568,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,Spleen,A,22224,1,,2106.0,
,In vivo,,,Autocuration,BAO_0000218,14512,0,,U,,,13257,CHEMBL627569,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,Kidney,A,22224,1,,2113.0,
,In vivo,,,Autocuration,BAO_0000218,14513,0,,U,,,13257,CHEMBL627570,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,Urinary bladder,A,22224,1,,1255.0,
,In vivo,,,Autocuration,BAO_0000218,14514,0,,U,,,13257,CHEMBL627571,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,Blood,A,22224,1,,178.0,
,In vivo,,,Autocuration,BAO_0000218,14515,0,,U,,,13257,CHEMBL627572,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,Bone element,A,22224,1,,1474.0,
,In vivo,,,Autocuration,BAO_0000218,14516,0,,U,,,13257,CHEMBL627573,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14517,0,,U,,,13257,CHEMBL627574,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,Kidney,A,22224,1,,2113.0,
,In vivo,,,Autocuration,BAO_0000218,14518,0,,U,,,13257,CHEMBL627575,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,Liver,A,22224,1,,2107.0,
,In vivo,,,Autocuration,BAO_0000218,14519,0,,U,,,13257,CHEMBL627576,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,Lung,A,22224,1,,2048.0,
,In vivo,,,Autocuration,BAO_0000218,14520,0,,U,,,13257,CHEMBL627577,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14521,0,,U,,,13257,CHEMBL627578,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14522,0,,U,,,13257,CHEMBL627579,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14523,0,,U,,,13257,CHEMBL627580,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14524,0,,U,,,13257,CHEMBL627581,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14525,0,,U,,,13257,CHEMBL627582,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14526,0,,U,,,13257,CHEMBL627583,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Autocuration,BAO_0000218,14527,0,,U,,,13257,CHEMBL627584,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,Spleen,A,22224,1,,2106.0,
,In vivo,,,Autocuration,BAO_0000218,14528,0,,U,,,13257,CHEMBL627585,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,Prostate gland,A,22224,1,,2367.0,
,In vivo,,,Autocuration,BAO_0000218,14529,0,,U,,,13257,CHEMBL627586,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,Muscle tissue,A,22224,1,,2385.0,
,In vivo,,,Intermediate,BAO_0000218,14530,1,10116.0,N,,,15413,CHEMBL627587,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14531,1,10116.0,N,,,15413,CHEMBL627588,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14532,1,10116.0,N,,,15413,CHEMBL628250,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14533,1,10116.0,N,,,15413,CHEMBL628251,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14534,1,10116.0,N,,,15413,CHEMBL628252,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14535,1,10116.0,N,,,15413,CHEMBL628253,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14536,1,10116.0,N,,,15413,CHEMBL628254,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Hypothalamus,A,50597,1,,1898.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14537,1,10116.0,N,,,15413,CHEMBL877493,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Hypothalamus,A,50597,1,,1898.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14538,1,10116.0,N,,,15413,CHEMBL628255,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14539,1,10116.0,N,,,15413,CHEMBL628256,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14540,1,10116.0,N,,,15413,CHEMBL628257,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14541,1,10116.0,N,,,15413,CHEMBL628258,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Hypothalamus,A,50597,1,,1898.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14542,1,10116.0,N,,,15413,CHEMBL628259,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14543,1,10116.0,N,,,15413,CHEMBL628429,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14544,1,10116.0,N,,,15413,CHEMBL626862,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14545,1,10116.0,N,,,15413,CHEMBL626863,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Hypothalamus,A,50597,1,,1898.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14546,1,10116.0,N,,,15413,CHEMBL625886,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14547,1,10116.0,N,,,15413,CHEMBL625887,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14548,1,10116.0,N,,,15413,CHEMBL625888,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14549,1,10116.0,N,,,15413,CHEMBL625889,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14550,1,10116.0,N,,,15413,CHEMBL625890,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14551,1,10116.0,N,,,15413,CHEMBL625891,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14552,1,10116.0,N,,,15413,CHEMBL625892,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Hypothalamus,A,50597,1,,1898.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14553,1,10116.0,N,,,15413,CHEMBL625893,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Hypothalamus,A,50597,1,,1898.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14554,1,10116.0,N,,,15413,CHEMBL625894,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Cerebellum,A,50597,1,,2037.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14555,1,10116.0,N,,,15413,CHEMBL625895,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14556,0,,U,,,12404,CHEMBL625896,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14557,0,,U,,,568,CHEMBL625897,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14558,0,,U,,,568,CHEMBL625898,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14559,0,,U,,,568,CHEMBL625899,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14560,0,,U,,,12404,CHEMBL626124,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14561,1,562.0,N,,,7624,CHEMBL628500,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,A,50212,1,,,Escherichia coli
,,,,Intermediate,BAO_0000218,14562,1,10116.0,N,,,7624,CHEMBL857856,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14563,1,10116.0,N,,,7624,CHEMBL628501,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14564,0,,U,,,4643,CHEMBL628502,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14565,0,,U,,,11532,CHEMBL628503,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14566,0,,U,,,11018,CHEMBL628504,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14567,0,,U,,,2276,CHEMBL628505,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14568,0,,U,,,2276,CHEMBL874452,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14569,0,,U,,,2276,CHEMBL628506,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14570,0,,U,,,2276,CHEMBL628507,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14571,0,,U,,,2276,CHEMBL628508,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14572,0,,U,,,8949,CHEMBL628509,,Michaelis constant (KM) was evaluated,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14573,0,,U,,,12404,CHEMBL628510,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14574,0,,U,,,7625,CHEMBL628511,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,B,22224,1,,,
,,,,Autocuration,BAO_0000019,14575,0,,U,,,7625,CHEMBL628512,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,B,22224,1,,,
,,,,Autocuration,BAO_0000019,14576,0,,U,,,7625,CHEMBL628513,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,B,22224,1,,,
,,,,Autocuration,BAO_0000019,14577,0,,U,,,7625,CHEMBL628514,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,B,22224,1,,,
,,,,Autocuration,BAO_0000019,14578,0,,U,,,12908,CHEMBL628515,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14579,0,,U,,,10368,CHEMBL628516,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14580,0,,U,,,13108,CHEMBL628517,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14581,0,,U,,,13108,CHEMBL628518,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14582,0,,U,,,15217,CHEMBL628519,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14583,0,,U,,,15217,CHEMBL628520,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14584,0,,U,,,10933,CHEMBL628521,,Binding constant was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14585,0,,U,,,2363,CHEMBL630443,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14586,0,,U,,,2363,CHEMBL630444,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14587,0,,U,,,2276,CHEMBL857732,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,14588,0,,U,,,14915,CHEMBL630445,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,P,22224,1,,,
,,,,Autocuration,BAO_0000019,14589,0,,U,,,8847,CHEMBL630446,,Catalytic rate constant of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14590,0,,U,,,15357,CHEMBL630447,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,B,22224,1,,,
,,,,Autocuration,BAO_0000019,14591,0,,U,,,2869,CHEMBL630448,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14592,0,,U,,,3484,CHEMBL630449,,Catalytic rate constant against phospholipase A2 was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14593,0,,U,,,1373,CHEMBL630450,,"Compound was evaluated for catalytic constant, Kcat",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14594,0,,U,,,8142,CHEMBL630451,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14595,0,,U,,,14131,CHEMBL630452,,Kcat calculated from 0.693/T1/2,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14596,0,,U,,,17269,CHEMBL630453,,Kcat was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14597,0,,U,,,3485,CHEMBL630454,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14598,0,,U,,,3485,CHEMBL630455,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14599,0,,U,,,3485,CHEMBL631487,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14600,0,,U,,,5962,CHEMBL631488,,Kcat value was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14601,0,,U,,,3133,CHEMBL876440,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14602,0,,U,,,3133,CHEMBL631489,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14603,0,,U,,,2276,CHEMBL857742,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14604,0,,U,,,2276,CHEMBL631490,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14605,0,,U,,,2276,CHEMBL631491,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14606,0,,U,,,2276,CHEMBL631492,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14607,0,,U,,,2276,CHEMBL631493,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14608,0,,U,,,4892,CHEMBL631494,,Kinetic parameter for rate of conversion to PABA was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14609,0,,U,,,3133,CHEMBL631495,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14610,1,10116.0,N,,,11488,CHEMBL631496,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Feces,A,50597,1,,1988.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14611,1,10116.0,N,,,11488,CHEMBL631497,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14612,1,10116.0,N,,,11488,CHEMBL631498,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14613,1,10116.0,N,,,11488,CHEMBL629776,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14614,1,10116.0,N,,,11488,CHEMBL629777,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14615,1,10116.0,N,,,11488,CHEMBL629778,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14616,1,10116.0,N,,,11488,CHEMBL630456,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14617,1,10116.0,N,,,11488,CHEMBL630457,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14618,1,10116.0,N,,,11488,CHEMBL630458,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14619,1,10116.0,N,,,11488,CHEMBL630459,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14620,1,10116.0,N,,,11488,CHEMBL630460,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14621,1,10116.0,N,,,11488,CHEMBL876550,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14622,1,10116.0,N,,,11488,CHEMBL630461,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14623,1,10116.0,N,,,11488,CHEMBL630462,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14624,1,10116.0,N,,,11488,CHEMBL630463,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14625,1,10116.0,N,,,11488,CHEMBL630464,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14626,1,10116.0,N,,,11488,CHEMBL630465,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14627,1,10116.0,N,,,11488,CHEMBL630466,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14628,1,10116.0,N,,,11488,CHEMBL630467,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14629,1,10116.0,N,,,11488,CHEMBL630633,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14630,1,10116.0,N,,,11488,CHEMBL630634,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14631,1,10116.0,N,,,11488,CHEMBL630635,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14632,1,10116.0,N,,,11488,CHEMBL630636,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14633,1,10116.0,N,,,11488,CHEMBL630637,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14634,1,9986.0,N,,,7132,CHEMBL630638,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14635,1,9986.0,N,,,7132,CHEMBL630639,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14636,1,9986.0,N,,,7132,CHEMBL630640,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14637,1,9986.0,N,,,7132,CHEMBL876551,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14638,1,9986.0,N,,,7132,CHEMBL630641,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14639,1,9986.0,N,,,7132,CHEMBL630642,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14640,1,9986.0,N,,,7132,CHEMBL630643,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14641,1,9986.0,N,,,7132,CHEMBL630644,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14642,1,9986.0,N,,,7132,CHEMBL630645,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14643,1,9986.0,N,,,7132,CHEMBL625599,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14644,1,9986.0,N,,,7132,CHEMBL625600,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14645,1,9986.0,N,,,7132,CHEMBL625601,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14646,1,9986.0,N,,,7132,CHEMBL625602,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Feces,A,50592,1,,1988.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14647,1,9986.0,N,,,7132,CHEMBL627470,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14648,1,9986.0,N,,,7132,CHEMBL627471,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14649,1,9986.0,N,,,7132,CHEMBL627472,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14650,1,9986.0,N,,,7132,CHEMBL627473,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,,,,Intermediate,BAO_0000218,14651,1,9986.0,N,,,7132,CHEMBL627474,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Urine,A,50592,1,,1088.0,Oryctolagus cuniculus
,In vivo,,,Intermediate,BAO_0000218,14652,1,10116.0,N,,,13925,CHEMBL627475,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14653,1,10116.0,N,,,13925,CHEMBL627476,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Blood,A,50597,1,,178.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14654,1,9615.0,N,,,12582,CHEMBL627477,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14655,1,9615.0,N,,,12582,CHEMBL627478,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14656,1,9615.0,N,,,12582,CHEMBL627479,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14657,1,9615.0,N,,,12582,CHEMBL627480,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14658,1,9615.0,N,,,12582,CHEMBL627481,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14659,1,9615.0,N,,,12582,CHEMBL627482,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14660,1,9615.0,N,,,12582,CHEMBL627483,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14661,1,9615.0,N,,,12582,CHEMBL875636,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14662,1,9615.0,N,,,12582,CHEMBL625764,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14663,1,9615.0,N,,,12582,CHEMBL625765,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14664,1,9615.0,N,,,12582,CHEMBL625766,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14665,1,9615.0,N,,,12582,CHEMBL625767,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14666,1,9615.0,N,,,12582,CHEMBL625768,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14667,1,9615.0,N,,,12582,CHEMBL625769,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14668,1,9615.0,N,,,12582,CHEMBL625770,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14669,1,9615.0,N,,,12582,CHEMBL625771,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14670,1,9615.0,N,,,12582,CHEMBL625772,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14671,1,9615.0,N,,,12582,CHEMBL625773,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Urine,A,50588,1,,1088.0,Canis lupus familiaris
,,,,Intermediate,BAO_0000218,14672,1,10116.0,N,,,12582,CHEMBL625774,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14673,1,10116.0,N,,,12582,CHEMBL625775,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14674,1,10116.0,N,,,12582,CHEMBL625776,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14675,1,10116.0,N,,,12582,CHEMBL625777,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14676,1,10116.0,N,,,12582,CHEMBL625778,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14677,1,10116.0,N,,,12582,CHEMBL625779,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14678,1,10116.0,N,,,12582,CHEMBL625780,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14679,1,10116.0,N,,,12582,CHEMBL625781,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14680,1,10116.0,N,,,12582,CHEMBL875637,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14681,1,10116.0,N,,,12582,CHEMBL626473,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14682,1,10116.0,N,,,12582,CHEMBL626474,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14683,1,10116.0,N,,,12582,CHEMBL626475,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14684,1,10116.0,N,,,12582,CHEMBL626476,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14685,1,10116.0,N,,,12582,CHEMBL634397,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14686,1,10116.0,N,,,12582,CHEMBL626477,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14687,1,10116.0,N,,,12582,CHEMBL631069,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14688,1,10116.0,N,,,12582,CHEMBL631070,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14689,1,10116.0,N,,,12582,CHEMBL631071,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14690,1,10116.0,N,,,12582,CHEMBL631072,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14691,1,10116.0,N,,,12582,CHEMBL631073,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14692,1,10116.0,N,,,12582,CHEMBL631074,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14693,1,10116.0,N,,,12582,CHEMBL631075,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14694,1,10116.0,N,,,12582,CHEMBL631725,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14695,1,10116.0,N,,,12582,CHEMBL631726,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14696,1,10116.0,N,,,12582,CHEMBL631727,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14697,1,10116.0,N,,,12582,CHEMBL631728,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14698,1,10116.0,N,,,12582,CHEMBL631729,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14699,1,10116.0,N,,,12582,CHEMBL631730,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14700,1,10116.0,N,,,12582,CHEMBL631731,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14701,1,10116.0,N,,,12582,CHEMBL631910,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14702,1,10116.0,N,,,15413,CHEMBL631911,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Hippocampus,A,50597,1,,10000000.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14703,1,10116.0,N,,,15413,CHEMBL631912,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Hypothalamus,A,50597,1,,1898.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14704,1,10116.0,N,,,15413,CHEMBL631913,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Hypothalamus,A,50597,1,,1898.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14705,1,10116.0,N,,,12017,CHEMBL631914,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14706,1,10116.0,N,,,12017,CHEMBL631915,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14707,1,10116.0,N,,,12017,CHEMBL875778,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14708,1,10116.0,N,,,12017,CHEMBL631916,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14709,1,10116.0,N,,,12017,CHEMBL631917,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14710,1,10116.0,N,,,12017,CHEMBL631918,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14711,1,10116.0,N,,,12017,CHEMBL631919,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14712,1,10116.0,N,,,12017,CHEMBL631920,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14713,1,10116.0,N,,,12017,CHEMBL631921,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14714,1,10116.0,N,,,12017,CHEMBL631922,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14715,1,10116.0,N,,,12017,CHEMBL631923,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14716,1,10116.0,N,,,12017,CHEMBL631924,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14717,1,10116.0,N,,,12017,CHEMBL630234,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14718,1,10116.0,N,,,12017,CHEMBL630235,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14719,1,10116.0,N,,,12017,CHEMBL630236,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14720,1,10116.0,N,,,12017,CHEMBL630237,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14721,1,10116.0,N,,,12017,CHEMBL630238,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14722,1,10116.0,N,,,12017,CHEMBL630239,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14723,1,10116.0,N,,,12017,CHEMBL630303,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14724,1,10116.0,N,,,12017,CHEMBL630304,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14725,1,10116.0,N,,,12017,CHEMBL630305,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14726,1,10116.0,N,,,12017,CHEMBL630306,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14727,1,10116.0,N,,,12017,CHEMBL630307,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14728,1,10116.0,N,,,12017,CHEMBL630308,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14729,1,10116.0,N,,,12017,CHEMBL630309,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14730,1,10116.0,N,,,12017,CHEMBL629309,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14731,1,10116.0,N,,,12017,CHEMBL629993,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14732,1,10116.0,N,,,12017,CHEMBL629994,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14733,1,10116.0,N,,,12017,CHEMBL629995,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14734,1,10116.0,N,,,12017,CHEMBL631993,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14735,1,10116.0,N,,,12017,CHEMBL631994,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14736,1,10116.0,N,,,12017,CHEMBL631995,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14737,1,10116.0,N,,,12017,CHEMBL631996,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14738,1,10116.0,N,,,12017,CHEMBL631997,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14739,1,10116.0,N,,,12017,CHEMBL631998,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14740,1,10116.0,N,,,12017,CHEMBL631999,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14741,1,10116.0,N,,,12017,CHEMBL632000,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14742,1,10116.0,N,,,12017,CHEMBL632001,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14743,1,10116.0,N,,,12017,CHEMBL874424,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14744,1,10116.0,N,,,12017,CHEMBL632002,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14745,1,10116.0,N,,,12017,CHEMBL632003,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14746,0,,U,,,3133,CHEMBL632004,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14747,0,,U,,,2742,CHEMBL632005,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14748,0,,U,,,2742,CHEMBL632006,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14749,0,,U,,,2742,CHEMBL632007,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14750,0,,U,,,2742,CHEMBL632008,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14751,0,,U,,,2742,CHEMBL632009,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14752,0,,U,,,2742,CHEMBL632010,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14753,0,,U,,,2742,CHEMBL857750,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14754,0,,U,,,2742,CHEMBL632011,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14755,0,,U,,,2276,CHEMBL632012,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14756,0,,U,,,2276,CHEMBL632013,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14757,0,,U,,,2276,CHEMBL632014,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14758,0,,U,,,2276,CHEMBL629622,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14759,0,,U,,,2276,CHEMBL629623,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14760,0,,U,,,2276,CHEMBL629624,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14761,0,,U,,,17269,CHEMBL629625,,Ratio of Kcat to that of Km was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14762,0,,U,,,2276,CHEMBL629626,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14763,0,,U,,,2276,CHEMBL629627,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14764,0,,U,,,15917,CHEMBL629628,,"Compound was evaluated for constant, Kd",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14765,0,,U,,,10933,CHEMBL629629,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14766,0,,U,,,10933,CHEMBL629630,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14767,0,,U,,,14293,CHEMBL856030,,Dissociation Constant of compound determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14768,0,,U,,,6698,CHEMBL629631,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,B,22224,1,,,
,,,,Autocuration,BAO_0000019,14769,0,,U,,,6698,CHEMBL629632,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,B,22224,1,,,
,,,,Autocuration,BAO_0000100,14770,0,,U,,,4318,CHEMBL629633,,Dissociation constant of compound with Fructose was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14771,0,,U,,,4318,CHEMBL629634,,Dissociation constant of compound with Fructose was determined; Not determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14772,0,,U,,,4318,CHEMBL629635,,Dissociation constant of compound with Lactulose was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14773,0,,U,,,4318,CHEMBL629636,,Dissociation constant of compound with Lactulose was determined; Not determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14774,0,,U,,,14959,CHEMBL629637,,Dissociation constant of the Compound,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14775,0,,U,,,5913,CHEMBL629638,,Dissociation constant by non-linear regression analysis,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14776,0,,U,,,14218,CHEMBL629639,,Dissociation constant was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14777,0,,U,,,10689,CHEMBL629640,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14778,0,,U,,,13925,CHEMBL629641,,Dissociation constant was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14779,0,,U,,,16359,CHEMBL631344,,Dissociation constant was determined,,P,22224,1,,,
,,,,Intermediate,BAO_0000218,14780,1,10116.0,N,,,10944,CHEMBL631345,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14781,0,,U,,,11080,CHEMBL631346,,The dissociation constant determined by fluorescence displacement assay,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14782,0,,U,,,17805,CHEMBL631524,,kd value surface plasmon resonance (SPR) method,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14783,1,10116.0,N,,,10944,CHEMBL631525,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14784,0,,U,,,16645,CHEMBL631526,,First dissociation constant of the binding of compound to V30M TTR,,F,22224,1,,,
,,,,Autocuration,BAO_0000019,14785,0,,U,,,16645,CHEMBL631527,,Second dissociation constant of the binding of compound to V30M TTR,,F,22224,1,,,
,,,,Autocuration,BAO_0000019,14786,0,,U,,,7793,CHEMBL631528,,"Compound was evaluated for equilibrium constant, Ke",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14787,0,,U,,,12199,CHEMBL631529,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,Hypothalamus,A,22224,1,,1898.0,
,,,,Autocuration,BAO_0000019,14788,0,,U,,,12199,CHEMBL631530,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,Hypothalamus,A,22224,1,,1898.0,
,,,,Autocuration,BAO_0000019,14789,0,,U,,,9680,CHEMBL631531,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14790,0,,U,,,9680,CHEMBL631532,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14791,0,,U,,,9680,CHEMBL631533,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14792,1,10090.0,N,,,13758,CHEMBL876552,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14793,1,10090.0,N,,,13758,CHEMBL631534,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14794,1,10090.0,N,,,13758,CHEMBL631535,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14795,1,10090.0,N,,,13758,CHEMBL631536,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14796,1,10090.0,N,,,13758,CHEMBL631537,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14797,1,10090.0,N,,,13758,CHEMBL631538,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14798,1,10090.0,N,,,13758,CHEMBL631539,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14799,1,10090.0,N,,,13758,CHEMBL631540,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14800,1,10116.0,N,,,14393,CHEMBL625637,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14801,1,10116.0,N,,,14393,CHEMBL625638,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14802,1,10116.0,N,,,15078,CHEMBL625639,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,A,50597,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14803,1,10116.0,N,,,13925,CHEMBL625640,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14804,1,10116.0,N,,,13925,CHEMBL625641,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14805,1,10116.0,N,,,13925,CHEMBL625642,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14806,1,10116.0,N,,,13925,CHEMBL625643,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14807,1,10116.0,N,,,13925,CHEMBL625644,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14808,1,10116.0,N,,,13925,CHEMBL625645,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Kidney,A,50597,1,,2113.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14809,1,10116.0,N,,,13925,CHEMBL625646,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14810,1,10116.0,N,,,13925,CHEMBL625647,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14811,1,10116.0,N,,,13925,CHEMBL625648,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14812,1,10116.0,N,,,13925,CHEMBL625649,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14813,1,10116.0,N,,,13925,CHEMBL625650,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14814,1,10116.0,N,,,13925,CHEMBL625651,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14815,1,10116.0,N,,,13925,CHEMBL625652,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14816,1,10116.0,N,,,13925,CHEMBL625653,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Zone of skin,A,50597,1,,14.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14817,1,10116.0,N,,,13925,CHEMBL625654,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14818,1,10116.0,N,,,13925,CHEMBL625655,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14819,1,10116.0,N,,,9712,CHEMBL625656,,Biodistribution of Compound in rat blood after 15 minutes of administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14820,1,10116.0,N,,,9712,CHEMBL625657,,Biodistribution of Compound in rat blood after 2 minutes of administration,Blood,A,50597,1,,178.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14821,1,10116.0,N,,,9712,CHEMBL625658,,Biodistribution of Compound in rat brain after 15 minutes of administration,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14822,1,10116.0,N,,,9712,CHEMBL625659,,Biodistribution of Compound in rat brain after 2 minutes of administration,Brain,A,50597,1,,955.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14823,1,10116.0,N,,,9712,CHEMBL625660,,Biodistribution of Compound in rat heart after 15 minutes of administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14824,1,10116.0,N,,,9712,CHEMBL625661,,Biodistribution of Compound in rat heart after 2 minutes of administration,Heart,A,50597,1,,948.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14825,1,10116.0,N,,,9712,CHEMBL625662,,Biodistribution of Compound in rat liver after 15 minutes of administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14826,1,10116.0,N,,,9712,CHEMBL625663,,Biodistribution of Compound in rat liver after 2 minutes of administration,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14827,1,10116.0,N,,,9712,CHEMBL875621,,Biodistribution of Compound in rat lung after 15 minutes of administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14828,1,10116.0,N,,,9712,CHEMBL628382,,Biodistribution of Compound in rat lung after 2 minutes of administration,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14829,1,10116.0,N,,,9712,CHEMBL628383,,Biodistribution of Compound in rat muscle after 15 minutes of administration,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14830,1,10116.0,N,,,9712,CHEMBL628384,,Biodistribution of Compound in rat muscle after 2 minutes of administration,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14831,1,10116.0,N,,,13925,CHEMBL628385,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14832,1,10116.0,N,,,13925,CHEMBL875753,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14833,1,10116.0,N,,,13925,CHEMBL628386,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14834,1,10116.0,N,,,6941,CHEMBL628387,,Organ distribution in rat blood 2 minutes after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14835,1,10116.0,N,,,6941,CHEMBL628388,,Organ distribution in rat blood 2 hr after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14836,1,10116.0,N,,,6941,CHEMBL628389,,Organ distribution in rat blood 30 minutes after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14837,1,10116.0,N,,,6941,CHEMBL632756,,Organ distribution in rat blood 30 min after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14838,1,10116.0,N,,,6941,CHEMBL628390,,Organ distribution in rat brain 2 minutes after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14839,1,10116.0,N,,,6941,CHEMBL631811,,Organ distribution in rat brain 2 hr after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14840,1,10116.0,N,,,6941,CHEMBL631812,,Organ distribution in rat brain 30 minutes after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14841,1,10116.0,N,,,6941,CHEMBL631813,,Organ distribution in rat heart 2 minutes after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14842,1,10116.0,N,,,6941,CHEMBL631814,,Organ distribution in rat heart 2 hr after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14843,1,10116.0,N,,,6941,CHEMBL631815,,Organ distribution in rat heart 30 minutes after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14844,1,10116.0,N,,,6941,CHEMBL631816,,Organ distribution in rat kidney 2 minutes after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14845,1,10116.0,N,,,6941,CHEMBL875758,,Organ distribution in rat kidney 2 hr after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14846,1,10116.0,N,,,6941,CHEMBL631817,,Organ distribution in rat kidney 30 minutes after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14847,1,10116.0,N,,,6941,CHEMBL631818,,Organ distribution in rat liver 2 minutes after intravenous injection,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14848,1,10116.0,N,,,6941,CHEMBL631819,,Organ distribution in rat liver 2 hr after intravenous injection,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14849,1,10116.0,N,,,6941,CHEMBL631820,,Organ distribution in rat liver 30 minutes after intravenous injection,Liver,A,50597,1,,2107.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14850,1,10116.0,N,,,6941,CHEMBL631821,,Organ distribution in rat lung 2 minutes after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14851,1,10116.0,N,,,6941,CHEMBL631822,,Organ distribution in rat lung 2 hr after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14852,1,10116.0,N,,,6941,CHEMBL631823,,Organ distribution in rat lung 30 minutes after intravenous injection,,A,50597,1,,,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14853,1,10116.0,N,,,6941,CHEMBL631824,,Organ distribution in rat muscle 2 minutes after intravenous injection,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14854,1,10116.0,N,,,6941,CHEMBL631825,,Organ distribution in rat muscle 2 hr after intravenous injection,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14855,1,10116.0,N,,,6941,CHEMBL631826,,Organ distribution in rat muscle 30 minutes after intravenous injection,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14856,1,10090.0,N,,,14439,CHEMBL631827,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14857,1,10090.0,N,,,14439,CHEMBL631828,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14858,1,10090.0,N,,,14439,CHEMBL631829,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,A,50594,1,,,Mus musculus
,,,,Intermediate,BAO_0000218,14859,1,10116.0,N,,,12582,CHEMBL875759,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14860,1,10116.0,N,,,12582,CHEMBL631830,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14861,1,10116.0,N,,,12582,CHEMBL631831,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14862,1,10116.0,N,,,12582,CHEMBL631832,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14863,1,10116.0,N,,,12582,CHEMBL631833,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14864,1,10116.0,N,,,12582,CHEMBL631834,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14865,1,10116.0,N,,,12582,CHEMBL631835,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14866,1,10116.0,N,,,12582,CHEMBL631836,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14867,1,10116.0,N,,,12582,CHEMBL631837,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14868,1,10116.0,N,,,12582,CHEMBL631838,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14869,1,10116.0,N,,,12582,CHEMBL631839,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14870,1,10116.0,N,,,12582,CHEMBL631840,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14871,1,10116.0,N,,,12582,CHEMBL631841,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14872,1,10116.0,N,,,12582,CHEMBL631842,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14873,1,10116.0,N,,,12582,CHEMBL631843,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14874,1,10116.0,N,,,12582,CHEMBL631844,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14875,1,10116.0,N,,,12582,CHEMBL631845,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14876,1,10116.0,N,,,12582,CHEMBL631846,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14877,1,10116.0,N,,,12582,CHEMBL875760,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14878,1,10116.0,N,,,12582,CHEMBL632199,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14879,1,10116.0,N,,,12582,CHEMBL631847,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14880,1,10116.0,N,,,12582,CHEMBL631848,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14881,1,10116.0,N,,,12582,CHEMBL628707,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14882,1,10116.0,N,,,12582,CHEMBL628708,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14883,1,10116.0,N,,,12582,CHEMBL628709,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14884,1,10116.0,N,,,12582,CHEMBL628710,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14885,1,10116.0,N,,,12582,CHEMBL628711,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14886,1,10116.0,N,,,12582,CHEMBL628712,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14887,1,10116.0,N,,,12582,CHEMBL628713,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14888,1,10116.0,N,,,12582,CHEMBL628714,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Urine,A,50597,1,,1088.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14889,1,10116.0,N,,,7415,CHEMBL628715,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14890,0,,U,,,7313,CHEMBL629179,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14891,0,,U,,,7313,CHEMBL629180,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14892,0,,U,,,7313,CHEMBL875108,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14893,0,,U,,,7570,CHEMBL629181,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Adrenal cortex,A,22224,1,,1235.0,
,,,,Autocuration,BAO_0000019,14894,0,,U,,,7570,CHEMBL629182,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Adrenal cortex,A,22224,1,,1235.0,
,,,,Autocuration,BAO_0000019,14895,0,,U,,,7570,CHEMBL629183,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14896,0,,U,,,7570,CHEMBL629184,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14897,0,,U,,,7570,CHEMBL629185,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Adrenal cortex,A,22224,1,,1235.0,
,,,,Autocuration,BAO_0000019,14898,0,,U,,,7570,CHEMBL629186,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,Adrenal cortex,A,22224,1,,1235.0,
,,,,Autocuration,BAO_0000019,14899,0,,U,,,7570,CHEMBL629187,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14900,0,,U,,,7570,CHEMBL629887,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14901,0,,U,,,7570,CHEMBL629888,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14902,0,,U,,,7570,CHEMBL629889,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14903,0,,U,,,7570,CHEMBL629890,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,Adrenal cortex,A,22224,1,,1235.0,
,,,,Autocuration,BAO_0000019,14904,0,,U,,,7570,CHEMBL629891,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14905,0,,U,,,7570,CHEMBL629892,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14906,0,,U,,,7570,CHEMBL629893,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Adrenal cortex,A,22224,1,,1235.0,
,,,,Autocuration,BAO_0000019,14907,0,,U,,,7570,CHEMBL629894,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14908,0,,U,,,7570,CHEMBL629895,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,A,22224,1,,,
,In vivo,,,Autocuration,BAO_0000218,14909,0,9615.0,U,,,14122,CHEMBL875109,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,A,22224,1,,,Canis lupus familiaris
,In vivo,,,Autocuration,BAO_0000218,14910,0,9541.0,U,,,16449,CHEMBL629896,,Absolute bioavailability in male cynomolgus monkeys,,A,22224,1,,,Macaca fascicularis
,In vivo,,,Autocuration,BAO_0000218,14911,0,10116.0,U,,,16449,CHEMBL629897,,Absolute bioavailability in maleSprague-Dawley rats,,A,22224,1,,,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14912,1,10116.0,N,,,12017,CHEMBL629898,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14913,1,10116.0,N,,,12017,CHEMBL630057,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14914,1,10116.0,N,,,12017,CHEMBL630058,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,A,50597,1,,2107.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14915,1,10116.0,N,,,12017,CHEMBL630059,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14916,1,10116.0,N,,,12017,CHEMBL630060,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14917,1,10116.0,N,,,12017,CHEMBL630061,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14918,1,10116.0,N,,,12017,CHEMBL630062,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14919,1,10116.0,N,,,12017,CHEMBL630063,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14920,1,10116.0,N,,,12017,CHEMBL630064,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14921,1,10116.0,N,,,12017,CHEMBL630065,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14922,1,10116.0,N,,,12017,CHEMBL630066,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14923,1,10116.0,N,,,12017,CHEMBL630067,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14924,1,10116.0,N,,,12017,CHEMBL630068,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,A,50597,1,,2048.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14925,1,10116.0,N,,,12017,CHEMBL631113,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14926,1,10116.0,N,,,12017,CHEMBL631114,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14927,1,10116.0,N,,,12017,CHEMBL631115,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14928,1,10116.0,N,,,12017,CHEMBL631116,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14929,1,10116.0,N,,,12017,CHEMBL630528,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14930,1,10116.0,N,,,12017,CHEMBL630529,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14931,1,10116.0,N,,,12017,CHEMBL630530,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14932,1,10116.0,N,,,12017,CHEMBL630531,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14933,1,10116.0,N,,,12017,CHEMBL630532,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14934,1,10116.0,N,,,12017,CHEMBL630533,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,A,50597,1,,2385.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14935,1,10090.0,N,,,15045,CHEMBL630534,,Biodistribution in normal mice blood after 120 hr,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14936,1,10090.0,N,,,15045,CHEMBL630535,,Biodistribution in normal mice blood after 24 hr,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14937,1,10090.0,N,,,15045,CHEMBL630536,,Biodistribution in normal mice blood after 4 hr,Blood,A,50594,1,,178.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14938,1,10090.0,N,,,15045,CHEMBL630537,,Biodistribution in normal mice bone after 120 hr,Bone,A,50594,1,,10000001.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14939,1,10090.0,N,,,15045,CHEMBL630538,,Biodistribution in normal mice bone after 24 hr,Bone,A,50594,1,,10000001.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14940,1,10090.0,N,,,15045,CHEMBL630539,,Biodistribution in normal mice bone after 4 hr,Bone,A,50594,1,,10000001.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14941,1,10090.0,N,,,15045,CHEMBL630540,,Biodistribution in normal mice heart after 120 hr,Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14942,1,10090.0,N,,,15045,CHEMBL630541,,Biodistribution in normal mice heart after 24 hr,Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14943,1,10090.0,N,,,15045,CHEMBL630542,,Biodistribution in normal mice heart after 4 hr,Heart,A,50594,1,,948.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14944,1,10090.0,N,,,15045,CHEMBL630543,,Biodistribution in normal mice kidney after 120 hr,Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14945,1,10090.0,N,,,15045,CHEMBL630544,,Biodistribution in normal mice kidney after 24 hr,Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14946,1,10090.0,N,,,15045,CHEMBL630545,,Biodistribution in normal mice kidney after 4 hr,Kidney,A,50594,1,,2113.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14947,1,10090.0,N,,,15045,CHEMBL630546,,Biodistribution in normal mice liver after 120 hr,Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14948,1,10090.0,N,,,15045,CHEMBL630547,,Biodistribution in normal mice liver after 24 hr,Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14949,1,10090.0,N,,,15045,CHEMBL630548,,Biodistribution in normal mice liver after 4 hr,Liver,A,50594,1,,2107.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14950,1,10090.0,N,,,15045,CHEMBL630549,,Biodistribution in normal mice spleen after 120 hr,Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14951,1,10090.0,N,,,15045,CHEMBL630550,,Biodistribution in normal mice spleen after 24 hr,Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14952,1,10090.0,N,,,15045,CHEMBL876426,,Biodistribution in normal mice spleen after 4 hr,Spleen,A,50594,1,,2106.0,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,14953,1,10116.0,N,,,12017,CHEMBL630551,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14954,1,10116.0,N,,,12017,CHEMBL630552,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14955,1,10116.0,N,,,12017,CHEMBL630553,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14956,1,10116.0,N,,,12017,CHEMBL630554,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14957,1,10116.0,N,,,12017,CHEMBL630555,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14958,1,10116.0,N,,,12017,CHEMBL630556,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14959,1,10116.0,N,,,12017,CHEMBL630557,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14960,1,10116.0,N,,,12017,CHEMBL630558,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14961,1,10116.0,N,,,12017,CHEMBL630559,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14962,1,10116.0,N,,,12017,CHEMBL630560,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,A,50597,1,,2106.0,Rattus norvegicus
,In vivo,,,Intermediate,BAO_0000218,14963,1,10116.0,N,,,12017,CHEMBL876427,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Thyroid gland,A,50597,1,,2046.0,Rattus norvegicus
,,,,Intermediate,BAO_0000218,14964,1,10116.0,N,,,14941,CHEMBL630561,,The Kel values in female wistar rats.,,A,50597,1,,,Rattus norvegicus
,,,,Autocuration,BAO_0000019,14965,0,,U,,,4646,CHEMBL630562,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14966,0,,U,,,8847,CHEMBL630563,,Hydrolysis rate constant of the compound,,A,22224,1,,,
,,,,Autocuration,BAO_0000100,14967,0,,U,,,11778,CHEMBL629673,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,P,22229,1,,,
,,,,Autocuration,BAO_0000019,14968,0,,U,,,2363,CHEMBL629674,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14969,0,,U,,,2363,CHEMBL629675,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14970,0,,U,,,2363,CHEMBL629676,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14971,0,,U,,,2363,CHEMBL629677,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14972,0,,U,,,8371,CHEMBL629678,,Apparent inactivation rate constant was evaluated,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14973,0,,U,,,14883,CHEMBL629679,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14974,0,,U,,,14883,CHEMBL629680,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14975,0,,U,,,4643,CHEMBL629681,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14976,0,,U,,,3519,CHEMBL629682,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14977,0,,U,,,10600,CHEMBL629683,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14978,0,,U,,,8501,CHEMBL629684,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,F,22224,1,,,
,,,,Autocuration,BAO_0000100,14979,0,,U,,,8505,CHEMBL629685,,Dissociation constant was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14980,0,,U,,,9778,CHEMBL629686,,Dissociation constant was determined,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14981,0,,U,,,9778,CHEMBL872932,,Dissociation constant at pH 7.4,,P,22224,1,,,
,,,,Autocuration,BAO_0000100,14982,0,,U,,,9778,CHEMBL629687,,Dissociation constant in presence of 1 mM dithiothreitol,,P,22224,1,,,
,,,,Autocuration,BAO_0000019,14983,0,,U,,,13007,CHEMBL872931,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14984,0,,U,,,13007,CHEMBL628151,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14985,0,,U,,,13007,CHEMBL628152,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14986,0,,U,,,13007,CHEMBL628153,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14987,0,,U,,,11482,CHEMBL628154,,Kinetic constant for aromatization of androstenedione,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14988,0,,U,,,11482,CHEMBL628155,,Kinetic constant for aromatization of testosterone,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14989,0,,U,,,2303,CHEMBL628156,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14990,0,,U,,,11964,CHEMBL628157,,Local inhibition constant was determined,,A,22224,1,,,
,,,,Intermediate,BAO_0000218,14991,1,4932.0,N,,,3140,CHEMBL857533,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,A,50347,1,,,Saccharomyces cerevisiae
,,,,Autocuration,BAO_0000100,14992,0,,U,,,10650,CHEMBL628158,,Dissociation constant value of the compound,,P,22224,1,,,
,,,,Autocuration,BAO_0000019,14993,0,,U,,,4667,CHEMBL628159,,In vitro permeability through cornea without epithelium,Cornea,A,22224,1,,964.0,
,,,,Autocuration,BAO_0000019,14994,0,,U,,,4667,CHEMBL875616,,In vitro permeability through intact cornea,Cornea,A,22224,1,,964.0,
,,,,Intermediate,BAO_0000218,14995,1,9986.0,N,,,9199,CHEMBL628160,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Cornea,A,50592,1,,964.0,Oryctolagus cuniculus
,,,,Autocuration,BAO_0000019,14996,0,,U,,,11966,CHEMBL628161,,Rate of enzyme inactivation for the compound was determined,,A,22224,1,,,
,,,,Autocuration,BAO_0000019,14997,0,,U,,,4667,CHEMBL628162,,In vitro permeability through cornea without epithelium,Cornea,A,22224,1,,964.0,
,,,,Autocuration,BAO_0000019,14998,0,,U,,,4667,CHEMBL628163,,In vitro permeability through intact cornea,Cornea,A,22224,1,,964.0,
,,,,Autocuration,BAO_0000019,14999,0,,U,,,8354,CHEMBL628164,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15000,0,,U,,,8354,CHEMBL628165,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15001,0,,U,,,8354,CHEMBL628166,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15002,0,,U,,,8354,CHEMBL628167,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15003,0,,U,,,8354,CHEMBL628168,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15004,0,,U,,,8354,CHEMBL628169,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15005,0,,U,,,8354,CHEMBL628170,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15006,0,,U,,,8354,CHEMBL628171,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15007,0,,U,,,8354,CHEMBL627434,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15008,0,,U,,,8354,CHEMBL627435,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15009,0,,U,,,8354,CHEMBL628110,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15010,0,,U,,,8354,CHEMBL628111,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15011,0,,U,,,8354,CHEMBL628112,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15012,0,,U,,,8354,CHEMBL628260,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,,,,Autocuration,BAO_0000019,15013,0,,U,,,8354,CHEMBL628261,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,A,22224,1,,,
,In vivo,,,Intermediate,BAO_0000218,15014,1,10090.0,N,,,14439,CHEMBL628262,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,15015,1,9606.0,N,,,14439,CHEMBL628263,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,A,50587,1,,,Homo sapiens
,In vivo,,,Intermediate,BAO_0000218,15016,1,10090.0,N,,,14439,CHEMBL628264,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,15017,1,10090.0,N,,,14439,CHEMBL628265,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,15018,1,10090.0,N,,,14439,CHEMBL628266,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,15019,1,10090.0,N,,,14439,CHEMBL628267,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,15020,1,10090.0,N,,,14439,CHEMBL628268,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,15021,1,10090.0,N,,,14439,CHEMBL628269,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,15022,1,10090.0,N,,,14439,CHEMBL628270,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,15023,1,10090.0,N,,,14439,CHEMBL628271,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,A,50594,1,,,Mus musculus
,In vivo,,,Intermediate,BAO_0000218,15024,1,10090.0,N,,,14439,CHEMBL628272,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,A,50594,1,,,Mus musculus
